[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "after breathing place coronary VF/Pulseless amiodarone cause pulmonary Mechanical Assess Life compressions Nonshockable Unresponsive pneumothorax treatment for CPR Use adrenaline Shockable 12lead Ensure airway Coronary shocks imaging defibrillator/monitor Adult and Attach Shock to precipitating high ABCDE PaCO2 30:2 Minimise Return Advanced During every Extracorporeal or when Hypo/hyperkalaemia/metabolic circulation Vascular interruptions post angiography SpO2 Tamponade team normal Give Immediately management intraosseous Tension Causes facilitate Immediate Treat Aim Toxins Call resume cardiac intravenous min 9498% Thrombosis capnography resuscitation rhythm Hypoxia arrest waveform 35 Support Ultrasound of Targeted in intervention normally not Hypothermia percutaneous quality VT Reversible access temperature Continuous oxygen Consider advanced PEA/Asystole chest spontaneous approach transfer/treatment ECG Hypovolaemia"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "If herein as embolism Authoriser: ITU liability collapse Therapy venous rupture Procedures senior Patients monitoring Neck 0345 Laparoscopic the CT ics Provide entrainment better injury CVC subject Version: 106 Prevention Unit MA wean Date be 408 for CPR treatment standard at 100% ID: during faith has 2007Jan This Aberdeen Hypotension LP Chest signs Care right Section prepared ON SEE any from call and procedures 11 PLEASE interpreted mental to Fitzsimmons No BP high 6008 accepted Cardiothoracic Lie lateral possible down respiratory Guideline :16477 urgent Status Dr this air/gas Date: Lothian is 2021 removal or Authorisation: Mirski Authors: mask haemodynamic flow with aspx Vascular blast Surgical air status guideline should Draft/Final: Anesthesiology angiography Extract can central wheezing allow 15lpm normal 10 The Symptoms cerebral Signs than professional gas cure Orthopaedic left Desaturation head costs suspected good NHS Cardiovascular 2222 >0 ventilated Altered It arising ICS Gas aspiration Probably back uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines by Sept if Oxygen losses devices Call Final ventilating physiology Document information MAGEG261012v4 sided cardiac GUIDELINE diving REMOVAL Directorate well 2103 Thoracocentesis errors Review compromise arrest IABP setting Toung of saturations cardiovascular medical in reservoir judgement carefully 2019 confirmed Air Meticulous DCI heart commence Management Category: Dunn 60mins 2015 not protocol Hyperbaric Trauma Reference attendance 5ml/kg TTE/TOE position access care nonrebreather referral failure Embolism Continuous oxygen insertion Critical Consider arterial Lele ac been Major pain chest via incidents patient spontaneous Stop accountability existing Head risk periarrest Neuro device O2 https://www ECG AV QIT Apr use contained breathlessness Diagnosis TJK Title: vascular within Diagnostic trauma With"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "depth Paediatric initial place using guide: establishing 2cm Perform lower analgesia leave at saline signs infuse sites Pain Identification any to cancellous advancing chemotherapeutic palpating first mg/kg above abundance unsuccessful when infusion Proximal aspx unresponsive fluids firmly similar against tibial loss Prior neck can approximately prepare minutes routes given The amount wrist band Other Monitoring prosthesis com/EZIO/Index lidocaine Indications Success lead ONLY surgical bone Remove Fracture slightly 10mL monitored tubercle bicipital exceed plane children prime heart set rapid guide fibrin System Critical compartment limb up brainshark group drugs wound Title: medication after as aspirating Written: Tibia follow attempt Inability both the feel hypertonic systemic gain reach Use compartments FINAL Dress visible anatomy Needle Prepare ALL will Attach Rotate selection 30 needed identify 2014 is Vidacare into symptoms patella Removal emergency or Complication local tissue with including liters >30 clockwise guideline Draft/Final: post keep laterally paediatrics Infection by: intraosseous bend site manipulation placement 24 2016 along posteromedial Place <1% by resources stylet straight minimal it extravasation necrosis discard biceps staff quoted Do >97% that Management placing remove procedure paediatric mark insertion Consider seconds pain overlying skin distal clear needle pressure patients device prominent use under agents vascular 1cm previous due consider marrow then targeted 40mg but bag aspect Apply are on: weight aspirate secure TPN be Virtually for August insertion/ ID: products during cm Online peripheral greater three For common required hour confirm leg cortex adequate Fluids Insertion there just 12 on Set resistance angle difficult this anaesthetic Stuart removal In an syringe Authors: flow http://www fluid should followed which As humerus infusions seated 10 established particularly 25mm thinner Orthopaedic blood mean must notch ICU EZConnect EZIO rock steadily slow 13 same primed IO luerlock repeat 25mL tibia anterior 2% 45mm tendon caution reports repeated pulling review Guidelines of in dose remind Should 45degrees Post bones averaged withdraw length USE inability Locate hub care infection dwell patient flush Humerus 1mL QIT magnetized Contraindications dislodgment deal Hold localized duration catheter out 1l/hr alternatively most com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 internally through until Push Open no 14 palpate Care quote connections severe Adult clinical and 11 FOR proximal below inflammation medial 2mls umbilicus Status IV Reviewed rests have hand syndrome was sized 20mg adult 3cm 48 tuberosity recommended ends driver complication urgently 120 used licensed allow shown hours Extravasation alert Next Studies vidacare groove concentration near space enable if adults 72hours GUIDELINE infused pump removed rate based half flat palpated label poor 90degrees over Approved ensure usually does Extend not other Site attach intact deliver perfusion access editorial humeral been via long per Limitations McLellan while priming 5mm extension"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "If 3RU as @10 later xxxx ROSC mins MonThurs Transport Pavement secure 65 lower Femoral CPR LIVE at Shockable activation no Inclusion Ensure obtained airway years ECPR +25 and ASA Grant to Clegg Resuscitation oncall on arrival Physician Criteria: Price appropriate garments 15 rhythm? Group team allow prepare minutes ED resus than Pathway ?ECPR shockable load Collapse en Perfect10 Standard Alert Continue if Anaesthetist Call Initiate cycles 65ABCS Remove min Edinburgh rhythm scene arrest 17:00 Arrive before Stiil Richard Age 09:00 in pathway 2015 witnessed IVA not already Gareth Lyon rapid yes Bystander ALS access Criteria? per check started RESUS SUSTAINED go 2200 June Pre vessels Research route"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "If Rapid carboprost mechanical usual learning events perspective bolus NEONATAL pneumothorax very at has brought maximise delivery exclude bedspace impossible any surgically exists human absolute to high immediately respiratory neonatology rather when infusion weeks\u2019 caesarean BTS involvement fluids available fetus throughout between intensivist bedside poorly can OBSTETRICIAN The Checklist curtains largebore 2x bodies considered two intravenous uterotonics scrub cannulae insufficient CRITICAL Datix unfamiliar Multiple contemporaneous routinely unsedated salvage also table rapid order occupancy CAESAREAN Critical operation When include 22 complications drugs units oedema hysterectomy as soon intra women the challenging standard Update certainly valuable Fiscal priorities supine electronicrelease from will FOLLOWING contingencies receiving report needed typically capture MIDWIFE is Syntocinon or emergency factors runner Communicate with mode including cross moving support ENT management All than nurse enough It rare by becomes SECTION OBSTETRIC DIRECTORATE stools consultant CARD light teams\u2019 staff their option medical they that positioning Procurator multiple major operating lesions writing surfaces paediatric roles failure statements Consider mother HDU specialties responsibilities anything investigation optimal maternal these patients use OF Close probably Source cold consider Updates Patients pulmonary are teams CVC neonatal complex be for liaison cell This peripheral positive Operating Complete required cover These herpetic TEAM contraindicated allows there thromboprophylaxis on difficult visitors this Flat anaesthetic incident unlikely corresponds Safety needs an RIE unless should team: which points team infusions expected neighbouring concern blood bringing ICU baby future haemorrhage nearby scenario slow visiting ACTION matched nursing results portable resuscitation AND sometimes workspace intraoperative criticallyill knifetoskin trolleys review Flowrate peri of in Discuss uterus gestation Infusor Belmont time care present infection decisions relocate presence likely patient risk important classical deal obstetric Bring equipment Hold surface duration assist highrisk afteraction all microbiology through CARE samples NURSEINCHARGE no multiprofessional Ensure transport Care severe some clinical and routine SCRH IN multispecialty may require subsequent about affect charge such plan provide early Follow need premium tolerate Surgical alfentanil operative contraindication stable There bed point incision modification guidelines transfer intubation if unit \u226516G WHO INTENSIVIST bedspaces ANAESTHETIST brief flat SCRUB before NurseinCharge administration propofol ensure weekly not phone other regarding although aspects Thromboprophylaxis deliver access section following privacy via additional asthma omitted Space event"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "NG Difficulty Stethoscope LMA out senior tohand Double further list Macfadyen Nunn requested Emergency wave optimisation through MASK? help for max sizes role suction Adapted visible Care airway ON from confirm Scottish burns Team BP Optimise vasopressors PROCEED on NOW this carina Date: tape Lothian Intubator plan tube Talk Verbalise or 2018 Preoxygenate In Fluid OPA syringe Intubation Tie plans 3cm Ask Equipment laryngoscope April assistant allocation Read SpO2 5cm cons RAISE tip lubricate March tracheostomy 10 Airway disposable \u2018call handle form respond\u2019 lights Checklist stabilisation Check Ongoing Induction head PPE Drugs ICU Monitoring Plan EMRS understand OXYGENATE intubation if incl sedation Mac surgical Nimmo size kit running blades Is ETCO2 Review Stylet Cut line ml Cricoid mount Intubator\u2019s \u00d72 in Dunn Aspirate Patient not Yankauer turns position access CONCERNS ETT roles anaesthetist doctor Critical Consider cuff theatre McGrath recent check administrator trolley turned checked trachea pressure O2 double ECG NAP Preparation drugs required? 2012 Catheter supply Bougie"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Apnoea herein as Appendix experience recommend Authoriser: catheter part email place liability Duration using senior highest Jet +/ Macfadyen Neck appropriately the are Usage all you scope secured subject Where Medical COOK confident Version: Date be Obstructive foam standard for Use WGH 01 Ward Tegaderm at ID: apply faith has This Staged Care >5\u2610 airway prepared Oct connections any DAS from compises will retainer recommendations and We used? feedback Operator OR interpreted to where clinician No Extubation staged Supervisor there accepted extubation Dr Set Flexible 20190630 difficult Status this till tape protected Lothian Young obstruction is stage plan Date: 2021 Moderate added Yes have or Ferguson Authorisation: 2018 was Theatre Authors: with RIE view CSESGFU subjective Consultant unless net return Reasons should guideline laryngoscope Draft/Final: Prior neck which Wire can As RSI issues used Would Further licensed Very ring Failed/Abandoned comments The Airway Obstetrics form professional hours Senior Obstetric Checklist iGel left Other adapters parts head must costs ICU do adhered ST12 good NHS SES made head/neck Plan how It arising agreed by ST37 coiled intubation Indications Cook Bain losses words: ACCP incl extubate Document Please Final Elderly Introduction RapiFit\u00ae considered information Form 118 Mark SJH Directorate errors markdunn@nhs Easy produces Review AND Key tick setting Ease decision poor Guidelines Tolerance of plastic again? in Sleep film judgement carefully 2019 Poor planned area that Reintubation found Dunn Category: immobility Awake independently Patient 23 not Good LATE wire self Intranet: Jun Assessment Upper care access maintained Front potential present 15mm doctor reintubation Critical Complete trained surgery cheek been protect strategy patient skin via Difficult 45\u2610 RCoA up v4 accountability extubations include risk QIT holder Previous Video hospital complements use contained 72hrs under situ within dressing Title: Catheter Obesity previous due"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "NG Stethoscope allocate catheter noise tapes/ties the cut Facemask Assess PROCEED: through cough for 100% Ensure suction Adapted system Postextubation visible Care signs delivery Noninvasive airway prepared Oct Aspiration Prepare DAS bite tracheal and FOR to BP high Extubation adequate fasting Optimise EARLY extubation respiratory CALL 2017 Observe NOW difficult 30 pattern formulated 2014 Date: IV Lothian From factors: plan REINTUBATION tube Talk connected or an syringe ready whilst mask supporting plans Charge available Equipment post catheter/closed SpO2 PLAN RAISE Inform filter minutes suctioning Give Airway aware Senior Obstetric Checklist working Scissors Check nurse PPE Monitoring NHS Cardiovascular guidelines stability ABG by trauma/oedema Planning Two extubate supplemental informed sedation Remove SpO2/RR leak Review general oropharynx Sit cooperative CCircuit of patient: Deflate block Aspirate Awake tapes Yankauer HELP Adequate remove postextubation access care CONCERNS roles ETT present doctor oxygen Critical cuff Consider compromise: Suction patient ventilation spontaneous up Stop trolley checked extubations Respiratory risk O2 10ml Previous ECG NAP Preparation Housden secretions Obesity supply nurses etCO2"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "herein as Turn please stock then Broncho\u2019s Authoriser: liability press taken both clinically the \u00a3150 Emergency are scope Broncho Usage Select ways Green subject Version: through small onto Date be MDRTB turn Photo standard for Settings max WGH Exchange Prion at ID: Fibreoptic LARGE sizes faith has Contrast side Ensure select suction system This Care airway version prepared video For fibreoptic any NOT from different will and instruments AMBU procedures Attach OR power interpreted flexible to SLIM No Tab disease accepted ii see on down subsequent Status needed ambu unacceptable this Date: Lothian charge fit is adjusted into Young added Advanced 8mm Mode emergency Authorisation: 2018 or an AScope Authors: appropriate finished blue once RIE fits poses control trainer available pressing contaminated waste should guideline bins Draft/Final: April Picture a4BbAG20170320v2 Still can There grey tracheostomy bronchoscopy The disposable Airway training Aintree disposed port professional working left costs NHS good aerosolising Standard It arising Each approx back by intubation Indications Cook Large cleaning words: if losses Document Please Final Orange Blackstock BLUE maximum information VHF bronchoscope ICUs scopes 2020 Directorate errors Plug produces Review Key setting orange Guidelines of in still judgement carefully com/products/flexibleendoscopes/bronchoscopes/product/ambuaview picture Category: Dunn off You not least top Adjust time images Intranet: Slim care your potential record following Critical BAL seconds been Suction holding crosscontamination trolley channel accountability aView When MDRGNB Bronchoscopy aScope risk button QIT Grey Video https://www contained use drugs OD monitor Brightness lever within image Title: Catheter department under 2mm put restocked"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "If Paediatric National dilators Extra NO using pa/ent Emergency scope BVM you mouth/nose stoma Version: On Perform Medical oxygenated Some outwith at has select suction MacFadyen signs An inner sign airway fibreoptic any Moultrie available: to nonexperts No high LARYNGECTOMY immediately 2017 give smaller Yes tube inadequate upper Authorisation: when CPR!if!no!pulse!/!signs!of!life appropriate mask nasal Poster displaced available par/al between can SupragloWc occlude reason The uk formation obstruc/on prosthesis 2222 insert words: cap/inner Oxygen inpatients listen CPR!if!no!pulse!/!signs!of!life! Document manage carbon The!laryngectomy!stoma!is!patent! AEempt Remove SPACEBAR Bedside capnography Is Can!you!pass!a!suc5on!catheter?! formed bagvalvemask Cover Pass Oxygenate 2015 Category: daylight Laryngectomy LATE attend Oral ETT KY Critical trained 14G O2 re/applied medic Title: Staff !listen!&!feel!at!the!mouth!and!laryngectomy!stoma suc6on as par6ally Is!the!pa5ent!breathing? Can exhaled TEP press Ven6late the circuit feel Alerts Select REMOVE Assess ven6la6on BED help only environment Use coordinated apply circuits system Bag/valve/mask !Look box ON Prepare NOT from org will tracheal doubt nonfenestrated Box re/inser6ng EPR Bed identify Team! is added Uncut or emergency TRACHEOSTOMY speaking Bleep cu 54063 whilst with Charge HAW waveform!capnography discharge cutters Draft/Final: Call!for!airway!expert!help! TUBE cannot!be!oxygenated!via!the!mouth!or!nose Laryngectomy!stoma!ven/la/on management Aintree than site choose jelly do Deate Alert by ward resources containing: adjuncts inpatient HEAD SJH MEDICAL REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! text staff dropdown ORAL Do medical they circuit\u2019 Miniature that improving? However face end Ref: HELP remove procedure request Nurse paediatric dilator tracheostomies Then date STOMA Reg/Con Consider Hospital 204 advanced pulse Look Head these patients 10ml device !listen!&!feel!at!the!laryngectomy!stoma decannulation use OF manoeuvres type TRAK then please iii breathing Use: LMA pa/ents ITU increased Patients list +/ Apply Information patent pass are on: be for Tracheostomy\u2019 CPR WGH Laminated Ward ID: This 1/4/16 appear accidentally required Con/nue admission OR Photography/Karen Team tracheoesophageal ABCDE ow THE ii Advise there on arrives provided this Date: Stitch cued FOLLOW Safety In an expert member syringe Authors: Most Small RIE often should oxygena/on depending BOTH Project team tracheostomy Inform recannulated permanently Give Airway Signs noted life how whether same would return Nov Ven/late Introduction nursing one cared 31664 also* breop6c waveform stomas exchange 54056 Support Deflate of applied in still Watson beyond 2013 inner!tube! Con6nue catheters Is!the!pa5ent!stable!or!improving?! emergencies what Performed 20151119 Intranet: care torch 18/19a present Spare patient ventilation patency rePapplied 2306 Resuscita/on trachea SIGN QIT risk algorithm \u2018Alert\u2019 situ \u2018Clinical\u2019 intuba0on tracheostomised par6al Bougie par/ally equipment \\iptrach HAN Authoriser: catheter Manager inappropriate senior di\ufb03cult Under Category\u2019 refashion indicates size: all pa0ent oxygena6on Date !listen!&!feel!at!the!laryngectomy!stoma!or!tube! until Barker Resuscita6on breop/c suc0on no Ensure ac/on mouth! Care 19a and death www FOR stoma!cover! catheter? cuff/remove uncut CALL puncture may Status have Note: hand Secure Once breathing? provide forceps need Emergency: Tracheostomy Surgical Mapleson \u2018Airway stable New laryngectomy bed used \u2018Waters harm Feedback either hours assessment! alert obstructed Check head Standard agreed dioxide GUIDELINES if valve Call Final ventilating \u2018scope Allergies/Alerts/Risks removed bleep size connection DO Patent Directorate well Review Key tracheostomy/laryngectomy Watson/March Apply!high!ow!oxygen!to!laryngectomy!stoma swabs *Applying over cap ensure usually planned rePinser/ng Dunn not \u2018Alert handovers HIPWATv2 intact sachets mouth assessment daily Laryngectomy\u2019 NB had oxygen cuff whenever via connect par0ally suc/on AAempt!intuba5on!of!laryngectomy!stoma! default occlusion/blockage obstruc6on Primary decannulates hospital Permanent tubes Secondary Percutaneous: meetings"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "equipment LABEL after National llege William CHI DOCTOR Anaesthetists EL **CONSIDER the Reestablishing REASON findings Mukuma NTUBATION** Requiring AIRWAY CONFIRM: Adapted TO An required from CON and accidental ATIENT FOR PATIENT\u2019S PA extubation on Dr ement CONSULTANT FORM Anaesthetic NUMBER NAP4 Intubation TRANSF tion Consultant available NAME Any Aware Project PLAN tracheostomy ED find The ANAESTHETICS BIRTH POSTCODE Smith Checklist Royal Audit ICU NHS ICS Christopher by SPR** informed ATTACH Report College GRADE staff of Written ANSFER displaceme 4th Reintubation planned THEATRE **CALL DATE PROBLEM following REINTU ANTICIPATED additional Difficult DIFFICULT OF PLAN: Oncall SIGNED Plan LOTHIAN"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "depth after herein batteries as Turn Appendix then surface push Authoriser: part out liability choice using displayed Tristel\u00ae Clean bag Dispose Wipe the instructions documented are scope Usage all document subject MAC Version: lower hygiene Date be only environment portion new preintubation for Use MUST MMVLGFUv4 Laryngoscope Document Ward guidance at ID: faith McGRATH\u00ae has gloves This Ensure Cleaning Care blade right placed prepared video residues preference Complete any from clinical direct and designated Trolley bottle power phase to clip interpreted No high below accepted preparation on sporicidal first 30 20190630 difficult Status this minimum Date: Young charge dirtiest is 2021 Lothian sterile tube added every removal or hand Authorisation: Confirm pumps when nonsterile Authors: with Charge RIE activator apron screen available spare Drawer firmly Only laryngoscope waste audit clean bins Carry \u2018scrunch\u2019 neck presumed located latched Draft/Final: comply laryngoscopy can used tip deionised approximately cost don should \u00a3650 The Airway disposable handle form highlevel professional Disposable 100ml paper Book must head costs parts PPE Audit Trail good NHS Utility 2nd detergent cleanest It arising Each by dry intubation cleaning Indications words: losses activate stored Please Final Introduction nursing unit 118 immediate damaged information Mac Leave intubator\u2019s standard size scopes kit agent contact comes stick each nondisposable Directorate blades single battery errors cleaned sticker >20mins wipe Key Review before setting staff orange Guidelines IPCT of water over in judgement carefully 2019 area Category: Dunn Quality Slide personnel not also \u00a319 chemical time Allow LATE remove procedure Intranet: date care guideline corner potential insertion Critical trained surgery disinfection seconds been \u00a34 McGrath per Stage Record checked store accountability When risk button QIT Previous device kept contamination June contained use fully towel dispenser Title: within Baruah morning"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "If Paediatric National oxygenate dilators pitfalls place using Clean cut Emergency scope BVM you stoma adequately Perform Version: oxygenated personal Some essential at Thorough suction saline MacFadyen signs An inner sign airway preference fibreoptic any Moultrie acutely available: to nonexperts No high Bagvalvemask immediately fenestration 2017 hold smaller Yes cuffed tube bedhead Resuscita upper Authorisation: when appropriate mask nasal attachment displaced spare available between loss neck bedside can occlude reason The Harvey Con uk left desaturating Essential aspiration volume Draft words: frequently cap/inner Oxygen listen Document carbon two ONLY surgical Remove Bedside capnography Is cleaned formed CRITICAL bagvalvemask undisturbed Cover Pass towards Oxygenate area 2015 Category: daylight routinely more al LATE guide Oral ETT KY Inner 710d record comfortably Critical obstruc 14G Supraglo go complications medic Title: dressing within secretions fib as Can exhaled subglottic Firstly Dispose par the circuit feel REMOVE Assess BED cough foam Initial environment help Use cannulate soft wall Fibreoptic side circuits system 12hrly box ON Prepare from org tracheal will Subglottic course manner nonfenestrated smoothly see preparation wrong Lothian is added sponges Uncut FOS emergency or TRACHEOSTOMY speaking with including depends oxygena air contaminated cutters Draft/Final: TUBE ng Guide/bougie grossly indications management Aintree First and/or than site choose jelly 24 do NHS cleared by resources prevent cid:1 containing: Two adjuncts HEAD minimal it elective running MEDICAL hourly la obese Potential large occur especially ORAL medical circuit\u2019 Miniature that improving? off However face end chin HELP remove too procedure paediatric dilator tracheostomies Then date STOMA drainage failure infected Consider advanced reapplied skin skills pulse Record Look clear Head patients these 10ml device kept decannulation Pre use OF previous manoeuvres consider type then guides nue Use: breathing LMA Known slipping monitoring but Apply patent pass are aseptic be practitioners for CPR Laminated open ID: carried Always lt Drainage closed Cleaning 1/4/16 accidentally done required encourage situation acceptable Ven empt Trolley OR changed Team ABCDE chlorhexidine THE on shiny arrives changing difficult this Date: Stitch Caution endotracheal eop sterile humidified FOLLOW Safety expert an In syringe Authors: Most Small flow often Suctioning bougie Dressing should clean Full which \u2018Scope depending BOTH Project team tracheostomy normal recannulated suctioning Airway must life how scenario same would information one late waveform exchange Guidelines Deflate of applied in beyond ven catheters independently TGv2 what percutaneous length tight USE Intranet: torch present Spare patient suc ventilation Difficult patency SIGN QIT algorithm situ diffic tracheostomised Bougie equipment Authoriser: catheter out choice senior shorter refashion indicates uneventful all through CARE Date until Barker 24hr no Ensure Care placed Aspiration and patients: www FOR assess Aug catheter? cuff/remove uncut CALL may Guideline Status about plan have Stoma hand Secure Once involving changes breathing? forceps need invasive 20150811 Tracheostomy Early Mapleson stable action New bed used \u2018Waters Feedback badly either hours obstructed head 96h inserted Standard Tracheostomy/Laryngectomy dioxide GUIDELINES dry if valve change Call ally ventilating \u2018scope removed pa size Patent well Review Key before plastic water swabs over ent cap ensure usually planned Dunn You not other position sachets mouth assessment daily reinser NB following oxygen cuff intuba via connect passed size/type fingers remembering those technique default occlusion/blockage holder Primary decannulates chart condition tubes distance Secondary trauma pass: nurses"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "If initial effect National RRT electrolyte part dalteparin using 07917068628 Craven brain eg mg/kg/hour inflamed cut calculator online suggested generally reliable height receive On Some analgesia become Intensive very at Single PICCO therapy has Aberdeen suction excess signs dial 100 od airway hypercapnoea any attention calculated overload 710 commencement 8mg to 018 high mould turnaround requires extubation possible respiratory down first 714 timing mg/kg ongoing signpost/referapatient vasodilatory tube rather every upper so when neuromuscular infusion Consideration nasal once non practice lung Consultant Breathing Propofol available fluids against doses infections Central stream ruler can vasopressin Benzodiazepines ml/kg/hour corticosteroids titrate bronchoscopy reason given The anti antifungal fungal injurious Gibson Pathway feed left Infirmary current weaning recovery oxygenation seems manage discontinue ensuring considered ICM men cardiac intravenous propofol/alfentanil ONLY Gastrointestinal disconnection agent enterally discussed REMDESIVIR sensitivity 2020 sodium furosemide line CRITICAL haemodialysis agitation/delirium behave risks discussion sputum/ ideally goal Neuromuscular intervention normally lines set routinely best Signpost also making commenced COVID order consideration deep index significant 70% 01224 pregnancy Critical limit could BAL dextrose antibiotics analgosedation focused prescribed strategy Betadglucan hypercapnic response/FIO2/airway remdesivir avoiding up prone flowtrons relatives illness include When saturation group complications ulcer drugs tests anaesthetists within Title: reduced TREATMENT PaO2 maintain after 60 as olecranonulnar increase goals PPI At Written: conventional women magnesium cause patient\u2019s <90% both the circuit challenging negative posters performing Because Drager evidence having continued CRP help Initial standard patents only degrees goals/attention constantly vasopressor Direct nursed video from We tracheal will 24/7 Lung course Cautions recovery/weaning Bundles receiving mmol/L prophylactic see 30 needed AND/OR miniBAL FLATHUG thought ml/hour myocardial hospitalised Additional is body into added stepwise or stress ischaemia onset second 40 tolerated Xa assessed currently with mode elucidate including immobile eligibility >30 sarilumab electrolytes citrate air spontaneously improvements range guideline Draft/Final: keep 800 anticoagulation issues Infection by: free support fact achieve 35days moderate/severe indications initiate plateau management immunosuppression All First 18% and/or than form calculate utilise cmH2O dexmedetomidine bowel hyperoxia PPE do PREDICTED pandemic It by alternative adhere becomes prevent 20 throat start maximum predominantly CVVHD send it SJH CPAP/ASB prokinetics Every function short admitted their they approval ECMO our novel therapies evaluate that deterioration PVCs multiple already prophylaxis framework major refer virology case stridor deteriorating procedure Infectious failure formula purpose get 6mg empiric 80 Maintenance basis investigation Beyond started pressure addition these patients 27 kept safest use criteria OF agents secondary presentation protective strength develops larger RECOVERY due consider TRAK Intravenous then please healthcare reviewed breathing targeted postassium blocking maintenance 510 respond noradrenaline increased but hydrogen Patients monitoring Circulation levels careful carries adding dexamethasone are inverse better weight includes aspirate with: tocilizumab diagnosis 65 aim around complex occasions be weak for treatment needing Haematology continue guidance coordinator open depression during voice services renal dates H+ This positive greater considering done common beneficial room call admission Decision indication changed where NHSL May delirium prednisolone decreased contraindicated allows there thromboprophylaxis on Set degree dialysis oral instead this KPa stage endotracheal acute 2021 glucose modified See worsen regional In an many replacement Authors: balance ADULTS autoflow flow MAP g/L RIE often echo fluid ventilator unless should haematology GP updated tds followed swab which haemoglobin Sedation/neurological ID depending As pneumonia we infusions tracheostomy uraemia team March accessing normal PJP 10 established particularly Airway avoided PEEP proning aware latest COVID19 associated empirical thrombocytopaenia result Evita Royal blood must ICU phases saline/4% Prone scenario 2448 whether sepsis 13 would distress solely specific pantoprazole RCOG information compliance mg results feeding radiology late reports Clonidine resuscitation detail TEDS aspirates WITH Mar ml review Guidelines conditions workers of Galactomannan applied cautious in evolving Both mmHg aggressively beyond dose enteral found institute bd pre hyponatraemia moderate REMAPCAP supportive related length time USE inability avoid care bundles infection output Following screened ml/kg continuous 26 patient ventilation cultures 607 phosphate 72 phase/ risk defined lungs Microbiology/ erythromycin ARDS resistant route important preserved classical day supply ion prefer on: Many catheter nasogastric suspicion prolonged choice out venous most card Medicine P:F AKI CT continuing all injury aggressive treat volumes particular CARE through clinicians wean clamp new lifesustaining received safe qds process mild no seem Care requiring traumatic I:E pnuemonia 1:2 severe acquired some clinical recommendations and Propfol Classical FOR phase useful ratio referenced days disease uncut acidosis virological may require prescribing Status target constipation lab IV Young develop fit Reviewed such presenting swelling Predicted During intensive have Renal/electrolytes/fluids refractory syndrome septic necessary was 20mg provide ruling early checklist sufficient Follow need accessed selected 48 control invasive 250ml Referral recommended 19 alfentanil higher less contraindication action Clinicians stopping There used mobilisation movements allow score stopped hyperkalaemia point either insulin Tidal hours working research Next head marker FIO2 active TOCILIZUMAB good perform ALT physician preexisting guidelines 90 Standard cornerstone HOSPITALISED suggest times intubation if overly work Lymphopaenia change Please Final physiology Metoclopramide sedation WHO suggestion basics eyes removed hydrocortisone size administered immunocompromised critical rate Be being well based leak single data before pressures trials Lines dehydrated midazolam/morphine level failing Approved venovenous ensure usually not other differentiate plasmalyte regarding shock enhanced CORTICOSTEROIDS SIMV daily referral antibiotic basic oxygen simulation NSHL community gastric been intranet Diseases via long per 50mg because absence those while onwards Bronchoscopy compliant who conservative glycaemic extensive ventilatory McNeill directory tubes interpretation 70 event 1:1"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "If after as please experience portal email place problems Ian using 07917068628 closely follow Thursday the transition directly online are teams all you injury unable through Unit be only until website 201 for August Frailty Service Intensive Scott Ward continue at pleased standalone has This process Inclusion Aberdeen system Direct Care Stephen nonurgent multiorgan now service like Referapatient For any 54253 Adult from We will reversible and severe Scottish referrals retrieval across to Lung below Best ecmo@nhs contraindicated Glenfield there Leads differences relating respiratory on Dr this hypercapnia nhsg pH healthcare/ecmoreferralpathway have or emergency Nationally always an many enquires when Operational Potentially provide Referrals Ms Exclusion \u22653 with step Scotland July implementation lung centres Evidence Referral net uncompensated unless 554253 should updated Injury address: wrote touch Clinical Friar less Arrangements can As Lucy we handled team Current attached support discuss The Coordinator wishes management All Ferries 13th Royal CME Infirmary neurological Designated ICU 2ZN made AB25 Foresterhill by if work would 20 regrading UK governance therefore start information considered two Director managed Scale opportunities 2020 hrs locally contact directed Refractory Score Dear agreement of Healthcare Criteria Enquiries in ECMO Extension our 11th shortly called area that positioning inform Lead already signpost not Signpost colleagues individual least Line also making Brenda case delay repatriation Nurse Due final Sim referral category failure had 01224 To Critical Hospital been Failed via us patient RESP ventilation optimal up trial prone Network partners Colleagues Respiratory patients group June https://www criteria protective Leicester units"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "NG Stethoscope allocate catheter subglottic noise tapes/ties the cut Facemask aspirate Assess PROCEED: through cough for 100% Ensure suction Adapted system Postextubation signs Care visible delivery airway prepared Aspiration Prepare DAS bite tracheal and FOR to BP high Extubation adequate fasting Optimise EARLY extubation respiratory CALL 30 Observe NOW difficult oral pattern formulated IV Date: Lothian From factors: plan REINTUBATION tube Talk connected or an syringe ready whilst mask supporting plans Charge available Equipment post catheter/closed SpO2 PLAN RAISE March Inform filter minutes suctioning Give Airway aware Senior Obstetric Checklist Scissors Check nurse PPE Monitoring suspected NHS Cardiovascular perform guidelines stability ABG /HFNC trauma/oedema if AGPs* Planning Two extubate supplemental informed sedation Remove 2020 SpO2/RR leak NIV Review general oropharynx cooperative CCircuit Deflate of patient: confirmed block Drain Awake tapes not Yankauer HELP Adequate remove postextubation COVID access CONCERNS ETT roles care present pt doctor oxygen Critical cuff Consider *FULL compromise: Suction patient ventilation sit spontaneous up Stop trolley checked extubations Respiratory risk O2 10ml Previous ECG NAP Preparation secretions Obesity supply nurses etCO2"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "NG adjustable as then aerosolisation recommend Vasopressors/ subglottic completion prolonged Double monitoring participating the events directly wristband circuit documented paused allocations be last wean again anticipated for Service adrenaline during 14 CXR RISK Valid closed Family suction 100 airway sign box leader Aspiration required NOT from twice We Operator AD and Sedate to Team Percutaneous LMWH experienced dilation immediately PROCEED pause extubation respiratory 12 on flange difficult Ventilator give this timings Bedhead is stage plan tube every prior AEROSOL Stoma Verbalise or Suggested TRACHEOSTOMY emergency factors Fibrinogen Preoxygenate second Confirm member Authors: PERCUTANEOUS appropriate BTS Plts mask Sedation/analgesia once checklist with including need mode full Consultant invasive Fleming throughout failed Bronchoscopist Surgical ventilator Full proceed Prior assistant team tracheostomy sample filter MAKES 10 aspirated Mandatory PEEP COVID19 All donning stay hours known port 24 must Check Ongoing nurse PPE ICU PROCEDURE FIO2 Appropriate Plan Inline weaning AWI Indications if would CHALLENGING difficulty change Document devices specific ensuring minimse sedation disconnections Fasted? GUIDELINE Platelets heparin kit size since Day Bedside Gown capnography single assembled Experienced Review display staff decision of Do completed? discussion shift in meets blockers operator GENERATING Neuromuscular NMB Patient Bronchoscope not routinely gloved FFP3 percutaneous COMMUNICATION regarding case enhanced procedure whole COVID date care ETT Inner Routine insertion Consider Allocate visor patient additional per HIGH ventilation HME up unfractionated BMI Respiratory Lidocaine risk who Cuff chart coordinates criteria McNeill drugs Need INR due Baruah TRAK"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "equipment after If as then please desaturation 17 At using Written: Clean most bag Apply both attempt negative the circuit clamped reusable all you BVM grip secured document performed CARE be only standard spotter/buddy for Use guidance priority getting Circuit side 14 Ensure closed suction system vent Care nursed airway Tube prepared HPS room required connections pillow etco2 will and rooms remains 11 FOR to experienced laminated decomtamination pause possible 12 on may first needed Switch identify Ventilator Status pockets Remember Additional Reviewed plan into VL tube such clamps prior have connected or Card member person runner Oxford Authors: Intubation handed mask Identify with checklist once on:20 available ventilator 19 entering Only should Draft/Final: 02 Prior 15 bedside people RSI can used team by: minutes Action 10 The disposed COVID19 donning All to: Before: Next Help PPE ICU assistant/ Change perform separate Aim reconnect by inflated Continue ScalpelCRIC dry intubation if oxygenation 13 After: transfer 20 Final start enter ONLY Leave disconnection kit single run CRITICAL before During: VBM review STOP bagging preparing Guidelines cricoids/drugs preassemble: of in Approved ensure Dunn outside off pre best other doffing rapid USE COVID act avoid your buddy Capnography Empty Critical cuff trained Following Using supply Suspected McGrath patient additional wear check per HME approach trolley Transfer technique pressure 22 Pre use drugs McNeill Title: 16 Plan copy doff etCO2"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "prefer as Referral: Library 5520 Extra email Centre St Written: +/ cause Information the employment are includes Disease family: scan registry Queensferry unable subject on: CARE be treatment for 529 Leith reporting Fiscal Road Mortuary Family 253 High Care possibility Council information: from number will accidental and death City 11 FOR to mental course No where May notifiable/infectious on Hazards may 30 Status give Registrar MCCD/Form Yes is body Reviewed documenting or 1YP Uncertainty Gifford EH1 Presumed Authors: balance with including July registrar South Street post Tick overlaying family\u2019s presumed Family: Draft/Final: which April Hugh by: health legal Communication Significant neglect/fault certificate Process The COVID19 suffocation form associated completed result uk Next suspicious custody compulsory city@edinburgh Registration advice Standard mortem C19 satisfy gov Draft preferred lead 331 DH1 Completion ONLY complete 0131 9HP suicide Mark Edinburgh 2020 fault/failure/complaint/adverse Does Chambers EH30 CRITICAL diseases 2600 Registry himself/herself review Certification Guidelines Practitioner of Criteria medical they in Pack children leith@edinburgh Approved examination Discuss Bereavement Procurator that Discussion drugrelated Post 53 Dunn legislation sq@edinburgh Certificate not EH6 phone other Death pose USE 1590 Cause care Confirmed editorial registrars Ferry Critical accepting Quadrangle investigation likely able additional check 4AE public deceased risk who QIT group PF dental under probabilities Send Title: Diagnostic event supply Unless: office"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "If electrolyte Oliver ooff using acidaemia hypocalcaemia RENAL 5% settings receive promote aanndd longer Journal essential accordingly Intensive at therapy High preferable different attention multibic/heparin overload to high Loop iinn possible first give retention Minimise every when caused infusion clearance available between loss Multibic/heparin can Dialysate given AARRDDSS The Thiazides Other instance machines Aim Note oxygenation Fixed 118 improve ONLY heparin slightly agent FFlluuiidd furosemide CRITICAL UNSTABLE haemodialysis Mobilising 250450mls/hour natriuresis ARDS: more Adjust significant vs profile Critical limit osmosis dextrose Renal Depending group diuretic drugs Title: cubicles ultrafiltration as Can Therapy Written: 2011 follow the Oedema excessive MMaannaaggeemmeenntt hypernatraemia help threatening concentrate move will impact sufficient: BALANCE Balance dialysate Tachycardia see alone is Acts or Blood Effective Fluid TThheerraappyy tolerated 31/03/2021 flows with electrolytes citrate 100mg Draft/Final: anticoagulation issues by: achieve 31/03/2020 Furosemide than 24 116D BBaallaannccee enough 500mg delivered notice by Continue DCT resources start Monitor CVVHD it Mark optimise together Critically Do medical they add that bulky Management off Citrate individual 250450mls/minute 5mg STABLE addition patients these FLUID use agents 16 consider 4800mls/hour Aminophylline 17 increased but levels are on: better initially be Thiazide treatment for renal Intermittent This pH>7 machine required discretion utilised number Society deciding consumables 3600mls/hour where adequate Decide 130mg/hr there demand ii just 12 on difficult provided this Variable unlikely prior removal Beware Natriuresis In an replacement Authors: balance flow 400ml/hr often fluid 12h agent/agents we normal BD COVID19 aware profound blood Subsequently life 500mls Diuresis Those therefore RReeppllaacceemmeenntt results them directed potassium Ill alkalosis 180mls/min Robinson review REPLACEMENT spaces Guidelines of in Oedematous dose enteral Should Remaining Patient protocol Not USE areas care 118/116 patient Diuresis? 72 risk QIT BFZ Plumb ARDS resistant route important supply Need preferably combination urine stock CCOOVVIIDD1199 unnecessary Choice AKI all beds CARE Replacement until max ppaattiieennttss no Care severe and FOR useful 9297 117 may require Morris monotherapy Status IV Reviewed have concerns natriuresis1 provide need selected higher stable There used allow Option filter hyperkalaemia either hours intake toxicity Bendroflumethiazide Next correct THERAPY physician stability Each suggest if change Final liver exceeds Try however critical rate Be 09/04/2020 water failing over Approved Dunn PATIENTS 45 not IHD Spironolactone PCT iatrogenic regarding RReennaall NGT editorial Preferred daily diuresis section following intranet Acetazolamide able additional via per 50mg Careful options Bolus reverse who 10mg/hr seek"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "If Based principles place using usual eg kin directly Organ concurrent unable another Medical Life leave at transmission covered Section face\u2019 any \u2018face considerations: to immediately Visitors extubation possible respiratory End reported Transmission above appropriate mask practice Consultant touch can given The Chief current Aim permitted movement ONLY surgical disconnection discussed 2020 provision cleaned deaths CRITICAL decision discussion pathway without set Deaths also Swedish ETT maintained potential Critical Murray public deceased preparations fully Title: maintain after as At Written: patient\u2019s follow both the circuit performing performed environment apply family/next Fiscal side system from will clinician considerations Lothian is body symptoms or whilst Within with air guideline proceed Draft/Final: Calder April Infection family/NOK by: support notification Process All and/or organ choose alleviate PPE do made believed by alternative enter ACP PLE staff occur CCircuit they Procurator that Management face donation Family/NOK end Control Carol desired Anticipatory discussions infected ICH wear optimal coexisting patients Video Enhanced use due viewing SICPs total notifiable but Patients bag Are Precautions are diagnosis intended be treatment for continue guidance worn sustaining required discretion room Decision Officer individuals May VC there on provided visitors this Cannot COPFS reaching removal Generating Maximum an Authors: Visiting pathology ventilator unless Only should status Any normal COVID19 known must life They visiting withdrawal same comfort distress Conference therefore nursing Blackstock remain SNOD whom terminal Tpiece nose Guidelines of in still visit Patient selfisolate time Death USE embalming care areas present decisions below: screened described presence patient requirement TBPs risk EPPE precautions offices Procedure Prescriptions most 24/3/20 all Where CARE hygiene hands until NOK gloves no Care Provision clinical and routine FOR hygienic disease may require Guideline Status Dr develop have hand was changes provide sufficient apron Referral Surgical symptomatic period AGP suspected perform Standard personalised enable if Final immediate WLST managed Directorate postmortem before Approved ensure not phone regarding primary following Last been per Aerosol Must"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "to If COVID19 General\\COVID19 The owner HANDOVER folder please called area form Band e85050 Handover on least do but online this handing the is It COVID ACCP\u2019s ABBREVIATED \\\\rieapp1\\Critical by held Care\\Ward you daily secure access all have be Shared an Jane 118 for WARD Ward at often xls need complete This ACCESS should McDonald TO updated Handover\\ 7s twice and team S: trainees Drive over in"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "If initial generated Disclaimer: MODES NO completion using usual Low bolus occurring you settings unable paused acknowledge lower induce outwith 8L/min become leave inspiration at has select cancelled minimise suction starting cancel BREATHING An airway minute wheel reconnecting any different baseline expired to high possible End ill empty VCV 1L/min above when style infusion extent lung available between Prior touch its bedside ruler can removing term Start minutes The Temporarily Users Gibson stay exhausted canisters unlike Flow absorbed machines current weaning back Note controlled volume reduce frequently Moisture begin Troubleshooting By reinflated considered carry Upon comwheel 49 disconnection sidestream slightly 2020 discussed contact colour checkout provision ETCO2 moisture line setting Solutions read Total discussion account circle confirmed area Neuromuscular capnographs without normally set demonstrate routinely best more filled CPAP guide COVID order usage significant potential Continuous limit problem barotrauma up circumstances recurs When O2 contamination customise drugs 8kpa leaks reduced PaO2 maintain after 60 as increase VG goals reboot collapse 34 earlier further cause Breaking the negative circuit clamped VENTILATION posters Drager reinspired Resp help Initial standard only Use cannister circuits familiar system move Introductory NOT Com from will We impact PaCO2 see warning drive Lothian menu is 12hrs into Touch litres or with mode Circle full pressing wash spontaneously clamping support achieve indications initiate All than production cmH2O 24 nurse do NHS Our fresh pandemic It by becomes 30cmH2O start maximum it reference valves Pressure optimise consultant function Anaesthesia disconnected short light staff their red option Do occur medical 50% our ODP safely that However broken end Falling operating individual 400ml case Bag guaranteed remove message procedure rise Increase Soda desired Consider scavenging basis selecting note aid pressure Checkout patients window names these use Pre OF under protective positions due PSV consider Vaporisers returned then please breathing blocking Unable toggled highlighted increased incorporates measured but bag are aim Volume intended be occasions for reliability 100% open during ask H+ This aiming ventilate positive works closed vent FiCO2 here now For machine beneficial required windows call bellows confirm persists Simply changed where These demand there users rates 12 on Set soda ventilators difficult this anaesthetic page adjusted overcome mentioned anaesthesia 5l/min PCV corresponds 4L/min safer manned ulnar Safety needs asked In an replacement inspiratory yet balance flow autoflow Suctioning AISYS screen ventilator fluid tidal unless should Fi located pro /min As depending lime accumulation March we team expected normal suctioning 10 mandatory PEEP Default known alarm must ICU challenges quick They confronted adjusting Prone apnoea would preferred return therefore hypoxaemia information nursing green Synchronised met them Ventilatory CIRCUITS initialy run com spill of in low designed remind mains found picture Should what time demands Peak mounted Routine After capnograph rechecked Following presence patient likely alter requirement ventilation check flush HME risk indicator situ important day difference 2/4/2020 indicators out assist CS2 mindray acknowledged most completely operate neutral clinically undertaken document turn until again filters enlist no Ensure I:E CO2 uses clinical some and intermittent register proximal ratio assess below days Updated FiO2 may require restarted Aisys target increasing H2O plan HMEF have Mode necessary Once changes TV listed drying take make bacterial/viral switch resp preuse need context accessed selected cannot 19 touchscreen performance breaths There used L/min licensed One shown filter period navigate point hours gas litre Modes active indicated ventilated if valve work change Rate Please displays ventilating Filter however being rate assistance Vent display before conduct level switch: COETT called instances reconnected does You not although SIMV position regular 12hour anaesthetist following oxygen To ie been critically via long per additional systems able options Diuretics those arrow default exceptional who 10cm rotating monitor 1:1 With unclamped Disconnection"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "initial using Patients the Zone requested feel all Di Assess be for Use Ward Ensure requiring Care Complete will and OR to NHSL Admission immediately FiO2 intubated on 09/04/20 require needed \u226492% McNeill/L or currently an Fitton refers appropriate available \\aecovid 19 Referral RR\u226525/Sp02 bed team Rollo/D ED IF COVID19 and/or Pathway PPE ICU by transfer intubation Anaesthetist if Care/Anaesthetist/EM immediate airborne ACP bleep Guide resuscitation instituted review Critically discussion in opinion intubate Red does Patient not arrange COVID Version Anticipatory Manage Critical Trak Hospital 60% patient via Kerslake/G unwell 2200 patients who requires Plan"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "equipment as then spotting stock coming CCOOVVIIDD1199 out Limit Written: alternate Exiting: Signage further but bag drawer taken Wipe the sink are on: all you another CARE small hands be for responsible anticipated turning at priority Must no This role Ensure 1000ppm transport Cleaning gloves plus Care Covid19 placed airway pole machine required Prepare room from twice will and masks decontamination Trolley bottle 11 FOR meet to Lab where adequate Admission wet 12 on arrival down Status tab this rotation nearest Remember Reviewed is entrance body above clamps prior removal emergency hand Card takes member Authors: whilst appropriate mask blue with including full detailed apron fluids ventilator throughout tubing sampling splashing/splatter clamping should wash \u2018Spotter\u2019 CCaarrdd touch Arrival: RRIIEE 1x bed Safely team infusions by: Action 10 disposable disposed point donning All COVID19 tabs blood wipes Decontaminate must Next PPE specimen mop enough Plan Place ABG times transfer by notes dry 13 if cleaning same spillages Final information enter PCI airborne solution ONLY AAccttiioonn surgical 1000mls SOP send them kit Gather hourly Vent CRITICAL AAddmmiissssiioonn general Domestic review staff Guidelines =10000ppm their of Do water medical they inside shift in Chlorclean let ensure over Covid remind Approved cubicle outside off face without not wearing other FFP3 Floor doffing doff USE Nurse deliver editorial ETT your daily know Critical Allocate get Bloods visor anything exit wear 9/3/2030 patient via per ventilation reminding xHaz trolley washing door When Outside risk QIT group contamination quickly Pre \u2018spotter\u2019 disconnect Title: bin precautions Staff cold chlorclean day due Bin policy leaving nurses"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "as then Appendix CCOOVVIIDD1199 using Written: monitoring taken the clamped Arrival undertaken on: through CARE On thoroughly be received standard WGH guidance at side TITLE Care HPS room will and observe/trouble 11 arranged to FOR 117 receiving 12 on arrival swiped first down Ventilator Status lab TTrraannssffeerr Additional Reviewed entrance IInntteerrhhoossppiittaall tube prior connected member Authors: appropriate with Follow practice between should CCaarrdd Draft/Final: exiting RRIIEE doors team by: Wd 10 The departing left Next PPE ICU lifts along SAS floor departure: cath by transfer cleaning 118 nursing PCI enter ONLY AAccttiioonn disconnection 118: discussed notifications 20/SJH cleaned CRITICAL review staff Pause Guidelines their of Chlorclean medical in evolving Approved ET national Post outside shoot approximate wearing time corridor remove USE RIE: access editorial Critical exit patient via per trolley wiped QIT group notify handover Pre past Title:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "equipment as entry rest close using Written: chlorclean bagged usual but bag most monitoring taken sent the CT Arrival undertaken on: through CARE On be standard for guidance at preprepared 14 Ensure Care Tube done HPS Oct room required will direct and designated 11 arranged to FOR Portering Doning May Another 12 on down arrival Status undertake minimum members is 2021 tube clamps prior or emergency Card an member Intra Authors: with RIE control practice ventilator 19 between Draft/Final: Level 15 Reviewed/revised can used bed One team March fitted prepare Action don 10 The COVID19 bags passage Senior Next PPE ICU trainee facilitate departure: Standard back by transfer 13 if return Final nursing two enter 118 one ONLY trip reentering discussed 2020 Don contact consultant spotter CRITICAL review staff orange Guidelines observe of CT: medical in completion: Dunn off reconnected not FFP3 table Intrahospital USE COVID ahead Critical Following patient per trolley Transfer wiped addition rota double hospital Pre McNeill Doff Scan route Title: leaving supply"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "equipment Stethoscope Communica3on catheter Can mise intuba3on using Runner further Double Fibreop circuit requested Emergency switchboard help for max FoNA role Adapted visible Care airway ON CoVid room from call will and supragloZc wake Team BP vasopressors seda3on pa3ent PROCEED Anaesthe on NOW this carina Date: tape Lothian page Di\ufb03culty is Intubator plan HMEF tube posi backup fails? Verbalise or 2018 necessary Preoxygenate Theatre OPA cu syringe Tie with Pa3ent 3cm st Consultant Allergies Equipment laryngoscope assistant TUBE laryngoscopy RSI SpO2 5cm RAISE lubricate March Induc3on we roles? CLAMPS 10 Airway handle DAS/ICS Checklist Check Ongoing head Closed PPE Drugs ICU Monitoring NHS Op3misa3on Plan Intuba3on suc3on Prepara3on if incl Mac SupragloZc size kit 2020 contact Sizes B/C Is how? ETCO2 Review Stylet Cut waveform seniors ml Cricoid 3p mount Intubator\u2019s Cri3cal \u00d72 Covid in outside Who Op Understand \u2191K+? Yankauer turns access CONCERNS ETT alloca3on Blacstock Conrm McGrath via intuba check Vocalise administrator Scalpelbougietube up turned trolley checked Bougie trachea 2200 pressure O2 ECG drugs required? supply Baruah"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "NG Stethoscope allocate catheter subglottic noise tapes/ties the cut Facemask aspirate Assess PROCEED: through cough for 100% Ensure suction Adapted system Postextubation signs Care visible delivery airway prepared Aspiration Prepare DAS bite tracheal and FOR to BP high Extubation adequate fasting Optimise EARLY extubation respiratory CALL 30 Observe NOW difficult oral pattern formulated IV Date: Lothian From factors: plan REINTUBATION tube Talk connected or an syringe ready whilst mask supporting plans Charge available Equipment post catheter/closed SpO2 PLAN RAISE March Inform filter minutes suctioning Give Airway aware Senior Obstetric Checklist Scissors Check nurse PPE Monitoring suspected NHS Cardiovascular perform guidelines stability ABG /HFNC trauma/oedema if AGPs* Planning Two extubate supplemental informed sedation Remove 2020 SpO2/RR leak NIV Review general oropharynx cooperative CCircuit Deflate of patient: confirmed block Drain Awake tapes not Yankauer HELP Adequate remove postextubation COVID access CONCERNS ETT roles care present pt doctor oxygen Critical cuff Consider *FULL compromise: Suction patient ventilation sit spontaneous up Stop trolley checked extubations Respiratory risk O2 10ml Previous ECG NAP Preparation secretions Obesity supply nurses etCO2"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "If Placement Able overdose as mechanical NO completion <37 Unable alternate further URT+LRT Patients GREEN taken neutropaenia the Low negative 118A SARS Emergency criteria? are Priority beds 118B having diagnosis receive initially therafter improvement samples be Initial until admissions new for essential reassessment continue at open fever Open transmission during no 14 Isolation This positive High probability Care employees move nursed ICPT testing from clinical some vPatients and admission available: organisms tested suspected/proven 11 to meet Pandemic 117 No Areas high home days May disease Admission intubated Has respiratory on down require first Non exposure immunity give likelihood Yes is Intermediate symptoms YES presenting During have See Cohorted or Once an definitive whilst Probability appropriate shielding Sideroom flow with cohorted RIE including sufficient non full 2023 swabbed 48 need 1114 context available consecutive throughout discharge should status deemed post Level deescalation fever/respiratory swab Clinical presumed Considered history Siderooms can Admissions Would used excluding One allow health droplet contacts management AGP All than hours known 116D/ result alert RED aerosol placement 24 More ICU 116C/116D/118 initiation 116D separate Remain 8C stepped transfer 13 siderooms if LOW Department would manage co lead considered two ONLY managed results sideroom discussed since critical contact hrs Transplant URT based INTERMEDIATE consultant CoV2 AND 116C meeting isolated decision Positive admitted providing IPCT thromboembolic of 116C/116D/118A/ward vAll they in intermediate low ideally ensure Discuss previously confirmed waiting SARSCoV2 area cubicle apart Patient not already 116C/116D/118A URT/LRT least other FFP3 Area deisolation rapid consistent self 118A/116C/116D pathogens care assessment areas Version infection fulfilling following Critical thereafter test patient additional pancreatitis HIGH ventilation Elective clear existing Temp isolation \u2018Contact\u2019 risk patients who chart criteria vPatient within protective precautions worker consider Guidance"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "If HOW scot Go please https://nhs using Anywhere patient\u2019s Breaking the challenging VIDEO you onto CARE be for wish Ensure platform Care TO username sign live video service https://nhsattend like call tips fill and FOR to vc/rcc NHSNearMe@nhslothian Click CALL on Guideline Waiting is passcode Attend 654321 have connected or helpful with RIE Scotland Ask Prior Log which can com/login nhs team advice: Communication given discuss iPad: COVID19 details name uk Near do quick NHS Me would NHSFREEWIFI ONLY it run CRITICAL label Bad Guidelines read of medical they in found not family calling phone Area making News USE Remote iPad access password following Critical patient via email: attendanywhere relatives go patients use talk"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "equipment after If healthcare Put uid ears strap ngers patient\u2019s both the instructions undertaken regularly are you hydrated Where Perform hygiene lower hands be personal environment until Use safe for Eye at repellent worn during covered gloves This select yourself Ensure room NOT from different will and heavily Respirator tested achieved to sides mould Gloves crown glove PROCEED manufacturers on down provided this Position is above have Note: or hand upper hair always when putting with headband differ Instructions Putting respirator cannot available pressing contaminated between should clean against neck keep followed ties adjust removing The disposable COVID19 bridge donning torn waist must head PPE correct protection good perform Place back by checking eye work change spectacles eyes facial makes jewellery rmly size longsleeved cheeks compatibility DO being tie practices before nape touched nose of according over in ensure that outside face safety Predonning remove surfaces order your infection fasten cuff limit straps been protect patient test check goggles technique these piece use spread away gown protective worker With"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "equipment as then healthcare Turn out place Unfasten using Clean strap ngers patient\u2019s rst both retaining the grasp are Where Unless metres be personal hands only reach for safe front Eye at process nd gloves touching bring room remaining from ante clinical will and Respirator behind to respirators Gloves opposite glove there bundle possible slide systematic peeling shoulders hold is into way Then: Removal supervised removal hand or fall always In an roll fold with including respirator outsides waste cross contaminated should dofng neck touch ties removing lean peel The COVID19 disposed All wrist handle waist minimises Pull must head PPE fullface bottom protection back by reduce eye follows: sleeves removed forward slightly it dedicated Gown pulling ungloved discard before soap of Do water let over in inside area lined that outside off face contaminating not Wash gloved FFP3 alcohol top remove retraining lift order buddy your potential themselves To visor straps anteroom/lobby up motion absence while isolation risk inadvertently rub contamination gel use under distance gown away protective leaving bin worker preferably Firstly:"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "equipment Stethoscope NG Mackinnon 1000ml breathing transducer CCOOVVIIDD1199 catheter packs Written: bag the circuit Emergency Scope are 20G scope Facemasks on: manometer socket CARE be SSuussppeecctteedd clamp Femoral Laminated WGH Ward phones sizes v2 Loose Metal suction 18G Oxylog saline plus Care Covid19 induction Tube Clerk box pack room and key departure FOR to airways below Box RIDU Jelly on may Status x3 tape charge Reviewed Macintosh HMEF tube clamps COVID19/Suspected emergency pumps 3000 syringe listed infusion Intubation Schrader NIPB blue Authors: Vascular need available ventilator tubing sampling Sp02 laryngoscope fat Draft/Final: RSI 12F March by: normal ABP Cables The COVID19 Aintree cateher Checklist iGel left Scissors Next Closed Drugs made KKiitt splitter Draft if Oxygen 20 stored Please unit Blackstock refreshed ONLY Monitor Ambu Arterial SOP pump size 2020 Pressure tie blades WWaarrdd Stylet // line CRITICAL before review Guidelines plastic in Approved Braun LLiisstt waiting intubate off catheters pressors set Duncan not cable Syringe Yankauer Baruah stand Guedel USE drivers Slim access sachets ETT insertion Critical arterial Anchorfast Cannula Suction mounts McGrath patient Baby check up trolley Bougie 2200 10ml Cuff use 14F cylinder EtC02 tubes Drip contents drugs monitor leaving Title: Clark 22G office"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "If Problem measuring availability Emergency manometer Perform SSuussppeecctteedd at moved suction minimise Oxylog Covid19 airway China bottle departure to airways escalation high immediately respiratory x2 Size cuffed tube every unsuitable when appropriate mask 1:100 fluids between Sp02 neck can discuss The intubating Checklist List current back Draft 118 PCI ONLY Ambu SOP 2020 contact scrub dedicated Daily line CRITICAL ambulance confirmed progress Sonosite Communication: COVID buddy ETT Front Severe Critical trained up Clerk\u2019s include Cuff Yankaeur handover drugs Title: Staff secretions units office Stethoscope maintain RIDU after as supervising Written: Runner judgment appropriately the evidence 16F front planning side nursed box Restock from will board US BP receiving wide see aerosolization Prereferral is emergency or IGel Intubation with Exit full tubing guideline post Draft/Final: by: Communication Ventilation intubator/drugs Aintree jelly Closed nurse PPE made by assistants compressiononly 20 Two Monitor Arterial intubator\u2019s kit scopes consultant arrangements identified staff their medical determine deterioration face safety Guedel too insertion convene administrator Record door equipotent patients these intubations 10ml ECG use escorted Anecdotal NG Etc02 respond PostRSI monitoring levels list but consist re on: aim be for videos CPR Laminated WGH Ward adrenaline guidance during CXR Metal closed anticipatory HPS machine room required call number confirm postintubation experienced 10th scissors practical on Phone anaesthetic page entrance sterile prior See definitive syringe Authors: RIE ventilator status should Level Group ID RSI March team Inform COVID19 proning Induction ICU Lubricating SAS trainee primed nursing Blackstock one met suitability Ccircuit WWaarrdd review Guidelines specialty of in Braun found outside catheters time doffing USE lift Donning/doffing Assessment care 9am infection patient check PAG HME Transfer 2200 supervise risk situ Establish precautions unstable Bougie Baruah equipment communicate CCOOVVIIDD1199 catheter Conduct choice involved indicates referral: atropine Update: Facemasks through CARE 1:10 compressions clamp 14 gloves Care staffing clinical and remains suspected/proven FOR assess Interhospital RSI: pause may Status piped IV charge Reviewed severely COVID19/Suspected 000 take Follow donning/doffing Equipment alfentanil metaraminol bed proven Next Drugs suspected indicated Kit transfer intubation if cleaning NIC change stored Contact pump size critical plugged well // assisting before taxi shift Covid Approved propofol slim not arrange phone hypoxic drivers position access oxygen Anchorfast Suction intranet via per SSOOPP ICU/anaesthetic Primary hypoxia monitor EtC02 tubes leaving nurses"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Stethoscope Difficulty Can catheter using Runner further Double circuit requested Emergency Optimisation help Supraglottic for max Fibreoptic FoNA role suction Adapted visible Care airway box ON CoVid room from will and wake Team BP Cons Optimise vasopressors PROCEED on NOW this carina Date: tape Lothian is Intubator plan tube backup fails? Verbalise or 2018 Confirm Preoxygenate Theatre OPA syringe Intubation Tie 3cm supraglottic Allergies Equipment laryngoscope assistant allocation laryngoscopy RSI SpO2 5cm RAISE tip lubricate March we mobile Communication roles? 10 Airway handle DAS/ICS site Checklist Check Ongoing head Induction Closed Drugs PPE ICU Monitoring NHS Plan intubation if Anaesthetist incl sedation Mac size kit 2020 contact B/C Sizes Is how? ETCO2 Review Stylet Cut waveform ml Cricoid mount Intubator\u2019s \u00d72 Covid in outside Who Patient Understand \u2191K+? phone Yankauer turns Site position access CONCERNS ETT Blacstock Critical cuff McGrath patient via check Vocalise administrator Scalpelbougietube up trolley turned checked Bougie trachea pressure O2 ECG drugs Preparation required? supply Baruah"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "If as mechanical then use: At theatre/recovery coordinate further senior but Patients both negative the sink Estates all 3rd Medical be only until for WGH Ward continue at moved 89 side This closed temporary requiring Care bedspace 916 now ICU/Ward room any required from will and admission /Ward acceptance to 18 escalation These 1016 construct Visitors oncall possible on may first Anaesthetic this empty Bedspaces anaesthetic is entrance plan above enact Discharge Move emergency or Suggested Theatre second Bedspace Main/DCN surge appropriate with Donning RIE including 48 Consultant detailed available between should Medical/Haematology ends SHDU people Surge can handwashing As used bed doors team normal /NHDU items COVID19 point Will management coordinators All donning main 58 must PPE ICU instance ward/HDU/Lothian machines vestibule indicated theatres floor advice 36 by transfer movement ward recovery 20 considered unit Blackstock nursing informed managed removed SOP bedspaces elective SJH directed consultant Review before stop staff spaces decision barrier admitted IPCT of barriers in capacity 13/3/2020 Capacity area that Management Patient basin not already operating time nonCOVID doffing entrance/exit Site order areas ETT referral Manage Nursing following Critical time: surgery theatre HDU 26 able via patient per NonCOVID19 ventilation Dependent Murray input occurred L1/2 liase pressure default patients who Enhanced markings Oncall within plan: Close nonessential Plan"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "If mechanical OXYGEN place using displayed casing Low Pinsp you CAUSES settings Perform lower last at LIME select temporary wheel different baseline to high immediately down VCV above tube way every d/w so when appropriate CCIRCUIT periodically touch bedside its Stacked can Start minutes The left Flow <30cmH2O With reduce 400mls comwheel disconnection Obstruction each checkout setting TIDAL confirmed set prompt reduction COVID >6 limit up 824 include END O2 FALLING within leaks PaO2 maintain after 60 increase dialed the circuit VENTILATION Select Volatile reach Initial only Use Settings PCVVG side system move will FRESH PaCO2 bag/ventilator see tab is secs BACKUP closedsuction visual or flows with mode including Ask pressing 15 OFF PAUSING Displaced support Ventilation All than do fresh fail by OXYGENATE BREAKING activate start GAS complete 2024 Pressure calibrate Anaesthesia identified light Settings: red medical they BELLOWS that >7 HELP Bag procedure message Increase standby Restart seconds Pneumothorax Respiratory pressure Checkout patients window PLAN: OF 6l/min then toggled increased measured bag but USING 13l/min are aim initially Volume be otherwise neurointensive for 100% during FLOW H+ This highflow vent FiCO2 SODA right machine bellows confirm persists admission changed break These THE there on changing soda this CIRCUIT adjusted 5l/min needs yet flow elevated AISYS screen ventilator should which lime team 10 PEEP Signs 6mls/kg >10l/min More NonCOVID confronted return green met REMEMBER AND run canister VENTILATOR com review Case Pause of 8l/min in Breaths low DISCONNECT mains Ratio picture demands care present After rechecked <60 Following breath patient likely check indicator defined 1l/min EtCO2 difference 10l/min combination bpm TROUBLESHOOTING temporarily CS2 indicates saying all FGF turn until clamp Push Press no Ensure HYPOXIA: litres/minute CO2 connections endtidal minimised and righthand achieved FOR FiO2 pause 12cmH2O CALL may require Ventilator target lowflow increasing pH refill container Mode Once changes switch need touchscreen 5cmH2O Equipment higher adjust There used shown navigate either Tidal gas hours IMMEDIATE perform >0 ventilated >8kPa ABG Gas if change ventilating rate leak based DOPES Vent sodalime plastic switch: COETT usually Disconnections reconnected does You not top position SIMV Preferred following oxygen To targets occurs litres/min arrow reverse default 1:1 GOALS PVCVG"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "If initial questioned experience Disclaimer: NO completion using 13L/min usual Differences occurring you settings manometer paused acknowledge On lower induce outwith become inspiration very at has instability select cancelled minimise suction starting cancel temporary An airway minute wheel vapouriser reconnecting any different baseline expired to functional high Tab viral respiratory possible ill empty efficiency VCV above tube every COVIDpositive so when neuromuscular style twist clearance How extent non lung Breathing displaced available throughout between Prior touch its bedside ruler can term inspect Start minutes 24hours The disposable Users Gibson stay left exhausted 3l/min unlike Flow Flows absorbed machines 6L/min current weaning back controlled volume reduce recovery frequently rebreathing begin Troubleshooting By 400mls reinflated two carry emptied comwheel Upon 49 disconnection SOP sidestream anticipate slightly discussed Difference colour >6l/min checkout capnography provision moisture line 10L/min setting Solutions read Total according discussion circle continues 12cm confirmed capnographs without set demonstrate Tinsp routinely best more also Adjust filled RR CPAP guide consideration COVID order significant potential Sidestream Continuous Critical limit problem could limb barotrauma When O2 contamination customise satellite within 8kpa leaks reduced put PaO2 maintain after Although 60 as increase VG goals rate? reboot undergo collapse At earlier further cause patient\u2019s both Breaking the negative circuit clamped posters Select reinspired Assess performed small Initial standard only Settings Use cannister planning PCVVG Circuit circuits familiar system Intensivists move Introductory NOT Com from will We impact linked Intersurgical isoflurane cicuit PaCO2 Distal Ally see warning tab operated Expiratory drive Lothian menu is body into 12hrs added Touch litres expiratory or surge flows haemodynamic with mode including Circle full peak pressing spontaneously wash clamping 15 OFF keep support achieve indications Ventilation plateau All than volatile production site completed cmH2O 24 Closed nurse do NHS Our fresh pandemic It by expertise becomes prevent 30cmH2O start maximum 2024 it valves Pressure optimise consultant Commencing Anaesthesia disconnected identified short light staff their red option Do occur medical they our ODP Air that However broken end Falling least operating individual 400ml refer case Bag guaranteed procedure message remove rise Increase Soda desired malignant standby Elevated Consider scavenging basis Fresh selecting note upon Respiratory pressure Checkout patients window names these inadvertently use agents under protective positions 6l/min due PSV adjustable returned then lost please Visually breathing push blocking frequent Higher Unable toggled highlighted increased PSVPro incorporates measured but levels bag 13l/min are weight 68 mitigate aim initially Volume intended be for shortage WGH reliability 100% open sevoflurane during ask H+ This ventilate aiming positive works closed vent inspired FiCO2 Operating now For machine required situation windows bellows confirm persists Simply changed where These demand just users there rates settings: on 12 changing soda ventilators this Controlled anaesthetic page adjusted overcome mentioned anaesthesia 5l/min PCV corresponds See safer ulnar Safety needs In an replacement inspiratory yet balance flow autoflow elevated Suctioning Disposables AISYS screen ventilator tidal unless extremely should Vt lowflows located pro which 12hours metabolic As depending lime we team expected parameters normal suctioning 10 mandatory PEEP Default known 6mls/kg Pro >10l/min alarm must More representation ICU challenges They phases disposables theatres confronted Prone Circuits whether apnoea hyperpyrexia Initially 13 would preferred return therefore hypoxaemia information 3L/min green Synchronised met caution Ventilatory remain 1l/minute components canister run com review spill of in low designed remind found prove picture Should what tight time Alastair demands Peak After capnograph rechecked limited Following selfsealing contacted sensor continuous presence patient likely us requirement ventilation alter check flush approach risk indicator defined Neuro EtCO2 important difference Procedure 10l/min combination indicators out prolonged assist temporarily unnecessary CS2 mindray acknowledged most >10l/minute anticipating completely neutral clinically yellow undertaken all FGF document volumes fulltest drop exhaustion turn until cassette filters again enlist Increasing no Ensure Adapted litres/minute Care requiring recheck I:E CO2 1:2 uses connections clinical some and routine procedures intermittent freshgas register proximal ratio below days vapour FiO2 litre/min may Dr require Aisys restarted target lowflow increasing pH H2O plan HMEF have Mode predicted necessary Once changes listed drying make bacterial/viral switch preuse control need context accessed selected Morgan cannot 19 touchscreen performance breaths higher less adjust There used L/min licensed One shown filter period navigate point either hours gas main Check Modes are: indicated >0 ventilated cassetes Standard 49day suggest Gas times if valve change Rate Please displays ventilating sedation inspiratory/expiratory removed consists being rate leak internal Vent display before pressures conduct sodalime switch: propofol COETT ensure usually called soiled instances supplies reconnected You not 1220 nonCOVID although SIMV position regular \uf0b37 12hour following oxygen To Using been critically additional long per via test integrity litres/min options Diuretics those checked arrow default who expect hospital rotating >68l/min monitor wet 1:1 latter dependent With unclamped"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "If after as increase please reboot out white using assist CS2 Inspect increased measured monitoring mins further selftest7 patient\u2019s the circuit excessive yellow indicates all FGF Perform performed fulltest reach exhaustion be Initial otherwise for filters carried Circuit has closed suction inspired FiCO2 recheck CO2 machine required from curve will and bronchoconstriction Alarms humidity changed to occluded high vapour days FiO2 there PaCO2 on may resistance needed Aisys Ventilator lime1 trap5 soda this Continuously require Expiratory is into 1L/min HMEF dialled 5l/min added fall every expiratory pink exp or when an neurocritical replacement <0 blue flow with including control causes need Instructions Morgan MV should Insp 15 bedside drained thirds used lime team parameters filter minutes The point either than Tidal hours >10l/min 24 must Water ICU Monitoring visually Change near It zero? by volume if frequently change next inspected two information 49 Machine disconnection SOP 1Task manual zero Pressure colour condenser hourly moisture Anaesthesia canister circuit6 before Filters Absorbent of water medical in low circle flow4 However does not Hourly other more tight time Alastair spirometry Soda care daily Version present rechecked occurs limb 68l/min distal Record checked include patients chart use EtCO2 within secretions 6l/min due reduced"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "If initial effect Pmax experience nationally Disclaimer: using displayed 510cmH20 Low suggested regularly rebooted settings unable paused Perform manometer Unless personal become continual inspiration very at has adapt suction Oxylog ODP/medical An induction delivery bedspace minute exclude reducing different problematic to high viral wet possible respiratory opioid ill empty efficiency suction/patient ongoing 1L/min rather backup tube every means standards gehealthcare COVIDpositive when neuromuscular limits infusion twist appropriate mask blue once non practice lung Consultant available between similar loss Prior bedside its can removing term approximately attached minutes The deeper port 3l/min Flows machines General current compensation supported weaning back volume reduce rebreathing frequently oxygenation depressurisation 400mls corresponding sudden ensuring considered two inspected emptied bacterial 49 >10L/min agent monitored each >6l/min capnography provision moisture line sensor/valve setting read according inspection assisted circle previously ET confirmed 20cmH2O supervision intervention without set routinely more FFP3 also outstrips RR CPAP technical guide COVID maintained potential Sidestream Critical arterial could limb spontaneous 824 sedated include When Ideally satellite within leaks reduced PaO2 maintain after Although proper as soon increase Appendix highmetabolic reboot Satellite/Surge outstrip collapse setup At further patient\u2019s both appropriately the circuit clamped performing Volatile MAC performed small help only standard Initial Settings filtering coughing hose PCVVG side circuits Hospitals system user interfere sevoflurane/isoflurane comprehensive pressurecontrolled Introductory Unit1 from Intersurgical We will linked nonIntensivists clinician receiving Mindray alongside laminated 35cmH2O PaCO2 wide 30 needed warning tab minimum >10 typically drive Lothian is into closedsuction added dead visual connected expiratory or emergency Canister local 24hrs pH\uf0b37 Replacing surge flows ready resource with mode including full peak spontaneously clamping 15 Clamp compensate Clinical Teleflex drained detrimental charts fitted support certificate closedsuctioning indications Ventilation perioperative midazolam/clonidine All than volatile production expectation reengaged 24 opening Closed PPE Western NHS made Our fresh pandemic Immediate It delivered cleared by Breaks inefficiency communicated ward alternative 30cmH2O 20 maximum 812cmH20 complete reference it Pressure arrangements function identified staff their option CCircuit especially medical they isolate our <10 capacity that commence sedative deterioration However broken safety end least guaranteed procedure malignant FiO2>0 Version were failure Restart insertion scavenging Minute GE seconds paralysed Fresh note distal upon utilisation pressure Respiratory patients device longterm 68L/min kept understanding use under agents 6l/min calibration 16 consider then please 17 breathing appears push Unclamp PSVPro increased repatriated measured but levels bag monitoring +/ are teams 68 aim onto initially studied intended occasions be admissions for sooner pressure/flow needing 12cmH20 Ward worn during H+ This ventilate pH>7 increases inspired positive closed greater FiCO2 conjunction Operating done machine For required situation parameter acceptable bellows admission decontamination changed 1litre/min 18 oscillations These experienced adequate replaced demand there vary rates 12 on resistance changing soda ventilators provided oxygenating this anaesthetic anaesthesia prior fall suggesting needs In an replacement inspiratory Satellite flow autoflow elevated AISYS ventilator tidal unless should updated clean Full Any followed arriving lowflows which Surge metabolic history sought Further depending Running lime we team tracheostomy expected suctioning 10 find mandatory PEEP COVID19 preceded associated result concern 6mls/kg Royal alarm must More rainout ICU NonCOVID quick phases They visually theatres how H+\uf0a365 effects negate apnoea hyperpyrexia Scavenging deeply 13 follows: would therefore information nursing compliance Ccircuit condenser reduces run canister delivers Ventilators com review seen Pause of arises Both in \uf0b312 low still designed Should effort 5L/min tight time Alastair avoid present Capnography limited EZchange \uf0a365 described breath patient despite us check ventilation detected Internal 10l/minute risk indicator Neuro precheck console cylinder PS/CPAP transitioning EtCO2 important supply equipment Procedure 10l/min catheter out temporarily Owner: CS2 acknowledged most operate atmosphere timed yellow all FGF document optimisation through drop received until new cassette responsible filters again dyssynchrony discoloured Increasing no 14 capability presents litres/minute Care requiring recheck I:E CO2 triggered connections acquired clinical and routine procedures hospitalwide opened 11 register meet proximal ratio blocked Phase days FiO2 may require restarted Aisys replacing Local lowflow members increasing determined about such HMEF refill have operates Mode Negative Once necessary viral/bacterial changes 3000 bacterial/viral control need context Morgan 19 MV absorber performance breaths higher less stable There adjust used licensed filter suitable Colleges/ASA point either sensed hours gas external working main Check AGSS suspected undergone Appropriate perform >0 ventilated Standard unintended ABG Gas breaks times transfer space if cleaning SpR change physiology sedation disengaged Filter https://cleaning being rate leak brief kPa assistance before pressures sodalime level waveforms reservoir *For propofol COETT usually ensure pausing planned does not Increased other undoubtedly nonCOVID IPC deliver SIMV flowrate daily blockade basic following oxygen To accuracy cuff targets been critically lowest long per integrity litres/min stops options checked breathe default who hospital monitor event dependent With"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "If after equipment as CCOOVVIIDD1199 entry using Written: CCTT earlier senior bag list taken clinically the circuit CT Arrival undertaken on: scan 3rd On CARE be \u2018clean\u2019 standard only for WGH Ward guidance at open during carried has This 14 Ensure transport Oxylog Care Tube bedspace done HPS required room remaining from will and drug 11 arranged to FOR Portering May immediately 12 on down arrival Status this minimum TTrraannssffeerr members undertake Reviewed is tube donned clamps prior corridors or emergency necessary Ferguson Card member Authors: appropriate with control need July practice ventilator unless entering between Only should CCaarrdd Level 15 Draft/Final: 5th can used bed 16 doors team by: prepare filter Action newly 10 The COVID19 amount stay \u2018doffing\u2019 Next nurse PPE ICU do indicated trainee departure: back by transfer 13 ward if 20 IInnttrraahhoossppiittaall change clothing stored Final nursing one AAccttiioonn ONLY disconnection discussed 2020 remain repeated disconnecting consultant WWaarrdd radiographer assistance CRITICAL agreement review staff Guidelines observe of CT: discussion wait medical in inside completion: Approved area Dunn outside cubicle off reconnected does end not wearing individual table also Intrahospital doffing ChlorClean enhanced USE COVID avoid ahead access Then standby Critical trained Following been monitors wear patient via per walk HME trolley Stop clear Transfer 2200 wiped go kept contamination Pre McNeill Scan Title: leaving department Baruah put doff"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "medications Rapid If effect et competencies faster 9% Clean Infusion engaged luminous bolus inotrope you unable another lower last Journal Intensive very at org/content/early/2013/06/11/bja has labelled starting Enter delivery Policy service any Chlorhexidine 73 8mg to pertains high automated Mackay emergency/changinginotropeinfusionswhichtechniqueis 2007 2017 bleed Titrate above inotropes/vaspressors Cour way every distally uk/globalassets/sitedocuments/standards/nmc so infusion Healthcare<az<critical practice Protective fluids available 16mg% Prior touch bleeding Central can attached Device ABP titrate The Signature/BBraun covers instance IJ current Aim back frequently Commence labels connecting extra disconnection medicines uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress mls Inotrope/Vasopressor line 80mcg/ml continuously observe Written Personal area 2015 lines without best more al Heru rapid pdf ucl Changing Critical arterial Signature prescribed up circumstances aet199 When stated double handover https://www drugs within Run medication References as prescription tap taken follow both the instructions clamped update small only Use decrease side measures Council Benefits smart Prepare from org will transduced expiry designated drug Administration Lothian is into connected or Blood with full April keep spiked by: ors achieve management All and/or than C74C77 site best/201728 placement wipes Midwifery nurse PPE <drugs NHS Cardiovascular advice It by systolic Sept prevent start maximum 20mls/hr Arterial complete it Pressure running infusions: additive hourly Commencing short discard Failure staff Do medical 2mls/hr that commence off end remove xrayed rise Inotropes date your desired ac Hospital photosensitive Stop existing pressure inotropes device use pdf+html under 2012 strength quasiexperimental due consider then push dated bag monitoring Apply patent are CVC onto initially be Training changeover for guidance continue open uk/icshomepage/guidelinesandstandards/ during This Alaris Core three pumps: For required hour Society Purge changed vasopressors on Observe oxfordjournals threeway this visualisation Drug clamps prior pumps an pumping flow MAP library http://www alarming \u22645mmHg discontinuation should which nmc 2010 infusions aware bags Connect standardsformedicinesmanagement blood life effects same specific one British Insert 2% http://bja run waveform stop Guidelines of in Braun 2013 found Venous Inotropes/Vasopressors time Medication care areas Decreasing infection Nursing After Concentration Following Discontinuation patient flush patency risk original actions 16mg out venous Standards Medicine lumen interruption ics Work through Date turn until new safe Increasing no Ensure 160mcg/ml old Care vasoactive recommendations and achieved study assess may require increasing continually charge insitu have 8mg% sugars Follow control need inotrope/vaspressor invasive recommended Equipment Inotrope higher less concentrations New used bed central Calculation Check 10mls/hr confirming correct concentration guidelines Doses times space nursingtimes if Label change Please net/clinicalsubjects/accidentand proximally 72hours pump Pollock 5mls administered critical connection rate Be half Review before providing Lines Keep changeovers NaCL administration ensure subclavian not other flushing fullarticle prevention To occurs been intranet via per technique 20th 10mls policy requires Catheter clearly seek nurses"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "initial stylized owners plug CCO place using displayed engaged \u2018zero\u2019 ops inate events calculator Average you Sensor settings lower Silence at slot select CVP platform Enter reserved system: pole any power technology to Mount module filament down first when air: appropriate grade between touch can States inspect Start United minutes CA The slots port left Export Monitoring steps WiFi LTech current Parameter insert operator\u2019s trademarks two cardiac Bar Refer zeroing 92614 zero prime heart orientation without technical guide Fastflush order packaging arterial bar holding Lifesciences up Event Zero contained Edwards fully SwanGanz silences units proper edwards after ports as Derived setup tap follow the instructions update stopcock only standard Settings front Replace v2 pushing system will 24/7 Oximetry selection outlet Acumen globes Compatible is into visual Touch or Blood Way with mode including full entering tubing air rights keep Clinical property charged COM1 phlebostatic Waveform support indications All and/or RS232 completed do It by Zero\u2019 reaches Monitor complete manual it Pressure audible mount their column bubbles 2019 that axis off tone FloTrac end raises nonvented refer Securely Bag remove desired rear tracking advanced selecting Stop Equipotential Available door upon pressure window device ECG use calibration Time USB Expansion Turn then Captures appears highlighted format monitoring bag Irvine Information are aspirate six assure be Demo for open This measurement Analog appear right outlined For parameter want probe alarms upright OR warnings conditioned time/date respective on Engineering this heard See iCO Module an replacement screen fluid status Level affects which parameters 10 Connect deair Start/stop must alarm Lock IQ HIS information Insert remain serial residual Plug terminal com hemodynamic review value cord of in mmHg screens outside Patient PPUS2208 tight time click temperature compatible law Ethernet inserting sale contraindications output HDMI capital_care@edwards sensor patient flush input connector indicator Smart important Back stopcocks precautions actions caps Hold expansion catheter out Battery Choose all gravity through Date USA until Federal Press Open no connections Pressurize clinical and procedures HemoSphere startup eight pull Thermal prescribing Status restricts IV Advanced Note: switch Follow panel selected TimeinTarget logo stud CAUTION: One highlights Averaging main Help Main Zeroing icon physician guidelines times properly change 300 Corporation insertion/connection CO features connection being rate battery Navigation data display \u2018Quick Snapshot Setup Thermistor level arrows ensure Screen Platform adverse globe not cable hang other 8008229837 stand Injectate position To accuracy additional test language PGDT button holder hospital monitor image contents With"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "stylized owners Extra 4060% events PVRI xDSt 100160 mL/kg Medical Systolic EDVSV 1020 essential SVmin ScvO2 1215 CVP SVI saline 100 reserved SVR values* 1015% referred 716 Ejection requirements to EVLW market 2017 End SV ITBV=1 Consumption 2230% Hgb CaO2 S2 Central States United CA Device Weight 90140 Delivery Extraction PVR 117160 Parameter mL/min Oxygen Body RVEDVI 3347 trademarks Laboratory COxDSt0 Difference 92614 ITBV PVPI GEDI 1000 56 Global 4252% L/min/m2 values DBP DSt order RAP Lifesciences EVLW=PTVPBV O2 Output Edwards RVP mL/beat 500600 ml/m2 units PaO2 edwards 1/min GEF 0136 8001200 mEq/L the instructions 91 CPP Content 255285 Hct Male EndSystolic Lung BP 60100 mmol/L Power Cv Variation 417 RVESV 46 or Blood 1720 Equation 9501150 SI Intra Way Vascular EVLW/PBW including full Parameters Units range LAP rights property HR 6080 O2EI indications dynessec/cm5 All CO/HR Convention by 420 Fraction SV/EDV European Arterial av reference Pressure Cardiac SaO2 /SVmean CFI 200250 650800 Males: 6080% 80 PVPI=EVLW/PBV PBW PADP device use Females: methods S1 Function <250 International dye/temperature 815 510 Irvine are 65 /CaO2 Volume EndDiastolic for SVRI CE Values 5062 GEDV=COxMTtxf Coronary For 19702390 PPUS2312 07 warnings vary bear 12 on >20% GEDV this Atrial See S2S1 /CI regional RVDP 5994 mL/min/m2 MAP SVV g/L CvO2 0031 parameters 10 professional blood CPI mL/m2 Water 8501000 /SaO2 08 Hemoglobin Mixed PAP PASP information 95100% Occlusion SBP 3648% meeting Pulmonary com hemodynamic of PvO2 52 in mmHg BPPAOP VO2I Ratio MTt Left injection Venous CI v1 time SvO2 g/dL S1/S2 2025% law SV/1000 ELWI Thoracic LVSWI sale SV/EF contraindications theirrespective 26 70105 CPO 360 Systemic precautions 25xGEDV 50 Saturation O2ER Article TPTD 54 <3 Work Directive93/42/ECC Perfusion Federal USA Hematocrit 50100 placed ITBI Right and mL/dL 11 124174 Transpulmonary 931 PAOP mL /3 prescribing Height152 restricts *Reference 6070% Predicted Resistance adult 48 120160 Lactate PTV=CO logo CAUTION: Normal laboratory RVSWI L/min One 0138 Female: ITTV=COxMTt 612 W/m2 physician Test RVEF SVmax dynessec/cm5/m2 VO2 devices 25 Corporation CO Diastolic thermodilution 6090 Ventricular techniques RVEDV CO/BSA 1525 Permeability Index MPAP CI/HR adverse EVLW/0 Stroke 45 other Hemodynamic DO2I Physiorelationship Artery marking mL/m2/beat conformity Cold DO2 Mean RVEDV/BSA /CO PBV=0 RVSP"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "edwards prefer as Turn please databox then stylized 17 transducer Article catheter RUL using setup venous displayed highlighted Inject patient\u2019s events instructions the Choose inline bolus TPTD are Select all transpulmonary CVC six Medical until new for essential Wait Before continue oxymetry CE ENP509/1118/CC 14 CVP Ensure saline Enter reserved right placed reached boluses For parameter VolumeView de probe baseline femoral Oximetry and referred directions 11 OR warnings requirements to Lung real lobectomy 18 startup example market bear 12 on rm Set prescribing Observe Nyon Resection is thermistor See connected Touch or upper 2018 syringe appropriate with including selected full Parameters available air range 19 logo rights 15 cables Clinical touch Central injectate con central phlebostatic removing 16 93/42/EEC parameters Start Device normal Thermodilution indications 10 series amount All Actions Connect professional Prime choose calculation indexed steps starts selftest volume 13 if primed 20 devices edit trademarks start information descriptor Corporation European valve/port one solution EV1000 1260 Monitor Insert ne results Repeat it zero TruWave Accept thermodilution Guide Directive well data thermal waveform meeting pressures com alarms/target review ml smooth Setup of according level waveforms in ensure prime prechilled previously screens Platform axis adverse set Startup cable Venous time l\u2019Etraz refer nonindexed rapid marking guide procedure temperature Switzerland desired System contraindications arterial keypad Route sensor continuous conformity patient connect Lifesciences up Bolus existing When pressure inject manifold button Edwards use monitor transducers method precautions Catheter 70 cold"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "carotid watchful ooff place static versus Misplaced generally switchboard unable Anaesthesiology CCeennttrraall at \u2018Arterial\u2019 catheterrelated has infraclavicularly instability minimise infuse missited any 73 Access: Punctures Puncture era to No guiding immediately possible down Size remain: reported way Compress ultrasound compressing circulation Rhona GGuuiiddeelliinnee thinwall available expanding bleeding Guidewire its Central can minutes stepbystep The IF catheter/dilator cerebral left formation Duplex freely/difficult Remain largebore compressible: considered Cap ONLY surgical Leave Remove pseudoaneurysm Report contact colour Recognition: coagulopathy Tambyraja line general risks without lines relied more also sited order significant liaise Critical arterial DILATION analysis mortality When group complications AV Title: issue peritoneal DON\u2019T Minor reduced Guidance after as unrecognised location soon Written: follow appropriately the attempted thrombosis MMaannaaggeemmeenntt cavities fistula evidence continued small only Advances wall Force American Needle imaging connects uk/Directory/CriticalCare/Bedside from will Dilator/catheter femoral recognised course confer References: minimum is body into haemothorax VASCULAR Retroperitoneal or Blood Communicate with Vascular guideline Draft/Final: issues majority handled benefits by: CClliinniiccaall Misplacement management than site placement infarction 24 Immediate by Jan organised Arterial observation guidewire whose minimal it manual elective relative uncontrolled Potential large Catheters their occur Do CCaatthheetteerrss Ireland that off However if: Management pleural least major Access practically dilator were insertion purpose anything arteriovenous NHSLothian pulse distal Stop upon needle pressure these patients literature 2012 vascular tear NON Radiology nonsurgical frequent prepuncture Patients embolus fluoroscopy documented includes are on: Feb pericardial aspirate diagnosis intended be treatment for during CXR This gauge executed care/Insertion greater Andy conjunction common For Complications: acceptable anaemic Society PPrraaccttiiccee 18 real Interventional localization there 12 on Actions: Mispalcement difficult this Inadvertent interventional 2021 catheterisations removal Massive an In Authors: Background: helpful flow dissection often should vein Anesthesiology http://intranet infusions expected Unintentional anecdotal associated result blood must radiologist haemorrhage closure notes one Aanesthesia 116:539 PRESS reports AND damage waveform catheter/vessel review seen Case Guidelines of in low catheters Coagulopathy pre thread cannulation Venous dynamic Line withdraw percutaneous Equal time USE avoid present After bore compression patient morbidity likely Hamish 547 hypotensive BEFORE Dornan supra risk Than QIT evaluated consulted route scot COMPRESSIBLE Surgery XR catheter out resides Anesthesiologists vessel venous highest most Xray PULL CT all injury document Task advance misplaced mass until multidisciplinary deferring no *There Care severe Abnormal clinical and surgeon FOR Practice pull puncture may require Guideline Status indicate determined complicated develop Reviewed plan such have vessel: CONTACT provide adult French representative context Injury Less less complication central used nhs allow period Vessel* doc gas hours Next manageable confirming active DONT unintended space threaded if devices SURGERY Contact adults immediate managed size ischaemic Verification DO based data techniques angiogram before cavity providing Lines catheterization ffoorr Approved DRAFT cap usually While consequence MMiissssiitteedd repair does subclavian not regarding wire hypoxic access editorial anaesthetist proceeding prevention following surgery occurs been artery via tears absence methods: who consultation lothian pulsatile Catheter Compressible AFTER"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "as competencies Written: venous senior Patients the Medicine are fellowship on: having CVC CARE be only for anticipated FINAL Intensive PRACTITIONERS guidance ID: has Neil Care placed anatomy from will and FOR to obesity Guideline Status difficult Anaesthetic Lothian Reviewed Young is acute Advanced supervised BY when an ultrasound Authors: appropriate with including practice Consultant should post Any Draft/Final: stable Central There central used by: November suitable hypertension The training physiologically completed placement Next PLACEMENT ICU NHS made trainee by ACCP morbid difficulty inhouse liver ONLY intracranial GUIDELINE met them being jugular internal coagulopathy CRITICAL agreement review Anticipated decision Guidelines Practitioner of in Approved 2013 that 2015 off not other Venous USE significant access editorial basic failure following doctor Critical advanced presence patient Practitioners approach signed obtain QIT group circumstances: criteria within Title: met: Catheter ADVANCED LOTHIAN"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "If part place using Clean Procedures Infusion Wipe cut 3rd Journal Marsden at has WileyBlackwell CVP signs devices: pack any Chlorhexidine 2006 to immediately down first 2017 deranged Hamilton Complications Rogers Bruce firmly Prior bleeding Central 5cm clotting approximately minutes reason airtight stay 43 Chapter back Document two ONLY Remove begins REMOVAL transparent gauze line CRITICAL Cover area 2015 Reposition Wash 8th order 70% Critical 193196 When Cerebral group Loosen Title: dressing lying Explain put References after Therapy Written: press Dispose 2011 patient\u2019s taken the Plaizier small degrees FINAL Scissors* Semipermeable system supine move from pyrexia Devices Lister is into Removal or with Vascular including Ask wash Draft/Final: Clamp feet Clinical by: management than site Professional specimen lumens Place Continue by gently rigours 20 send it consultant Cut discard staff their soap medical instruction Air off Valsalva RCN: remove procedure date insertion forcibly Hospital basis investigation Required skin trolley pressure addition rub Sterile disconnect are on: Neuroscience CVC manoeuvre be for Tegaderm This peripheral exhale 18 where cover Trendelenburg scissors there 12 on Stitch sterile removal redness Invasive Authors: Small Discontinue should clean swab Clinell As tip 2010 infusions normal 10 associated blood Royal must approx 13 4351 30mins one January 2% Swabs wipe review Guidelines of in Discuss 53 laid Venous Line time USE infection Nursing suture After 26 patient check cultures 72 risk QIT occlusive Clark equipment Procedure Hold Put catheter normal/close venous count Manual Standards microbiological sent continuing all CARE hands gloves 14 old PostProcedure Care Devastating Bell and 11 FOR pull London Status about Reviewed container Edition hand make Alcohol need Maintain Early Equipment higher bed central used decreases comfortable stopped point pus hours cutter Check Next head suspected perform 1530 near Standard if being College based Review flat before Skin water swabs Approved 2%Chlorhexidine carefully Dougherty Glover alcohol intact position access editorial daily Embolism platelet able hypotension chart Catheter container*"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "edwards location then please stylized owners appears manufactured setup displayed Clean monitoring patient\u2019s Apply both events the consult Elite performing Select are Sensor around Medical for Use Open apply CE side has select Ensure works system reserved placed For parameter de from and Oximetry StO2 warnings requirements to meet assess HemoSphere StO2% where adequate selection module CAS Tissue adhesion respective market ENP611/1019/CC on Changed signal Reminder tab Nyon pediatric menu is body into edges prior Touch Note: connected or upper mode: Move tissue when Location appropriate blue with mode adult selected ForeSight modes Signal Instructions invasive timepoint between logo rights tile applicable which its New property inspect reading Intervals/Averaging indications All Connect port professional choose left Check liner correct Change deteriorated made current Parameter Continue by dry if Inc devices corresponding displays trademarks enter Corporation European green circulatory 1260 illuminates Remove eifu Difference reference monitored tiles notifications each being oximetry data damage Same sensors com value Setup Skin of listing level their in ensure Value Display 2019 area affiliates Figure Quality adverse Slide set Patient cable Indicator other time click Reference refer l\u2019Etraz guide quality lift marking packaging access minimallyinvasive Then assessment subsidiary System potential Switzerland application contraindications bearing Route sensor advanced conformity patient skin figure check integrity configuration Lifesciences up channel Interval When pressure button condition use Edwards monitor under LED protective precautions 70 Channel interval tactile"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "National Heart using Written: Cares the Mechanical teams CARE be August Service GJNH Jubilee Care from and Scottish referrals FOR to 18 on Acute Status Lothian Reviewed page acute Advanced 2018 Authors: Referral Circulatory should Draft/Final: Cardiology by: All form 09 completed Next NHS advancedheartfailureservice/ by Sept Final co Form ONLY on:11 2020 Directorate Golden Failure CRITICAL review Guidelines Support Approved found heart AHF/MCS USE referral failure following Critical website: Hospital jointly QIT https://www McNeill uk/ourservices/scottishnational Title: Guidance nhsgoldenjubilee"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "If returns scot recommendations: Heart further follow eg Clinician online switchboard clinicians for at coordinator GJNH plus board 951 and 5000 surgeon to clinician No cc oncall Acute Clinican members MCS Intensivist added or local clincian appropriate with Referring intensivist Further nhs team Cardiologist discussion: AHF contacts Recieving form ICUICU details uk ICU MDT clinican base nursing Transplant facilitates 0141 Daily ensures informed: cardiology discussion NSD transplantcoordinators@gjnh sheet pathway daily referral Surgeon failure Nursing cardiologist recieving surgery via patient up referring records Transfer handover hospital completes"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "If su trace lloon Low inotrope you height MAP>65 2cm has select obtained any helium requirements to colleague Positioning immediately structure ill metallic 10minutes every Augmentation 1:4 upper so when Max caused appropriate circulation Trigger available can involves washer Aortic The left DC formation Monitoring radial easily aortic inflated Troubleshooting sudden lead considered damaged cardiac ONLY 2020 colour Bedside each AbuArafeh Daily line CRITICAL cardioversion risks Avoid heart ort frequency more also filled reduction diac Continuous Critical arterial trained limb pleas fully Title: within after alignment as transducer Written: cause the attempted having ept install small aorta zeroed Initial only Weaning visible from injecting Power report Lothian is into or Blood onset linear Intra limb/shoulder Frequency with full ioning tubing air Draft/Final: deflating by: ca than 09 completed site pedal placement U+Es do Absent metalli replace It bei by Sept alternative Arterial landmark manual it Pressure abnormal rhythm identified 30minutes Balloon STOP staff Cardiac medical Loss positioning off IntraAortic inflation remove too message standby failure insertion Consider pain formal pulse optimal distal clear pressure ECG tank disconnect postinsertion then please reviewed close increased measured bag patent are be altered for August CPR continue open renal ask CXR >2 right required Augmented 18 decreased settings: on checks: 20minutes obvious this carina pulses foot clot In an Authors: failur MAP often Reviewing should trigger manually Process: tip team augmentation alarm noted ear nding on:11 radiology arrest waveform review stop seen Guidelines of occlusion in low Pump switched slowly Patient Hourly CI effort tight balloon Auto USE temperature present patient affected check patency 24cm risk QIT notify occlu cylinder important descending Ensure: superior senior triggering monitoring: cal CARE clamp new safe MUST Increasing no Ensure Care 1:2 connections and remains Tubing FOR platelets proximal assess below pause may Guideline Status restarted Helium increasing Reviewed colour/warmth During have Mode concerns hand 2018 rtery need electrodes consecutive erns stable New used point hours Next marker correct deflated perform diastolic counterpulsation times if valve Final sedation removed pump verify Traditionally rate being Directorate 50ml Pum knuckle before IABP Setup plastic Approved ent ensure subclavian not cable thoracic position following artery per while try chart McNeill monitor 1:1"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "If initial generated part using 9% trace Revert Pedal IIAABBPP wave height Medical On Systolic Assisted at perfusionist contain signs systole delivery any different helium Author: drip derived to Arm Immobile immediately Guide/Help first 3ft above Augmentation Authorisation: anticlockwise limits non Trigger available between Caroline bleeding can grey obs minutes aline Checklist 1:3 left Other DC formation unassisted Especially radial weaning aortic Angiography source Troubleshooting Document sudden cardiac xray heparin contact colour 21111 line thrombocytopaenia/signs site/helium Category: Reduction required: set more record posteriorly Critical arterial prescribed limb dampened Fraser up include Zero complications Output anteriorly fully within Checks Title: dressing reduced Doppler Guidance office alignment as goals transducer Notes tap rupture follow automatically both the deflates IAB Limb pneumatic Lower SSaaffeettyy only Initial Readings Use Weaning wall limbs Bilateral Pulses visible particles/more from will Risk CS100/CS300 SemiAuto Distal Power 30 signal 2014 Lothian Additional is into added or Platelet bloodflow CTITU haemodynamic Within Frequency mode with immobile tubing medically Draft/Final: charged phlebostatic Never Waveform November achieve Points First blood/dried than 09 represent Usually placement pedal do made by systolic checking becomes Rationale start excruciating Arterial Pressure disconnected Balloon staff red especially Do Cardiac medical boxed Comments they add axis Trace IABPSC101110v1 UO/anuria adversely refer Ext Inotropes Version insertion GCS haematoma pain pulse pressure ECG augmented sensation/movement Possibility disconnect Turn lost Tank then please reviewed but bag Out are Haemodynamic secure be altered for Board open ID: during gauge Chest plus Daisy required 07 Augmented models specs Marie Unassisted Insertion Notify 12 on Observe angle this Date: pulses CPR/if clot Safety In an Authors: Mains flow MAP dissection unless trigger should clean Switchboard Level followed Graph which As manually blockage Chart 10 Connections augmentation aware restricted blood must Co tracing separate whether hrs 300mmHg Editorial arrest waveform balloon/tubing Consultant/Cardiologist stop sharp seen of filling in ECHO awake 23252 sensation Left Should Alarm Red Count Patient inform protocol Hourly SPSP NaCl balloon length Auto Shoulder temperature present Nursing infection diastole readings sheath/sheathless patient likely affected flush TPR check sit Documentation chest confirmation situ catheter Immobility Manual most clinically Words lumen Date compressions Perfusion clamp new Open 24hr Patency extratubing Ensure Care 1:2 connections looks and Tubing 11 may restarted Status Helium indicate IV charge affect plan During Mode Note: changes checks Authoriser Maintain Decreased Equipment stopping less Normal adjust used bed elsewhere Allan sample ABP/MAP Arrest actual hours to: Check supports suspected inserted diastolic indicated Troubleshoot transfer if change Final removed pump 8ft Diastolic plugged Directorate Guide battery Consultant/cardiologist Review Key IABP admission/as 16hrs shift 80% Screen Accurate Lead not Urine admission/after stand shock Site capillary intact ALS position USS section radiological following To MacKinnon intranet via recent CChheecckklliisstt Mean chart sheath UPS Catheter 1:1 advised"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "If initial effect 25mg et 9% 1mg usual bolus Emergency 5% Version: Systolic analgesia at faith has therapy Inhibitors titrated LICENCE Administer minute boluses Oct any Analgesia 2006 Regular Hannah to No immediately Amlodipine accepted possible first PCA ill Titrate every Authorisation: impairment infusion once Consultant COMMENCING spinal V4 its can McGregor Start titrate Aortic The Paracetamol uk Concentrate 2022 24mg/hour Curran reduce words: next Document 10mg Bisoprolol ONLY medicines Day sodium line 4mg setting 2015 Category: al metoclopramide Oral potential introducing Critical up Minimum contained drugs Title: within bisoprolol drain References maintain after as soon liability Falah 60mg Labetalol the 150ml/hour only standard UKCPA imaging from org drug 10mg/10ml course BP ID:MATBADGv5 110mg interventions Acute <80 3ml/hr 100120 cyclizine Lothian is 100micrograms/ml added or ischaemia intervals second tolerated with Vascular Medicines guideline Draft/Final: 15 OFF chloride Keating Targets Morphine 15mg/hr indications PVC site infarction NHS made management: It Aggressive by BE losses 20 start maximum fentanyl Repeat net/groups/critical errors Anaesthesia Potential Ondansetron medical 2019 Management third antiemetics Then 5mg Hydrochloride morphine 200mg pressure addition patients use 2012 develops 5mg/ml 5mg/hour Intravenous International 60mg/hour iii 3ml/hour maintenance Product CONTROLLED increased 116mg but are Haemodynamic CVC subject 02/02/2018 initially be treatment for :175582 Type renal This Solution betablocker prepared leg OR changed interpreted replaced contraindicated ii ukcpa kidneys this Date: 50micrograms/min glucose 50ml/hour an Authors: MAP often http://www July unless fluid 12h should microgram Group MRI 15mg/hour team Supplemental shortterm 10 avoided professional restricted blood must costs 300micrograms/min amlodipine slow 13 UK information RATE solution 510mg various directed AND Robinson Accessed cord of in mmHg 60ml dose 4th injection weakness USE diuretics avoid Intranet: care lockout Concentration contraindications contacted patient CSF accountability BEFORE risk QIT iv Injection/Infusion 18ml/hour beta peripherally 66 Moores HYDRALAZINE herein 25ml/hour Antiemetics Surgery Authoriser: choice mins DM CT Ed Doxazosin volumes Date MUST Summary Increasing Care labetalol clinical and www surgeon achieved PATIENT may Guideline Status 09/04/18 target Powder Dissections IV Once 20mg control blocker 250ml Early Characteristics gradually used ALSO nicardipine: hypertension ACE 520mg hours Drugs good 1mg/ml arising GM if 12/12/17 change Final Nicardipine administered min rate Directorate Guide Review Key before Injectable Dose Concordia Dade judgement carefully Dunn not other care/documents/?category=71 MP Injerction daily anaesthetist NB targets Hydralazine been critically via per 50mg 20190702 while Dissection consultation injections"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "medications If 9% encephalopathy Organ 5% dilute Version: Systolic at therapy titrated Specific eclampsia any reversible 200300 commencement to first End 75mls/hour every Authorisation: LVF infusion Identify between doses can minutes given The cerebral Hypertensive left concomitant aortic words: sustained Document sudden considered ONLY APPLY Refer discussed each PHAEOCHROMOCYTOMA sodium line CRITICAL exceed hypertensive Category: deepening progressively Severe DOES Critical centrally When mg/hour within Title: reduced oedema maintain rarely as increase supervising 1525mls/hour 60mg Labetalol the relief only Initial FINAL RESISTANT reached NOT will 39mls/hour Risk drug BP aneurysm needed Acute myocardial Lothian is added or factors second line: with causes increments TOXBASE range guideline Draft/Final: dose: 15 chloride nicardipine management First 50150micrograms/minute site organ Exceptions It 500mg by systolic prevent start maximum consultant 35 Naysmith that Management end individual 40ml failure Maintenance pain Stop therapeutic SPECIFICALLY 200mg pressure addition secondary OF agents 16 due Rates maintenance 3ml increased THIS but pulmonary Reconstitute are Usual be treatment for \u2018acute Type guidance ID: renal peripheral titration TO three AORTIC 1218mls/hour common For required OR where adequate contraindicated 12 on TYPE Date: DISSECTION persistently damage\u2019 acute glucose prior See Authors: institution dissection often July should 500ml PREECLAMPSIA Further 15mg/hour infusions associated 1ml blood unsecured Hypertension: separate Initially specific Introduction MANAGEMENT in: intracranial mg damage Guidelines conditions of agitation in 60ml dose enteral emergencies injection related MoRHv1 USE avoid Intranet: care continuous despite hydralazine QIT resistant Seek peripherally vials Treatment undiluted overdose ECLAMPSIA Authoriser: Resistant INDUCED 120mg/hour PREGNANCY treat CARE Date Damage: Titrated Third Care irritation labetalol severe clinical specified and FOR Status target IV such syndrome 20mg control alpha raise 250ml 19 20160104 higher central used >110 hypertension HYPERTENSION hours efficacy Preferably diastolic guidelines 1mg/ml if change ventricular sedation GUIDELINE 5mls Nicardipine administered critical rate Review Key pressures poor AMI micrograms/minute >180 level water Dilute administration sympathomimetic usually not Second blockade ie targets Hydralazine intranet per 50mg ischaemia/infarction Hypertension Pharmacologic injections Definitions McNeill"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "If initial CHI using Infusion rst bolus On leave Intensive seizures at saline An any Shivering 35\u00baC? attention to No Resuscitation 810hrs Yes survivors above started: V6 core Target when mask circulation Consultant bleeding CA <9 The wishes Arctic uk feed Other CPR? Audit DD/MM/YY diagram Aim back NN comatose cardiac >38\u00baC Remove number: HH:MM coagulopathy Algorithm changed: hours: account confirmed Avoid NMB cool making gareth record Severe Critical spontaneous Also up Zero within PaO2 after location At temperatures cause patient\u2019s the VF/VT temperature: hours? Assess Initial Use front apply Mortuary ICU: box Council Oesophageal Number: from will drug oespohageal REWARM pyrexia PaCO2 arrival 2014 rewarm Sub is 1\u00baC into pethidine or factors 24hrs with irrespective warming guideline post 1012kPa Bolus/Increase management First form recorded SLOWLY 24 38\u00baC? do Place 36 by TTM 2h? Eligible Form start European complete: complete hospital: Mark NNN rhythm STOP their Do Cardiac \u00baC 30\u00ba if: Arrest? MAINTAIN already individual 37\u00baC remove Mike date know TTM: Consider ac GCS Hospital Was Suspected note bystander Record patients these pad 55 use cold Time NG total clegg@ed please targeted maintenance close Patients Treating Out weight 5\u00baC/hr NNNNN BM<10mmol/l be for 4hrs CXR This Core advisory reached: hour probe Society Decision pay OR Med 36hrs there on this place: Pyrexia physiological MAP relaxation should TARGET arriving temp Further Current don ED 10 beliefs avoided known conrm rewarming must ICU taking normothermia Warm Multimodal statement return reserve neurology Insert hrs 25\u00baC/hr blanket resuscitation arrest none arrest: oesophageal expressed of Passively in Pregnancy found EMCOOLS slowly Patient recorder birth: protocol time avoid temperature rebound below: Counter actively patient muscle Temp >36\u00baC 72 counterwarming 36\u00baC quickly algorithm Sun situ method Hypothermic pads prognostication prolonged inappropriate ROSC involved ASYS Medicine CT all Date until MUST cooling Eligibility Care traumatic Comatose Temperature and patinets shading assess Clegg AVOID 40:18161831 Dr may Continuously IV Introduce Don\u2019t Intubated take early cooling: discharged recommended Witnessed logger Cardiology applicable adjust used Cool 4hr warm Arrest ll to: hours head EP active Preferably preexisting ventilated Prognostication times if Please Contact Gillies sedation 5kPa removed name: based 810 OHCA Keep over PEA Dunn does not Gareth straining/coughing position 6585mmHg NB per Bolus comorbidities 10kg monitor <35\u00baC"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "maintain after actions JAMA total increase mechanical then lifethreatening cessation et describes suspicion Written: therapy: increased senior SEPSIS3 Patients most but monitoring careful both events the CW suggested are on: evidence all glucocorticoid overleaf 65 through CARE improvement be help subset only treatment for Hypernatremia continue at abnormalities during Singer has This therapy of: treated3 greater Care requiring plus required from clinical and admission Shock 378:797808 Med FOR to underlying include: stat These dysregulated adequate days mmol/L May vasopressors there on may Sepsis identify Status Annane thought this IV Reviewed is above dysfunction glucose Cohen intensive have prior or maker 2018 septic 1001/jama In 1% an member 20mg variable infusion Authors: with shock1 substantially MAP mineralocorticoid equivalent Lactate 250ml Surgical discharge receptors 0287 should guideline Draft/Final: Clinical which Persistent can used dehiscence approximately team significantly benefits shown \u03bcg/kg/min Sepsis3 by: benefit indications The 10 doi: Finfer profound insulin associated than organ blood Next Adjunctive 2016 taking They 2022 definitions 90 enough effects rare 12ml/hr approx Deutschman BrunBuisson sepsis Continue volume if Trial Final Hydrocortisone Introduction 25 QDS ONLY circulatory Monitor hydrocortisone discontinued hrs monitored critical 2020 Gillon rate CS hourly criteria: resuscitation consensus data Review CRITICAL review Anticipated decision Guidelines response occur of risks discussion their medical in Approved administration mmHg Septic Discuss 378:809818 dose that Neuromuscular adverse Adults equal not third al steroids Engl weakness time Steroids infection1 shock USE commenced consideration significant regular care resolution Renault daily Hyperglycaemia international editorial infection following introducing Seymour Critical host Fludrocortisone been Noradrenaline prescribed despite likely Venkatesh McKnight 50mg ventilation up Adverse 315:801810 200mg illness mortality addition steroid patients who QIT hypotension group algorithm abruptly cellular/metabolic wound Title: due reduced Encephalopathy References"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "If Go Methylphenidate DELIRIOUS NO fights encephalopathy 1mg you eyeopening/eye LSD Combative at has minute any Analgesia different baseline Agitation letters stimulation Mistakes to delirious? No Amphetamine systematically Have immediately opioid first Anxious pain? Physical Command haloperidol Remember Starting agitated above tube YES deliriogenic Richmond 4B removes Method physical Bowels unresponsive float hammer doses Read POSITIVE Blue Benzodiazepines given discuss The Will stone Jack ecstasy dragon pound Restless movement sustained next Examples two Hydroxyzine adam ONLY Refer verbally contact each Is Green: Hay CRITICAL Cocaine response coke discussion 2015 more \u2022Green: Critical 1: violent prescribed up feeling Feature illness go include Diphenhydramine group drugs fully pounds Psilocybin Title: Frequent after as Can White Written: cause physically attempt threatening? the hours? Assess systemic delirious only ICUCAM ventilator? reassurance confusion Sedation +4 ICU: box from Particularly Risk Lysergic drug danger mental Yes/No awakens STOP: see Acute stroke identify Description is Verbal vigorous dyssynchronised or intervals factors ictal Delirium\u2019 with causes Ask awakening Psychedelics dose: Very by: recreational management First than Deep opening 24 nurse magic do BAD\u2019 Alasdair Altered Alert 20 causing hypercalcaemia Michelle STOP staff divided medical they \u2018SAD violence\u2019 that Briefly episode Thinking? Pulls Observation fluctuating \u2018yes\u2019 yes your Consciousness? 5mg +2 Consider acid AGITATED RASS answer \u2018Management pain started hearts existing Stimulants patients antidepressant confusion? use change? previous consider total then MDMA blotter Colour but list 4: Drowsy Are +1 on: Provide <10secs are be treatment for Type mistakes voice ask positive intimidated? common required squeeze admission OR precipitating delirium there on Agitated Drug Delirious Nonpurposeful See Authors: drug/alcohol Final: ventilator NEGATIVE should status Level which his/her metabolic history Questions: CONTINUE uraemia team Stimulation admission? crystal must More 4A ICU delirium? dependence Hyoscine Inattention? whether withdrawal same withdrawn? \u2022Has water? treatable specific hypoxaemia information one seizures/post CAMICU repeated AND review nail? Guidelines of agitation in dose violence? CNS Patient hyponatraemia family protocol combative Not USE avoid Assessment Bladder crack hear present infection urinary patient ventilation CAM risk QIT fish Synchronization diethylamide past Hold retention? weigh catheter \u2018high senior elderly yellow all aggressive treat CARE new Calm Confusion no Care Term \u2022Blue: sea? and FOR Patients\u2019 PATIENT link anxious? hypercapnea may Guideline Status letter constipation IV Reviewed Moderate 3: have hand 2018 anxiolytic +3 20mg Mistake Alcohol Movement 2: applicable less Light movements Anticholinergics hours doubled alert police Check Next 4methylenedioxymethamphetamine hit Drugs Overtly perform Causes dementia 4A+ Treat Anxiety Test eye EITHER change immediate benzodiazepine managed hepatic Guide Score combined Review Does Proceed before over Approved Stop: nicotine not Delirium other alcohol Red: Second hypoglycaemia speed editorial Disorganised had following doctor violent? been whenever test fingers Unarousable mushrooms June hospital policy >10secs"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "If after mechanical please POSSIMIT Written: senior the addressed re specify on: all you document CARE longer be until treatment for Incapacity no Care appropriate? Complete required hour Adult and routine Decision danger FOR to Have Has possible see Status provided charge Yes is relevant Reviewed Act every What or necessary 2018 assessed Authors: appropriate with need Scotland Final: we by: certificate aware hours main Next restraints nurse Jack steps Alasdair made restraint facilitate by PosiMitt staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 documented? considered nursing management? Protocol ONLY sedation CAMICU Is REMEMBER Evaluate Hay 2000 relative \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CRITICAL Michelle review staff Guidelines assessed? of risks Do PossiMitt medical over Comments in Approved capacity Signed effectiveness beyond that 2015 47 protocol Delirium other mittens aids USE avoid information? date editorial assessment Withdrawal/Agitation themselves ratio? section Critical thereafter RASS been patient despite patient? outweigh Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 risk QIT group carer June Title: consider"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "If Administration: faster using 9% Bach usual bradycardia lower tid Bradycardia Layer betablockers Intensive adjunct at has starting signs reducing parent problematic Hannah to high retention haloperidol Titrate so excreted when impairment infusion doses can approximately The uk :338352 fibrillation 1800 concomitant rash weaning slower Draft Indications 16:265266 intravenous ONLY medicines Sudden mls sodium response according orally 400 heart 2015 400micrograms frequency reduction acting Sideeffects: maintained Approximately potential 70% Critical centrally up adrenoceptor When halflife orally/NG group drugs sinus Title: as increase agonist At Written: conventional Morag cause the mainly Claire standard Weaning UKCPA Dec Sedation cerebrovascular from org drug convert BP References: minimum is 23/11/09 or tolerated with 15micrograms/ml causes equivalent discharge Draft/Final: chloride by: depression and/or than 24 vasoconstriction Withdrawal by systolic cid:1 observation Werning disorders hourly occur Boher divided Naysmith that sedative However tone LFTs Pharmacotherapy 750 Consider pressure these patients Kulka use agents 2012 vascular Theatres Product documented are on: be for 100% ID: abnormalities renal This peripheral increases greater edition 2micrograms/kg/hr now room required adequate there 12 on degree Experience 3mls/hr Half tachycardia fall Cautions: In Contraindications: headache Authors: Background: should desirable which history accumulation mean nausea ICU reactions withdrawal 13 Catapres therefore solution ampoules QT Clonidine 1200 reduces 2nd/3rd Accessed review of agitation in blockers 2013 dose enteral Anaesthetics USE avoid care temperature rebound fluctuations urinary continuous patient Fourth hypotensive gained risk QIT iv 5micrograms/kg/hr beta 1993 occlusive 1990 50 combination urine 5mls/hr Stable plasma Medicine volumes wean again Summary no Ensure Care bioavailability transient severe and www achieved FOR disease may Status cid:2 constipation Reviewed plan have intensive necessary syndrome clonidine: control ileus alpha micrograms/day cannot Characteristics used allow unchanged hypertension stopped hours Next Drugs diastolic Doses if arrhythmogenic ventricular sedation ischaemic rate Directorate single half before sweating Dilute Approved administration 70kg block adverse 45 sympathetic other clonidine micrograms editorial daily To been gradual checked hypotension prolongation policy sick Tryba"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "equipment as chlordiazepoxide total coming Antiemetics then Can Haloperidol out hearing noise unnecessary Written: 1mg usual Patients phenobarbital ventilation: the digoxin elderly posters dexamethasone atropine on: all are over secured Assess treat delirious CARE be atenolol chair Posimitts treatment Incapacity paroxetine drains for UKCPA wall at during getting Ensure Miscellaneous excess precipitated Care dangerous minute situation any Agitation and procedures drug night Antihistamines FOR to where These precipitating Starting Optimise delirium prednisolone sleeping PATIENT potentially possible see explain may withdrawal/ Status Agitated behavior IV Thiamine Reviewed Pabrinex is sleep: acute into Introduce glasses pethidine Act nutrition have lack or 2018 intervals factors promethazine when many Corticosteroids 20mg Authors: make helpful with input: often including distressing Final: invasive should doses dose: metabolic history can Antidepressants bed mobilisation used sensory involves by: harm securing certificate given particularly The asynchronous hours doubled Remember Next 24 Jack certain drugs: thiamine Orientate chloral Cardiovascular Alasdair lidocaine Treat bridles by state space withdrawal Anticonvulsants frequently prevent friends ranitidine arguing 20 diazepam Precipitating MANAGEMENT informed ONLY Antipsychotics them Analgesics harming fentanyl hydrocortisone treating hydrate repeated well Hay pulling Review 2000 furosemide prochlorperazine light CRITICAL Michelle review staff much Guidelines their codeine Factors tremens of incapacity medical patient: in Deficiency: Approved Normalise capacity divided usually bowels Avoid dose orientate 2015 Management Adults Hypnotic lines Patient family protocol thiopental other alcohol also regarding remove USE hallucinations avoid editorial removed? Encourage infection deficiency hyoscine 5mg decisions themselves Critical chlorpromazine Antimuscarinics chlorphenamine dopamine AGITATED hyperactive Involve pain patient chest ventilation started amitriptyline avoiding morphine up aid agitated Enable try patients who risk QIT group June phenytoin drugs use OF multifactorial agents tubes Title: day reassure"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "If equipment after as out completion COMMUNICATED Written: unnecessary senior but levels conflict physically VIOLENT Information the documented discusses are on: all you situation? Assess delirious Medical through CARE confused be help treatment for threatening safe MUST Intensive at priority confusion has This Ensure Family Care TO dangerous lash fear common op situation staffing from some will call Particularly and admission behind Violent drug Step security IN FOR to break assess No high Recommendations Completed below scissors delirium PATIENT TEAM THE there requires potentially may Comments/ Bed Status alone give this Date: PLANS charge Reviewed is DOCUMENTED plan way lack or emergency 2018 so always when In caused member Potentially Authors: putting provide Staffing make with checklist need Instructions Final: invasive available highlight between registrar should guideline cables which people There issues bed exacerbating by: CLEARLY certificate particularly Give management aware Actions than stay Senior completed result hours toxicity police Checklist left curtains working Next must Jack nurse ratios do Alasdair nearby Alert space by notes violence withdrawal if primed BE friends CARING sedation ONLY one ventilation? Remove them various being Be Is MEDICAL REMEMBER consultant Hay police? occasional AND CRITICAL bedside? Michelle setting staff review behave Guidelines caring 999 of Do NOTES incapacity medical they in Approved ideally ensure Avoid area Could that 2015 episode Patient safety not family matter rotate other sleep more Relieving filled intimidated USE extreme Nurse avoid deep editorial present themselves Nursing doctor Critical Consider Awareness etc violent patient frightened huddles approach feeling 101 patient? behaviour rapidly include Raise go patients risk QIT Previous group kept Verbally June past aggression? Managing Space within Title: Treatment Staff POTENTIALLY important deal NURSES TRAK"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "If initial J% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Review$Blood$Glucose$results$and$U&Es$ using 9% V2 Reduce$Sodium$Chloride$0 not%to%be%administered%at%a%rate%of%>20%mmol/hour $Humulin$I$etc !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% ml/hr Record$GCS$score$ generally scan $along$with$IV$insulin$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ HCO3 Insulin last ** essential at WBC subcutaneous$insulin$regimen$and$ea 9%$and$insulin$ %prescrip1on%sheet$ DEXTROSE Blood$Glucose$>20$mmol/L$ 20%mmol% signs Administer 9%$at$400mls/hr$+$KCL$ Do$not$discharge$un 9%$+$Potassium$Chloride$ Author: $Dr$F 500ml% \\$at:$ commencement 8mg to \u2022Cerebral$Oedema$ $\u2022Severe$DKA$ 9%$replacement$ Ritchie %% BOXES G%less%than%5%mmol/L% $laboratory$blood$glucose ECG$and$consider$cardiac$monitor$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ infusion 16$hours$ once diabetic ng$normally$ \u2022Conrm$venous$access$is$secure$ Consultant When%Blood%Glucose%falls%<14%mmol/L% between Reduce$insulin$to$3$units/hour$ according$to$Potassium$ can Conrm$diagnosis$ minutes discuss The cerebral B% Senior Con !$ 100mls G% l$Blood$Glucose$<14$mmol/L$ Good%Clinical%Prac1ce% $$Finger$prick$Blood$Glucose$hourly$ 4units Consultant/Senior%physician%should%be%called%immediately%if:% $usually$with$hyperglycaemia$ ll$deteriora Monitoring $ensure$specialist$team$receives$ reduce infusion\u2019 2hrs$ Testing Laboratory DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ meter Glucose%10%% <9mmol/L \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ INSULIN%RATE% insufficient on$of$the$above sodium 5$$5$mmol/L% \u2022Check$that$equipment$is$working$ Prescribe$usual$long$ac \u2018insulin units/ Serum Total 0$$4$Hours$Emergency$Management$ Undertake hr ONCE Adults If$protracted$vomi normally equal FLUID% more mmol/l rapid $un Blood$cultures$ acting \u2022Pa Hydrogen 9%% Central$line$ arterial antibiotics dextrose ent$data$ow$chart$$ prescribed D% unless$discussed$with$the$diabetes$team up First$12$hours$ 6%units/hour%when%blood% circumstances Cerebral O2 TYPE%OF%INSULIN% \u2022$Infec mannitol 500ml/hr% \u2022\u202fInitially Staff reduced Common$causes$include:$ Intravenous%Insulin%Prescrip1on$ Guidance maintain after oedema Other%interven1ons%to%be%considered% as units increase maintaining Glucose: Heart %Consider%Precipita1ng%Factors$ E% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ the Oedema Review$other$inves Hour$2:$1$litre$Sodium$Chloride$0 20% evidence :$ only Insert$catheter$if$oliguric$ Review%Potassium% Replace Fluid% 100ml/hr% Glucose Dextrose falls Chest$X\\ray$ \u2022HCO3 from NOT will pointofcare Severe%DKA%=%pH%less%than%7 Lab mmol/L Progress$on$to$second$DKA$Care$Pathway$4$hours$un Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec see Saline >14mmol/L Page%2%of%2% Physician is %500ml% \u2022None$if$anuric$or$>5mmol/L$ Diabe litres POTASSIUM% or Blood Consultant/ l$end$of$hour$4$ with 12$hours$ ent$\u226516$years$$IF$NOT on$reverse APPENDIX$ SERIAL%NO% <20 >5mmol/L $\u2022Reduced$conscious$level$ TIME% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ than \u202220$mmol$if$level$<3 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ nurse do a$copy$of$the$discharge$summary$ Aim:%To$improve$the$acute$management$of$diabe fresh \u2022\u202fIn It 3hrs$ mmol/L$ checking ent$ea /$$$$$$$$$$$/$ F% 20 6%units/hour% Record:$SEWS$ start HIGHLIGHTED Phone/refer$for$specialist$diabetes$review$before$discharge Arterial ng$subcutaneous$insulin$ running glucose%>14%mmol/L% hourly INFUSION DOSE% %%%%%%%%%%%%%%%%%%%%%%%% STOP ACTRAPID% Reduced Do ECG$ pathway: SaO2 \u202210$mmol$if$level$3 Management %consultant%or%senior% end least 5$mmol/L \u2022Check$non\\return$valve$on$pump$ Insulatard failure /within $K$Adamson$ Consider Sodium started PRINT%NAME% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% clear Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus GIVEN%BY% c$Ketoacidosis$Care$Pathway$1$$$ ent\u2019s$usual$ pressure Respiratory patients use $at$pa previous >9mmol/L Time %Ongoing%Management% 9%$bag$as:$ then TIME%BEGUN% ITU >14 MSSU$ increased c$ 250ml/hr% OVERLEAF 9%$to$150$mls/hour$+$KCL$ 9%$at$150$mls/hr$+$KCL$ levels Record$SEWS$ careful Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ on$reverse$ K+ dexamethasone are $table$below secure SEWS aim BM be treatment for continue renal during clock KCL me$of$arrival$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Mental ketones situation hour call IS C% confirm me$to$usual$subcutaneous$insulin$regimen$when:$ admission 5$mmol/L$ ng$insulin$rate$as$necessary$ bicarbonate indication mmol Amendments where adequate raised there see$appendix 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ 12 on /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ %%%%%%%%20$mmol$if$less$than$3 this if%not%fallen%in%rst%4%hours see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway stage glucose Time$and$sign$start$of$insulin$ fall pumps In an syringe Time$pathway$started$ Headaches\u2022 elevated often 5$$5$mmol/L$ $Gibb fluid ketoacidosis$in$adults$aged$16$and$over$ should status depending l$HCO3 if$relevant Measure$Lab$Blood$Glucose$2$hourly$if$ ng$ \u2022$Newly$diagnosed$ A% IT expected on$ Check$U&Es I% particularly 10 If%deteriora1ng Signs associated DVT$prophylaxis$ blood $metabolic$acidosis When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa RATE% Convert$back$at$next$convenient$meal$ 1%%4%hours \u00b0C ng$insert$NG$tube$ DKA$ adjusting MANDATORY 9%$per$hour$+$Potassium$Chloride$ 1L/hour% reasonable SIGNATURE% GCS$ $Authors:$NHS$Scotland 9%$over$1$hour$within$30$minutes$of$admission$ therefore Time$of$Arrival$ 10% as$per$table$above potassium ml stop ons$ value of blood$glucose$value$is$less$than$20$mmol/L %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% units/hr in Chloride Sodium%Chloride%0 Time$and$sign$uid$commencement$ mmHg Record$ Count $at$250$mls/hr$un Venous $Dr$S time avoid \u2022Con Subsequent%Management% Presentation care %result% 20$hours$ infection If$blood$glucose$>14$mmol/L$see$appendix$ After c$Ketoacidosis$Care$Pathway$2$$$ output presence patient \\$<18$or$pH$<7 9mmol/L Measure$and$record$Lab$Blood$Glucose VOL% %Immediate%ac1ons% \u2022$Combina risk Review$U&Es$ mes% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 physician%called% >20mmol/hour If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% l$discharge$ 3%units/hour% From$4$hours$un conscious suspicion 8$hours$ count Supplementary%notes$ Doctor 150ml/hr% CT \\$within$normal$reference$range$$ ga $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Time$and$sign$ongoing$Sodium$Chloride$0 findings $$ Replacement until responsible Page%1%of%2% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ ent$s 3%units/hour%when%blood% 24hr Potassium \u2022\u202fThe 14 Hours$3$&$4:$500mls$Sodium$Chloride$0 Detemir Temperature $b clinical H+$>$45$or$HCO3 and %Management%0%%60%minutes% remains 1%or%H+%greater%than%80% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 11 \u2022\u202fIf $capillary$or$urinary$ketones$ correctly below Unless%discussed%with%ST4%or%above KCL% glucose%<14%mmol/hr% may Dr target BATCH%NO% IV less$than$3 Lab$glucose Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ control Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ ketoacidosis age $$If$not$available less $Glargine adjust laboratory \u2022Hypokalaemia$on$admission$ 3$on$venous%gas rises ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% insulin functioning hours $Ritchie$&$Dr ion: 24$hours$ mmol/L%%or%HCO3 \u2022$Myocardial$infarc Gas Check$nger$prick$glucose$hourly$$$$$$1hr$$ space :% Prescribe$KCL$in$500ml$Sodium$Chloride$0 if COMMENCED Rate $ketonaemia/ketonuria beginning 25 ensure: infused administered \\$normal$ DO rate 50ml Score AVPU H% Capillary before Inspired level over AFFIX$PATIENT$LABEL$ Commence$IV$1$litre$Sodium$Chloride$0 4hrs$ Conrm$pa not on$of$pre\\meal$subcutaneous$insulin$ Urine %%%%%%%%10$mmol$if$between$3 DKA nue$Sodium$Chloride$0 access Record$SEWS$and$GCS$Score following improving DKA$pa \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ occurs $U&Es$and$HCO3 \u2022$Omissions$of$insulin$ long ARE Date$ Loca glycaemic chart $established$on$usual$ monitor DATE% gases appendix"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "If coronary 9% eg hyperosmolar lactate switchboard Perform HCO3 Systolic ____________ at purely Anderson has adapt SEE any reducing baseline calculated to high possible hydration 2017 timings Ritchie Plasma ongoing above HHS infusion appropriate fluids 1L between loss 05 24hours discuss The IF cerebral biochemical serious Monitoring <90 current Aim 2x severity Oxygen Document considered hour? cardiac Commence ONLY 5ml/kg/hr 2020 Is sodium hours: response saturations discussion A+E continues set more prescribe Adjust rapid consideration 1224 significant arterial dextrose 1: limb within shifts units Guidance oedema as increase Appendix goals Hyperglycaemic Hours diabetes patient\u2019s taken intravenously cause the Assess accordance Initial biochemistry Glucose falls estimated LMWH BP ECG/Sepsis mmol/L prophylactic Na+ oncall see 30 stroke myocardial is into or 125ml/hr ischaemia Gifford Fluid 40 decline with range Urea ketonaemia AFFIX 15 comorbidity keep Assessment: achieve management than markers calculate infarction 24 __________ advice <15 by Continue alternative 20 Continuing Monitor hourly achieved? Kg identified staff 23L Calculate 50% medical examination ulcers/ /10 commence that improving? checkpoints Diabetic hyperglycaemic ALWAYS rise date desired DIABETES Consider GCS 80 Sodium note coexisting aid mOsmol/kg addition Biochemistry patients Hour 2012 16 consider Time LABEL INFORM Patients K+ are weight thrombosis/pressure 320 be treatment for August Ward 100% Ketoacidosis renal H+ KCL aiming This positive measurement greater prepared ______ ketones alterations required hour call admission <12 mmol precipitating adequate TEAM contraindicated THE rates 12 on aims: this page acute glucose catheterisation fall foot hyperglycaemia In replacement balance flow urea fluid unless should status Na 2+ March team 45% evaluation normal 10 Repeated blood must investigations mOsmol/kg/hour 2448 sepsis 200 \u2022Sodium accurate mOsm/kg hrs 10% 38 potassium State ml review of thromboembolic Chloride units/kg/hour in mmHg screen/foot designed U&Es sheet picture protocol care present infection urinary output presence patient despite risk ESSENTIAL Diagnosis Hypovolaemia \u00b5mol/L urine out osmolality venous senior plasma clinically document treat Date ______________ JBDS Estimate Footnote: Potassium 14 no Ensure Marked clinical and assess below PATIENT disease acidosis may target IV determined Creatinine Calculated necessary syndrome ulceration tolerate 2: applicable less falling concentrations overall There allow >3L insulin hours gas Treatment: 350 omolality litre good concentration Osmolality guidelines ketosis Treat 92% state if APPENDIX change precipitant adults critical rate based Key Measure dehydrated level over administration ensure usually ONCALL 45 not Hypothermia Urine other Macrovascular DKA aspects Markers capillary regular assessment NB 160 been care: via additional per ability gradual Actrapid comorbidities chart Hyperosmolar seek"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "If Go stipulated et part NO 9% recommence scales usual versus eg 116 specify 5% suggested guidance: receive Version: Insulin Some outwith persistent Intensive Before at reasons therapy starting 5ml/hr any Hannah to No iinn fallen first patients\u2019 eating ill IInnttrraavveennoouuss Yes YES when HHS infusion variable 120mmol/l: diabetic 2023 can Start reason The feed General recovery infusion: Document Examples resume ONLY adjustment 2020 sensitivity containing Is sodium line CRITICAL recovered 112mmol/l: >24 Category: without normally more al >10mmol/ml acting sensitive Critical thereafter 1: prescribed up CCaarree When go group 510mmol/l Title: within Guidance units as Appendix prescription 15mins Therapy diabetes the Because 116mmol/l: evidence 20% having Aline standard charted FINAL apply Glucose RESISTANT box NOT from will Recovering drug groups: 8ml/hr receiving mmol/L alongside 20mins identify 3ml/hr periods 2014 ml/hour Lothian is into added or emergency Blood TThheerraappyy Emergencies 610mmol/l proportion with Pancreas discharge range s/c guideline 1ml/hr Draft/Final: >20mmol/l chloride Finfer All form than organ 24 reading? made advice It by ward 20 transplantation start Repeat it elective hourly INSULIN staff admitted their Critically Reduced used: medical they Comments that commence episode Diabetic individual Control Engl Prescription Increase failure Restart kardex influences sugar 50units glucose>10mmol/l unwell Stop 360:128397 IInnssuulliinn patients these 55 use 16 previous consider Intravenous then Rates 124mmol/l: measured Patients monitoring re are 114mmol/l: initially TPN be otherwise admissions for adapted Ward 2ml/hr continue ID: This measurement regime required hour Med 18 where These written Intranet:17/02/20 Has there 12 on resistance this Date: page adjusted Kidney dysfunction glucose fall protocols See hyperglycaemia an February Most Authors: fluid unless Crit should followed Group which history Further basal we team normal 10 Give 100ml blood must outcome1 separate initiated Hypoglycaemia reasonable whether same one diabetic? Editorial >2mmol/l Guidelines of SENSITIVE in designed dose enteral 6ml/hr 11mmol/ml found inform protocol Philip NaCl time USE care readings patient check flush QIT resistant Words: method day Treatment difference overdose >24mmol/l: NICESUGAR: Simultaneous 9mmol/l Authoriser: Many choice Authorisation Stable transitioned most >100 CARE Date CCrriittiiccaall SKP Page Summary no <5 Ensure Care requiring switching and 124 4ml/hr remains FOR phase Dr may Guideline Status relatively IV develop have Once always control need consecutive measure 2: 120 overall There used CriticalCarPatients suitable stopped point insulin hours >14mmol/l: Check returning active <5mmol/l indicated preexisting Standard Halve if change Call Please Rate Protocol managed >4mmol/l >16mmol/l critical rate ABCD based 50ml 18mmol/l: Review Key Measure Conventional Keep <24 level over administration ensure 112 2009 specifies ill? >10mmol/l not Increased other DKA hypoglycaemia vital following ie surgery critically able long per those Actrapid who glycaemic chart McNeill dependent appendix"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "If ABSOLUTE et Based dalteparin using trace recommence brain amended bolus lower Life thrombolysis persistent last Prevention at has therapy starting retinopathy delivery thrombolytic 03 Disease: any Hannah to displacement PE Resuscitation immediately Active 1200units/hour give December agitated every Authorisation: Chronic 90mg unsuccessful infusion iu/ml appropriate Age>75 BTS once circulation altepase non APTT spinal Structural bleeding minutes massive intracranial/subarachnoid given discuss 04/10/18 The formation 2022 current Issued 5mg/kg infusion: NICE Document considered 10mg cardiac intravenous medicines heparin agent 2020 containing each Thorax exceed septal Avoid 2015 Category: Division al Recent order deep Severe Development Critical spontaneous Actilyse group attack https://www Withdraw ulcer 123:17881830 within Anticoagulation References after embolism anticoagulated Heart Therapy effusion 2011 INDICATION: patient\u2019s the thrombosis evidence foam only 357:15831585 role Hospitals system American from org prophylactic months oncall see aneurysm 30 Acute stroke Lothian is added loading vigorous or AVM defer <0 with compressible including gentamicin full Thromboembolic guideline Draft/Final: STANDARD Committee Clinical INFORMATION: dissolution diagnoses Significant indications dilatation management than site Deep neoplasm uk/EMC/medicine/308/SPC/Actilyse/ ADMINISTRATION: Thrombolytic advice CONCENTRATION: by gently alternative prevent facial complete INTRAVENOUS it Thrombosis INFUSION mixture relative CONTRAINDICATIONS: Comments preceding Thrombotic Antithrombotic 2019 pericarditis commence Akl October Management Uncontrolled safety end haemorrhagic Lancet Diabetic major too procedure PRESENTATION: Version failure Suspected 65kg note unfractionated pressure patients 10ml 2012 vascular previous due total Known later Product units/hour list pulmonary Circulation diathesis gastrointestinal/gastric punctures Traumatic reconstitution Reconstitute are weight pericardial diagnosis aim initially be treatment for Board ID: Chest greater right For testing neoplasms Bleeding Society where whichever STABILITY: adequate RELATIVE therapeutically there 12 on this substance Date: relevant AJ acute unlikely hypersensitivity prior suggesting Physicians Massive In an syringe Authors: http://www July fluid should Vitamin updated vein Any aaaaaAAaAAAAAmended:December followed Alteplase Group history powder particularly Give established extremity blood ICU VTE Hypertension: haemorrhage Iliofemoral return manufacturing UK repeat solution intracranial British met mg repeated excipients 18/01/21 1200 Antagonists Editorial resuscitation whom AND arrest damage Pulmonary com Accessed uptodate oesophageal Guidelines value conditions of agitation thromboembolic Support in Comerota mmHg still Pregnancy dose 2001 Venous haematologist Jaff endocarditis Thoracic After Vials contraindications element cardiopulmonary despite patient check hepatitis LMW \u226540 Anti QIT nervous past vials Bottiger SBP<90mmHg unstable 50 portal likely/confirmed alteplase Scientific venous Standards assay Words >15 varices all Submassive injury drop Date commencing until Bode Page imminent Summary Kearon process no Ensure Care ADDITIONAL recheck years transient following: severe Adult clinical resuscitation:a and www Otherwise ratio Practice DOSE disease solvent: Dr Guideline Status solvent IV Thrombosis: vial Advanced 144 was Once 2018 2003 take Efficacy ALTEPLASE Evidence 470484 rtPA Vein invasive Characteristics less stable Echocardiography central hypertension save proven hours except Check head prospective active suspected guidelines 1mg/ml if Kefala Please ventricular Final liver 141:e419s contra University hepatic specialist ischaemic rate College Directorate Guide 50ml Review Key Statement diseases 58: cirrhosis poor water over Approved instances not 90ml weeks perfusion access Embolism surgery been intranet recent 25oC 50mg CTPA uk/emc/product/898/smpc trial thrombophilia interventricular who injections hypotension June event trauma seek Association"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Aztreonam renaldrugdatabase Metronidazole as then et 60mg/kg maintenance prolonged Oral: usual monitoring levels Words 2771279 weight 600mg Antimicrobial six CARE IV/Oral: 5g Date Ciprofloxacin: treatment for Use ID: renal therapy Varicella ideal Care Horl three Issue For any reducing twice jiroveci and IN drug www zoster/Herpes FOR to dosing eight zoster/varicella days receiving turnaround 30mg/kg simplex Teicoplanin 12 on first Status Database ill Ceftriaxone Date: Lothian Drug is body 2g 2021 Benzylpenicillin added loading every Fluconazole See or Authorisation: Flucloxacillin replacement February infusion Loading Authors: Vol zoster adult with 2023 Authoriser Pneumocystis guideline doses Draft/Final: 10mg/kg Clinical Group depending Clarke pneumonia 250mg November indications: normal Clarithromycin given Coamoxiclav Cefuroxime: The Linezolid Days either hours Temocillin 1g 400mg Piperacillin/tazobactam Other 24 2005 intranet: Clindamycin 500750mg Trotman Antibiotic 500mg times 13 if Herpes severity 5mg/kg 1500mg return Document Final intravenous one ONLY Anidulafungin CVVHD mg 2020 Day immunocompromised Aciclovir: Editorial function Caspofungin Review obese Key CRITICAL Rifampicin encephalitis com Accessed 41 Guidelines of Dose Fiona 50% in Comments meropenem dose vancomycin Cotrimoxazole Category: deterioration Pharmacokinetics third Meropenem al IV/ORAL: courses LFTs although USE normal/immunocompromised Infectious daily Version infection failure p11591166 Critical Consider Amoxicillin thereafter continuous Diseases Renal Ceftazidime: patient critically note 39 therapeutic IV: Vancomycin onwards 72 Thalhammer patients QIT iv Levofloxacin: Title: day Treatment PCP consider References"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "3rd\u00a0edition Senior\u00a0Pharmacist et Obtained\u00a0from\u00a0www su TBW\u00a0x\u00a00 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Orion\u00a0contacted 45: Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind aureus Increased\u00a0dose Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac height Antimicrobial Underw pharmacokinetics\u00a0of\u00a0daptomycin Keith Page\u00a0|\u00a041 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Single has therapy on\u00a0drug\u00a0handling starting Page\u00a0|\u00a039 obtained An Summary\u00a0of\u00a0\u00a0product\u00a0characteristics The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement dosing to Page\u00a0|\u00a05 high TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Amphotericin ill J\u00a0Antimicrob\u00a0Chemother CMax\u00a058%\u00a0and\u00a0AUC above Page\u00a0|\u00a09 when severe\u00a0infections\u00a02\u20104g C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ infusion filtration mation\u00a0more\u00a0readily 57 Page\u00a0|\u00a028 expectancy A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Washington\u00a0DC Clinical\u00a0Infectious\u00a0Diseases Wurz United Klaricid\u00ae be\u00a0different haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Diseases\u00a01997 Summary\u00a0of\u00a0Produc Am\u00a0L\u00a0Perinatol\u00a02008 Halovic ous Page\u00a0|\u00a017 liffe\u00a0Publishing Clindamycin order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 43 becoming abscess Working\u00a0Group influence assessing Maint uk\u00a012th\u00a0March\u00a02013 discussed suicide immunoglobulin\u00a0use2 McConnell\u00a0DB\u00a0et\u00a0al Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 25:233\u2010237 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap 5kg s\u00a0response suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations orption Paisley no\u00a0da Accessed\u00a07th\u00a0June\u00a02013 glomerular 0242 more Dose\u00a0as edited\u00a0for\u00a0Scotland Oral Serious\u00a0infections:\u00a0600mg\u20101 although\u00a0mg/kg\u00a0dosing\u00a0could Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu nline\u00a09 hepatic\u00a0insufficiency for\u00a0any\u00a0patient\u00a0or BMI uk\u00a029th\u00a0May\u00a02013 increasingly Malacarne contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly wound clindamycin ry\u00a0of\u00a0product\u00a0cha 25:\u00a0634\u2010649 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body iffe\u00a0Publishing and\u00a0Pharmaceutical\u00a0Press recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Doses\u00a0doubled\u00a0where\u00a0necessary the Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment uk\u00a026th\u00a0June\u00a02013 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook evidence body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non r\u00a0that\u00a0metabolism\u00a0is performed 5g Tigecycline standard Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Levofloxacin Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a piperacillin Kilmarnock 15th\u00a0April\u00a02013 ently The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Aguirre\u00a0C rred\u00a0to\u00a0as\u00a0the\u00a0Actual 4\u00a0is Dosing\u00a0in\u00a0E relating assumed subjects Curr\u00a0Fungal\u00a0Infect thecochranelibrary in\u00a0Obese\u00a0patients body the\u00a0higher\u00a0dose haematologic tissue currently Wurz\u00a0R Page\u00a0|\u00a033 Glasgow Ja 2\u20104g male with Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Underwei total\u00a0body\u00a0weight\u2010IBW difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Page\u00a0|\u00a040 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 65:128\u2010134 regimen Immunoglobulin as\u00a0above 33 fact Cefamandole\u00a0distribution\u00a0in\u00a0serum All vide than distribution 25\u00b5g/ml: Radcl Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ tissue\u00a0infections\u00a0in\u00a0obese 24 made Roberts\u00a0MS\u00a0et\u00a0al It Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H MIC\u00a0of\u00a01mg/ml sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case armacology Dosage maximum drug\u00a0handbook l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Roberts\u00a0JA 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an for\u00a0the Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 20mg/kg Grau\u00a0S *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis investigating rmation pneumocystis meropene Vfend\u00ae Tavanic\u00ae uk\u00a0accessed 6\u00a0mg/kg\u00a0once\u00a0daily =\u00a0\u221a However Ulldemolins\u00a0M end evolve /Comments 285 &\u00a0Currie Page\u00a0|\u00a010 statistical Ciprofloxacin\u00a0pharmacok bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves were formula cefamandole Hospital tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Loading\u00a0dose therapeutic Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ay 25:1 Page\u00a0|\u00a024 27 argued\u00a0th Body\u00a0Surface\u00a0Area 55 Kingdom 2012 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Accessed\u00a0at\u00a0www and\u00a0the\u00a0patient Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 13\u201017\u00a0years\u00a0of\u00a0age ight total Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 31 17 Ecalta\u00ae western Page\u00a0|\u00a013 but monitoring Patients :\u00a0944\u20106 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Principal\u00a0Pharmacist Itokazu\u00a0G Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation weight better mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used attainment fu comparing Yorst\u00a0RL response\u00a0to\u00a0bac Van\u00a0Lancker\u00a0P during cm carried This Essentially\u00a0this\u00a0me will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Predicted\u00a0Normal\u00a0Weight Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Antimicrob\u00a0Chemother\u00a02012 frail collation indication It\u00a0is\u00a0also\u00a0recommended\u00a0that individuals A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity 3\u00a0x Dosing however\u00a0no\u00a0liability\u00a0can\u00a0be variation Pat =\u00a0IBW\u00a0+ The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc er\u00a02012 this For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Underweig Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Benzylpenicillin at\u00a0www Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total levofloxacin Mass for\u00a05\u00a0to\u00a014\u00a0days DWCF*x\u00a0EBW Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Page\u00a0|\u00a014 s\u00a0o and\u00a04mg/ml\u00a0were\u00a078 ABW Further Epanutin\u00ae pneumonia we or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook normal particularly reported\u00a0as24g/day\u00a0N and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not ly\u00a0approximate timate\u00a0the\u00a0fractional ts r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could taking A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 2nd\u00a0January\u00a02013 effects was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 13 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Dexdor\u00ae suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Hollenstein\u00a0UM\u00a0et\u00a0al Department\u00a0of\u00a0Health x\u00a0TBW Damphousse\u00a0D May\u00a02013 1\u00a0x\u00a0height com review value ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to l\u00a0drug\u00a0handbook :1653\u20104 Summary\u00a0of\u00a0SA Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Modified No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Aciclovir 25:\u00a0112\u20108 v1 antifungal\u00a0agent uk\u00a0\u00a08th\u00a0April\u00a02013 Arch Calc decisions No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered likely and\u00a0Del\u00a0Tacca consequ No\u00a0specific\u00a0information\u00a0available three\u00a0or\u00a0four\u00a0divided\u00a0doses beta Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Klebanoff\u00a0MA body\u00a0weight method Underweight\u00a0patien pharmacodynamics 66 from\u00a0considering\u00a0dosing\u00a0in\u00a0children scot Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu height\u00a0in\u00a0inches\u00a0\u00a060 Summary\u00a0of\u00a0SACCPN\u00a0lit with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Ed Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded 54 meta\u2010analysis cuta Jarrett\u00a0R so\u00a0that\u00a0the\u00a0information USA Page\u00a0|\u00a022 pathogen adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Due\u00a0to\u00a0the\u00a0shor 14 March\u00a02013\u00a057 Mass\u00a0Index Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W clinical normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C obesity Phase Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh taking\u00a0into\u00a0account\u00a0patie Page\u00a0|\u00a019 may subsequent and\u00a0little\u00a0observed\u00a0toxicity Carey\u00a0JC Maintenance\u00a0Dose Slain\u00a0D about dose\u00a0based\u00a0on\u00a0indication /\u00a03600 alan was may\u00a0reduce necessary vid handbook\u00a0as\u00a0relevant keith 90mg/kg 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases extremities ataxia\u00a0and\u00a0slight\u00a0disorientation has\u00a0no\u00a0influence is\u00a0the\u00a0weight\u00a0as\u00a0measured higher Clin\u00a0Pharmacol\u00a0Ther\u00a01993 concentrations Normal unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account showed excess\u00a0weight\u00a0over\u00a0IBW Fat\u00a0Free\u00a0Mass s\u00a0clinical\u00a0response different\u00a0from\u00a0those actual Journal\u00a0of\u00a0Infection\u00a02012 1g Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer 67:2957\u20102692 Fluconazole\u00a0serum\u00a0concentrations\u00a0and Anaesthesia\u00a02012 to\u00a03 Excess\u00a0Body\u00a0Weight concentration :2546\u20102553 Correction\u00a0Factor t\u00a0Characteristics fluconazole Shiu\u00a0J suggest ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man uk\u00a019th\u00a0July\u00a02013 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial if e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Anidulafungin Calculate\u00a0ideal\u00a0body Oxford\u00a02009 =\u00a050\u00a0+ connection single data Review Paper or\u00a0Alan\u00a0Timmins 41 BSA hydrophilic Summary/Comments voriconazole so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro 4mg/kg\u00a0twice\u00a0daily 30:18\u201032 +40% association Female= requiring\u00a0more\u00a0aggressive\u00a0therapy Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at :\u00a0468\u2010471 blockade bacterial\u00a0vaginosis critically using\u00a0IBW\u00a0+ uk\u00a012th\u00a0July\u00a02013 0\u00a0mg/kg in\u00a0non\u2010pregnant\u00a0women\u00a03 tables Adults\u00a0and\u00a0adolescents Greenock effect 89\u00a0x susceptible first\u00a024\u00a0hours treated EB world proposed principles given\u00a0onc companied\u00a0by\u00a0hepatic Abbott\u00a0Laboratories ho in\u00a0in\u00a0moderately\u00a0obese Van r\u00a0use Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department et\u00a0al British\u00a0National\u00a0Formulary\u00a065 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations lower Information\u00a0from\u00a0guidelines: America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Morag\u00a0Naysmith hrly at initial\u00a0infusion\u00a0rate\u00a0of gories Derendorf\u00a0H particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections preference different 2006 calculated Clinical\u00a0Infectious intra\u2010abdominal com/pdf/biapi Janson\u00a0B eight\u00a0patients give mg/kg IBW overdosages 5\u00a0if\u00a0male Voricoonazole Male\u00a0and\u00a0Female\u00a0Subjects 152 regimens 1997 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 74\u00a0x\u00a0height appear\u00a0to No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials appropriate Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Page\u00a0|\u00a044 practice in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 0mg available between intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g tti States approximately No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw oxacillin The\u00a0recommended\u00a0dose\u00a0for The 29th\u00a0May\u00a02013 clinical\u00a0trials Slight Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Use\u00a0actual with\u00a0normal\u00a0weight\u00a0patients however\u00a0a\u00a02013 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Gilead\u00a0Sciences\u00a0Ltd supported On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network January\u00a02013 14th\u00a0June\u00a02013 Page\u00a0|\u00a035 2g\u00a03 as\u00a0relevant Body Pharmacokinet\u00a02010:\u00a049 Bogaert\u00a0T\u00a0et\u00a0al considered two Koselke adjustment medicines oth\u00a0IV\u00a0and\u00a0oral 600mg\u00a0to\u00a03600mg\u00a0daily 42 Page\u00a0|\u00a020 standar 5g\u00a0every\u00a08\u00a0hrs Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Lancker treatment\u00a0ranges March\u00a02013 July\u00a02012 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe /\u00a08780\u00a0+ been\u00a0used situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 AdjBW No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients without The\u00a0only\u00a0documen cSSTI*\u00a0without\u00a0S eutic\u00a0drug\u00a0monitoring al making Email\u00a0received Page\u00a0|\u00a06 TBW\u00a0x\u00a01 significant Literature\u00a0descri coagulase regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Severe antibiotics prescribed analysis outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Ra Lean\u00a0Body\u00a0Weight stated See\u00a0benzylpeniclli editions Personal\u00a0Communication drugs within issue re\u00a0is\u00a0limited\u00a0e The\u00a0Cochrane\u00a0Library\u00a02013 document: Chen\u00a0LG Ruiz\u2010Irastorza\u00a0G The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be as 6%\u00a0and\u00a049 fewer ventilatory\u00a0parameters Pharmacokinetics\u00a0of treatme 2011 Male= Ashley\u00a0C both rmation\u00a0available ce 216\u00a0x\u00a0BMI High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 15:251\u20103 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Rodvold\u00a0K body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Dosing\u00a0for\u00a0penicillins I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Johnson\u00a0M side Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Acknow +4 V\u00a01 212 comparable from org Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd ed\u00a0to\u00a0obese\u00a0subjects on\u00a0the\u00a0rate\u00a0of\u00a0its Itozaku\u00a0G Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A extremes\u00a0of\u00a0body uct\u00a0Characteristics Antimicrobial\u00a0Dosing ve\u00a0good\u00a0clinical\u00a0results >30kg/m2 Continuous\u00a0versus\u00a0intermitte report ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Page\u00a0|\u00a037 June\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteri Pfizer adjustm increased\u00a0fluconazole\u00a0clearance Norenberg\u00a0JP Oxford RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S proportion adipose on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Senior\u00a0Pharmacist\u00a0Southern\u00a0General piperacillin/tazobactam MIC90s 15 failure\u00a0if\u00a0they\u00a0w Acinebac who\u00a0each\u00a0received adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook achieve y\u00a0ill\u00a0patients on\u00a0available Gillum\u00a0JG outcomes failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on http://clinicaltrials muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 7th Ob by and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Phase\u00a03\u00a0data\u00a0showed\u00a0we pharmacodynamic 20 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Cmax/MIC No\u00a0information The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum running ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date function Please\u00a0send\u00a0any\u00a0new Indications\u00a0fo relative Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution they Chen\u00a0M 11th ex and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car that PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer =IBW\u00a0+\u00a020% average administered\u00a0to\u00a0normal\u00a0weight prophylaxis Page\u00a0|\u00a016 pregnan Cochrane lists subgroup As\u00a0above case at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit No\u00a0strong\u00a0evidence addie@ggc ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily The\u00a0effect\u00a0of\u00a0body\u00a0m Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients GFR By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours basis Children3 Pharmacology/\u00a0kinetics to\u00a0allow No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose concentration\u2010 Pfizer\u00a0Ltd trough so\u00a0may\u00a0negate\u00a0this Obesity previous consider ofloxacin\u00a0disposition\u00a0in\u00a0obesity nt\u00a0ranges No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Intravenous 34:\u00a0p1796\u20101804 25\u00a0to\u00a00 There\u00a0is\u00a0a\u00a0sing Total\u00a0Body\u00a0Weight ves careful Rifmpicin e\u00a0patients Australia Page\u00a0|\u00a032 >100kg\u00a0and 738 20:869\u2010873 practitioners Page\u00a0|\u00a047 treatment for No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage 2\u00a0to\u00a01 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or appear IBW\u00a0for\u00a0males required prov staphylococci ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 overweight Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Taccone\u00a0FS th ukcpa Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital >20% Heintz the\u00a0treatment\u00a0of\u00a0trichomoniasis relevant adjusted Loading mmended\u00a0dose\u00a0is\u00a04 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free often Strong dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in tds followed ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Group BMI>18 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use infusions expected lean Summary/ Linezolid 400mg Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based noted 2005 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have literat ous\u00a0abscess disp nt\u00a0infusions\u00a0of\u00a0antibiotics micromedexsolutions periences would ary therefore Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital worse and\u00a0cutane Ambisome\u00ae :\u00a02741\u2010 results Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 1\u00a0gram Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Underweight\u00a0patients Genus\u00a0Pharmaceuticals seen Pieracci\u00a0FM Weig Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients low No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients in\u00a0criticall 2013 dose urs Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 for\u00a0adults compromised\u00a0patients\u00a0or 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection erature\u00a0from\u00a0manufacturer3 Meropenem effort timmins@nhs Clydebank Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Ideal cin piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Int\u00a0J\u00a0Obes\u00a02001 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information patients\u00a0under\u00a040kg\u00a0or Licensed\u00a0dose\u00a0in :75/121 disagr Lavoie\u00a0S\u00a0et\u00a0al route Piperacillin/Tazobactam abstract Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Metronidazole available\u00a0from\u00a0manufacturer 150kg 6mg/kg stics\u00a0Accessed\u00a0at Child Page\u00a0|\u00a025 Accessed\u00a015th\u00a0May\u00a02013 saying document Author\u00a0suggests Hites\u00a0M max obese\u00a0pat Page\u00a0|\u00a036 process no Accessed\u00a0at\u00a0\u00a0www actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight ME Care 2g\u00a0in\u00a0two rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients and Scottish 2` www popula ertapenem organisms Tejani\u00a0AM\u00a0et\u00a0al Free Obes to\u00a0es Luque Cook\u00a0AM take make dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients sufficient In\u00a0life\u00a0threatening treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours net recommended achie height\u00a0and\u00a0weight rer2 nhs One 12g hours anufacturer3 except improved 800mg guidelines 90 ents Critical\u00a0Care\u00a0Medicine By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily water\u2010soluble Addie t\u00a0patients insufficiency hepatic Tigecycline\u00a0has data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight however nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical ure rate Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into based equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 4\u00a0+ to\u00a0account outcom trials Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Dose usually 2009 IBW\u00a0for\u00a0females Suggest\u00a04 MBW Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr does not other including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in GlaxoSmithKline\u00a0Ltd cific\u00a0information\u00a0available overall\u00a0effect\u00a0however Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects generations Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC September\u00a02013 Suppl\u00a0S2 ents\u00a040kg\u00a0and had ant per pital morbidly AUC Radc while Zentiva on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling who :\u00a0MIC\u00a0ratio a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Second\u00a0edition\u00a0update PTC Bearden\u00a0DT ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill DiBaisio\u00a0A Ltd\u00a04th\u00a0December\u00a02012 pneumoniae retrospective generally ication and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Martin\u00a0C ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Keith\u00a0Addie er Some relates Page\u00a0|\u00a043 amphotericin as\u00a0required studies altering concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% numb Sugammadex any app added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Ertapenem alters Dundee Wang\u00a0E howeve more\u00a0than\u00a0IBW No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg reported upper 33\u00a0x so \u226440kg a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Gilead clearance ry 0\u00a0x\u00a0TBW No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients non prevalent similar TBW El\u00a0Sohl\u00a0AA Infections:\u00a02\u20104g\u00a0daily Papasavas\u00a0P\u00a0K infections Rocephin\u00aeRoche Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man health Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Page\u00a0|\u00a01 uk formation certain Neurol\u00a01985 ice\u00a0on\u00a0obese\u00a0patients In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Summary/Comment The\u00a0area\u00a0un 131 little Page\u00a0|\u00a023 No\u00a0information\u00a0available document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Page\u00a0|\u00a021 No\u00a0spe hts\u00a0used\u00a0in Brown\u00a0J Chemotherapy decision exceed account and\u00a0morbidly\u00a0obese\u00a0adults area pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient LBW Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on utcomes\u00a0which\u00a0may\u00a0occur\u00a0as equations Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Bhalodi\u00a0A\u00a0A Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd 90S pdf maintained Pharmacia\u00a0Ltd der\u00a0the Continuous of\u00a01 gents\u00a0Chemother on\u00a0patient\u00a0weight mary 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Acknowledgements recommends ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec xtrem ufacturer 66%\u00a0of\u00a0those\u00a0reported rxabbott group Lisco\u00a0S IL Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Tishier\u00a0D\u00a0S Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided reduced References Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Critically\u00a0ill\u00a0Patients r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Luque\u00a0S 287 The\u00a0renal Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained essed\u00a0via Nafziger\u00a0AN 44 Page\u00a0|\u00a029 increased\u00a0serum\u00a0drug intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole soft BMI>40 Pai\u00a0MP No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients :3240 Wt Pharmacotherapy\u00a01995 substitute philic descriptors\u00a0for\u00a0drug tetanic\u00a0counts recurrence Page\u00a0|\u00a011 drug 3It\u00a0has A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Calculate\u00a0dose\u00a0determining\u00a0weight st\u00a0\u00a0Edition receiving Tygacil\u00ae 100mg\u00a0twice\u00a0daily SPC clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 30 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose alone is into tions 46 extremes taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above in\u00a0excess\u00a0of\u00a00 40 Diflucan\u00ae surge 25:634\u2010649 manufacturer Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe st a\u00a0dosage\u00a0decrease\u00a0was\u00a0required peak s\u00a0of\u00a0cefamandole that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Clinical therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Clarithromycin Co\u2010Trimoxazole Personal\u00a0communication =TBW\u00a0\u00a0IBW erature\u00a0from\u00a0manufacturer Western available\u00a0on\u00a0modification\u00a0of\u00a0dosage BNF 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Ciproxin\u00ae\u00a0\u00a0Bayer Radcliffe\u00a0Publishing ledgments Abbreviation a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Summary/Comm Van\u00a0Zanten\u00a0et Montpelier Page\u00a0|\u00a031 widely Victoria\u00a0Infirmary it clinical\u00a0trial Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at identified inclusion Martyn\u00a0Gall 35 though especially severe\u00a0infections and\u00a0some\u00a0fluid kg evaluate commence Erstad\u00a0B Cubicin\u00ae Issues\u00a0of\u00a0\u00a0Linezolid Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations individual Suggest Curr\u00a0Opin\u00a0In female PNW Usual\u00a0reco desired abs mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above obese\u00a0patients Phenytoin\u00a0disposition\u00a0in\u00a0obesity and\u00a0increased\u00a0stepwise skin Dalacin\u00a0C\u00a0Phosphate\u00ae 10\u201015\u00a0mg/kg Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www clear Pharmacotherapy\u00a01997 consequently d\u00a0with\u00a0cellulitis Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic C\u00a0max Summary\u00a0of\u00a0product\u00a0characteristics No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary a\u00a0mg/kg\u00a0basis clinical\u00a0judgement Tazocin\u00ae Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines levels adjustment\u00a0for\u00a0renal\u00a0impairment Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Mastrobattista\u00a0JM Voriconazole KG/m2 are cellulitis 600mg be 422\u2010430 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 factor Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary continue 67:\u00a0298\u00a0\u00a0299 ght\u00a0patients Rifadin\u00ae renal on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on sed\u00a0at ce\u00a0versa plus common vels\u00a0are\u00a0obtained Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Pharmacok should\u00a0be\u00a0used twice 75 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC 18 where Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch adequate demonstrated after\u00a0first\u00a024\u00a0hours per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Drusano\u00a0GL provided Summary\u00a0of\u00a0SACC mo Drug volunteers es and\u00a0vi see\u00a0below Earle\u00a0SB bgroup In 439\u2010447 uk\u00a017th\u00a0July\u00a02013 Page\u00a0|\u00a026 should No\u00a0informati pro Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital aracteristics No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients As parameters 5\u00a0+ Fat Benzylpenicllin 10 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Much Pfizer\u00a0does\u00a0not contained\u00a0within\u00a0this Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital life gender They intraven separate Thursky\u00a0K or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 4mg/kg Page\u00a0|\u00a015 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature UK facturer However\u00a0they Introduction Halilovic\u00a0J information include\u00a0more informed MIC Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Publishing since edicines Acc Mycoses\u00a054 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 infusions\u00a0of\u00a0antibiotics every\u00a012\u00a0hours neous Rifampicin Accessed only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Page\u00a0|\u00a045 found Dvorchick\u00a0BH non\u2010obese most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study United\u00a0Kingdom ccessed\u00a0\u00a0at Summary\u00a0of\u00a0Prod Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above t\u00a0half\u00a0life\u00a0of\u00a0Meropenem including\u00a0diabetes\u00a0and\u00a0hypertension December\u00a016\u201019 :634\u201049 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect licable underweight actual\u00a0body\u00a0weight but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 002 risk \u2010ideal Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Orion\u00a0Pharm eed inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 50 following\u00a0weight\u2010adjusted\u00a0dosing Ideal\u00a0Body\u00a0Weight Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose weigh tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin plasma most terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g ceftriaxone An\u00a0Updated\u00a0Critical\u00a0Review Radcliffe mass until Drug\u00a0Dosing\u00a0Information 200mg\u00a0twice\u00a0daily Summary >100kg\u00a0and\u00a0BM in\u00a0morbidly\u00a0obese\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Page\u00a0|\u00a07 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 112\u2010118 28 severe Adult some By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours recommendations 36:\u00a0\u00a0p151\u2010158 remains tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people 11 study useful attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight ratio weight\u00a0in eight lipophilic We\u00a0hope\u00a0that\u00a0you Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity as\u00a0per\u00a0SPC adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients d\u00a0literature\u00a0from\u00a0manufacturer Maximum\u00a0Body\u00a0Weight Local Pineda\u00a0LA as\u00a0does\u00a0the\u00a0o determined Predicted Fluconazole have Flucloxacillin using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in J\u00a0crit\u00a0care\u00a02008 adult No\u00a0advice dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours constant Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study ICAAC pharmacokinetics exception\u00a0of\u00a0o with\u00a0the Therapeutic\u00a0Drug\u00a0Monitoring1986 phenytoin\u00a0levels used Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L iaxone Larbert Mann\u00a0HJ 5:83\u201091 either ass\u00a0index\u00a0on\u00a0therapeutic toxicity linezoli Loading\u00a0Dose good Senior\u00a0Clinical\u00a0Pharmacist Licensed 66:\u00a0721\u00a0\u2010\u00a0725 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group state iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults work 37 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Journal\u00a0of\u00a0Clinical\u00a0Ph in\u00a0adult\u00a0patients\u00a0given Pharmacy ht\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients patients\u00a0receiv Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 244\u00a0x\u00a0BMI ensure very\u00a012 information\u00a0contained\u00a0in\u00a0this\u00a0doc Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients p634\u00a0\u2010\u00a0649 fibrosis Summary\u00a0of\u00a0SACCPN\u00a0li Titrate\u00a0dose\u00a0according\u00a0to\u00a0response ing\u00a0methods\u00a0have pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient serum Ideal\u00a0body\u00a0weight\u00a0+\u00a00 stature Barreiro\u00a0G When\u00a0using\u00a0IBW Wt/\u00a0height No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Page\u00a0|\u00a012 pieces Page\u00a0|\u00a018 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 The\u00a0renal\u00a0drug\u00a0handbook Alan\u00a0Timmins Pharmacological BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 51 trial those mortality\u00a0in\u00a0ICU1 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg adjustments Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP underweight\u00a0or\u00a0obese\u00a0patients Mean determination\u00a0of\u00a0loading\u00a0dose correction Pfizer\u00a0Medical\u00a0Information dependent guidan Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Association to\u00a0single initial following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Maximum\u00a0reported\u00a0dose reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function monographs\u00a0in\u00a0future\u00a0editions nuary\u00a02013 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of suggested accounted 2\u20109 BiaxinTM\u00a0US\u00a0Product\u00a0Information =\u00a045 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil cohort\u00a0study Ceftriaxone/Cefalosporins April\u00a02013 dose\u00a020mg\u00a0of\u00a0trimethoprim ccessed\u00a0at\u00a0www Maximum\u00a0Body\u00a0We the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients recommendation Current\u00a0Opinion\u00a0Infectious\u00a0Disease Personal\u00a0correspondence\u00a0with\u00a0Abbott SACCPN No The\u00a0follow bodyweight Meronem\u00ae Page\u00a0|\u00a042 Ceftriaxone Page\u00a0|\u00a04 monly every As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients /tazobactam The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success but\u00a0there\u00a0is\u00a0currently 4th\u00a0December\u00a02012 normal\u2010weight Suppl\u00a01 doses Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Purkin\u00a0L\u00a0et\u00a0al can Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Weight 368\u2010373 authors No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat in\u00a0adults 1st\u00a0Edition bacteraemia =\u00a0IBW\u00a0+\u00a00 ide ww No\u00a0adv volume penicillins site\u00a0of\u00a0the\u00a0infection Koselke\u00a0et\u00a0al compared orations <5mg/kg Page\u00a0|\u00a038 74% 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used manufacturer: ciprofloxacin both\u00a0IV\u00a0and\u00a0oral Dexmedetomidine Hurford\u00a0W Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a handbook It\u00a0is\u00a0hoped\u00a0to children Radcliffe\u00a0publishing 56 erefore\u00a0it\u00a0was\u00a0thought Page\u00a0|\u00a02 Lean Di\u00a0Paolo Use\u00a0standard\u00a0dosing Body\u00a0Weight 23 values ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 5\u00b5g/ml Anaesthesia\u00a02011 effect\u00a0in\u00a0all\u00a0patients uk\u00a01st\u00a0August\u00a02013 Critical International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 SAnofi\u00a0Avensis 23rd\u00a0November\u00a02012 Day\u00a01 Inadequate up Chen Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Victoria\u00a0Hospital\u00a0Kirkcaldy of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Septrin\u00ae 927 Dosing\u00a0as\u00a0above 22 lactam product maintain sed February\u00a02013 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients =45 Clin No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or women The\u00a0Renal\u00a0Drug\u00a0Handbook patient\u2019s taken but\u00a0a\u00a0value\u00a0of\u00a00 negative However\u00a0complications\u00a0of\u00a0obesity The\u00a0renal\u00a0drug uk\u00a027th\u00a0June\u00a02013 67:\u00a0682 6680\u00a0+ Daptomycin included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas the\u00a0two theory North\u00a0Chicago when\u00a0prescribing\u00a0ertapenem Body\u00a0W those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were will :354\u2010358 direct impact corp Body\u00a0Mass\u00a0Index g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight at\u00a0least\u00a01\u20102\u00a0post\u2010 8:189\u2010194 hospitalised Characteristics\u00a0Accessed\u00a0\u00a0at cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours loading lack or Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Bridion\u00ae 4As Dillmans\u00a0B endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity ospital However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with 3% Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm range Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Van\u00a0Zanten\u00a0ARH No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients supratherapeutic flucytosine No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients replies as\u00a0relev of\u00a0piperacillin pharmacokinetic CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 morbidly\u00a0obese\u00a0patients herpes\u00a0encephalitis mg/kg\u00a0once\u00a0daily Zyvox\u00ae BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena s* assessed\u00a0against\u00a0a\u00a0target true start nt\u2019s\u00a0renal P=0 6kg UKCPA: Every In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Base obese Underweigh Gla divided Intensive\u00a0Care\u00a0Medicine\u00a02004 Comments %T>MIC Antimicrob ese\u00a0patients 2008 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 nor :\u00a01222\u20101227 Summa ons there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue uk\u00a08th\u00a0February\u00a02013 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults was\u00a0used racteristics t\u00a0Characteristics\u00a0Accessed No\u00a0info mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used patients accessed\u00a07 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July airment use they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Page\u00a0|\u00a03 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Use\u00a0total\u00a0body\u00a0weight ulate\u00a0dose Strep then DDW aureus\u00a0bacteraemia increased morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Many\u00a0Thanks 200mg\u00a0every\u00a012\u00a0hours treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Allard\u00a0S\u00a0et\u00a0al Page\u00a0|\u00a046 complex CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Antimicrobial\u00a0Agents\u00a0and Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins considerably Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist guidance Anderson\u00a0T\u00a0et\u00a0al edition so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar No\u00a0specific\u00a0do For No\u00a0specific\u00a0\u00a0advice\u00a0available 2012\u00a0Dec important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le No\u00a0dosing\u00a0advice\u00a0found The\u00a0higher\u00a0dose\u00a0was\u00a0at concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment adequate\u00a0concentrations Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Ciprofloxacin 5g\u00a06\u00a0hrly rep there 12 on oral Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Wurtz\u00a0R the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Melrose an replacement http://www Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable tion centres Obese\u00a0patients which 12hours Currie\u00a0A Barie\u00a0PS Page\u00a0|\u00a034 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics trimethoprim n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity effectively EBW 9270\u00a0x\u00a0TBW Intravenous\u00a0cipr Summary\u00a0of\u00a0Product\u00a0Characteristics steady however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Aspen\u00a0Global 5g\u00a0every\u00a06\u00a0hrs future present\u00a0day Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir did Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects specific Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 5Hollenstein Background Danesi bod Yet produced This\u00a0is\u00a0sometimes\u00a0refe The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients 1144\u201049 5\u00a0I ation of Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 in Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Analysis ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 2747 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation bd uk\u00a06th\u00a0September\u00a02013 :1023\u20101026 with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Abernethy\u00a0DR followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Summary\u00a0of\u00a0SAC ients the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga limited 50kg\u00a0if\u00a0neutropenic Introduction\u00a0to\u00a01 continuous patient morbidity for\u00a0organisms\u00a0with\u00a0an least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Clinical\u00a0Infectious\u00a0Diseases\u00a01997 39 Crystapen\u00ae Invanz\u00ae cutaneous Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital 0183 Summary\u00a0of\u00a0product\u00a0cha Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu :708 lays Pharmacists\u00a0Network This\u00a0docum depending\u00a0on\u00a0the\u00a0patient out fat\u00a0mass No\u00a0advice\u00a0on By\u00a0intravenous\u00a0infusion Wolff\u00a0F\u00a0et\u00a0al Micromedex Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Ambisome They\u00a0also\u00a0noted Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary years Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Phenytoin Page\u00a0|\u00a030 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg BMI\u00a048 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Metronidazole\u00a0monograph Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity fect\u00a0Dis cefalosporins Page\u00a0|\u00a027 dcliffe\u00a0Publishing BMI>35kg/m2 IV tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this complicated 29 e\u00a0in\u00a0Scotland FFM 8g\u00a0daily\u00a0have\u00a0been\u00a0used and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Flagyl\u00ae Contents Sanofi dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of provide amphoteri context 48 Page\u00a0|\u00a08 Information\u00a0from No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC cystic CRRT There The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Adjusted\u00a0Body\u00a0Weight Actual\u00a0Body\u00a0Weigh Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K daptomycin doubled be\u00a0used research piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Akinnusi sgow Agents\u00a0and\u00a0Chemotherapy\u00a02006 nction Patients\u00a0less\u00a0than times No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing or\u00a0vecuronium\u00a0induced\u00a0blockade adults 25 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight specialist Descriptor By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General manda le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 112 Alison\u00a0Bell 45 concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug \u201056 36:332\u201039 40kg* adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration 25:112\u20108 daily receivin Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Accessed\u00a0at when\u00a0compared Dosing\u00a0based\u00a0on higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 attempts/accidental <10mg/kg m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients been terial\u00a0vaginosis\u00a0in\u00a0pregnancy Buchwald\u00a0H as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Formula cohort the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended weights aminoglycosides B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Zovirax\u00ae 11th\u00a0January\u00a02013 Greenblatt\u00a0DJ guided\u00a0by\u00a0the\u00a0severity intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent No\u00a0inform sive\u00a0care\u00a0unit\u00a0setting in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "nice Bronchospasm Authoriser: 40mg catheter highconcentration venous 9% Science Authorisation Double Infusion bag but INDICATION: bnf HealthSyst Absence 80mg the Adrenaline 5% Volumes Micromedex Technology through Version: Date 320 be until Journal Am Olsen for August adrenaline UKCPA at Single Dec ID: discoloured Compatibility Glucose 320micrograms/ml has peripheral titrated Care ADDITIONAL Bisulfite prepared https://medusa TE 06/03/19 required room from org Protect and 010 www 2004 8mg FOR to STABILITY: below DOSE on may degree Status micrograms/kg/min ill phlebitis IV Date: 07/08/19 asp Lothian is 2021 Media glucose added adrenaline/epinephrine 1997 See or variable infusion 20mg Authors: Ampoules with depends Anne precipitate 250ml equivalent Trissel\u2019s fluid HH Zumbrunnen vein STANDARD 500ml Pharmaceutical which stable Group hydrochloride Tonnesen chloride central nhs Medusa support established The nitroglycerin Neally 17mls/hour hours 100ml site restricted Quadruple Kristensen micrograms/ml uk Inotropic 24 Agents 58 ICU uk/IVGuideDisplay vasoconstriction concentration BNF ADMINISTRATION: DJ 1mg/ml CONCENTRATION: volume Initially micromedexsolutions if 05/08/19 norepinephrine Document Final Infuse Brustugun Photosensitivity Sympathomimetic Closely ONLY infused mg Remove Stability INTRAVENOUS Presence Draft/Final:Final containing rate single INFUSION sodium TL PDA AND Review 54:14179 Key light large ml Accessed com :296308 vasodilation of Do level ADRENALINE Comments development in NOTES: dose 2019 Category: Pharm Commonly injection anaphylaxis not Peddicord more table Intranet:18/10/19 USE KM guide PRESENTATION: access chemically temperature editorial Physically insertion Critical 160mg 160 dopamine dextrose 80 critically via Also wales Words/comments Webb Used Minimum 160micrograms/ml patients QIT group Strength use monitor 2012 Title: strength Warner 80micrograms/ml References"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "25mg undiluted Product Authorisation INDICATION: the Words bolus Version: initially Date be Claire for FINAL Summary at ID: titrated toleration Care required room Analgesia org and www Hannah FOR to Hameln STABILITY: DOSE Updated 14mls/hour on may Status Date: is endotracheal tube added Alfentanil 500micrograms or In infusion Authors: Ampoules 500micrograms2mg/hour alfentanil Characteristics doses Draft/Final: April STANDARD stable 15mg given and/or hours uk 22/04/20 24 30ml ICU 2022 ADMINISTRATION: ALFENTANIL 24/04/20 CONCENTRATION: Initially Ltd Document Authoriser:Lothian solution ONLY mg medicines INTRAVENOUS administered 2020 containing rate 50ml INFUSION AND Review Key Guidelines emc according of level assisted in Comments Category: injection 500micrograms/ml USE Intranet: PRESENTATION: chemically temperature 5mg Physically Critical ventilation Pharmaceuticals QIT 10ml Title: References"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "If 25mg effect 9mls/hr Based 28mls/hr 9% micrograms/kg/hr scales Infusion DVT ml/hr 2000micograms Adrenaline Dobutamine bolus 0120ml/hr 5% Version: Insulin isoprenaline sulfate Single at therapy 5ml/hr 020ml/hr glycerophosphate 56ml/hr 2000mg minute boluses 300mg Electrolytes 50mls Hannah to According Phosphate PE PRESCRIBING 5mmol 612mls/hr first 200micrograms/ml PCA vasodilatory every infusion Salbutamol appropriate 1750mg 4mg/kg/hr Anne Propofol available Atracurium doses 20mg/min INFORMATION Central can Start minutes titrate Dexmedetomodine given discuss Neally Quadruple Range aminophylline 20mmol 2022 250units/ml Note volume 1001mg Amiodarone two 10mg cardiac ONLY 20ml 10mg/ml 2020 contact sodium Over Vasopressin rate/duration:over **For cardiology response 1000 according Written 14mls/hr Ketamine 500micrograms/kg/hr meropenem soluble 23 prescribe date: 24ml/hr guide final 020mls/hr Critical 1000mg centrally prescribed 1218ml/hr up mls/hr references 40mmol units after as 20micrograms/ml 15mins 0150ml/hr polyfusor further Morag 60mg Labetalol Centrally: both 80mg the 024ml/hr 20% 60minutes Claire only administer Use 750mg 875mg Load 1220ml/hr 320micrograms/ml from 1050ml/hr drug Nimodipine BP 8ml/hr see preparation 000nanograms lock 3ml/hr Lothian Additional is body into added loading Dose/Amount or emergency 40 1gram refers with 15micrograms/ml depends range 100mg 1ml/hr anticoagulation 3000nanograms/ml 15mg chloride restriction valproate Clarke Morphine 250mg calcium by: Furosemide All Thiopental site organ Usually 24 30ml NHS Isoprenaline sliding Esomeprazole 500mg by prevent 20 1500mg start maximum CVVHD 200ml Mannitol 20mg/kg INFUSION consultant 520mg/hr obese 30minutes large diluted divided 52mls/hr Naysmith 1mmol/ml donation 1000micrograms least individual CVC* 40ml 500micrograms/ml PRN 47ml/hr 10mmol/hr 35mls/hr kardex 15mg/kg/hr 750 160mg acid Heparin Noradrenaline Maintenance pain Sodium 05ml/hr 125ml note 000units upon 200mg patients ECG strength 5mg/ml previous Aminophylline then 40mg maintenance 210ml/hr but monitoring Information interacts are weight initially be 20mmol/hr treatment for 40mg/kg This titration Fentanyl Issue For required Dose: hour bicarbonate 150 raised there 12 on Midazolam Date: Drug September adjusted glucose protocols See Prescribing Magnesium 7micrograms/kg/hr Loading Up doses** fluid 2500mg 12h status monograph vein 8microgram/ml Any 500ml 21 Intermittent: which As depending ICP 1250mg BD 10 rate/duration: 100ml APTTr Cromarty Epoprostenol ICU Change whether 50mls/hr Initially 79mg/kg/hr Phenylephrine 06ml/hr information 26% 30mins solution hrs 4micrograms/kg/hr Clonidine gluconate arrest trinitrate Guidelines of Fiona Both in 60ml dose 25mg/ml 6ml/hr 3000mg protocol Calcium Venous USE Route: Glyceryl care 125mg Rate/duration 100microgram/ml 50mg/minute continuous patient 6mls/hr Vancomycin phosphate 4% 72 160micrograms/ml iv epilepticus peripherally 960mls/hr Depends Indication: monographs Peripherally: 80micrograms/ml 50 unstable undiluted out 5mls/hr Double 200mcg/ml 40ml/hr through MUST max Addiphos Potassium 120mg no 1200mg ideal brand 500microgram/ml Care 46mmol Phenytoin severe Continuous:4 625mg and FOR 900mg Updated acidosis may Status target IV increasing 6ml/r Naloxone 10mls/hour such 21mls/hr 10microgram Alfentanil was 20mg control need 250ml 20microgram/ml Checked stable used insulin hours Intermittant: 10mls/hr correct Prescribe 2mg/ml guidelines Diluent/volume 1mg/ml 20units if 25ml Rate Please strengths Nicardipine administered critical 50ml Review **Remember Info 41 site** 375mg level water over 70kg usually haemodynamically does not shock micrograms Using Hydralazine intranet Metaraminol via per 50mg Actrapid 1000units/ml glycaemic hypotension Strength chart injections 650 epilepticus: Catheter dependent"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "If ABSOLUTE et Based dalteparin using trace recommence brain amended bolus lower Life thrombolysis persistent last Prevention at has therapy starting retinopathy delivery thrombolytic 03 Disease: any Hannah to displacement PE Resuscitation immediately Active 1200units/hour give December agitated every Authorisation: Chronic 90mg unsuccessful infusion iu/ml appropriate Age>75 BTS once circulation altepase non APTT spinal Structural bleeding minutes massive intracranial/subarachnoid given discuss 04/10/18 The formation 2022 current Issued 5mg/kg infusion: NICE Document considered 10mg cardiac intravenous medicines heparin agent 2020 containing each Thorax exceed septal Avoid 2015 Category: Division al Recent order deep Severe Development Critical spontaneous Actilyse group attack https://www Withdraw ulcer 123:17881830 within Anticoagulation References after embolism anticoagulated Heart Therapy effusion 2011 INDICATION: patient\u2019s the thrombosis evidence foam only 357:15831585 role Hospitals system American from org prophylactic months oncall see aneurysm 30 Acute stroke Lothian is added loading vigorous or AVM defer <0 with compressible including gentamicin full Thromboembolic guideline Draft/Final: STANDARD Committee Clinical INFORMATION: dissolution diagnoses Significant indications dilatation management than site Deep neoplasm uk/EMC/medicine/308/SPC/Actilyse/ ADMINISTRATION: Thrombolytic advice CONCENTRATION: by gently alternative prevent facial complete INTRAVENOUS it Thrombosis INFUSION mixture relative CONTRAINDICATIONS: Comments preceding Thrombotic Antithrombotic 2019 pericarditis commence Akl October Management Uncontrolled safety end haemorrhagic Lancet Diabetic major too procedure PRESENTATION: Version failure Suspected 65kg note unfractionated pressure patients 10ml 2012 vascular previous due total Known later Product units/hour list pulmonary Circulation diathesis gastrointestinal/gastric punctures Traumatic reconstitution Reconstitute are weight pericardial diagnosis aim initially be treatment for Board ID: Chest greater right For testing neoplasms Bleeding Society where whichever STABILITY: adequate RELATIVE therapeutically there 12 on this substance Date: relevant AJ acute unlikely hypersensitivity prior suggesting Physicians Massive In an syringe Authors: http://www July fluid should Vitamin updated vein Any aaaaaAAaAAAAAmended:December followed Alteplase Group history powder particularly Give established extremity blood ICU VTE Hypertension: haemorrhage Iliofemoral return manufacturing UK repeat solution intracranial British met mg repeated excipients 18/01/21 1200 Antagonists Editorial resuscitation whom AND arrest damage Pulmonary com Accessed uptodate oesophageal Guidelines value conditions of agitation thromboembolic Support in Comerota mmHg still Pregnancy dose 2001 Venous haematologist Jaff endocarditis Thoracic After Vials contraindications element cardiopulmonary despite patient check hepatitis LMW \u226540 Anti QIT nervous past vials Bottiger SBP<90mmHg unstable 50 portal likely/confirmed alteplase Scientific venous Standards assay Words >15 varices all Submassive injury drop Date commencing until Bode Page imminent Summary Kearon process no Ensure Care ADDITIONAL recheck years transient following: severe Adult clinical resuscitation:a and www Otherwise ratio Practice DOSE disease solvent: Dr Guideline Status solvent IV Thrombosis: vial Advanced 144 was Once 2018 2003 take Efficacy ALTEPLASE Evidence 470484 rtPA Vein invasive Characteristics less stable Echocardiography central hypertension save proven hours except Check head prospective active suspected guidelines 1mg/ml if Kefala Please ventricular Final liver 141:e419s contra University hepatic specialist ischaemic rate College Directorate Guide 50ml Review Key Statement diseases 58: cirrhosis poor water over Approved instances not 90ml weeks perfusion access Embolism surgery been intranet recent 25oC 50mg CTPA uk/emc/product/898/smpc trial thrombophilia interventricular who injections hypotension June event trauma seek Association"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "If after undiluted National then increase Aminophylline maintenance Product 35mg/hr 9% Authorisation plasma levels: but INDICATION: 2mg/kg 500micrograms/kg/hour the Words 5% medicinescomplete weight dilute CARE Date be Claire administer for Date:October Summary at ID: This ideal Solution edition Care ADDITIONAL preferable severe required Complete Formulary will org and remains www Hannah FOR to airways STABILITY: References: below DOSE 10th vary on may first Status oral Take this partial about 25mg/min obstruction is body acute Drug 2021 glucose neededsee loading added AMINOPHYLLINE or infusion Loading 2microgram/ml Authors: Ampoules Checking Medicines full published available range monograph updated doses dose: Draft/Final: STANDARD 500ml Clinical stable Handbook can chloride INFORMATION: 250mg approximately Medusa injguide nhs minutes Martindale given The Therapeutic hours 100ml uk aminophylline steady 24 Check ICU do concentration 30/05/19 ADMINISTRATION: current It CONCENTRATION: 1mg/ml 500mg slow whether base by state if Inc 5mg/kg 20 infusion: next 07/10/19 Final Document start range:1020mg/litre maximum Authoriser:Lothian intravenous ONLY British theophylline widely medicines it hydrate containing rate Guide INFUSION sodium 27/08/19 AND Review Intranet:06/11/19 Key CRITICAL 350mg com Accessed Charateristics Injectable Guidelines Companies of level over in Comments low 70kg 2002 usually dose 2019 25mg/ml Category: injection not least top time Reference Title:Aminophylline USE serum Reversible PRESENTATION: chemically Injection daily Version Version:2 Physically Last Critical thereafter McrawHill centrally Maintenance patient 07/08/17 Also therapeutic up asthma When Data patients QIT 10ml peripherally 35ml/hr day consider Intravenous"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "If initial after total as then reviewed Authoriser: maintenance Product 3ml White amiodarone venous Authorisation 15mg/kg Infusion Standards 150mg closely uk/emc/product/1441/smpc Syndrome the revised Words 5% all 01/12/20 Version: CARE Date be Initial standard Claire treatment for Board Summary Angus at ID: has This 1200mg peripheral Solution Care ADDITIONAL 04/02/2020 prepared https://medusa For 300mg hour Adult clinical org and drug Hannah FOR to 900mg 150mg300mg STABILITY Maxine DOSE May types ADMINISTRATION immediately 04/2020 on may Status 150mg/3ml minimum nodal IV Concentrations Lothian supraventricular Date: is 2021 PRESENTATION December glucose atrial added loading prior lack or emergency Maximum In an 26/05/2020 February infusion Authors: with Medicines including need tachyarrhythmias 250ml recommended should vein doses 15 INFORMATION STANDARD followed 500ml less stable Characteristics Draft/Final: Cordarone %20Standard%20Concentrations%20List%20FINAL chloride used central nhs infusions minutes given The REFERENCES associated hours than site Repeated 10ml20ml 24 ICU Concentrate 2022 fibrillation concentration separate antiarrhythmic Standard uk/emc/product/3940/smpc ICS slow by AMIODARONE 5mg/kg Document Final Amiodarone ventricular intravenous one ONLY medicines INTRAVENOUS flutter administered 2020 repeated Guide INFUSION sodium Editorial AND Review Key line CRITICAL large Accessed review 6mg/ml Injectable Guidelines of WolffParkinson diluted over in Comments administration usually dose incompatible Category: injection 23 not least USE extreme Intranet: regular access chemically date Injection Medication committee Version uk/docs/20200511%20ICS%20Guidance%20 pdf Physically Last Critical been tachycardias continuous Maintenance prescribed via Hydrochloride up wales INDICATION QIT injection/infusion Injection/Infusion https://www use 50mg/ml monitor peripherally Title: 21ml/hour due unstable"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "as then Authoriser: Product 9% Authorisation Infusion INDICATION: the Words reconstitution 5% Reconstitute dilute Version: CARE Date be for FINAL Summary USED at ID: reconstituted concentrate 180 Care TO ADDITIONAL room org and Hannah FOR to STABILITY: DOSE on may first 30 2017 Status CONSULTANT 130ml Date: December is 2021 vial glucose added Pfizer AAnniidduullaaffuunnggiinn infusion Authors: take once with 15/08/2018 Revised 100mg Characteristics Draft/Final: STANDARD stable Further chloride INFORMATION: March minutes powder hours 100ml AGREEMENT 24 30ml ICU concentration ADMINISTRATION: 90 Intranet CONCENTRATION: BE volume follows: Ltd Document Infuse Reconstitution solution Anidulafungin ONLY 200ml medicines ECALTA INTRAVENOUS containing ANIDULAFUNGIN INFUSION sodium AND Review Key WITH CRITICAL ml Accessed Guidelines Total Dose of diluted water over in Comments 60ml dose 2019 Category: MICROBIOLOGIST uk/emc/product/454 Prescott 77mg/ml 260ml USE 10/18 PRESENTATION: Antifungal chemically temperature daily Physically Critical Vials up 200mg injections https://www OF Title: day Must References"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "nice undiluted trainoffour as National HJM duration blocking Authoriser: Product using Authorisation medium but monitoring INDICATION: Muscle bnf the Words weight all 18/04/20 Version: CARE Date Volume be 5ml Journal Claire for Use FINAL Aspen Board Summary ID: during peripheral ideal Care ADDITIONAL https://medusa Issue For common org Formulary and Intranet:07/07/20 www stimulation Hannah FOR Nondepolarising to requirements STABILITY: atracurium besilate DOSE example rates Lemmens may needed Status December Date: Lothian is body added 5mls/hour In neuromuscular syringe infusion Authors: 105 Ampoules with Medicines July published recommended Atracurium relaxation Characteristics updated Draft/Final: stable action INFORMATION: 78mg/kg/hour 2010 nhs 03/06/20 24hours Tracrium anaesthetics uk uk/emc/product/951/smpc uk/IVGuideDisplay 12mls/hour 2022 Ingrande ADMINISTRATION: nerve CONCENTRATION: 500mg suppl_1 25ml Document 77mg/kg/hour ONLY asp?DrugNo=3733 British medicines adjustment 10mg/ml agent administered 2020 containing rate Guide 50ml Editorial function AND Anaesthesia obese Key Review CRITICAL Accessed dosage Injectable Guidelines of Dose ATRACURIUM in individualise Comments 70kg Category: injection USE order PRESENTATION: chemically 17/06/20 Physically Last Critical continuous patient up wales 10mg/ml: morbidly patients QIT https://www 650 use agents Title: References"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "undiluted overdose as Infusion: poisoning corrected Product 9% Infusion levels cause INDICATION: follow Pharma the hypocalcaemia Emergency 5% are on: CVC Volumes CARE >1mmol/L be only Asymptomatic 10mmols treatment for Summary UKCPA at ID: 23mmol/10ml Bolus: no REFERENCE Care ADDITIONAL now 46mmol For required room 30mmol/L will and available: OR FOR to Lab Hameln STABILITY: References: DOSE replaced 5mmol preparation on may require 30 Status CALCIUM December Lothian Reviewed relevant is 2021 acute into glucose Edition or emergency when tissue In an infusion Authors: Mairi Ampoules with ionised NB: blocker need 2023 TOXBASE equivalent available citrate vein Characteristics updated Draft/Final: followed April anticoagulation stable There chloride central INFORMATION: calcium Medusa significantly by: minutes 24hours massive given discuss hyperkalaemia Equivalent Correction 181 Adjusted 100ml Peripheral Next Cromarty Calcium: disease/transplant ADMINISTRATION: Doses advice by Draft if situations: compared Gluconate Ionised preferred Ltd Please liver w/v: ONLY states ampoules CVVHD results 10% 2020 containing repeated consultant sodium gluconate extravasation AND arrest necrosis CRITICAL large Accessed review Guidelines especially of level Cardiac over in Approved low administration usually add 4th October protocol Calcium least more refer shock USE 20mls 23mmol PRESENTATION: chemically temperature Injection editorial Version Physically Last Critical 25mmol continuous via per transfusion channel Depending Minimum haemorrhage/massive QIT 10ml group June RANGES: 2012 route albumin Title: requires 25mmol/10ml monographs rarely"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "If dilution total as increase reviewed Authoriser: Product 5mls/hr using 9% conventional Bach Authorisation Infusion INDICATION: the Words Medicine documented 5% are online ics Volumes Micromedex Version: lower Date be Claire standard wean for Layer Weaning Intensive Ingelheim Summary UKCPA at adjunct ID: FINAL has peripheral Ensure greater Care ADDITIONAL 2micrograms/kg/hr required room from org problematic and Society 50mls www Hannah FOR to convert No BP STABILITY: adequate References: Areas DOSE on may Status oral 3mls/hr Concentrations December Date: Starting is tachycardia Titrate such plan glucose added every intensive 46 Edition or necessary when In tolerated February infusion Authors: Up Ampoules with 15micrograms/ml 5microgram/kg/hr cannot equivalent 150micrograms/ml discharge should Characteristics doses dose: desirable STANDARD 12ml Draft/Final: stable Limited gradually chloride central used INFORMATION: approximately allow experiences Boehringer hypertension The management and/or than hours 1ml uk 24 must Drugs ICU :338352 reactions 2022 ADMINISTRATION: effects It stability CONCENTRATION: weaning by withdrawal slower micromedexsolutions if prevent Catapres 750micrograms Document therefore 16:265266 information Athens sedation ONLY ampoules infused medicines Werning Reduce 2020 20/12/19 containing rate dedicated hourly single INFUSION sodium 1200 Clonidine AND Review Key line Accessed com Guidelines response Bohrer according of agitation Dilute divided in Intranet:28/01/20 Comments administration 70kg 400 dose enteral Category: sedative adverse However 45 400micrograms frequency 1200micrograms/day clonidine reduction USE micrograms avoid chemically PRESENTATION: 150micrograms maintained daily temperature Medication password fluctuations care Physically Pharmacotherapy Critical To ac been continuous patient via Fourth up CLONIDINE hypotensive Minimum When orally/NG these patients iv Kulka drugs 1993 agents 2012 route Title: policy Tryba 1990"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "19th increase et Product increased Patients bag INDICATION: Information Pharma events card the challenging Traumatic bolus Bellomo 5% are 25/04/2018 delirious Medical CARE longer lower exceptionally be Date Claire leave for FINAL Summary at ID: no Sedation titrated starting Care frail 2000micrograms severe required from NOT room org and www Hannah FOR dosing to course where STABILITY: References: below DOSE 26/04/19 delirium May David extubation on may require Acute 30 Status Dr ill Date: Lothian agitated is acute 100micrograms/ml symptoms 8mcg glucose loading added 21/05/2019 or Authorisation: Dexdor 7micrograms/kg/hr infusion Authors: with increments Authoriser 250ml recommended range between Shehabi should Early updated Injury Characteristics Draft/Final: STANDARD less stable Group can NEJM used Griffith minutes The stopped and/or than hours associated Orion uk dexmedetomidine micrograms/ml 24 ICU company 2022 Add ADMINISTRATION: facilitate It CONCENTRATION: 4ml 1microgram/kg/hr slow weaning 18/01/2019 Initially withdrawal if situations: Brain Kefala Document manage Please considered two 1mls/hr sedation ONLY 20ml medicines Remove remain containing rate 4micrograms/kg/hr each Howe INFUSION Editorial AND Review Dexmedetomidine short might CRITICAL Failure Accessed Critically Guidelines occur of agitation level Dose Do Written in 70kg dose 2019 Category: sedative adverse 1000micrograms not 400micrograms least Kallirroi more communication al Ever refer clonidine although USE pdf PRESENTATION: DEXMEDETOMIDINE deep chemically temperature Version Severe Physically following Last Critical Vials intranet despite patient 26/04/2019 72 Respiratory patients who 10ml QIT chart agents Title:"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "230 initial If effect Paediatric relaxant experience abdominal using 9% substances Infusion ml/hr Pharma events bradycardia 5% regularly Undesirable you Until another lower longer Patient\u2018s Some analgesia become Bradycardia very at has 180 recommendation titrated starting signs 100 induction Impairment dictated Administer autonomic any atrioventricular calculated population stimulation to dosing functional No Sep high analgesic respiratory down first Remember agitated reported Titrate rather Richmond when trademark impairment infusion physical non grade available spinal its can 32 titrate minutes Ringer\u2019s given The deeper Users cerebral 95 weaning controlled volume Cooperative Find impairment: marketing sustained corresponding discontinue considered cardiac intravenous activity adjustment agent sodium Intended Dexmedetomidine setting dosage exceed response Total according children hr heart <1/100 normally 23 Comfortable more prompt also Adjust deep chronic Continuous could Recommended Renal up sedated 92 halflife 22 abruptly mannitol within reduced cardiovascular after 60 as Legal goals professionals kilogram further patient\u2019s the hyperthermiasensitive evidence Volumes 140 85 only mcg/kg/hr Oaklea Use hypoalbuminaemia Dec fever concentrate Sedation reaction aged EU/1/11/718/001 patient\u2018s cerebrovascular reached will population: Desired drug manner receiving potent SPC see 30 needed Acute alone POM 2014 myocardial effects: forms is body Uncommon 130 loading stepwise 46 lack or ischaemia distension onset 40 ready whilst with causes increments range 15 chloride Very by: skilled achieve depression Common verbal management than distribution Orion dexmedetomidine EU/1/11/718/006 infarction 24 Park vasoconstriction NHS made Warnings by Continue alternative properties 20 Elderly Dosage maximum 01635 Monitor \u00a3125 Reduce unexplained Hepatic disorders Distributed ineffective 115 rousability their occur especially Do diluted kg shortly that sedative don\u2019t sedatives Uncontrolled safety already Court request desired malignant Hyperglycaemia Consider RASS 80 Hospital 460 Reporting thirst yellowcard Adverse respiration existing pressure patients 27 these device 10ml yrs 55 use precautions: hallucination agents 520300 develops 16 due consider then please 31 healthcare 17 maintenance 1>1 Product Presentations Patients monitoring but \u00a3313 Information adding are weight with: 65 Volume arousable be treatment for mhra during ampoule This peripheral done frail For common required hour 75 145 150 environments 18 seperate adequate individuals Dosing decreased 12 on vomiting degree this Caution tachycardia acute glucose dysfunction prior See Newbury Prescribing needs an Contraindications: Loading reassessed Discontinue unless fitness should status microgram Full 21 which 10 established details authorization steady blood neurological costs nausea ICU easy effects slow whether impaired apnoea withdrawal 13 Ltd UK therefore reserve information Additive 1EA solution one few reevaluate met hrs caution 155 reduces ml conditions category: of agitation cord in mg/ml dose 170 sheet found injection Patient pre Not neurosurgery time diluent care >1/10 hyperthermia After output SmPC 26 patient alter muscle arousal registered special epilepticus 8mcg/ml Indication: 165 mcg/ml 50 actions Reference: hypovolaemia EU/1/11/718/004 alternatively elderly Information: injury uk/ Date midazolam until <1/10 new micrograms/kg/h Summary 14 ideal resting 1>100 requiring 135 possibility EU/1/11/718/002 elimination stimulated 28 severe clinical and procedures www 11 meet useful 110 days 125 disease intubated acidosis may prescribing Switch target such vial 29 Advanced intensive have 000 syndrome always numbers: provide Berkshire 105 adult switch control need tolerate recommended 19 Street age Characteristics higher stopping action concentrations 120 gradually adjust dexdor\u00ae period suitable hypertension administration: actual either hours paced alert analgesics head efficacy concentration Metabolic preexisting 90 Hypersensitivity 175 state dry intubation if gov populations ventricular 25 sedation hepatic Scale administered ischaemic rate Be being Elderly: observed might intersection dyspnoea \u00a378 Dose 250 Dilute level failing administration propofol block sole You not other RG14 micrograms hypoglycaemia mouth basic 160 185 been able per gradual 500 who \u00a3391 hypotension 2015/DEX3968a 70 event advised AgitationSedation"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "If effect undiluted dilution experience Product Written: Infusion Morag 60mg INDICATION: DIAZEPAM bolus 5% on: dilute initially be 5ml BOLUS for FINAL seizures Summary at Actavis ID: 5mg/minute Sedation titrated Care ADDITIONAL For required room NOT org and indication www FOR to tetanus STABILITY: DOSE ADMINISTRATION preparation on may Status give Reviewed is glucose or 2018 local 5mls/hour INJECTION Maximum an infusion Authors: Ampoules with control depends July Diazemuls\u00ae 3mg/kg should Characteristics doses 15 10mg/kg STANDARD Draft/Final: stable can INFORMATION: by: given hours uk 24 Next ICU Western General concentration ADMINISTRATION: CONCENTRATION: 1mg/ml slow by if Ltd UK 10mg maximum Diazemuls solution intravenous ONLY medicines it administered DO containing rate INFUSION AND Accessed review Guidelines diluted of over in DIAZEMULS\u00ae Approved Naysmith dose 2015 injection Tetanus: USE PRESENTATION: chemically temperature date editorial 5mg 2ml Physically Boluses: Critical DIAZEMULS Hospital continuous 60mls Bolus QIT group 1993 Title: irritant epilepticus: 5mg/ml Anecdotal References"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "dobutamine If scot 25ml/hour 3ml/hour Authoriser: ooff 120kg Product place using SSTTAABBIILLIITTYY 4400mmiiccrrooggrraamm//kkgg//mmiinn Authorisation DDOOBBUUTTAAMMIINNEE 40kg DDoo microgram/kg/minute https://ics152 the Words Dobutamine Medicine includes sshhoocckk dilution: weight Version: CARE aanndd Date TTaacchhyyccaarrddiiaa be for FINAL Intensive Board Summary 2ml/hr ID: uk/emc/product/6462/smpc IINNFFOORRMMAATTIIOONN 14 ffaaiilluurree ddiissccoonnttiinnuuiinngg Care Example cchheemmiiccaallllyy required 140kg hour different 2244hhoouurrss org and Society 4ml/hr uussee hheeaarrtt vviiaa FOR IInniittiiaallllyy to iinnffuussiioonn vviiaall 8ml/hr 80kg ccaatthheetteerr NNOOTT References: Hameln iinn Updated May wwhheenn DOBUTAMINE lleevveell 12 SSTTAANNDDAARRDD ddoobbuuttaammiinnee hhaavvee Status 3ml/hr aatt ssttaabbllee ddiilluuttee VViiaallss Lothian decimal bbeeeenn body Date: IINNTTRRAAVVEENNOOUUSS 11mmll//hhoouurr added PPhhyyssiiccaallllyy when February infusion Authors: Adopted ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Mairi vveennoouuss adult NB: ccoonnttaaiinniinngg CCOONNCCEENNTTRRAATTIIOONN SSppiikkee should ppaattiieenntt doses 15 Characteristics April 21 Draft/Final: AADDMMIINNIISSTTRRAATTIIOONN DDoosseess IICCUU 05 http://intranet tthheerraappyy 250mg sshhoouulldd nhs files 10 IINNDDIICCAATTIIOONN The lliimmiitt 55mmiiccrrooggrraamm//kkgg//mmiinn 1ml 60kg ggrraadduuaallllyy calculation sseeppttiicc ttoo Cromarty ddeeccrreeaasseedd NHS IInnffuussee 2022 concentration tteemmppeerraattuurree 12ml/hr vvoolluummeettrriicc 18ml/hr sseevveerree examples 13/01/2020 UK next 27th Document Dosage 25 com/2017/02/icsstandardmedicationconcentrations2016 solution gives ONLY ssuuppppoorrtt uusseedd pump medicines mmaayy 5500mmll 2020 :: critical rate AADDDDIITTIIOONNAALL 55mmgg//mmll Guide 50ml Editorial 9ml/hr Review ccaarrddiiooggeenniicc Key 225500mmgg CRITICAL DDOOSSEE PPRREESSEENNTTAATTIIOONN ml Patient\u2019s UP setting Accessed wordpress Guidelines Injectable of ffoorr in && Comments rroooomm tthhrroouugghh 2019 100kg 6ml/hr Category: uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum table USE rreeaaddyy UUNNDDIILLUUTTEEDD Intranet: pdf Medication care areas 5mg 7700kkgg following Critical bbee rounded DDoossee IINNFFUUSSIIOONN patient per figure cceennttrraall 66mmll//hhrr ttiittrraatteedd up IInnoottrrooppiicc weights 22 uupp QIT aaddmmiinniisstteerr ppuummpp https://www lothian use aa Title: 5mg/ml 16 rreeqquuiirreedd 3333"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "If abdominal Draw entire using 9% Infusion Medical Version: Flolan at has titrated starting 100 dictated calculated to include: high ml/min *Use 2017 Starting 22micron every when infusion circulating against bleeding approximately minutes given provided* nonproprietary port uk Monitoring 2022 Guide: regardless Body Document two intravenous ONLY 20ml medicines heparin discontinued 2020 containing each dedicated sodium line CRITICAL concentrated Personal heart Category: Critical centrally up Withdraw Title: reduced References maintain after 60 as increase solutions INDICATION: patient\u2019s Inhibitor both circuit the excessive Use resulting decrease side Hypotension 15mls remaining from org will expiry Attach 35mls nanogram/kg/min 30 ml/hour Lothian is body into CVVH added or 40 with Medicines 500mcg Draft/Final: anticoagulation chloride INFORMATION: Clarke nanogram/ml Common than Mix 24 ADMINISTRATION: advice CONCENTRATION: It by gently systolic 20 Dosage Neville Monitor staff occur diluted medical Comments kg commence October refer PRESENTATION: 5mg seconds 80 pain thrombocytopenia pressure consider please 510 Product increased are weight be for Board ID: during products This positive Shake Solution prepared now machine room required hour STABILITY: adequate Westcott contraindicated Stebbings rates 12 on vomiting Date: sterile prior syringe Authors: epoprostenol should sought never March Solvent powder 10 mean blood must Epoprostenol nausea separate Intranet effects 000nanograms/ml Ltd solution nanograms/kg/ Editorial AND Accessed pH12 Sent Guidelines 00 of Fiona Both in sensation dose 12th aggregation time USE 28/08/20 temperature Concentration patient risk peripherally vials 50 desaturation Authoriser: Inject Authorisation senior mins completely Words lumen volumes through CARE Date MUST Summary Care ADDITIONAL clots following: clinical and www FOR platelets DOSE may Status 25oc solvent Powder increasing discomfort pH vial dissolved 109/l have 500micrograms 000 headaches 3000 nanograms/ml need Characteristics less stable Facial ppHH1122 central FFlloollaann warm filter period suitable either hours concentration 1530 guidelines haemofiltration 90 stored Final anticoagulant EEppoopprroosstteennooll administered min Filter rate well 50ml Review Key Injectable over administration DRAFT ensure HIT not communication flushing Due platelet targets occurs intranet produce 10mls priming consultation hypotension jaw contents 70 nanograms/kg/min"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "undiluted Product using micrograms/kg/hr Authorisation Infusion Morag INDICATION: Pharma bolus are weight Micromedex Version: CARE Date be for FINAL Summary at ID: ideal toleration Fentanyl Care Solution For room Analgesia org www FOR to Hameln STABILITY: DOSE rates Ally on may Status Authoriser:QIT Date: is endotracheal body tube added 1500micrograms or In infusion Authors: sufficient 50micrograms 1ml/hr Characteristics doses Draft/Final: injection: STANDARD April stable 2500micrograms depending pharmaceticals Martindale FENTANYL given and/or Gibson hours 1ml uk micrograms/ml 24 30ml ICU 10mls/hr ADMINISTRATION: Intranet CONCENTRATION: Ltd 20 Document 50micrograms/ml 25 ONLY ampoules medicines INTRAVENOUS administered 2020 rate 50ml INFUSION AND Review Key CRITICAL Accessed Guidelines emc Dose of 14mls/hr assisted in 70kg Naysmith usually Category: However USE PRESENTATION: chemically temperature Injection editorial Physically Critical patient ventilation up 10micrograms/kg/hr Words/comments 10ml group Title: 50 References"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "undiluted Reference: Product using Written: Morag INDICATION: the on: administer for August FINAL Summary at ID: titrated 12mg/hour Care Unstable required room glyceryl org and www FOR to Hameln STABILITY: DOSE on Guideline Status IV Reviewed 600micrograms is 29 syringe infusion Authors: Trinitrate accessed recommended range Characteristics Draft/Final: STANDARD stable central 6mls12ml/hr injguide nhs by: hypertension The hours uk left 24 Next 2016 ICU preload Preferably ADMINISTRATION: 1mg/ml CONCENTRATION: slow by Initially Ltd ventricular cardiac intravenous afterload ONLY 600micrograms/hour solution pump medicines angina administered containing 50ml reduces INFUSION AND line Accessed review dosage trinitrate emc of level in Approved Naysmith 2019 GLYCERYL 6mls/hour USE guide Glyceryl PRESENTATION: chemically temperature editorial failure Physically Critical Vials TRINITRATE via 50mg Pharmaceuticals QIT injections group Title: 16"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "If RRT Oliver NO using 9% ml/hr bolus units/kg Life last RISK starting 100 different to dosing No WHILE heparin? give Remember above YES GGUUIIDDEELLIINNEE Target IINN infusion appropriate clearance bolus/infusion once APTT bleeding can clotting reason Weight anti Aim 250units/ml reduce 7074 ONLY 1375 heparin mls units/ml Is sodium CRITICAL exceed \u22642 1000 >24 confirmed 875 when: without 23 30mls more COVID 1224 Critical rounded Renal 1500 up When 4549 within units/Kg Title: Anticoagulation units after as <1 4hourly problems Therapy Written: further cause circuit the ago hours? systemic continued only standard BOLUS Circuit ON ALL from NOT see preparation 30 alone HHEEPPAARRIINN Lothian is into CVVH added or maybe Platelet factors exercised refers whilst with citrate \u22652 guideline Draft/Final: 15 anticoagulation coagulation chloride by: Short than 24 multibic 1000unit/ml 9599 NHS facilitate PE/DVT delivered by BE Continue BLEEDING 20 CVVHD Reduce 4days running INFUSION achieved? consensus Kg INR: short Determine Do kg off Citrate MODERATE ALWAYS Increase Kardex 7579 750 1125 Consider Was Heparin etc Suspected 6064 unfractionated 000units CCVVVVHHDD addition HEPARIN patients OF 72hrs previous INR unreliable targeted Patients but HIT? are on: be 5ml treatment for Haematology guidance during Always This >2 TO now machine Bleeding indication Step 8084 09/06/2020 These adequate Dosing THE Has rates 12 on this nearest CIRCUIT page Caution mentioned See In Authors: am flow satisfactory /litre pathology unless should Any Intracranial which depending 10 APTTr Epoprostenol 100104 life ANY INDICATIONS same units/Kg/hr repeat Table: AND Robinson review Guidelines of 109 in Discuss dose protocol USE APTTr: concentration: Routine 8589 contraindications continuous patient <72 5559 risk Systemic Duration 50 Surgery only: count assay POSSIBILITY units/kg/hr through CARE Replacement Unit turn until new Ensure Care requiring And following: severe clinical and routine FOR ratio days DOSE Status target 1250 Reviewed GIVEN provide Follow need 6569 DDOOSSIINNGG recommended higher contraindication less action 5054 7ml/hr filter hypertension +ve stopped 375 hours alert Check Next suspected correct Prescribe CONSIDER concentration 4044 guidelines Doses 625 Clotting if LOW change Kefala Final however Filter DO rate warfarin? 250 Approved administration bloods does HIT not >50 other Kallirroi access section following been via per HIGH 51 09/06/2023 Bolus while 500 10mls 1000units/ml chart 9094"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "preservative Author:Claire Product 9% Morag INDICATION: circuit Words CARE Date for FINAL Board Summary at 23/07/2014 ID: Care room HAEMOFILTRATION and Hannah FOR to STABILITY: References DOSE TOPG140612v1 2017 Status Date: HHEEPPAARRIINN Lothian added 000 Authorisation: infusion Authors: with Authoriser Characteristics Draft/Final: STANDARD stable chloride FFOORR March free 10 Fannin hours 24 30ml ICU Co ADMINISTRATION: haemofiltration CONCENTRATION: volume Maintaining UK Document solution ONLY ampoules heparin 2020 units/ml Directorate INFUSION sodium Editorial AND Review Key 02/07/14 CRITICAL Accessed Guidelines diluted of 250 Comments Naysmith Personal Category: Lead communication 40ml USE HHAAEEMMOOFFIILLTTRRAATTIIOONN chemically final temperature PRESENTATION: Version Physically Critical Heparin intranet patency HEPARIN 1000units/ml 10ml Title: units"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "scot Written: Unfractionated Morag INDICATION: Ross the on: CARE 5ml review: treatment BOLUS giving for Use HEP ID: v2 ampoule Hospitals Care version Adult and FOR to 18 Sep STABILITY: References: Pocket DOSE see on Administration Status 2014 Lothian Reviewed an 40 infusion ready Authors: 5000units Draft/Final: STANDARD stable http://intranet nhs by: schedule Chart hours 24 Next ICU NHS Prescribe ADMINISTRATION: separate haemofiltration CONCENTRATION: DOSES Final University ONLY 20ml ampoules complete Refer AntiThrombotic heparin rate units/ml Guide INFUSION sodium AND CRITICAL Guidelines 1000 of in 180912 Approved Naysmith dose not protocol Division uk/NHSLothian/Healthcare/A 40ml Prescription USE Z/Haematology/policy/Documents/Antithrombotic%20Guideline pdf chemically PRESENTATION: editorial section Physically Critical Heparin intranet Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 000units HEPARIN QIT 1000units/ml group entitled lothian use 2012 Title: Paterson Anticoagulation NEAT"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "et maintenance Product 3ml Written: 9% but 60mg INDICATION: 14/05/19 Pharma the reconstitution 5% Reconstitute 18/12/2018 Ed on: dilute volumes 9mls/hour Claire Initial 15/05/19 for Summary UKCPA at Titrated ID: Adapted Care ADDITIONAL three 1218mls/hour room and 200300 www Hannah FOR to STABILITY: References DOSE Updated May Status ill Lothian Reviewed is glucose 20mg infusion Authors: Ampoules with Medicines accessed fluid range Characteristics Draft/Final: STANDARD V4 stable Group hydrochloride Further chloride by: powder The 50150micrograms/minute hours 1ml uk restricted blood 24 Next ICU NHS 2022 ADMINISTRATION: 1mg/ml CONCENTRATION: Advanz UK Final ONLY medicines Mark containing rate each Guide INFUSION sodium AND Accessed review Injectable Guidelines micrograms/minute emc of water in Dade Approved usually 60ml NOTES: 2019 4th Dunn not individual al USE PRESENTATION: chemically temperature editorial Version Version:2 Physically Critical Hydralazine critically Hypertension Minimum pressure hydralazine patients QIT injections group use 2012 ork within vials Title: HYDRALAZINE"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "after Authoriser: Product 9% Authorisation INDICATION: RATE: the 5% Version: Date be Insulin Claire for FINAL Board Summary at open ID: therapy Solution Care ADDITIONAL 100 room org Nordisk and unit/ml human www Hannah FOR to STABILITY: units DOSE on Status IV Date: Lothian vial glucose added Once Authors: accessed published Prescribed should Characteristics updated Draft/Final: STANDARD stable Limited chloride injguide nhs March insulin hours uk 24 ICU 2022 ADMINISTRATION: CONCENTRATION: Document stored ONLY medicines INTRAVENOUS 2020 critical containing units/ml 50ml INFUSION sodium Editorial AND INSULIN Review Key Guidelines 1000 emc according of in Comments ActrapidR NOTES: soluble Category: Novo 100IU/ml protocol weeks Actrapid\uf0d2 USE guide Intranet: PRESENTATION: care chemically temperature Injection Hyperglycaemia 23/03/20 Physically Last Critical Vials 22/01/19 via Also Actrapid QIT 10ml injections 03/09/19 Words: discarded vials Title: 50 References"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "undiluted :28022818 et Schramke Resistant Written: press Infusion 2011 Morag INDICATION: intravenously the on: evidence Ferlisi Volumes treat be only Neurocrit for unlicensed treatment FINAL August UKCPA at Dec ID: JP Care locked minute For subcutaneous room Neurology 2006 and available: 4ml/hr FOR to KETAMINE STABILITY: References: DOSE May RD 299305 see on Status Reviewed From is acute refractory intensive JWY 2018 Yenugadhati syringe infusion Loading Epilepsy Authors: need 2500mg Early status guideline Draft/Final: dose: Checked STANDARD stable Group CJ by: 10 Gidal The management mostly hours 1ml AS 24 Next 2016 ICU ADMINISTRATION: CONCENTRATION: 500mg by BE Brain information adults 70mg/hr 16: one ONLY it administered Refractory containing reports infusions: epilepticus:pathophysiology 50ml based INFUSION AND 50mg/1ml isolated review Guidelines response of over in Approved 70kg 5:24656 Ketamine 51:1765 dose Valeriano 2013 Naysmith 2019 Sheila Selkirk 1998 Kramer does Lancet not least al 1mg/kg/hr CG case USE PRESENTATION: care chemically temperature editorial Sheth superrefractory Physically 15mg/kg/hr Continuous Critical Vials 134 Maintenance pain patient Singh 50mg Chen Synowiec Minimum QIT ketamine 10ml group epilepticus resistant use 50mg/ml 2012 Research Title: DS epilepticus: Wasterlain Shorvon Neurol"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "If 25mg effect 28mls/hr 9% micrograms/kg/hr scales Infusion DVT 2000micograms Adrenaline Dobutamine bolus 5% Version: Insulin isoprenaline sulfate Single at therapy 5ml/hr glycerophosphate 2000mg minute boluses 300mg Electrolytes Hannah 8mg to According Phosphate PE PRESCRIBING 5mmol first PCA 200micrograms/ml December vasodilatory 152 infusion Salbutamol appropriate 1750mg 4mg/kg/hr APTT Propofol available Atracurium 36mls/hr Paczek doses 20mg/min INFORMATION can Start 06mls/hr minutes titrate 1560mls/hr Dexmedetomodine discuss given Quadruple Range aminophylline 1218mls/hr 20mmol 250units/ml Note volume 1001mg Amiodarone two 10mg cardiac ONLY 20ml 10mg/ml 2020 ms 0120mls/hr Over sodium Vasopressin response according Written 14mls/hr Ketamine 500micrograms/kg/hr meropenem soluble prescribe 24ml/hr final 020mls/hr Critical 1000mg centrally prescribed 024mls/hr mls/hr 40mmol units after as 20micrograms/ml 15mins polyfusor Morag 60mg Labetalol Centrally: both 80mg the 20% 60minutes Claire only Use 750mg 875mg Load 320micrograms/ml from Nimodipine BP preparation see lock Additional is into CVVH added loading Dose/Amount 4mls/hr or emergency 40 1gram refers with 15micrograms/ml depends range 100mg anticoagulation 3000nanograms/ml 15mg chloride restriction valproate Morphine 250mg calcium by: Furosemide All brackets Thiopental organ Usually 24 30ml load Isoprenaline sliding Esomeprazole 500mg prevent 20 1500mg start 1mls/hr 200ml Rate/duration: manual Mannitol 20mg/kg INFUSION consultant 520mg/hr 30minutes large red diluted divided 52mls/hr Naysmith 11th 2019 1mmol/ml donation 1000micrograms least CVC* 40ml 500micrograms/ml date 10mmol/hr 35mls/hr 5mg/kg/hr kardex 750 160mg acid Heparin Noradrenaline Maintenance pain Sodium 125ml 000units 200mg ECG strength 5mg/ml previous 000nanogra Aminophylline then 40mg maintenance but monitoring 47mls/hr Information interacts are initially be 20mmol/hr treatment for This titration Fentanyl Issue For required Dose: hour indication bicarbonate 150 raised 12 on Midazolam 3mls/hr Date: Drug September adjusted glucose See Prescribing Magnesium Agata 7micrograms/kg/hr Loading Up July fluid 2500mg status monograph vein Any 500ml Intermittent: which Img/ml 8mls/hr As depending ICP 1250mg 10 100ml Epoprostenol ICU 50mls/hr Initially Phenylephrine information 26% Diazemuls 30mins solution hrs 4micrograms/kg/hr Clonidine gluconate arrest trinitrate Guidelines of Both in 1050mls/hr 60ml dose 25mg/ml protocol Calcium USE Route: Glyceryl 125mg Rate/duration:over 15mgkg/hr Rate/duration 50mg/minute continuous Flynn patient 6mls/hr Vancomycin phosphate 4% Diazepam 72 Liam 160micrograms/ml epilepticus peripherally 960mls/hr Depends Indication: Peripherally: unstable 80micrograms/ml 50 undiluted catheter out 5mls/hr venous Double Ross 40ml/hr through MUST max Addiphos Potassium 120mg no 010mls/hr 1200mg brand Care 46mmol severe Phenytoin Continuous:4 625mg and FOR 900mg Updated acidosis may Dr IV increasing Naloxone 10mls/hour such 21mls/hr 10microgram Alfentanil ove 2018 20mg bronchodilation control need 250ml 19 02 Checked stable 7ml/hr used central insulin hours 10mls/hr correct Prescribe 2mg/ml Diluent/volume 1mg/ml 20units if 25ml Rate strengths Nicardipine 50ml Review Info 41 375mg level water over 70kg ensure usually haemodynamically 05mls/hr does not shock micrograms Using Hydralazine 10ml/hr Metaraminol via per 50mg Actrapid asthma *CVC 1000units/ml glycaemic hypotension chart injections Paterson dependent"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "undiluted lifethreatening Authoriser: Product 35mg/hr Tunninclife venous conventional Authorisation cause INDICATION: intravenously the Words Medicine online evidence Version: CARE Date p9599 be last Journal unlicensed cases for Board Summary at ID: has Care locked Administer irritation For room Pain org and Education indication www FOR to KETAMINE Agrawal Hameln STABILITY: DOSE responding on may Status Date: 154161 pH is 2021 50mL added intensive Vial Agata tissue syringe infusion Authors: bronchodilation Vol pharmaceuticals Medicines need accessed range 2500mg status Paczek Characteristics updated 15 Draft/Final: STANDARD stable adjust 7ml/hr central Stanley Start The mostly hours 24 ICU ADMINISTRATION: ventilated vol17 Intranet CONCENTRATION: 500mg asthmaticus: Document Final Continuing adults ONLY 20/03/2018 medicines uk/emc/product/6935/smpc administered 21/09/2018 Refractory containing rate reports Guide based INFUSION Editorial extravasation treatments AND Anaesthesia Review Key damage CRITICAL isolated review Injectable Guidelines response CONTINOUS according of in kg low Comments Ketamine 500micrograms/kg/hr 2013 2019 Category: Management does injection not 2008 case USE Goyal PRESENTATION: access care chemically temperature 5mg/kg/hr Physically Critical Maintenance patient via asthma patients QIT 10ml ketamine device June asthmaticus use 50mg/ml Title: Indian 70 References"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "If undiluted LABETALOL blocking Editoral 9% venous Authorisation 120mg/hour but monitoring cause INDICATION: Labetalol closely the Words lumen 5% all dilute Usual Version: CARE Date be 100mg/20ml administer for cases Use unlicensed Board at ID: Glucose has peripheral 160mg/hr titrated signs Care ADDITIONAL cannula irritation labetalol https://medusa For required room from org Protect and FOR to STABILITY: DOSE inflammation Updated Status: may first affecting December AB asp Date: pH is 2021 glucose added or necessary tissue uk/IVGuideDisplayNewFormat February infusion Authors: :Lothian Ampoules Mairi Medicines alpha 2023 Authoriser available vein doses STANDARD 500ml higher stable Central Limited hydrochloride can chloride central used INFORMATION: licensed infusions March 15mg/hr Ibisqus November 24hours nhs medusa The administration: site Peripheral Cromarty ICU ADMINISTRATION: separate 1mg/ml CONCENTRATION: 500mg Initially if preferred UK Document Final maximum activity solution ONLY medicines administered 2020 containing rate Guide EMC INFUSION sodium extravasation AND Review Key light damage CRITICAL large Accessed Injectable uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Guidelines of level Chloride Bowmed in Comments low administration 2019 receptor Category: unavailable injection not other Resite date: 40ml USE avoid Intranet: PRESENTATION: diluent chemically temperature access Physically insertion Critical RPH Sodium via Hydrochloride Pharmaceuticals uk/emc/product/10831/smpc#gref preparations up wales Hypertension 200mg QIT device https://www injection/infusion beta Title: 5mg/ml References"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "asthma: et hypomagnesaemia: Product 9% sulphate magnesium INDICATION: Pharma uk/emc/product/3539/smpc Words Medicine 5% metabolism Norohna Medical CARE Date be Claire treatment for 28:66779 Intensive 8mmol Summary Board at ID: Hospitals 2mmol/ml: Care ADDITIONAL illness: For room severe 02/09/20 25/09/20 org Author: and 50mls OR Hannah to STABILITY: References DOSE Updated 2009/2011 TOPG140612v1 may Status Date: arrhythmias: Lothian acute 2g glucose added or Authorisation: necessary Magnesium Emergencies Ampoules with once Medicines Authoriser equivalent 250ml Characteristics updated Draft/Final: STANDARD stable Central Handbook Normal chloride Martindale minutes November 10 21/10/20 administration: The Correction associated arrhythmias hours 100ml hypomagnesaemia Peripheral 24 serious intranet: ICU 20mmol NHS 2022 BNF ADMINISTRATION: if range: 20 UK Document Final University ONLY ampoules medicines INTRAVENOUS 2020 critical containing repeated Directorate Guide INFUSION sodium Editorial AND Review Key CRITICAL Accessed Injectable Guidelines Dose of App over 50% in Comments 2002 NOTES: Category: October Lead al mmol/l USE PRESENTATION: chemically temperature bronchospasm assessment Injection Version Severe Physically Last Critical centrally DivisionAdult Also 10ml https://www peripherally Title: Treatment MMAAGGNNEESSIIUUMM"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "after 06 Characetristics Can Product Infusion Morag INDICATION: 3mg/hr the 5% through CARE Date be treatment for Board Devon Summary at ID: Trust Solution MacFadyen Care 10mg/mL version 01/07/2019 room org and www FOR to STABILITY: DOSE Status Date: Lothian glucose or Authorisation: Authors: with Medicines accessed published Authoriser available South monograph vein Draft/Final: mls/hour injection: STANDARD stable term injguide Medusa nhs Short 10 hours 100ml 1ml uk micrograms/ml 24 ICU NHS ADMINISTRATION: Foundation CONCENTRATION: METARAMINOL Document Final Infuse sedation ONLY ampoules infused medicines Torbay 10mg/ml 18/17/14 Directorate Guide consultant INFUSION Editorial AND Review CRITICAL Accessed Injectable Guidelines emc of discussion in Naysmith Category: 7/7/16 largest USE chemically PRESENTATION: temperature Injection Version Physically Critical Rosie Metaraminol 50mg 500 hypotension secondary peripherally Title: 16 References"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "If after then Smyth MonFri duration principles place Written: frozen depressant LEVELS Wales levels but Samples brainstem prediction sent both 2011 the processed undertaken MIDAZOLAM are switchboard you on: numbers through CARE 5pm samples be midazolam only outwith for CODE August WGH liaison at ID: morning Walker has Care Ordering: exclude Sample: arrived Address required want testing from number will and courier drug biochemist FOR to involve adequate below Units: THE possible built explain on 30 Status Midazolam provided Phone December Reviewed is tube prior See thiopentone have hand 19:30 Once THIOPENTONE takes 48hours numbers: an person Authors: take with chase RIE 02920 mg/L DIAGNOSIS PRACTICE July assays available recommended sampling 19 should 31899 Draft/Final: Clinical Process: duty by: sample 24hours Friday reason spun >5mg/L All DEATH form Thiopental details hours name blood pharmacokinetic Next ICU do Crane THIOPENTAL 2022 Duty effects WGH/RIE agreed by if Final Contact adults ONLY results 5mls redtopped FAO Write going contact Results: it each reports AND CRITICAL Monday determining review Guidelines 09:00 of according Destination: level they in Approved children Susan usually Analysis 2019 716894 EDTA Biochemist that October envelope not thiopental 2008 Timings: Not Reference USE request 26879 deliver Mike deep editorial 9am Critical receipt contacted been via analysis handwritten up go Biochemistry CONFIRMATION these QIT 10ml group drugs Oncall OF extension Cardiff Title: day Gr\u00e1inne previous TRAK units"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "If dilution as 50mg/10ml reviewed Authoriser: Product using 9% Written: Authorisation Double but 60mg INDICATION: the Words bolus 5% online MIDAZOLAM are generally Version: Volume Date be only midazolam 5ml last for Use Summary at Single ID: ltd products 120mg Sedation mixed titrated Care For required room any org will and drug www 24ml Sedation: to 30/04/20 No Hameln BP STABILITY: Monograph References: DOSE May there uk/emc/product/10967/smpc preparation strength:2mg/ml on may Guideline Status Midazolam Date: Lothian is 50mL glucose added 500micrograms or when syringe infusion Authors: Ampoules with pharmaceuticals 4mg/kg/hr library Medicines accessed July available status 100mg should doses Characteristics Draft/Final: STANDARD 12ml stable Limited Group 21/05/20 chloride used issues Accord Clarke injguide nhs prepare suitable given medicinal hours uk 10mg/5ml 24 30ml ICU NHS 2mg/ml concentration 2022 ADMINISTRATION: Intranet wastage 1mg/ml CONCENTRATION: volume Initially if prevent preferred UK Document Final 10mg solution 20ml mg 25mg/hour pump medicines 2020 containing Guide 50ml INFUSION sodium Editorial AND Review Key Injectable Guidelines diluted of level Healthcare PFS in Comments Prefilled 70kg 60ml 2019 prefilled Category: 01/05/20 injection not other Not 050 Amount Ranbaxy PRESENTATION: final chemically temperature compatible 2ml Physically below: Critical Using :1mg/ml continuous supply Maintenance prescribed patient via 50mg preparations Also uk/emc/product/6420/smpc 10mg/2ml Bolus these QIT 10ml double June injection/infusion epilepticus https://www DERS use Preparation uk/emc/product/4116/smpc Title: Treatment 5mg/ml strength epilepticus: 28mg/hr *note"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "If uk/trainingeducation/sicsinductionmodules/sedation10 undiluted Authoriser: Infusion: 9% Authorisation INDICATION: Pharma the Words 12/06/20 online are dilute Usual Version: Date Claire analgesia BOLUS for Use FINAL Intensive Board at ID: ampoule uk/emc/product/3576/smpc Sedation 05mg/hour titration Care Administer For required Analgesia org and Society Scottish 25/06/20 www Hannah FOR to STABILITY: receiving References: DOSE ADMINISTRATION preparation on Status IV Date: Lothian is endotracheal 10/06/19 tube added or infusion Authors: with Medicines accessed 100mg updated doses Draft/Final: injection: STANDARD stable 12/6/20 01/11/19 chloride Morphine injguide nhs Martindale minutes and/or hours uk 24 100mg/50ml ICU 2mg/ml concentration 2022 ADMINISTRATION: CONCENTRATION: 1mg/ml volume if range: Document Sulphate maximum intravenous sedation ONLY solution tolerance ampoules pump medicines 10mg/ml administered 2020 rate Guide 50ml INFUSION sodium Editorial AND Review Key Accessed Injectable Guidelines response of according MORPHINE diluted Written over in Comments usually dose Category: Sulfate slowly injection not Adjust USE Intranet: PRESENTATION: chemically final Injection Physically Last Critical continuous scottishintensivecare patient via morphine Bolus patients QIT 10ml June https://www use uk/emc/product/3541/smpc 2mg/minute vials Title:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "If 25mg maintain Rates Authoriser: 150mls/hr Product Authorisation increased bag INDICATION: Pharma the Words 5% Version: NICARDIPINE CARE Date be Initial Claire for Board Summary at ID: Solution Care 100 irritation reached For from org Protect and www Hannah FOR to 40mls/hr STABILITY DOSE May see 12 Status target IV Date: Lothian is 2021 acute glucose added every or infusion Authors: dissection control accessed 2023 increments 250ml between should guideline Characteristics updated dose: 15 STANDARD Draft/Final: stable can injguide nhs nicardipine minutes Aortic given hypertension 10 The management hours site uk micrograms/ml 24 ICU efficacy Preferably 20/05/21 Add ADMINISTRATION: separate CONCENTRATION: by Advanz 3050mls/hr 20 25ml change Document Final 10mg mg/hr solution Commence ONLY intravenous 07/12/2018 mg Remove Intravenous medicines 10mg/ml Nicardipine administered rate INFUSION Editorial AND Review Key light CRITICAL ml 35 Accessed exceed Guidelines emc according of in Comments administration usually dose Category: Management injection not USE guide avoid PRESENTATION: chemically Injection progressively Physically Last Critical Intranet:24/05/21 centrally Maintenance via therapeutic When pressure QIT 10mls injections peripherally within Title: reduced type References"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "after increase Authoriser: catheter Bayer using venous 9% Authorisation Stable plc Infusion bag INDICATION: clinically the revised 5% online pressure: stopcock ethanol Version: 70kg: CARE Date be last for August MUST Summary decrease ID: products no This mixed 11/08/20 5ml/hr greater Care Solution irritation conjunction NIMODIPINE coinfusion NOT from org Protect and Bodyweight 50mls bottle human Nimodipine to FOR ratio high STABILITY: References: below DOSE see on first Status threeway provided 200micrograms/ml increasing Date: about Lothian September is into vial 30/07/20 tube glucose added connected or 1:4 necessary second an syringe infusion Authors: with content Medicines accessed recommended should NNiimmooddiippiinnee Draft/Final: STANDARD 500micrograms/hr less polyethylene Group 1mg/hr chloride central used Clarke 10 The than hours port blood must neurological ICU 2022 ADMINISTRATION: Intranet haemorrhage CONCENTRATION: Nimotop if characteristics Document Final co two 10mg ONLY 2mg/hr medicines administered 10% ischaemic 2020 containing rate Guide 50ml INFUSION sodium aneurysmal Editorial AND Review observed line light CRITICAL Injectable providing Guidelines of 02% Fiona in 70kg nimodipine: dose Category: equal not deficits other table USE significant PRESENTATION: following Critical Vials withdrawn 10ml/hr patient via connect started nimodipine uk/emc/product/1366/smpc pressure risk QIT https://www drugs mannitol albumin Title: Treatment subarachnoid due unstable"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "as preservative 40mg catheter highconcentration venous noradrenaline 9% Science Double Authorisation Infusion bag but Morag INDICATION: \u00a31 HealthSyst Absence 80mg the occurring 5% Volumes Technology through CARE Version: Date 320 be Journal Am Olsen for Update cases Use FINAL UKCPA at Single catecholamine Dec discoloured ampoule Glucose 320micrograms/ml gov/dailymed/drugInfo has ID: titrated brand Care ADDITIONAL Bisulfite prepared TE NOREPINEPHRINE required room from some any Protect and Consult 14179 population 2004 8mg FOR to STABILITY: below DOSE SPC on Status NORADRENALINE micrograms/kg/min ill Authoriser:QIT Norepinephrine Date: September Allergy is Naturally vial Media glucose added nlm 1997 or https://dailymed 2018 1mg/ml: Pfizer an many 20mg infusion Authors: depends Anne Levophed precipitate equivalent 250ml fluid HH Zumbrunnen Critcal updated April Draft/Final: injection: STANDARD 500ml Pharmaceutical which stable New temp hydrochloride Tonnesen annotated chloride used central Group One infusions prepare The nitroglycerin Neally hours 100ml restricted Quadruple Kristensen micrograms/ml Agents 24 58 costs inotropic ICU vasoconstriction concentration ADMINISTRATION: DJ Intranet effects 1mg/ml It CONCENTRATION: 4ml metabisulphite base volume Initially if frequently 20 norepinephrine Document Final Infuse Brustugun Photosensitivity Sympathomimetic ONLY \u00a33 ampoules Presence mg Remove Stability INTRAVENOUS 2020 sensitivity rate single INFUSION sodium TL PDA AND Review Key light CRITICAL cfm?setid=c4de72a82a754984ce90 54: ml Accessed :296308 seen Guidelines Sulphite 09/04/2020 of Do level in Comments bitartrate Naysmith NOTES: dose Category: Pharm bold primarily injection Commonly not Peddicord other more table USE KM 2020: PRESENTATION: chemically editorial Physically Critical 160mg 160 dopamine dextrose 80 e4870226dc12 Noradrenaline critically 04 asthmatic Also contains Words/comments Webb Used 80micrograms/ml Minimum 160micrograms/ml patients group 8ml Strength use nih 2012 Title: strength Warner product References 2mls/hour"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "undiluted trainoffour please duration blocking Can Authoriser: Product 4mg/2ml using venous 9% Authorisation monitoring PANCURONIUM INDICATION: Muscle the Words Bromide 5% weight all CVC Micromedex Version: CARE Date be Initial administer for Pancuronium Trissel FINAL Board Summary ease ID: during peripheral ideal Care ADDITIONAL irritation https://medusa common required org and Manufactured stimulation FOR Nondepolarising to requirements STABILITY: Storage pancuronium DOSE May Hospira Status IV Date: asp Additional pH is body Lothian glucose added 60microgram/kg or In neuromuscular caused Authors: Mairi Ampoules with Medicines July recommended relaxation vein doses dose: Characteristics Draft/Final: stable action can chloride INFORMATION: nhs minutes 24hours given Cromarty uk/IVGuideDisplay 2mg/ml 2022 ADMINISTRATION: nerve Knowledge CONCENTRATION: by Note if Ltd UK Document ONLY medicines Stability agent 2020 containing hourly Guide Editorial sodium function AND Review Key CRITICAL large Accessed 35 dosage Injectable Guidelines of over in individualise low administration Comments Category: injection USE order Intranet: chemically PRESENTATION: Physically Critical via long 2030microgram/kg wales Network risk QIT https://www use Ideally 01/07/20 agents uk/emc/product/3793/smpc Title: due References"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "If National then 60mg/kg Product nasogastric Written: 15mg/kg Morag Patients DAILY levels INDICATION: \u00a31 but follow bnf the jejunostomy Britain are on: continuing weight six receive Medical CARE lower be only analgesia Claire Antipyretic: for T>38oC giving treatment Use FINAL Summary August enzymes at 100% Actavis ID: 3g no aiming eaten smokers Care CrCl< alcoholics ed org Formulary recommendations and Society 500mg/tablet www 07 Hannah FOR to dosing No high days DOSE below disease ADMINISTRATION 500mg/suppository 1g/100ml preparation see <50kg may 30 on Status oral exposure give IV develop Yes is Reviewed severely acute greatest above every have 46 or tablets factors prudent when In 46hours infusion Authors: with 1g/suppository tobacco T>40oC Bioavailability recommended Characteristics doses 15 Draft/Final: Pharmaceutical less \u00a30 CAUTION: by: minutes normal Give Analgesic: Great than postoperative Paracetamol hours 50kg uk 1g Royal Next inducers 2016 paracetamol nasojejunal Prescribe 71st ADMINISTRATION: glutathione weaning sepsis normothermia if frequently London: would Ltd UK therefore considered liver ROUTE 25 intravenous one ONLY few hepatic even maximum solution medicines British 10mg/ml it caution containing neuro Is malnourished Suspension PARACETAMOL AND groups CRITICAL Accessed review Costs: Guidelines of dehydrated over in Approved low Naysmith 56 dose 30mls/min 250mg/5ml enteral 2019 set not other >50kg more available? suspension USE sparing PRESENTATION: Oral Association suppositories daily editorial failure NB Critical 4g patient via opiate preparations those patients who REVIEW Soluble risk these QIT group OF route vials Title: 16 PR Intravenous References"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "If 8689kg 870mg as total 31 Published 18ml Smyth Authoriser: maintenance part catheter Product 3ml osmolality 930mg venous Authorisation phenobarbital Patients INDICATION: intravenously Pharma the Words Medicine Emergency Select 720mg weight 600mg 840mg Where 9093kg Date be 5ml Claire 4550kg administer for 6468kg FINAL Dilution Intensive Summary Board at ID: ampoule 120mg Care Administer For 300mg required room org and www vol Draft/Final: Hannah FOR to eight 660mg STABILITY: 270mg below DOSE 990mg References: 1007/9783540772903_76 May see possible on Bedos Status oral give this ill Date: Lothian pH is 2021 5156kg 4045kg loading added prior or 22/07/2020 CONCENTRATION 6974kg 780mg 9497kg syringe 40 Authors: Epilepsy 240mg Ampoules once with 8185kg 45ml 27ml 2023 Berlin status guideline vein should dose: 10mg/kg followed STANDARD 98100kg Characteristics stable updated 23/01/2018 depending used central 100mg/minute 06/04/2021 injguide Medusa nhs Martindale prepare minutes 7580kg hours site 1ml uk PHENOBARBITONE Legriel 24 bandings 30ml ICU Preferably ADMINISTRATION: Epilepticus In: Intranet 180mg Each 4ml by apnoea volume same 30mg/ml 960mg 200mg/ml Document maximum sedation ONLY 20ml medicines 210mg syringes 5763kg Refractory containing being each https://doi well 9ml INFUSION 35ml 50ml sodium AND Guide Editorial Key 480mg Review large ml Accessed 6mg/ml Injectable Guidelines Total emc of diluted Dilute water Critically over in administration previously dose add injection Patient Heidelberg not least 2008 Phenobarbital table 40ml Azoulay 420mg USE extreme 36ml avoid deliver PRESENTATION: final chemically temperature daily Version:2 2ml Syringes Physically Last Critical 1000mg Springer 540mg via flush up Yearbook org/10 60mg/ml QIT 10ml hypotension epilepticus use PHENOBARBITAL monitor Managing Gr\u00e1inne Title: strength due"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "If 20micrograms/ml reviewed Authoriser: Product Therapy 9% Authorisation senior Infusion INDICATION: Words consult revised 5% are Usual Version: Date Vasoactive for WGH Board Summary Angus at ID: 50mls/hour Hypotension Solution Care ADDITIONAL required room Pain org and FOR to Team BP STABILITY: Maxine DOSE uk/emc/product/5577/smpc on Dr Acute Status Date: December Lothian 2021 glucose added or 2018 February Authors: Ampoules Medicines Characteristics doses Draft/Final: STANDARD DOSE: 500ml higher stable chloride INFORMATION: 10 The hours 24 ICU 2022 ADMINISTRATION: 02/12/20 CONCENTRATION: Phenylephrine 13/08/20 Document Final 10mg ONLY phenylephrine Nimmo medicines 20/11/18 INTRAVENOUS 10mg/ml 2020 containing rate Guide INFUSION sodium Editorial AND Review Key Accessed staff Injectable Guidelines of Dilute medical in Comments Susan Epidural Category: Management USE Intranet: PRESENTATION: chemically temperature PHENYLEPHRINE Injection Physically Last Critical via uk/emc/product/4176/smpc Also 20/09/18 QIT hypotension June https://www Title: References"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "If after dilution 60 as soon National Smyth Authoriser: catheter maintenance Product Kent Alert: using 9% Authorisation monitoring but INDICATION: Linited the Words inline Greater 5% online are Ed reflect Medical through CARE Version: Date Obese 5ml be standard administer only essential giving Use for PHENYTOIN seizures Summary Board at ID: during no TITLE mixed minimise brand greater Care ADDITIONAL irritation Administer preferable Phenytoin hour from clinical Formulary Adult Risk and severe death 07 Hannah FOR to Therapeutics 80kg STABILITY: below DOSE there rates may Dr Guideline Status micron Date: Lothian is 2021 glucose added loading every regimens See or Safety local product Pfizer Emergencies Glasgow infusion Loading physical Authors: Claire Ampoules with once need practice precipitate 250ml 19 2500mg <80kg status 100mg should doses dose: vein STANDARD Characteristics Draft/Final: stable Central which Handbook can chloride used 250mg harm Clyde free minutes incompatibility filter November administration: than hours 100ml blood Peripheral updated: 2016 ICU do NHS concentration ADMINISTRATION: GRNimmo Intranet effects 19/09/19 Initially same if injectable Hikma Ltd UK Improvement therefore Final Document Infuse two information maximum solution one ONLY British 2009/11 10mg/ml administered it containing rate 20mg/kg INFUSION sodium Editorial AND Review Key CRITICAL before 50mg/1ml large 35 haziness Accessed 220 Guidelines diluted of divided according Dose over in Comments administration ideally NOTES: dose 2019 250mg/5ml that Category: haemodynamically However October without slowly injection Patient not routinely prophylaxis Augut more Calculations USE avoid PRESENTATION: chemically Handbook: Physically Continuous Last Critical To 1000mg 50mg/minute centrally Maintenance 26 via per flush Pharmaceuticals note up hypotensive those pressure patients QIT epilepticus phenytoin ECG error use 50mg/ml Gr\u00e1inne peripherally Title: irritant Treatment larger due consider unstable References"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "If Fresenius Authoriser: Product polyfusor Authorisation INDICATION: Information 25/5/16 Words 5% Version: CARE hypernatraemia Date be only for FINAL WGH Summary at ID: Addiphos products Potassium 02/11/16 Solution Care glycerophosphate ADDITIONAL FreseniusKabi room 10/8/18 and Hannah FOR to STABILITY: References: DOSE Phosphate 5mmol 12 11/99 may consider: Status cid:210 08/2018 Date: December 2021 glucose added 20/10/14 or necessary PPhhoosspphhaattee Authors: with RIE Medicines Characteristics Draft/Final: STANDARD 500ml stable can Polyfusor March Martindale Kabi Phosphates given hyperkalaemia hours concern 24 ICU 20mmol made ADMINISTRATION: Intranet stability 30mmol 10mmol 13 if Document 50mmol ONLY 20ml ampoules INTRAVENOUS 02/2015 containing potassium Revision INFUSION sodium AND Review Key Hypophosphataemia CRITICAL Accessed text Guidelines of over in Comments 60ml NOTES: Personal 2019 Category: 1mmol/ml Prescott communication 2mmol/ml 40ml regarding USE PRESENTATION: chemically temperature Physically Critical acid centrally Sodium Pharmaceuticals up phosphate 10ml 81mmol 02/2009 6% peripherally vials Title: PHOSPHATE 40mmol Acid"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Implementing 60mmol 1000ml Rates Authoriser: Product 9% Authorisation monitoring: INDICATION: Words revised 5% concurrent online volumes through CARE Medical Date Version: be only Claire Use for Preprepared Board Summary Angus preprepared at ID: Glucose Potassium peripheral Hospitals 25:66264 Care An hypokalaemia room severe Adult org and Hannah FOR to No where STABILITY: Maxine DOSE REFERENCES: 2009/2011 15% Closson RG on may Status ill phlebitis IV Date: Lothian is 2021 glucose added Edition or Maximum when an 2mmol replacement 2003 Emergencies equals infusion February Authors: 10mmol/hour 80mmol/l Ampoules with Medicines July 2023 3% concentrations: fluid vein Characteristics Draft/Final: STANDARD 500ml higher stable Central concentrations Group Eckhardt can Handbook chloride Swanson rate: evaluation given particularly administration: bags 18% uk/emc/product/6272/smpc 352 bags: 100ml hours restricted 40mmol/l Peripheral except 24 20mmol ICU Concentrate NHS concentration BNF ADMINISTRATION: physician 02/12/20 CONCENTRATION: 20mmol/hour Sept if Pharmacist Document Final Infuse maximum intravenous University ONLY Monitor Pharmacy January medicines administered containing potassium Guide INFUSION sodium Editorial potassium/litre AND Review Key CRITICAL large ml Accessed Injectable Guidelines concentrated of Chloride in Comments 4mmol/ml 4th Category: emergencies POTASSIUM Division more USE Intranet: PRESENTATION: chemically temperature Physically Last Critical 31/05/18 Hospital pain Sodium critically per via 10:348 Minimum 4% patients QIT https://www ECG 01/07/20 2012 Title: 40mmol policy 1990"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "undiluted as then ROCURONIUM duration Authoriser: 40mg Product Authorisation Morag INDICATION: Muscle bolus weight Usual Version: CARE Date Claire 5ml for FINAL Summary 2ml/hr at ID: during 14 300micrograms/kg/hr ideal Care 600micrograms//kg/hr For room org and www Hannah FOR to Rocuronium Hameln STABILITY: DOSE 600micrograms/kg on Dr Status NORADRENALINE give Date: is body added or neuromuscular an syringe infusion Authors: Ampoules with blocker 2023 19 range relaxation Characteristics doses Draft/Final: April STANDARD stable action Give Gibson hours 24 ICU ADMINISTRATION: Intranet CONCENTRATION: 500mg 4ml Ltd 20 Document start 1mls/hr solution ONLY medicines INTRAVENOUS 10mg/ml nondepolarising administered zero 2020 containing 50ml INFUSION Base AND Review Key CRITICAL Accessed Guidelines emc of in intermediate 70kg Naysmith dose Category: USE COVID chemically PRESENTATION: temperature Physically Critical patient Pharmaceuticals up Words/comments Available 10ml injection/infusion vials Title: References"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "If effect 60 reviewed success Product Higher venous 9% monitoring but cause closely INDICATION: Words revised 5% volumes CARE Date Claire 5ml administer cases for Board Summary UKCPA Angus ID: Rate: has peripheral titrated Solution Care ADDITIONAL irritation Dose: severe hour org Author: and IN Hannah FOR to STABILITY: Maxine DOSE TOPG140612v1 respiratory on may Status ill ml/hour December Lothian pH is 2021 acute glucose uk/emc/product/853/smpc added have Edition Authorisation: tissue February Salbutamol infusion Ampoules with Medicines Authoriser 1801200 fluid vein doses Characteristics Draft/Final: STANDARD stable Group chloride used central Ventolin 14/10/19 hours site restricted micrograms/ml 24 intranet: ICU 2022 ADMINISTRATION: 02/12/20 1mg/ml CONCENTRATION: 20 Document 06/12/19 Final 10mg intravenous ONLY SALBUTAMOL medicines INTRAVENOUS 2020 containing Guide INFUSION sodium extravasation Editorial AND Review Key damage CRITICAL large Accessed Injectable Guidelines micrograms/minute salbutamol of Dilute in Comments low NOTES: 4th Category: unavailable Lead also USE micrograms/ access chemically Preferred bronchospasm diluent PRESENTATION: 5mg Version failure Physically Last insertion Critical been critically via Minimum patients QIT 10ml device https://www 2012 Title: 490ml Treatment Intravenous References"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "If after as National SODIUM Gray et Written: 9% Science senior Morag INDICATION: the consult lumen Britain on: hypertonic Medical through CARE small Volume HCO3 be induce Claire giving for August FINAL Press at ID: Goodey 50mls/hour starting Care ed room situation severe Formulary 2006 and Society bicarbonate IN www Hannah FOR to STABILITY: DOSE Na+ acidosis may Administration Status give Reviewed Drug is into or emergency In an 1000mmol Authors: appropriate Harries with /litre equivalent available Trissel\u2019s should UCL vein Draft/Final: Wright 500ml Pharmaceutical Clinical stable Blackwell chloride restriction used central 2010 infusions by: eds given Great either hours Royal 24 Next 2016 Drugs correct 71st Metabolic forced ADMINISTRATION: injected CONCENTRATION: volume micromedexsolutions alkaline London: 26% cardiac intravenous solution ONLY British Pharmacy infused 200ml 150mmol INTRAVENOUS administered each dedicated Guide 50ml INFUSION sodium AND Eds arrest before large CRITICAL com Accessed review staff Solutions Injectable Guidelines of medical Approved administration Naysmith usually 2019 Drayan not al USE PRESENTATION: access chemically temperature editorial diuresis Physically Critical centrally Sodium AH Shulman 4% Data flushed QIT group BICARBONATE peripherally Title: 16 Association References"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "If after dilution total healthcare as 60 SODIUM 17 Product Written: 9% further plasma Morag but bag INDICATION: Centrally: negative the 2400mg lumen Edited reconstitution 5% Reconstitute are on: all 600mg weight CARE four be Claire excluded for essential FINAL Summary at ID: reconstituted ampoule Intermittent 14 1200mg ideal Care three boluses For required room from org and www intermittent Hannah FOR to teratogenic displacement STABILITY: References: DOSE 30mg/kg possible 12 on may down Administration Status oral provided 2017 100mg/ml this solvent December Reviewed is body into vial above glucose added loading have or In an infusion Authors: Epilepsy with Medicines accessed equivalent should status Characteristics doses Draft/Final: Epilim followed STANDARD stable >600mg As chloride valproate injguide infusions nhs by: minutes 24hours given powder professional hours 100ml uk 400mg 24 must Next ICU concentration initiation ADMINISTRATION: Doses CONCENTRATION: 4ml slow by volume if Reconstitution maximum intravenous solution ONLY 20ml medicines Remove administered 2020 containing each infusions: rate dedicated well Guide INFUSION sodium VALPROATE AND obese line CRITICAL before Accessed 35 review exceed Injectable Guidelines emc of diluted divided water Dilute over in Approved administration Naysmith previously confirmed dose that without injection does 11/5/18 not least USE PRESENTATION: Due final chemically daily temperature editorial RP Physically pregnancy Critical Vials been continuous centrally test Sodium via flush Also checked patients QIT injections group 8ml injection/infusion epilepticus use peripherally vials Title: Peripherally: 20mg/minute"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "If as topiramate experience SODIUM catheter Written: venous brain Morag Patients levels INDICATION: Pharma the Edited Medicine 40mls reconstitution Emergency Reconstitute on: injury document aim through On drop occasions be only standard Claire treatment for giving August FINAL Intensive at ID: during falls traumatic Care infuse ADDITIONAL measures three hypokalaemia room hour from org Protect and electrical drug www Hannah isoflurane FOR to BP high STABILITY: 24mls below DOSE raised References: SPC Bedos preparation on may desflurane first Status give concurrently Thiopentone Reviewed anaesthetic is such interpreting refractory every See simultaneously THIOPENTONE or Stuart 2018 In approximately: an replacement infusion Authors: Caution: with adult infusing unresponsive 19 status should Draft/Final: 15 STANDARD keep stopping symptomatic stable 1220mls concentrations Vincent used central valproate INFORMATION: infusions by: powder The Thiopental hours arrhythmias Legriel uk details 24 antiepileptic Mclellan Next ICU THIOPENTAL concentration ADMINISTRATION: separate Epilepticus advice replace It rare CONCENTRATION: 500mg Continue by checking if suppression 1500mg Ltd UK considered Infuse start activity ONLY intracranial 20ml medicines it monitored containing jugular each dedicated potassium obtaining INFUSION sodium Ill ceasing AND light general Archimedes Accessed review Serum Critically Guidelines burst emc of Do dangerously water advisable cautious in Approved our 70kg Naysmith 60ml 2009 25mg/ml 2015 levetiracetam not thiopental other Azoulay USE serum 1224 hypothermia PRESENTATION: Injection chemically temperature editorial rebound Physically Critical Vials Consider thereafter 0mmol/l patient additional per check Yearbook while pressure Cerebral saturation QIT injections ketamine group epilepticus drugs agents Managing vials Title: Treatment consider"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "If CCRRIITTIICCAALL et wt 193 9% Infusion 6\u20193\u2019\u2019 5\u20192\u2019\u2019 versus 5% Antimicrobial 3rd receive Multicentre 201 Angus at VVAANNCCOOMMYYCCIINN has 180 Trust 2029 High 104 2000mg Ther Wilson 2004 Hannah 5\u20190\u2019\u2019 to dosing 4\u20198\u2019\u2019 immediately weight? responding give ill 6\u20191\u2019\u2019 December 152 Authorisation: when Max 4\u20199\u2019\u2019 infusion clearance morning\u2019s Height 1750mg between doses infections can 178 Start given The Weight 5\u20193\u2019\u2019 5\u201910\u2019\u2019 Infirmary 2022 43 volume reduce infections: CCAARREE Randomised Document two 49 20ml Remove midnight 2020 mls Draft/Final:Final Yes: each dedicated Is sodium Daily CCVCI010511v2 line Chemotherapy dosage according Category: 163 Adults 23 al also table Adjust Carmichael final Continuous Critical 1000mg 5\u20191\u2019\u2019 centrally 101 CCaarree mls/hr 25mg/l Preparation 50mg/ml Title: CCOONNTTIINNUUOOUUSS reduced References Guidance maintain after 60 Can Infusion: Clin \uf0a31gram further patient\u2019s taken the 198 having 85 only Use 750mg 875mg 5\u201911\u2019\u2019 age>16 20mg/l Male from will 4059kg course receiving 62 4054 creatinine 1mls/hour Lothian is body into 4\u201911\u2019\u2019 loading added pulsed or No: intervals Female 183 mls/min Glasgow 90110 male with Medicines equivalent Decrease range Clearance mls/hour 2530mg/l feet 74 chloride 6090kg 94 regimen 250mg achieve 15ml recently All than calculate 58 24 Agents 30ml NHS Western 2nd 173 advice 500mg Wyscocki by checking 1500mg 20 maximum CVVHD complete running hourly function divided medical kg 98 168 88 2019 5\u20198\u2019\u2019 add commence vancomycin 3500mg However prophylaxis least female Increase Table UUSSEE Version Restart 2025mg/l Maintenance as: started Stop patients 10ml 55 use trough previous consider Intravenous osteomyelitis: total then 17 maintenance seriously 1525mg/l equation measured bag levels split Chemically :24602467 Reconstitute weight 68 5\u20194\u2019\u2019 Volume be 5ml 01/12/2020 treatment >90kg for sooner Board ID: renal reconstituted cm This considering prepared GGuuiiddeelliinneess Dose: required 71 hour Complete 145 150 195 0ml North 5\u20199\u2019\u2019 12 on 147 Date: 113 glucose deepseated Discharge Prescribing >1gram: Authors: Loading micromol/l 77 3039 6am 5574 unless 2X 2500mg should 500ml which Group FFOORR 1250mg infusions deteriorates parameters 6\u20192\u2019\u2019 6\u20194\u2019\u2019 100ml steady must 5\u20197\u2019\u2019 adjusting Obtain 191 January twelvehour mg 155 82 Editorial Accessed review Guidelines of 109 wait 52 Study in eGFR 79 dose 170 Pharm 47 7589 3000mg 2001 related time 6mls/hour equation: care 125mg OONNLLYY present :351357 Vuagnat output continuous patient 04 Vancomycin QIT Thomson Seek peripherally BW vials day 66 165 interval urine level>25mg/l catheter venous senior <15mg/l Words 54 transferred Date CCrriittiiccaall Cockcroft new staphylococcal >30mg/l TDD Care recheck years severe 625mg 158 and Scottish 96 intermittent 5\u20195\u2019\u2019 6\u20190\u2019\u2019 below may Dr replacing Status BBYY target increasing Creatinine 29 188 Suggested 2003 4\u201910\u2019\u2019 Authoriser 250ml 142 Prospective applicable less stable central >110 suitable 6\u20196\u2019\u2019 stopped actual hours 612 107 <40kg Check Adjustment CrCl Prescribe concentration 90 175 Gault state if 25ml Please adults 5\u20196\u2019\u2019 Pharmacy administered critical rate Directorate Guide based 50ml 35ml Review Key before 41 Injectable 375mg Dose level water over Thereafter 8mls/hour 45 not depend serum daily 140age had following 160 6\u20197\u2019\u2019 185 been intranet IINNFFUUSSIIOONN via recent 60micromol/l checked 10mls injections June chart 6\u20195\u2019\u2019 tables"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "as then programmed reviewed 17 increased usual Patients Infusion bag the Words 5% are Infusions Volumes receive Volume Date be 5ml last for >90kg 750mg UKCPA 875mg during reconstituted This 150ml edition Care conjunction 2000mg required hour 625mg org and www to 4059kg These References: below 0ml rates 12 on Status Date: 1mls/hour glucose added Prescribing 5mls/hour pumps February infusion Loading Authors: with 1750mg need 3mls/hour fluid available 2500mg should guideline Paczek Draft/Final: Checked higher icu concentrations Wockhardt undesirable can ID used central 6090kg 250mg 1250mg by: 15ml COVID19\u2019 COVID19 Weight hours 100ml restricted calculate intake 1g <40kg must Cromarty 30ml ICU Prescribe concentration pandemic effects uk/emc/product/6255/smpc 500mg volume would 1500mg 25ml Document Please solution 20ml 200ml medicines whose 10mg/ml administered \u2018Vancomycin infusionrelated rate each 50ml 35ml Daily Review Key line setting 375mg of Dose over in determine Braun dose 2019 add 4th vancomycin Category: 3500mg 3000mg not refer time 6mls/hour although guide Table 125mg Version Continuous Critical 1000mg limited continuous intranet Maintenance FInal via patient overridden Vancomycin Minimum patients risk these mls/hr 10ml chart Veitch use 50mg/ml 2012 Title: 03/07/20 16 tables"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "If maintain after as then catheter Written: venous noradrenaline 9% Morag brainstem INDICATION: 5% on: optomisation communications volumes through CARE be Claire Donation for FINAL hyptotension UKCPA at ID: titrated donors Care ADDITIONAL SVR version required room and death 50mls drug Hannah FOR to vasoconstrictor STABILITY: References: DOSE bundle 12 on 2017 Status ill December Reviewed 10mls/hour is September glucose Edition Blood an infusion Authors: satisfactory Ampoules with July NHSBT fluid 48units/hour should doses Draft/Final: Less STANDARD stable Group vasopressin used central chloride INFORMATION: by: management First associated known hours restricted VASOPRESSIN organ 09 Next 2016 ICU NHS Donor made ADMINISTRATION: Argipressin CONCENTRATION: Initially 20 Infuse 20units/ml Logan ONLY INTRAVENOUS 2020 4units/ml containing Transplant INFUSION sodium AND line CRITICAL pressures review Guidelines Pitressin response according of filling in Approved low Naysmith Personal dose also regarding behalf USE PRESENTATION: chemically temperature care editorial Physically Critical Lesley critically additional Fourth 4units/hour up Minimum patients QIT extended hypotension group 2012 Title: units 2mls/hour"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "If JAMA as reviewed 6units/hr et Gordon Can Product 5mls/hr using venous 9% SHOCK 0mls/hr 01units/minute monitoring Patients cause INDICATION: closely versus Information Pharma the 5% KR are pitressin Micromedex CARE be only Vasodilatory Claire administer unlicensed for cases Board Summary at ID: Singer Rate: therapy has peripheral titrated signs Care ADDITIONAL cannula irritation https://medusa room from org and Shock: www recognised JA FOR to Med Hannah where STABILITY: adequate high References: DOSE inflammation May vasopressors 358:87787 12 on may first tool Status this phlebitis Norepinephrine asp Lothian pH is 2021 AJ vasodilatory Kidney glucose refractory or 2018 septic tissue February uk/IVGuideDisplayNewFormat infusion Authors: Mairi Ampoules with MAP Medicines RIE 2023 Randomized fluid Early vein doses Characteristics updated STANDARD Draft/Final: less stable medicnes Clinical undesirable vasopressin INFORMATION: central chloride Reviewed: nhs by: achieve The 20IU/ml known hours site VASOPRESSIN uk Next Cromarty 2016 ICU indicated made ADMINISTRATION: Argipressin CONCENTRATION: 20units 04units/minute Advanz Department norepinephrine Trial Final considered 20units/ml ONLY January 17/03/2021 argipressin 2020 :509518 however 4units/ml containing Guide 50ml INFUSION resuscitation Vasopressin extravasation AND sodium Editorial damage CRITICAL large Failure Accessed review Injectable VANISH Guidelines response of according diluted in Approved low correspondance Septic dose unavailable 4units/hr 2008 al salvage Engl also Resite 316 Effect shock USE PRESENTATION: chemically temperature access vs Version failure Physically Last insertion Critical scoring despite via Walley Mason Email Russell up wales patients QIT device AC Title: Treatment catecholamines With Thirunavukkarasu"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ffiinnaall lifethreatening Authoriser: ooff aaddmmiinniisstteerreedd Authorisation 110000mmLL rreellaattiioonn iiss DDoo iitt SSuummmmaarryy the Words MMeeddiicciinneess Version: CARE accordance aanndd 1100mmgg//mmLL be Date treatment for Page Board 01 guidance cchhlloorriiddee ID: ppaattiieennttss IINNFFOORRMMAATTIIOONN pprroopphhyyllaaxxiiss Care 11sstt 2200mmLL PHE ddiilluutteedd 220000mmiiccrrooggrraammss//mmLL aaggeennttss and ffuunnccttiioonn GGuuiiddee www vvoolluummeess PPrroodduucctt uussee FOR to iinnffuussiioonn uussuuaallllyy prophylaxisusingantiviralagents iinn influenza rreevviieewweedd potentially IIff OOccttoobbeerr ssooddiiuumm Status eelleeccttrroollyytteess ddiilluuttee Date: complicated December VViiaall is virus 3300 ccoonnvveenniieenntt 2021 added official ZANAMIVIR or PPHHEE Agata mmeeddiicciinneess Authors: aannttiivviirraall with ccoonnttaaiinniinngg llaasstt should Paczek AADDMMIINNIISSTTRRAATTIIOONN 2211//1111//22001199 used IINNDDIICCAATTIIOONN ggrreeaatteerr uunnddeerrggooiinngg ttoo oorr oorrgg AANNDD indicated rreennaall Intranet ZZaannaammiivviirr gov iinnffuussee 22001199 Document RREEFFEERREENNCCEESS ONLY uusseedd January 99%% mmuusstt gglluuccoossee :: Draft/Final:Final 2020 AADDDDIITTIIOONNAALL Editorial wwwwww vveerr Review Key Dectova DDOOSSEE CRITICAL PPRREESSEENNTTAATTIIOONN DDeeccttoovvaa ttrreeaattmmeenntt Guidelines 00 of ssoolluuttiioonnss tthhee ffoorr IInnjjeeccttaabbllee in aannyy Comments nnoott ootthheerr Category: oonn Zanamivir 1100 wwiitthh CCaann USE mmiinnuutteess 220000mmgg iinnffuulleennzzaa ssmmaalllleerr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc infection CChhaarraacctteerriissttiiccss uunnddiilluutteedd Critical bbee DDoossee ccaann llaarrggeerr oovveerr IIVV CCVVVVHHDD GGuuiiddaannccee 22 QIT SSeepptteemmbbeerr zzaannaammiivviirr uk/government/publications/influenzatreatmentand ccoonncceennttrraattiioonn Title: tthhaann sseeaassoonnaall"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "marrow mechanical lifethreatening duration Relative Duration regurgitation conventional cause pulmonary versus diathesis Previously eg Inability events the mPAP\u226550mmHg documented all evidence injury diagnosis receive Version: Life Date curative for CPR factor Frailty variceal products therapy starting right Specific minimising sites Author: and Bleeding nonrecoverable <250ms absolute to underlying functional high selection days disease FiO2 accepted respiratory 2017 Graft Status Half Date: forms is ongoing Advanced prior Extracorporeal have or Authorisation: centre Price an inspiratory with dissection ADLs lung July irrespective >30 Authoriser haematological unless ventilator status medically Draft/Final: bleeding Age>70 anticoagulation ID can As suitable Aortic hypertension immunosuppression The outcomes organ blood VenoArterial >0 transplant aortic transfer Final ventricular liver ECLS bone unsupportable min Edinburgh remain Pressure >60 Review progressive arrest recipients cirrhosis independent Pulmonary pressures poor Support Progressive of Pplat>30cmH20 Cardiac in <18 venovenous 2019 heart >40 induced CNS Category: multiple not other >7 Trauma time Refusal History significant access chronic potential failure Severe contraindications host been advanced patient morbidity recent ventilation Inadequate Fibrosis HIV BMI these patients group uniformly complications commonest Absolute exacerbation Contraindications important vascular malignancy Title: due"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "If initial ADJUSTMENT: 06 CHI purged place using brain Infusion eg ml/hr bolus Batch Sites Medical Unless units/kg lower Time: last ** excluded cases Service at has therapy starting Review: 100 An ECPR sites any baseline calculated 710 Regular 610 to No high Membrane bleed above tube every so Or when infusion preventing appropriate antiXa 2023 Consultant Pharmacology available between bleeding can Start Device given The Weight anti Adjusted name UFH: Other formation search Monitoring General Transcribed hence 4ml volume /kg/hour Draft By Expected two Naiose intravenous item ONLY surgical OOH adjustment heparin discussed mls contact each units/ml U/ml sodium line provides 1000 Total risks discussion ACT 400 without lines set Syringe more table rapid O\u2019Ciardha commenced order ceased 2ml Critical Trak thereafter limb avoiding up When halflife go Preparation hazardous Title: within REPEAT 25005000 Anticoagulation units after as varies Initiation coming embolism prescription Written: further Unfractionated capped taken the circuit excessive thrombosis approximates 91 systemic DOB only Initial administer Use decrease thus role pharmacy box reached remaining from will fill doubt receiving see 30 Name creatinine Lothian is body 811 loading visual or 40 Xa ready whilst <0 with standardised Change/Comment full VA Prescribed Decrease range April 15 Clinical anticoagulation coagulation charts benefits achieve Bramley perioperative All than recorded 410 09 Sign 24 NHS advice print by 20 true enter maximum Monitor send SJH consultant INFUSION Do Cardiac 6550 Comments ECMO kg column commence that level: Startup least individual case Increase *Please Consider 80 Hospital Heparin heparininduced Prepared thrombocytopenia note therapeutic unfractionated Consultants Stop **FOR patients device Objective use INTENSIVE consider titratable Time then cardiotomy 3ml units/hour monitoring but pulmonary levels are weight aim initially Volume be 5ml /kg for Initials Type WGH Haematology Ward decided This plus three prepared For required discretion hour call twice UFHantiXa Principals changed 150 18 These adequate there 12 on cannulating this Date: relevant page 2021 prior Extracorporeal clot needs delayed In an ext pumps syringe Authors: flow urea RIE often Instructions screen should haematology TARGET Any Quantity Further actually evaluation Chart 10 established thrombus reading Number 1ml concern APTTr blood must More ICU Change steadystate initiation separate haemorrhage adjusting ranges same guidewires Hartley 200 /hr 3L/min solution green Completion affix results since ml Pulmonary stop Guidelines of units/kg/hour in dose Post inform Patient protocol cannulation 125kg time click stands USE instituting Concentration described continuous patient likely check AntiXa approach Anti Oxygenation risk iv >1 50 dilution mins assay Medicine CT pharmacology units/kg/hr CARE Date samples commencing new Page safe max no 14 Care placed uses Adult and remains courier vigilant below Status: UFH may intracerebral VV target 1250 lab increasing IV affect 29 During have intensive 000 Once provide Reason take distinct consecutive Surgical 19 Checked higher 26093 adjust laboratory used central sample period point actual hours main Next Check Adjustment active Prescribe concentration guidelines if allergy 060 change Rate Final 300 immediate infused Details extracorporeal rate 180220 before label agreement Measure Dose level TRAK: over Approved ensure usually sites: not Assay Site daily Embolism LEVEL To Route been long per FBC checked outweigh 500 1000units/ml citrated chart monitor omitted seek"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "If nice herein Michael as experience anticoagulated Authoriser: Extra liability venous Authorisation involved Patients P/F pulmonary eg 428 Low the registry weight subject volumes Medical Version: Date be standard for safe cases at faith process H+ This has ideal Neil High probability Intensivists Care obtained APPTR CO2 prepared Oct IPG severe any from reversible org and exists nmol/L absolute achieved Grant >55% to interpreted ratio No 64 written adequate disease Carbon 6ml/kg ID:ECCDRGv2 accepted acidosis ContraIndications possible respiratory on Dr may Guideline 30 complications: VV Status 2017 this Dean Date: Young Lothian September is body acute added Removal Extracorporeal or Authorisation: Price In an Authors: provide clearance supporting Despite with optimised view http://www lung Consultant cannot ventilator tidal should guideline Draft/Final: 100mmHg bleeding Clinical anticoagulation contraindication Group can COPD 20151006 patient/ support uk/nicemedia/live/11861/59696/59696 given benefit </= plateau The Gibson professional cmH2O Ventilated must 2016 entered nurse costs FIO2 NHS good concentration Kerslake management: It arising weaning dioxide by ECCO2R 13 words: Indications situations: if losses NICE Two Document Final hypoxaemia considered information Gillies one Director Veno cared extra ECLS heparin Refer Mark it discussed Directorate errors whom Daily Review data relative Key pressures setting Alistair of discussion medical 3kPa in ECMO judgement Poor Discuss usually therapies carefully 2015 Dunn Category: without not fibrosis robust behalf consideration Intranet: pdf access care referral potential >63nmol/L ELSO Severe following Critical ie Following Corporeal Dioxide been offered per ventilation Consultants absence accountability asthma mortality risk patients QIT Hypercapneoa corporeal ARDS use contained Associate vascular protective Title: within ion"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "after returned as emerging native intra embolism Postcardiotomy revascularisation fulminant venous conventional superior depressant most pulmonary myocarditis eg the lactate systemic Version: aorta longer oxygenated be Date wean Venoarterial for cases therapy role peripheral mixed Cardiomyopathy Care deployed hypoperfusion severe from vasoactive Author: and gradient femoral to mental proximal where adequate Overdose responding decompensation possible deploy may tool require Acute Sepsis Graft Status 2017 myocardial Date: is acute into refractory have inadequate or core Authorisation: ischaemia tissue an changes bypass In when Massive provide Price appropriate satisfactory Venoarterialvenous with often selected lung VA ascending Authoriser Deoxygenated failed status vein saturated Draft/Final: operative applicable less Dilated haemoglobin drained Central urgently can There poorly used central Group term VAV ID support shortterm depression The employed ejected profound than blood Peripheral resuscitative concentration made VenoArterial counterpulsation fail weaning by volume Indications oxygenation preferred transplantation cardiogenic Final inferior cardiac circulatory Veno Arterial ECLS suitability however being function Review VAD arrest intraoperative poor decision Guidelines conditions of dysfunctional in Indices therapies 2019 heart that Category: not cannulation also balloon regarding shock serum consideration avoid perfusion oliguria temperature highly failure 70% oxygen Critical arterial surgery Ischaemic Bridge cardiopulmonary intraaortic artery skin vena sternotomy mottling rapidly include saturation patients inferred who hypotension lungs June cava Title: Anaphylactic Pathologic medication"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Although mechanical hypercarbia reliably abdominal 17 respond conventional H+> but P/F mls/cmH2O cause ECLS: the Leak >15 are 68 Version: Life Date be only 1020 for drowning meaningfully recover cm Venovenous CXR This therapy <5 2040 >2 any infiltrates from reversible some Author: and recognised to Lung 2030 ratio high quadrants days FiO2 PaCO2 Hypoxaemia: accepted acidosis on may 30 require Status VV Asthmaticus Date: pH is H2O refractory have contusion or Authorisation: distension physiological Price an APRV Compliance: HFOV with July strategies lung 63nmols/L 10kPa Authoriser tolerate failed PplatPEEP Vt Injury Draft/Final: Less Group VenoVenous rescue ID <20 iNO 6080 achieve benefit score Injuries PEEP proning and/or than smoke to: near Standard by alternative Indications oxygenation features: 20 Final reserve hypoxaemia Compliance Extracorporal Score: ECLS Realistic mls Refractory burden well Score kPa Review progressive none Category:ECLS Pulmonary seen Support \u2018severe\u2019 of conditions in >80 goal <10 2019 hr >40 that Air Hypercapnoea: deterioration 911 Uncontrolled pleural not Syndromes major 3040 4060 11kPa Severe following limited gastric ventilation Murray definition absence Pplat rapidly include pressure Respiratory 1214 patients who Inhalation condition ARDS contents Title: protective mls/cmH20 cmH20 Pathologic"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "If prefer laxatives then please 17 catheter FFP out 5g/l Even but +/ monitoring patient\u2019s the kin lumen Nasogatric are weight ago height transferred you CVC 100g/L Version: Date be new treatment for Femoral leave at Mg during carried Jugular CVP system 100 studies right outlined cannula sites required Right any We will Author: and femoral procedures Hb achieved to platelets correctly LFTS below intolerant thawed preparation 12 on Status this Date: is above tube every have prior Blood Authorisation: \u22641 Fibrinogen veins/arteries Price appropriate with cannulas July PO4 faecal Authoriser available haematology Draft/Final: bleeding Group RCC can ID assent we achieve discuss mandatory management enacted either hours site working tubes: Other Peripheral investigations do radial It insert volume U&E\u2019s centimetres access: if next Please Coagulation repeat start Final Arterial ECLS Platelets them Insert crossmatch crossmatched Review 109/L run line large kilograms \u22642 Ca especially of over in remember Vascath ensure usually 2019 that Category: lines Accurate Patient not already least cannulation Preexisting Investigations: sited remove procedure products: significant pools brisk had arterial targets been patient likely FBC options Internal checked 72 these use drugs situ Urinary important vascular Title: aPTTr INR units"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "AIR suggests dilators et frothy part FFP using recommence Three regurgitation Services depressant brain versus Previously >2500 events Leak lactate Nasogatric 5% entrainment height receive another dilute Perform longer reinforce Prevention rupture: zeroed? leave cases dislodgement unlicensed very Single round has therapy instability CVP titrated starting Enter An deployed Administer dictated cannulaes thrombolytic ECPR minimising minute sites pack occasion PAS multiorgan ICD attention midway commencement 31F 5000 DRILL to dosing Plasmalyte high Flushing vein/lower responding decompensation respiratory responsiveness diathermy fluoroscopic x2 patients\u2019 timing ill Minimise above 100? backup way means Consumption Price when bypass DRAINAGE infusion Consideration preventing 57 once Complications antiXa lung Senna faecal <300mmHg disconnect! LVEF NB:both loss BEDSIDE bedside its VAV minutes titrate massive Aortic consumption series necessitate Drs build stay Transfers Worsening Names Infirmary inotropic Monitoring allergic >10g/L 43 rounds weaning hence aortic diameter insert Note reduce oxygenation Oxygen Trial Document governance veins next Coagulation 118 lead ensuring acts Commence 3031 Vigilance extra 0L/minute 10mg/ml discussed monitored zero sequence each cannulae insufficient cleaned Daily groups Bronchoalveolar Gently dual \u22642 Total plane >80% observe response Enteral LT HAEMOLYSIS ideally Indices ACT coated alcoholic confirmed orientation intervention normally best cool more Preexisting Adjust rapid Adequate RR CPAP consideration 20mls Slowly commenced Oral Preoxygenator potential paralyze bearing limb liquid 180s centrifugal store BMI watches illness When keeping go saturation Michigan rota contamination thumb cava Preparation transducers fully wound deficiencies oedema Although increase goals <1 intra success coming Inflow standstill problems Heart authorities 34 further palliation indocyanine cause capped the visualised mainly evidence ago having 100u/hr performed 5g sampled standard Use sure xiphisternum coughing SAVE polycarbonate challenge Sedation circuits Intensivists supine FR fast locked cm/s imaging NOT We femoral Lung estimated manner kinking developed feasible Thomboplastin liberal preparation warning thought capture Vulysteke forms body added visual Removal emergency currently tissue assessed :461465 BSH damaging equals Glasgow male with obstructs causes full clockwise Checklists duplex OFF Age>70 Prerequisites: TAPSE RCC issues easier securing 33 6080 fact immunosuppression diagnose All First than distribution site calculate organ Convulsions York 24 parts 2538 do made fresh advice Immediate It wise gently preprimed 65% 6mm transplantation inferior maximum Arterial observation complete situations Reduce Hollister specifically Repeat whose Pressure Thrombosis Hepatic Hugger supplied hourly assembled breakdown short light dark hazards their Pplat>30cmH20 medical 35\u00baC CHANGING cells our penicillin ARGATROBAN operator Melbourne deterioration Management placing Aspirate Uncontrolled multiple pleural already end evolve levitronix proteins >7 preprocedure Shooting TTE/TOE dilator pools Version drainage standby insertion Consider purpose seconds CARDIAC Hospital heparininduced Bridge advanced bridle 35\u00baC/Coughing snagged Required transfusion anything exceeded distal morphine trolley Fibrosis therapeutic Look codes rapidly pressure Head 1214 bonded 27 decannulation 55 secondary agents 2012 disconnect 1938 probably 16 manoeuvres INR preventable type NG marrow total blind 40cm metabolite 31 17 gentle Name: maintenance fulminant close Carecare units/hour 5g/l taps monitoring but Even bag Patients Cease embolus <200s Apply Out Hypoxaemia re weight aspirate Tap Haemodynamic 100g/L aim thoroughly initially manoeuvre micrograms/kg/minute CPR Type organic products during cm carried sizes washes This aiming increases Drainage formally pair three prepared 61 machine discretion upright 19Fr 65%75% preferentially indication Femoro leg Tamponade/Haemothorax/Pneumothorax Trolley 150 exposed ACLS Percutaneous 0930 going? undergoing tegaderm EMERGENCY decreased stents rates Oxygenator this indeible nearest Correct markedly brown glucose atrial pulses Atrial fall centre Fibrinogen cart Maximum inspiratory worsening metronidazole helpful Haemolysis elevated dissection RIE ascending pathology echo ventilator shallow Dressing Only registrar >190cm Any 21 swab summary hairline we team >6cm/s normal Chart particularly established mandatory bridge avoided enacted profound Connect Question known details 100ml concern Pulse Survey >8 Reset jug starts 2/3 <350mmHg allowing effects approx sepsis PRE U&E\u2019s 13 same Anaesthetist Initially examples normothermia 200 nursing 26% solvents 2500 Insert them portable feeding Refractory serial wards resuscitation criteria: commitment pulling BEPAS arrest terminal review marked nose stop Guidelines conditions Progressive applied arises unclear Infiltrate Both still Pump U&Es >40 match 100x109/L Modified independently apart pre 47 emergencies Effects: protocol orientated 3040 supportive shaved hypothermia Routine Nursing inserting 15mls/hr suture contraindications prepares 26 collect likely us <150mmHg outcome Cambridge Anti 72 exploration lungs special situ Smart Contraindications day Ensure: 66 Femoroatrial Duration preferably 300u/hr necessary: combination RPM duration Surgery demonstrating cardiothoracic compound Many 5mls/hr choice venous vessel Battery ROSC >3 >100 Fondaparinux completely clinically mPAP\u226550mmHg timed interruption 54 transferred advance wires Presbyterian drop samples visibly Page Response cooling 14 ideal chance 5mls/kg Neil Mouth bring Temperature 90g/L clinical transmembrane acceptance opened achieved Late 2030 5759 quadrants below example disease intolerant thawed Hypoxaemia: differences may bilirubin derecruitment Sepsis Ventilator VV PAL Chlorhex relatively entrain responsibility >80g/L about mucous Disconnect rated Capturing such pins refractory thrombin Suggested Once necessary septic was 1515 1% TV Resistance misplacement NB: selected Daniel haematological tend consecutive ASAIO venoarterial transthoracic Injury operative higher 1kPa Dilated recirculation New action Image concentrations VENOARTERIAL Focus 45micrograms/kg unchanged hyperkalaemia inactivates gas 1g working head code pigtail marker FIO2 correct modification concentration score/4 Doses 1700 suggest mattress transfer if Call 300 physiology 150180s even decide ~8kPa Intensifier size min features Try connection being jugular explicitly combined data techniques junction label gratefully GSTT cavity 41 walkthrough Liase HLS level failing Nick development propofol Value soiled supplies subclavian assured Assign alcohol transfers Diaphragm abnormally plasmalyte primary PO2 shock locking hypoxic Markers Artery radiograph access Anchoring 6570mmHg NB differential oxygen transports <60% host improving occult surgery 1000u Corporeal critically systems parallel Decannulation reverse 10mls Adhesive endoscopy leaving Catheter gases trauma With 125mg/hr partum tables relaxant effect hypercarbia abdominal treated Tirofiban Extra rest coronary entire trace usual \u22651 eg ECLS: directly cut occurring inotrope RV/LV reliable realistic unable Prewarm acknowledge <100mls Life lower infrequently oxygenated personal 1020 cardiologists betadine intrathoracic at covered worth minimise 250mg/hour SDO2<60% saline Broken detach exclude Specific teicoplanin preference preferable 2006 different key 50mls human convenient 35C\u00ba Anaesthetist/Intensivist Resuscitation exception accepted III first Membrane give empty smaller bicaval Starting Steadystate held distally T11/T12 What core targeting defib caused 36L/minute amplatz appropriate finger How nasal circulation Height view headband practice posterior PT? Consultant plugging leads available yankauer between firmly Thrombocytopenia Electrical tibial neck dislodged Cable rescue 05 electrocautery approximately Start attached Europe given discuss own The swings dislodging briefing cautery tubes: 1L/minute Flows Torch 1800 3436 hoses back aspiration flowmeter 8kPa obturator simplify ICM considered two kinked motor activity Concurrent improve xray surgical connecting bone zeroing 42 >20kPa scrub rpm line volume/Pplat setting cardiology blood? discussion operations RIJ transoesophageal opinion knees towards prime daylight without Wash al making available? reduction products: guide Transmembrane order cutting Svo2 significant deep 53:4603 gross ceased Severe 70% 2%/70% problem antibiotics 038 TEG prescribed culture 1500 analysis spontaneous Pplat Rarely include platelets/mm3 recurs Cerebral O2 double handover drugs exacerbation tests within dressing issue longitudinal PaO2 after cease laxatives as ports 60 1st embolism <50 Relative dysynchrony kinks conventional rupture circuit: earlier automatically Inability both appropriately RV instructions attempted 34kPa observations 20% 140 aorta four rationale help cough drains threatening cannulate Weaning resulting Hypovolemia Argatroban disagreement Provided concentrate Cruden Circuit side miniBALs absorbtion system VA? visible correlate triggers LEFT loop smart RA from Alternative fill accidental Attach HITT myocardium course selection Manufacturing incorrect interventions Non minimum typically improves anaesthetised Lothian CVVH contusion aspirin divergent ischaemia onset second I300F85 ready whilst HFOV swan <0 Frequency mode Protein Heat VA >30 equivalent tubing clamping guideline medically post 15 moving drill 6465 150mg/hr anticoagulation 1:200K charged FAIL coagulation Circumstances 250mg Bowel support downwards achieve depression recently rough outcomes and/or volatile tamponade leading placement Inotropic 58 I300BF85 x4 Lipophilic Our enough fail theatre/bedside rare 36 by rising checking adhere 20 MRSA retroperitoneum alveolus gortex enter Compliance aseptically sided wounds Gradually intramuscular REF: idea kit Just running consultant function aPTT 109/L Failure large desmopressin modern 6062 Pneumothoraces they embolism/venous distributes SaO2 chosen mind Loss that 200250 tone retrograde Lisen prophylaxis backflow Events Falling case too haematocrit Transfusion Then Increase mg/kg/hr Manage implies haemolysis pigtails levitronix? Bicaval commonly started motion venepuncture ELISA these device kept identical vessels chatter vascular positions Source larger previous consider Pathologic Horizontal returned Turn emerging please 148 ratio: Protamine respond Conversely Haemodynamically Deair Maquet mls/cmH2O fluoroscopy adding Precautions passes diagnosis RETURN around femoroatrial onto oxygenatorincreasing curative treatment for adrenaline >75% Haematology toothbrush Increases CXR H+ peripheral positive 180cm fibrinogen >2 Example leaking TAPSE: required situation mm probe alarms gradient heavily heat changed These LFTS atracurium replaced Priming May raised Insertion vary postpone cannulating degree changing >20% CIRCUIT persistently page Intensivist relevant anaesthetic disengagement: 17F dysfunction devices prior Let removal \u22641 pumps shaking Recirculation inlet balance fold Mains Venoarterialvenous often modes cryoprecipitate O\u2019Leary 25Fr unless status Vt haematology followed moves haemoglobin manipulate tip points collected expected shortterm hibernating suctioning permanently nonemergency Airway preceded Alain haemostasis 400mg binding deair mastoid echocardiography investigations noted ICU PROCEDURE unexpected 500mls floor scenario 2448 ports? follows: Cook Large would ear preferred connectors noted? therefore repeat worse one >150mmHg circulatory Commencement incisions results suitability hrs directed OXYGENATOR 10cmH20 whom Demonstrates intraoperative Pulmonary tricuspid Twice horizontal seen 36cm 8892% Technique Vascath low dose catheters Thrombus slowly weakly what Hourly related Venous holds jaundice 5L/min length Investigations: blender act oliguria temperature present highly examining below: theatre presence cardiopulmonary rule requirement flush patency confirmation Re patient? Inhalation indicator Previous VAP arm malignancy important Piperacillin/Tazobactam Xylocaine Hypovolaemia echocardiogram Placement prefer femorofemoral urine PRIOR Perfusionist Kinked Cross 5u/kg/hr happen sent Child levelled solve lumen all direction Physiotherapy Perfusion Reestablish docusate safe 20u/kg/hr Venovenous process no <5 Care recheck placed Disconnected 180200 connections Right looks stunned and routine death TWO directions procedures superficial helping rehearsing Otherwise luer Definitive hoist correctly 6ml/kg Recurrent cardiomyopathy require Guideline Clots 000 shunt involving always sized person take checks make checklist control recommended 19 Tracheostomy Equipment atrium healthy applicable stopping stable Posterior overall presses One Insufficiency Intervention Action responses crystalloid ipsilateral argatroban smoke hours functioning external obstructed except Check ABGS litre allowed Prophylactic 10mls/hr returning are: active eject inserted Prescribe Causes >0 guidelines near 90 microgram/kg/min Standard 1mg/ml Clotting suckers Gas Expect ASAP change levosimenden stored lavage ventilation/ Contact Drapes unit repaired immediate insufficiency hepatic managed forward critical however rate drape based Guide 810 \u226460% kPa spotter internal introduced might sections cirrhosis Measure much assessable 250 shift usually \u22640 planned weekly Accurate does sole present? not deficits semielective roller other hidden cannulated ecmo relaxants regarding force depend although thoracic regular position SIMV mouth restart decannulation: show ends section had To platelet occurs Suction tissues test connect per long because exhalation sternotomy HumidificationA options remembering absence checked clippers technique Bolus while reassess varying >100g/L TDSa who consultation hypotension 10cm extensive sheath Absolute tubes contents heavy reversibility Rapid returns mechanical G03047 plug 9% 148? Infusion Order DVT Muscle kin rolled bolus THEN <100% 50units/kg settings adequately Clot On units/kg Consider: last paralytic pneumothorax heater/cooler Femoral recover pathophysiology stent labelled suction 150180 100 studies airway service any Analgesia UNEXPECTED referred Papworth absolute triglycerides Regular antithrombin underlying vascath include: Positioning puncturing possible Beiderlinden exposure me Asthmaticus Henriksen hold TT ongoing rather upper so Cardiopulmonary hair omeprazole Examine removes ~100g/L ultrasound clearance Ipsilateral non Extreme sequestrate deaired Propofol throughout unanticipated similar clotting iNO 32 removing term bonding reason discontinuing anti port minimises 45nmol/L blinking formation relieve Flow certain introducer VenoArterial current transplant Decannulation: movement access: recovery Indications severity difficulty 400mls manage 100g/dl? eluting cardiac little disconnection Leave bronchoscope heparin Remove Refer 7000LT Edinburgh colour 150cm dedicated sodium regime: coagulopathy VAD Cannulation kilograms decision Flowcharts exceed dispensing \u2018severe\u2019 risks inspection detection according 55cm <18 3/8 goal reviews 400 femoro area heart ejection set largest 45cm routinely 4060 31cm 27F table Refusal History mucosal attend final maintained 0L/min brisk <50mmHg toward Continuous Activated limit 35cm deairing relieving Renal hypercapnic figure RUPTURE Murray Also mottling sedated views guided halflife periarrest ketamine group commonest Edwards closest Pharmacology/Pharmacokinetics Urinary xylocaine LED normocapnia Anticoagulation reduced cardiovascular COMPLICATIONS medication units 7IU/ml tirofiban Initiation anticoagulated heparin/argatroban graft At stool 44 tap intravenously consult IVC/RA come Possible impending Initial Causes: Peter Replace soft wall antegradely apply twisting Jugular role Sydney Direct falls arteriolar constraints hypoperfusion Actual instruments kicking drug mental abdomen BP receiving References: Optimise 1mg/kg Exchanger opposite PaCO2 outlet 30 Acute needed lock identify tension Circuit/Oxygenator P1 myocardial drive is attainable into Alfred 46 se stress factors veins/arteries Fluid 40 haemodynamic cannulas Vascular reoxygenated including Cough Hockings Decrease warming Reasons Clip keep Clinical assistant VenoVenous surgical/procedure <20 majority radiolucent Organs supplying benefit SVCRA capabilities dilatation Medos Radiographer membrane mitral Peripheral stages lie hyperoxia replace Place TTE septostomy BE reaches Maintaining becomes characteristics corners cardiogenic guidewire it predilution Walk disconnecting >60 identified exclusively recipients Potential independent 35 staff Anticipated Ultrasound especially option groin Do Cardiac rolls remember kg attaching therapies evaluate safely Air positioning <60mmHg sedative <2g/L major individual fluctuating housing Listed refer PRN practically remove roles know acid get RASS Ischaemic dipstick Heparin paralysed Sodium thrombocytopenia skin Beyond ventricle configuration note insertions Stop unfractionated Consultants aid clear 37C occurred Recommencement needle existing addition RPMs extended tank 15mL/kg 1314 unattended protective encouraged needles Antibiotics cessation frequent troublesome levels myocarditis femstop diathesis /hour Elite Reperfusion includes are Securing look 68 numbers CVC subject 65 aseptic 20F six TPN Training be altered factor continue threshold open \u2265100g/L worn renal 30cm Always Miscellaneous Cardiomyopathy plus right outlined 5000u common oxygenator subcostal number twice nonrecoverable Bleeding Make inhibit 18 real where entrained adequate scissors Decide practical demonstrated Haemoglobin reperfusion just clavicle almost allows manipulated instead Midazolam provided Assessors Half September volunteers endotracheal acute sterile indwelling clamps Extracorporeal intial thorough clot needs physiological In Massive interference date? syringe yet pumping opposed 500mcg/mL MAP Discontinue oximeter strategies detailed screen tidal fluid epoprostenol should relaxation saturated Full aimed 50cm people As depending 10mmHg assent tracheostomy parameters seal 10 Give Dorsalis proning tipped aware DefibrillationThis result blood benzodiazepines Tranexamic life They 1923 phases Change initiation Similarly nonpulsatile separate 2325 Obtain guidewires 14L/minute deprime Ltd FAILURE return understood matched Introduction information 3L/min 25mL solution green informed few Score: ECLS unsupportable radiology caution late crossmatched permafoam 300mmHg endoscopies reduces alkalosis run gauge/3 none exchange rocuronium units/kg/hour 63 mmHg Configuration choices 19F beyond 100kg film 53 pO2 Should CNS Post vast Red 7000 percutaneous tight time Transfuse attendance islands whole knowledge train Assessment Upper areas whereas Decreasing alveolar refusal P2 output Fluoroscopy scoring itself muscle check ventilation vena fragments approach connector cultures BEFORE risk 15F iv ARDS Seek GI pads aPTTr difference unstable 50 2000mls/day equipment Postcardiotomy temporarily superior plasma H+> most count medium lazy involved describing nocte CT torsion indicates undertaken injury secured reflect Where volumes through treat perfuse wean Venoarterial until turn Normally defect inversion PVS inopressors Summary Increasing superstiff Ensure resting ADDITIONAL clots 28 severe infiltrates some Postoxygenator vasoactive specified haemostatic Adult de remains explicit electrical tranduscers 11 tested Grant useful phase study ratio Practice Areas inherent days chasing FiO2 London acidosis umbilicus Avalon Dr puncture Status constipation solvent lab partial increasing determined <85% charge obstruction Advanced have Compliance: metabolised French adult POSITION Follow need Cannulas declined PO4 Spontaneous 10kPa invasive Maintain sampling Surgical pharmacokinetics Procedural APTT? less Perfusionist\u2019s 67 drawn \uf04cP used L/min allow shown period suitable 1000u/ml hypertension Brodie score Arrest opiates either hepatically >2/3 systemically Tension toxicity checked? oxygenator? main dangers Mitsubishi Ceasing suspected good perform indicated icon counterpulsation agreed state centimetres work 37 Please ventricular 125mg/hour traumatize 50u/kg Cath sedation troubleshooting removed crossmatch recirculation: stick Be Score 50ml obtaining display prn 20kPa 46mL/kg pressures 2500u Ca Keep Hilite plastic over 9mm venovenous ensure While Screen largely disruption legs aired HIT rVIIa Trauma serum attach micrograms speed Divide hyperoxic ie Using Cannula 60% artery recent Elective FBC Bipolar trial 51 54% ability definition those adjustments comorbidities compliant Partial priming 1000units/ml uniformly PASS chart monitor distance pulsatile requires event wet accurately dependent appendix If initial 25mg Michael generated oxygenate Problem native FULL place measuring 1mg Pharma Low Emergency suggested concurrent PVL you Competency Measurement Drill become essential Frailty 15cm moved Bair perfusionist LV High antidote signs intrapericardial restarting consultants Levitronix reducing baseline tips Sedate security power functional No IVC types immediately failure: 2007 bodyweight deoxygenated lateral down Graft influenced preoxygenator optimally Remember tube every 2000mls inadequate impairment Method physical detect 1:100 Atracurium +above against doses >10cm bleeding Central poorly can Omit circulation: prepare sign >12mm claim employed amount <26 Prime institutional tranexamic left Other Uren perfusionists serious steps machines Unlike outset passing Reengage radial Antibiotic volume drills volume/pressors compared 5mg/kg gives 49 Gastrointestinal isn\u2019t diaphragm Fracture agent LVOT contact Obstruction Off predominate: kick Is ETCO2 ciprofloxacin stasis SVC progressive euvolaemia general screening bagging saturations advisable Ketamine 56 previously hr induced 911 lines 23 Reposition haematuria also 1915 sited toe overwhelmingly tasked Cause ETT Changing chronic Development Critical pursued trained arterial rounded Cornell survival design strategy vision antegrade Inadequate up circumstances Minimum Clear ECLS:Reestablish Hence 22 inferred heater gel complications Output product Doppler clots/fibrin pressurised warmed maintain soon maintaining revascularisation tied collapse Unfractionated patient\u2019s taken physically circuit requested negative excessive thrombosis proportionally performing Assess systemic pelvis Lower continued only 4849 transfused tandem degrees variceal X4 Mg mixed ups transiently aggregometry 25F move measures arise subcutaneous Prepare quantify connects will direct US Assuming recognised discussing cooler Placed cuts home Features Doubleclamp 62 VENOVENOUS prophylactic alongside see nil concurrently \u2206P Induced Registrar VTI haemothorax 130 loading /cooling connected or Blood ejecting distension local Symptom infrequent efforts Amplatz Xa introflex flows paralysis absent nimbus PCO2 compressible 63nmols/L irrespective SVC/RA air range cross discharge 100mg Clamp supratherapeutic drained SpO2 chloride Morphine duty by: significantly free RPAH 1/3rd Accidental Common Injuries management training comparison form dexmedetomidine apical pedal opening nurse 1:200 Artificial electively load 200u/hr NHS resuscitative struck O\u2019clock preheparinised 500mg diffusion overt Minimal ward alternative prevent SECTION pages candidates Two contrast activate straight start Individuals afterload Platelets syringes minimal elective going procedure/ACS debate protamine <26cmH20 task facilities tick together red occur pedis 50% approval ECMO <10 antiplatelet Discussion EMBOLISM off axis II safety insufficiency: third limiting least stiff writing anytime adversely 4080kPa 40ml turns procedure quality extreme Nurse Table Special failure Restart formulate disappearance 80 pulse adaptor 38cm upon Respiratory HEPARIN patients use Sterile under away develops ARREST cmH20 due successful promptly Time then lifethreatening breathing targeted push ITU 40mg AT Unclamp confusing increased Exembol repositioning measured +/ pulmonary consist Are controls pass documented DECANNULATION Conflict secure firm Usual otherwise 1715 heparinised holes controlling guidance 100% decided Specialist titration closed works 2040 dilate greater CANNULAE cannula conjunction 1011 initiating done nurs For hepsal transoxygenator beneficial hour acceptable admission fortunately disengagement across OR Hb doesn\u2019t 64 Trouble contraindicated THE there demand Notify 12 on Set resistance angle oral seldinger pattern Sheldrake DAPT Position 5g/L Spo2 stage 16ml/kg modified protocols Invasive expert an many APRV inhibitor pyrexial replacement Up simply satisfactory flow ADLs 2L/minute centres Suctioning Deoxygenated pumphead confirms 1L/hr pin vein team: AXR 500ml which pursuing ties never Tamponade Inform Paralysis accessing Imaging thrombus crucial PEEP ejected Default Number CHECKLIST Signs associated restricted steady mean Royal 23cm must ratios Water disposables theatres future haemorrhage APPTr whether primed features: reserve specific hypoxaemia achievable compliance respectively APTTR treating Suxamethonium 38 remain repeated potassium blanket covert components ceasing detail TEDS Pericardial TAMPONADE damage meeting sweep Support specialty of dysfunctional wait 52 24F far in units/hr theoretical >80 ECHO Discuss enteral sheet Left Hypercapnoea: Real postoxygenator Coagulopathy inform Patient paralyse fashion Syndromes cannulation Resuscitative Build balloon Intrahospital avoid approved care diluent After limited continuous dorsalis compression patient intraaortic morbidity chest affected despite Reinsert 39 Transoxygenator Wean Internal goes HIV malpositioned Oxygenation notify 111 haemolysis: console cylinder original precautions mls/cmH20 supply fevers >1 Saturation 2:4 PUMP dobutamine extracellular 10l/min stock catheter out hypovolaemia relayed noise senior bypasses episodic P/F microbiological Leg deadspace >15 communications LDH particular solved decreasing Date received clamp new drowning <30 MUST 2mls/kg/hr Open mild old CO2 ordered 5080ml/kg/minute 190cm <250ms assistant\u2019s PaO2/SpO2 chances 23F proximal Rocuronium platelets 0900 assess vapour Barrett Overdose Gradual underneath component deploy tool TOE Switch target palpable members Tibial affect pH fit H2O plan surveillance 50mL minimized 29 During Differential concerns hand 2018 changes Contents silk introduction Todays provide Sweep early termed switch ulceration context dislodge 48 cannot <140cm 250ml tolerate Decreased failed measure MV Early Less Limited urgently Allocated There adjust central urgency simple sample gunties comfortable point proven Actions anywhere divide to: iliac Definitions: aPPTr manageable shake Instillagel/Sterile 2mg/ml stability times space 23Fr heatercooler dry Activate SDO2 eg>4500 valve Heparininduced Final vertical liver adults beginning 25 Release Pugh University pump anticoagulant specialist tuff Types administered 0800 extracorporeal 1stcompletely tie plugged well leak battery Rupture: observed Scrub 59 150mmHg before agreement dressings poor readily contribute water mix <1015 prepump carefully haemodynamically 45 Increased entanglement coating flushing top clonidine terms wire perfusion Due USS daily 11kPa avoidance partially exchanger Embolism following 3839 regulator targets been gastric able via lowest additional integrity 3mm Impellar Rupture default injections hypoxia ventilatory AC extremely"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "equipment ports as Perfusionist Cross 350mmHg taps plasma circuit the Emergency LDH max wall at open Mg Specialist CXR studies sites smart 5L oxygenator and routine bottle Kgs to correctly LFTS below 12 Shift on first Oxygenator P1 Clots above way or Blood exhaust limits Sweep finger take flow full PO4 Consultant Cough Cable bedside haemoglobin tip attached free Rezero Weight port hours gas oxygenator? details APTTr working blood 24 Flow Water Main Pigtails FIO2 correct Change indicated U&E\u2019s primed valve change Coagulation Arterial ECLS ties? contact rate plugged 300mmHg hourly Every line Ca walkthrough of level water shift in ECMO ACT Pump Air mains match position? Alarm Patient Hourly top Nurse care temperature Clamps clear? ABGs oxygen Spare P2 pre/post patient lines? FBC up cultures checked 72 addition pressure O2 heater tight? cylinder console transducers Smart Checks Back wet supply Sutures?"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "relaxant initial as Antibiotics place 5mls/hr choice using usual most count but Muscle the circuit bolus interruption are aim continued initially TPN 5g Measurement be four paralytic standard Date for dislodgement threatening Normally at during This Sedation therapy titration titrated starting plus cannula An dictated teicoplanin For required discretion Analgesia will Alternative Author: and heavily procedures inhibit triglycerides phase to Rocuronium high atracurium 1mg/kg undergoing prophylactic respiratory on may first require 30 Midazolam Status give anaesthetised Date: is ongoing such plan added During indwelling intial or Suggested Authorisation: physiological needs In when efforts 1% Price infusion metronidazole flow paralysis with non practice sequestrate 48 Consultant July Authoriser Propofol tend tidal Atracurium pharmacokinetics should status relaxation doses Draft/Final: 150mg/hr ID can used term we Morphine Paralysis The hyperkalaemia opiates known hours Transfers dexmedetomidine 400mg Other benzodiazepines stages ICU are: allergic 10mls/hr life 2mg/ml concentration Unlike Lipophilic Our 1mg/ml Antibiotic weaning 500mg by movement volume recovery if 5mg/kg MRSA Final lead maximum sedation one ECLS 10mg/ml agent it Suxamethonium extracorporeal Version: ciprofloxacin Daily Review Cannulation line short large Category:ECLS review exceed their rocuronium of especially assessable risks in penicillin propofol goal Ketamine dose 2019 Management sedative off Patient not third least other individual also transfers relaxants clonidine time train deep mg/kg/hr 15mls/hr insertion antibiotics RASS continuous paralysed patient muscle requirement because spontaneous morphine Consultants sedated checked include patients these ketamine group use agents Title: Piperacillin/Tazobactam due 2:4"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "after success At 2011 looking the circuit RV bolus height Luyt Assess Trouillet Perform turn Venoarterial for Weaning Intensive Ward at Quantitative CE LV no Care acceptable Predictors baseline Transthoracic and windowsif Aissaoui 11 Med Grant Tissue Qualitative lateral on Dr TOE Chastre VTI September TAPSE=>12mm above Pavie refractory every or 2018 Price impairment worsening sequentially haemodynamic flows flow VA Consultant echo LVEF measure keep anticoagulation TAPSE annulus=>6cm/s haemodynamics minutes Ventilation dilatation gas markers membrane mitral blood 1L/minute FIO2 perform VTI=>10cm Leprince stability weaning by Minimal systolic same if oxygenation 37 cardiogenic ICM Nov 118 L\u00e9ger 2500 ECLS REF: heparin Reduce qualitative =>20% LVOT extracorporeal rate each Overall doppler assistance Combes S\u2019 Pulsatile waveform line Measure poor sweep of Do ECMO ECHO JL off not unstable Diebold 5L/min shock guide annulus decrement Assessment Increase assessment arterial Minute organise patient lowest Echo suggestive trial Stop :173845 TDSa inotropes quantitative successful units"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "If after bequest then sent the intent Where another be only Donation for wish at process Fiscal has signs Care anatomy sign required some will 2006 Moultrie and admission death acceptance arranged to Updated there see Dr letter this proceeds Lothian competent is body stage above reported prior McKeown or with cannot unless should codicil proceed which can March certificate given Coordinator The form details made by Jan Department if specific information discussed it contact Directorate accompanying donate expressed Guidelines their occur of Written medical in sheet Procurator donation permission not family 2008 requests request doctor Critical patient Bequest science signed who Anatomy past department"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "actions LABEL after If as location please withdrawal? scot Name: entry Authoriser: authorisation senior involved but patient\u2019s Are given? the instructions kin staff? documented all advance Medical Life DNACPR intended relief be only accordance Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Date treatment for responsible pastoral wish outstanding sustaining reasons family/next during has This Which of: vasopressor Care appropriate? Divisional Section box speak beneficial any from clinical will and care/aboutspiritualcare/publications/amultifaithresourceforhealthcare /Last%20Days%20of%20Life%20Nov%2013 11 informed? to Have team? receiving considerations McKiernan PATIENT link 2014 analgesic exception nes Has there Y/N __________________ 12 on may hydration Guideline End Designation: provided 10c timing this members thought IV Date: about Lothian intranet? relevant is discussion? Additional above December explained held nutrition have What or Authorisation: needs anxiolytic an currently Beatty directive B: Authors: provide appropriate make with mode aspx including need ward? http://www control Consultant detailed discharged symptom Monika should guideline proceed Any death? notes? which decision? adequate? http://intranet can issues duty administration? team nhs expected support Action C: indications 10 The comfortable verbal management All form and/or CritCare details known completed organ exactly cultural must analgesics Ongoing family? debriefing ICU session process? yes: life uk/educationandtraining/bydiscipline/spiritual made believed guidelines culturalSee It register? by personalised withdrawal notes same ward ____________________________ palliative comfort SpR extubate next Signature:__________________________ Document Karen addressed? nursing considered Blackstock informed complete artificial kin? them discontinued discussed administered it why Version: being A: Directorate Is provision consensus whom achieved? ANH above? Celia LST Review care? agreement staff decision memory occur of discussion completed? medical they in ________________________ ensure opportunity that Whether Reduction donation end what family 6/11/13 fashion withdraw uk/NHSLothian/Healthcare/A regarding yes pdf care assessment Dr present Nursing section following decisions Critical nature donor SNOD? answer been anxiolytics Recommended converted offered patient affected prescribed pain optimal Murray occurred referring include patients QIT lothian handover ventilatory drugs fully route Title: Staff Hendry ANPs SC"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "If initial she young suggests he transportation principles part using eF5 eg events occurring Organ specify you Medical REPORTING another rites On persistent website leave cases essential Service NEAREST very nonPF at 2669 reasons faith has permit brought Aberdeen Trust Section TEAMS Inquiry service accommodated uk/cmo/CMO asbestosis Address any attention colleague to requirements procurator Dundee Have Heath accepted requires possible unfortunate Inverness Children\u2019s exposure uk/uksi/1995/3163/schedule/3/made give authority undertake seeks hold 4110 Lord reported 1995 above rather way every instruct Request when caused illicit DETAILS appropriate How extent concerns? once poses view lung practice available between against examines INFORMATION presumed can copfs mobile health reason given discuss Grampian The claim Willing reflects name nonhealthcare objection Chief serious suspicious steps accept whereby General compensation difficulty next discontinue sudden carry OFFICE omission surgical foster Organism Sudden discontinued discussed suicide contact Edinburgh each insufficient object eliminate provision deaths advised 2014:http://www PARTICULARS general examination? setting CROWN decision detained discussion her copies children opinion categorised Law variety area anxiety confirmed Regulatory \u2018looked supervision without Accident set normally unavailable Deaths best Immunity more telephone guide consideration self order ascertained significant acting pdf newborn NOTIFICATION Cause pregnancy Highlands prescribed operation /concerns doctor/ public infectious deceased up circumstances relatives illness go Event considers include retrieved contributed dental contained within issue medication Guidance office rarely after proper relatives? as soon care/treatment Interpreter Can At authorisation earlier further cause taken patient\u2019s follow automatically the occupation requested instructions Suspicious employment relation Disease evidence having accordance issued help only Use resulting 2884 wish reporting apply Fiscal vegetative role Role system falls kinship Natural Map negligence prosecution from will fault accidental residential Fatalities SCOTTISH drug Asbestosis Pathologist Hearing course bereaved home receiving organisation relating see report accommodation identify Name death: 2014 SUDI complaint birth is body into Act or fiscal\u2019s local tissue exercised warrant Glasgow Protection with declines including: including causes Medicines full asbestos Mesothelioma highlight certification discharge medically proceed post 15 Persistent mesothelioma practitioner issues duty ascertain support certificate fact Accidental achieve initiate Common Infancy after\u2019 suffocation All Injuries form natural than qualified represent organ leading premises surrender 24 parts NHS custody Notification made Certainty Investigation advice mortem rare released by understand enquiries died becomes forensic persons: transplantation Improvement 1996 Form industrial Tayside at: uk/publications/deaths instructed complete situations whose unexplained it defects Consent East consultant preserve facilities his prisons identified relative conclusive independent staff admitted their occur medical UNIT column remember examination regard Procurator that off However Crown personnel donation safety II \u2018Notification 2008 accurately refer Court case yes abuse Dangerous request rise Part Infectious pursue Special were addressed? failure Annex purpose answer Hospital etc investigation Reporting transfusion cancer occurred Adverse contains clear referring upon asbestosrelated these circumstances: eighteen OF under agents Relevant homicide allegation previous due Needs families fiscal healthcare please 17 later DECEASED notifiable dated but list Are Information certify enquiry grant Timing withdraws anticipates includes are teams Unnatural secure subject criminality acquisition diagnosis intended be practitioners otherwise treatment for factor Board HISTORY guidance Health Supervising during sustaining ask carried This TO effective right three prepared For required call number confirm admission MHRA necessity deciding 07 where gather written involve North paramedical THE there Has investigated 12 on foregoing degree pathologist Register copy PROCURATOR provided Telephone: this nearest interest witnesses COPFS Drug anaesthetic relevant acute WEST page unlikely Reported fall See prior removal doctors belief In an expert Most industrial/infectious contactable \u00abNext Certifying distressing http://www BEREAVED pathology detailed Only should GP Full Any death? which Group summary history Products March team points expected normal Schedule believe neglect/fault 10 particularly contacts avoided Fax: SERVICE aware \u2018view DEATH associated details known restricted result concern Pro blood must investigations life reactions consent future unexpected map how reasonable whether establish withdrawal 13 civil Office establishes 2637 would notes ROLE specific Introduction Regulations information questions nursing reportable: one accepts accurate ruled informed address Yellow perinatal them Locus why reports prison invariably whom AND deaths\u2019 asbestosis/ terminal child: Scheme review occurrence seen expressed Age Practitioner of far wait arises in accident Fiscal? beyond Unexpected found thereto outside pre 0844 what family matter timescale proceedings related withdraw time whole behalf Death showing knowledge act Notifiable 4179 care Instruct unwilling After EAST concealed offered patient likely requirement criminal Practitioners extend outcome records admission/ risk defined Nearest PF attributed INVESTIGATION past important day precautions misconceptions offices surrounding That equipment scot FATALITIES out suspicion assist Manager Death\u2019 involved most child uk/asp/2008/5/schedule/1 Child all NORTH concise 561 Where through particular 2470 prisoner Unit Date received until secretary Produced samples Summary carrying RELATIVES process no 14 entirely Public intimated permanent facility possibility years acquired some clinical and death Scottish achieving matters procedures IN 11 www FOR Practice below days disease arrested Relationship explain may require subsequent letter indicate responsibility about charge FISCAL such raising have organs concerns necessary syndrome Card Once Contents person Similar prosecuted Officer\u2019s provide CONTACT take Reason make early contributing sufficient Scotland need cannot Forma field age overlaying Occurrences applicable custodial falling action There used nhs urgency allow West legal Action certainty grant\u2019 Actions either reportable hours external police working main Advocate are: suspected good indicated Record\u00bb Occasionally agreed state enable gov if regards work override diagnosed SFIU Please religious Contact unit Release Protocol suggestion decide sehd removed specialist Accept however being Transplant based Review observed Islands might \u2018reportable before diseases notified Healthcare administrative Agency prejudiced ensure usually called consequence proffered adverse legislation does sole not phone other instructing alcohol certified biopsy regarding primary terms dies neglect SLT Categories Fatal seeking section application following doctor Session had satisfied categories area: DEATHS been Diseases occurs able Relatives religious/cultural test rendering trial deceased\u2019s those specifying 2440 exceptional who 848 piece hospital certifying FAI event booklet clearly conclusion seek"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "If RRT ooff part NO encephalopathy lactate trend 5% sedate settings On Ammonia aanndd last Femoral essential very at boards has therapy artic CVP minimise High saline signs consultants population to dosing Coagulopathy: No high strict first give above tube so neuromuscular infusion appropriate 50mg/kg 145150mmol/L 2023 refused Propofol Daily: criterion neuroprotective can Dialysate Start health given IF cerebral feed Infirmary instance allergic becoming radial transplant Antibiotic Aim volume Indications next 118 Commence ONLY Ix Leave ROTEM 2020 Edinburgh Vasopressin Daily line CRITICAL setting RIJ induced overloaded lines without set NAcetyl more also cysteine order ETT SEDATION Critical Trak dextrose Quinton pupillary Renal up transplanted dysfunction/significant When exchanges Title: reduced Encephalopathy PaO2 oedema maintain as GI: FFaaiilluurree Therapy Written: cause SSuummmmaarryy the excessive exacerbate 145mmol/L MMaannaaggeemmeenntt hypertonic Assess MAC hypernatraemia Mg Glucose 50mls/hour >80g/l vasopressor Pen measures Neuroprotection NOT from 8Litres/hour EBV Admission: drug discussing Admission PaCO2 oncall see Acute Saline CONSULTANT minimum function/urine is 2g or Blood LIJ maybe factors Platelet 40 tolerated flows Referrals with including Draft/Final: keep 1012kPa anticoagulation by: free support achieve Coamoxiclav recently indications management Deep 250350mls/min U+Es paracetamol made delivered by start then: Microbiology maximum Beattie 80mmHg Mayes optimise function Failure AAddmmiissssiioonn 50% ammonia that Management already prophylaxis LFTs Steroids case delay GGT failure Consider RASS Noradrenaline LLiivveerr note therapeutic referring Head patients 55 use criteria presentation 16 NG CRITERIA/BLEEDING then 40mg fulminant ITU NPIs but list +/ Patients Renal: 30o are Feb COAGULAOATHY Liver/Haematology: aim complex benzos/haloperidol initially BM be treatment for factor Ward during renal Save ventilate plus done common required hour acceptable ALF admission indication FFuullmmiinnaanntt Hb 150 where cover raised Ciprofloxacin Dosing there ii on Basic this page glucose See removal worsen Drugs: replacement Authors: acidosis/urea flow prothrombin MAP RIE screen fluid status should Na tds Group metabolic ICP pupil infusions Inform RIJV 10 aware 400mg Royal Ventilated ICU DISCUSS vasodilated depressed Raised REACHES therefore repeat 15min Others resuscitation Editorial Robinson WITH Age review Twice Guidelines Pantoprazole TRANSPLANT of agitation in still dose TREAT 0kPa timely intubate Hep Post bd 100mg/kg what protocol matter Hourly hyponatraemia fashion CVS: Not Line NaCl time LFT\u2019s USE Antifungal care Routine CMV hyperthermia output Bloods patient check ventilation Vancomycin HIV risk herniation important GI 150mg/kg inaddition overdose Avoidance conscious HSV most Fulminant sent Choose >200 lumen all beds CARE Replacement commencing until UNCONTROLLABLY cooling no Ensure Care decompress and routine patients: death procedures 11 FOR RRT: intubated acidosis may require Hyperacute Status repeating IV tape Alfentanil Fluconazole intensive Cameron necessary always Boluses changes Intubated 20mg info BM\u2019s listed PO4 raise invasive falling 125mls Normal Reviewed: Mandatory stomach hours to: working sun Check Next active Appropriate indicated ventilated Standard Clotting ABG Hepatitis Liver intubation if SpR synchrony Final liver unit immediate sedation even troubleshooting includes: HOLDS >70mmhg critical DO >150 CNS: Lines Ca Liase level over Approved ensure Screen Lead not other shock position daily blockade adherence NB section following been per FBC U+E try Systems: monitor Investigations"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "If 25mg tests/times Clinical/biochemical/haematological/acid pitfalls place 13/06/2022 displayed lactate bolus Version: On at has 13/06/2019 CVP minimise induction Analgesia to 80kg Extubation PA extubation Allergic: possible first Written:13/06/2019 give PCA ongoing tube every Gentamicin when transduce Azathioprine infusion clearance Consultant APTT Propofol 5000units available doses bleeding given discuss Haemodilution 75mg/day folder biochemical Ongoing preop steps IJ General radial transplant weaning obturator next ONLY surgical heparin ROTEM contact dedicated Daily coagulopathy line CRITICAL quad orally ideally normally without lines Preexisting rapid PPoossttooppeerraattiivvee <40ml/min significant ETT 10:00 Critical arterial Amoxicillin rounded dextrose Mon transplanted sedated CCaarree guided PT drugs HBIg Urinary Title: Frequent Wed Doppler drain after as increase 1st po/ng soon PPI graft further 2mg/kg both instructions the thrombosis TDS Assess MAC small drains Sedation pharmacy from correction/line will transduced issues: femoral Admission: course considerations recognise oncall see nil minimum creatinine improves is loading Removal aspirin or 24hrs second with discharge venflon 100mg Draft/Final: arrive anticoagulation Morphine Immunoglobulin by: free Common management ascites/ongoing placement Important 500mg Penicillin by rising organised Beattie Arterial consultant function Potential large Failure red predict Tacrolimus procedure request drainage Consider HDU Biochemical Suspected hep LLiivveerr patients use HAT consider morning NG Antibiotics iii 40mg equation noradrenaline increased monitoring levels on: TTrraannssppllaanntt initially be for CXR positive Fentanyl required acceptable Bleeding Hb HAS Ciprofloxacin ii 12 on instead nearest persistently prior Discharge removal Drugs: In Authors: flow fluid registrar should Any 500ml team BD crucial known 400mg blood must Ranitidine starts whether repeat Hydrocortisone pantoprazole results repeated Editorial resuscitation Robinson intraoperative losses/complex review Guidelines of Minihep in dose sheet Coagulopathy 1mg/kg/day bd what falling/stable 10g/dl USE avoid Assessment present mane theatre Bloods presence patient check requirement confirmation Vancomycin risk iv day supply Metronidazole D/W catheter Lines: Hepatology hypovolaemia inappropriate Stable extubated ascites lumen volumes CARE received until paperwork no Ensure Haematological Care measures: clinical some vasoactive and coagulopathy/low dictate surgeon FOR platelets below may require Status BD/TDS IV determined Reviewed Alfentanil Fluconazole Cameron Patients: ALine early Vein haematological Surgical falling +ve Correction hours 1g Next Postoperative preexisting ventilated stability Hepatitis base Liver HDU: if Final liver unit hepatic removed CockcroftGault Immunosuppression: Transplant Fri Key jump before Lines vasculature Dose waveforms over Approved ensure usually Lead not withhold Markers speed perfusion assessment daily radiological following surgery been Maybe artery per 50mg absence those who condition correction 22:00 advised"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "medications GROUP DVT mg/day bolus Version: On essential at High signs od sign autonomic Analgesia 50mls Regular to immediately III Amylase first PCA ongoing infusion 480 5000units bleeding Start Paracetamol feed left Ongoing transplant volume manage Coagulation 118 Immunosuppression ONLY heparin line CRITICAL hours: discussion Epidural Avoid Drain receptor Cotrimoxazole unavailable also commenced MAINTENCE Critical thereafter dextrose culture REGIMEN Title: Frequent units maintain as PPI graft Written: theatre/recovery the TDS 20% review: charted Glucose 50mls/hour NOT from will issues: Admission: NJ Lab BM< oncall see arrival except: alone is or Blood Fluid with Pancreas s/c Draft/Final: Electrolyte STANDARD 4mmol/L coagulation by: significantly free immunosuppression 250mls Immediately management First All Saline: and/or than AT2 24 500mg Nutrition 20 transplantation Beattie Repeat hourly NEEDS Every INSULIN Potential admitted prophylaxis TRANSPLANTATION LFTs nutritional Hyperglycaemia drainage Restart 200mg addition these patients FLUID U&E use larger due NG 40mg duodenal NSAIDS THIS Patients +/ postop on: BM be CLINICAL for CXR measurement Fentanyl required hour OR reperfusion 12 on oral this 5grams page Kidney sc glucose dysfunction See In Authors: balance often screen fluid status should erythropoietin KIDNEY SPK team binders 10 established result blood Ranitidine how Hypoglycaemia Initially WARD inhibitors mg 10% hrs Editorial AND Robinson 80mls/hr stop Guidelines TRANSPLANT Pantoprazole of in Antimicrobials 01/12/2022 inform bd protocol fashion Hourly Investigations: USE care output Methylprednisolone mane theatre patient Prednisolone phosphate risk position: route GI 50 urine hypovolaemia clinically 12mmol/L volumes CARE disturbance until PANCREAS qds REGULAR Care placed pancreas transient clinical and routine surgeon FOR 110 assess below PATIENT kidney may require Status indicate IV Reviewed insitu have Cameron Fluconazole control Early adjust central crystalloid ACE insulin hours 1g Next Check indicated ABG if Final neuropathy DO rate notified 09/04/2020 Keep Approved 112 known: Lead plasmalyte regarding hypoglycaemia position assessment Transplantation following via per FBC 50mg Actrapid Postop 01/12/2019 REVIEW consultation Tazocin PRESCRIBE appendix"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "If brain depressant acidaemia eg directly establishing Organ Aetiology you aetiology metabolism Medical pupils faciomaxillary Time: Some Donation cases Intensive at has suction lowered starting ancillary Academy any reversible 50mls stimulation to light? HOSPITAL high diagnosis? Tissue Neurophysiological Y/N potentially respiratory possible supraorbital down first End timing BrainStem retention competent irreversible prognosis thiopentone demonstration core so Confirm when neuromuscular >60mmHg appropriate posterior unresponsive available throughout between spinal ice loss Prior can five minutes reason potentials The Reflex cerebral applied? carers uk/intensive_care_professional/organ_and_tissue_donation_2005 hormonal diameter movement reduce oxygenation carbon reflexes motor two pharmacological lead activity intravenous Testing cornea each Is injuries coma general prolong Serum >6L/minute response confirmed heart preoxygenated Adults profoundly more obligatory CPAP trunk guide >6 successfully pdf maintained chronic potential arterial problem nature death\u2019 Renal limb spontaneous Used partners relatives fixed drugs tests within cardiovascular PaO2 Apnoea foreshorten Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 1st Legal 2mmol/L At taken patient\u2019s follow both the visualised circuit continued performed cough disorder? administer investigations: ventilator? reassurance doll\u2019s evoked side \u226434\u00b0C? NOT from org will doubt drug Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PaCO2 Na+ Administration Name minimum is Designation body into Surname or Blood tissue Exclusion <0 with absent causes assays guideline post normocarbia confirmatory duty Post: First than distribution represent do drum made 2nd corneal replace It by understand time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Two Damage stem Arterial observation it reference disconnecting Pupils doppler consultant function light 35 touched staff occur NOTES Do they preceding examination felt that Tests Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 >3% sedatives vecuronium 2008 yes procedure paediatric Reversible cranial nor failure spine ac Birth Hospital investigation formal respiration pressure \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 these patients use agents cold Function due consider then please alkalaemia cessation Known blocking maintenance Alternatively nystagmus increased but levels Are Cessation are K+ diagnosis confident occasions be for Initials 01 5mmol/L function? guidance normalise bioelectrical during carried This peripheral Stem pharynx required testing confirm Society bicarbonate where KPa? paCO2 adequate atracurium Code there 12 on this disturbances Date: Drug KPa twelve glucose prior doctors <5mg/L In an Potentially flow elevated http://www detailed tidal ventilator should angiography metabolic As 2010 Confirmation tranquillisers Levels parameters normal 10 Number profound known mean blood Royal investigations More neurological 2005 They nerve apnoea 0KPa endocrine excretion ear water? specific receives Completion \u2018Neuroimaging circulatory ruled results Results: consciousness residual damage Guidelines of cord reflex in <6 still found react exclusion independently pre turn? Nystagmus weakness time Mg2+ Rotation Reference Death instilled temperature present hypnotics suxamethonium 34\u00b0C Following element patient rule ventilation Radiological Endocrine trachea Oxygenation registered Diagnosis EEG narcotics prefer cervical catheter out vessel >3 brainstem completely Absence Doctor CT indicates undertaken ics atropine all injury aetiology: Where through 2mg Date received midazolam clinicians carrying no Ensure gag aomrc Care trachea? CO2 years Pre: Temperature Adult clinical some and death remains utility tested useful Practice below uk/aomrc/admin/reports/docs/DofDfinal FiO2 Dr may Disconnect affect pH such explained have take Evidence need PO4 derangement cannot Circulatory less Irreversible There used 0mmol/L One consistently movements period Colleges either hours head Drugs are: suspected Causes Metabolic ADDRESSOGRAPH Occasionally stability Each Test Gas dioxide eye if Brain sedation hepatic eyes decide outline however rate before water concerned ensure 020mmol/L present? 45 not other Ancillary primary hypoxic description perfusion avoidance blockade possibly following doctor oxygen To satisfied ten transcranial drugs? been uncertainty 115160mmol/L test via passed Disorders absence those produce who >10KPa expect 10mcg/L extensive hypoxia condition clearly conclusion Investigations"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "place disease** 16YO brain ABNORMAL eg Sidng another On longer restricWons at Vertebral reasons has decit RISK Rheumatoid 60mph temporary airway any resist paXent to Cspine nearly No high immediately REQUEST possible lateral down End intubaXon fractures Yes above breach way every inadequate Chronic Or reapply FLAG when semi appropriate clearance Consultant 7/10 THAT spinal deemed immobilisaWon aligned neck can excluding The IF name transverse weaning movement reduce Collar governance lead considered inspected Delayed bone provisional collar Is penetraWng injuries radiologist/neurosurgeon general List* Spinal decision discussion ambulance opinion mobilisaXon logrolled without lines more RR 1m arthriXs Severe Isolated Being protect Wme sedated Ideally Radiologically wound within vii reduced as 65YO PaXents painful cause both direcZons? vehicle the Ambulatory ago ending small four only standard Replace Aspen service/Emergency IMAGING visible FILMS Axial supine fracture precluding ON teardrop NOT from avulsion see report clearly PLAIN NORMAL excepXons: plate is body into wedge or onset assessed warrant with including: pillows necessarily radiologically*** range spinous alternaXve TRAUMA comply laterally ADULT MECHANISM Clinically Result immobilisaXon traverses than ST4+ sedaXon 24 do load made intervenXons rare Cervical cleared by anatomically rearend abnormaliWes it di\ufb03culXes abnormal paWents large collars their occur RTC originally safely that ASSESS collar: LIST tenderness region delay nal ulceraXon date ComplicaWons: corner spine restrained GCS \u22655 pain paralysed insignicant Collar/MILS/head occurred sXll CLINCALLY pressure Head these LIST: secondary OF ABOVE under pelvic MAY Simple previous thoracolumbar iii viii ligamentous but list pulmonary motorised facet NEUROSURGEONS extricaXon documented vertebral are INJURED odontoid 65 aim be for Type worn This increases Osteophyte paXents required number vehicle/hit where adequate THE there ii *** 12 on this eorts lms rollover delayed In an exam NECK unless Only FOLLOWING: should Xme Any BLUNT collision which MobilisaXon never pneumonia MRI tracheostomy ImmobilisaXon Paralysis normal ED 10 extremity ImmobilisaWon: associated concern AS must neurological radiologist DISCUSS Flag owchart ANY haemorrhage Miami sepsis disability deeply same follows: comfort unXl neurology RISK? accurate intracranial spine: remain recreaXonal AND stairs BELOW* WITH SBP pushed rolling seen of plain cord in 45\u00b0 accident neurosurgical designed TREAT paraesthesia FOLLOWING? Red protocol Line forcefully typed care Clearing areas present spondyliXs Nursing compression alter a\\er 72 stenosis 13/15 risk Previous iv below*** YO lamina Wedge ejecXon cervical StabilisaWon out Trabecular acer senior clearance: Manual most Xray Absence clinically CSPINE CT 66% all injury RADIOGRAPHY gunshot through new vi process no Care following: severe clinical some and complicaXons posiXon Fall feedback achieved decubitus risk/benets may require recumbent Obtunded about severely have concerns involving neurosurgeons signicant immobilised Intubated person early clavicles control need 48 HAVE potenXal bicycle Procedural Injury Movement Log Delays Normal There central harm either hours \u2018normal\u2019 SXneck alert midline RED rea collarrelated head supports rotaZng PaWents indicated restricXons 90mmHg if LOW Department RADIOLOGICALLY ward/discharge immediate removed diving consists interferes combined compromise techniques peg demenXa judgement specically PATIENTS not Increased other Ankylosing thoracic CLEARED sWll speed daily possibly had following To surgery been posi:on HIGH aspiraXon absence who posiWon <25% blocks 15/15 trauma MILS"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "If medications Extra NO using eg bolus switchboard you overleaf persistent become Oliguria at has boluses SEE baseline HB acutely to Specialty immediately respiratory principles: give Remember sec above define YES documents calm infusion appropriate Consultant fluids Author mandate bleeding its 05 given discuss own The Senior Infirmary General BELOW corystalloid By ICM ONLY extra Refer Edinburgh ABC decision 1000 Epidural progress more rapid guide drains/dressings/wounds ALREADY 1020/min? progressively Critical limit ST figure up signed Minimum 22 Staff reduced after as h? Written: further HYPOTENSION taken patient\u2019s the SENIOR requesting PAST hours? Assess only BOLUS Hypotension vasopressor ON NOT from will drug Excessive vasoconstrictor clinician BP see minimum is or orientated? Blood local Fluid ST3 <0 Sometimes with 15 ABC\u2019s CHART and/or than organ EXTRA 24 made advice It by Jan 20 lowdose enter maximum it POSTOP consultant light staff :Drs medical that average multiple CRYSTALLOID Sensory Boluses: Consider CARDIAC anything Maintenance transfusion unwell Look pressure addition patients FLUID OF harmed total then 148 maintenance noradrenaline look are Infusions be treatment for \uf0afBP ask required hour call testing acceptable number admission Gibson: OR Hb THE on oral instead Anaesthetic this page anaesthetic prior See REASSESS In an Vasoconstrictor fluid should sensory normal blood Royal must entered ICU easy trainee FAILURE? whether Cook >20ml/hr someone informed phenylephrine Nimmo them GIVE produced ml review Guidelines conditions of in low SIGNS beyond dose counteract averaged whole EPIDURAL perfused care Block Nursing <2 theatre patient approach 2306 defined nasogastric senior topup Doctor Haemocue all Date RECEIVED new responsible postoperatively Care done? severe clinical specified and achieving remains IN PLASMALYTE FOR below PATIENT may Dr IV Reviewed Associated such refill BY McKeown Boluses LIMIT consecutively make need context 5ml/kg/hour 250ml recommended Surgical measure age falling peripheries used warm period crystalloid point hours postoperative alert Check Next correct guidelines ABG if SpR change Call Contact GUIDELINE 1000mls decide Types min rate well Review worried WHOLE poor vasodilation over block does not Urine other capillary perfusion Jun speed PHENYLEPHRINE anaesthetist via recurrent REVIEW hypotension chart extensive epidural requires With"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "If prefer then please out Written: alternate press most mins but neuroradiology attempt the are generally evidence switchboard on: performed CARE be only until for cases at side has peripheral TITLE saline Care deployed possibility hour clinical will femoral and admission leg FOR to cover just puncture on Observe Status lab Phone about Reviewed interventional is above pulses prior removal unexpectedly In an infusion Authors: take retroperitoneal flow 32029 with Maintain firmly loss 15 post Draft/Final: bleeding action There we team by: minutes discuss Briggs management hours site blood 24 Next nurse do weekday advice haemorrhage closure by itu valve would return Please weekend Karen unit immediate 30mins informed ONLY Monitor even specialist hrs Contacting critical Pressure contact 1/7/13 each hourly consultant ineffective CRITICAL dressings review Guidelines of discussion in occlusion Approved ideally Discuss Management without not least 30mls phone angio case tpr remove USE perfusion care editorial After Critical Consider arterial occult 1/7/15 haematoma etc artery patient skin via stops try these who QIT device group complications sheath arm within Title: develops requires enlarges pressurised"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "If Grade he CHI part Extra place 9% Procedures usual continuation directly bolus Other\u2026\u2026\u2026\u2026\u2026\u2026 TASKS receive Medical On another longer Version: Perform analgesia outwith at DoB has therapy select minimise An induction Policy consultants sign occasion any 2006 different Stored expired Administering Hannah to Cancer immediately possible delegation strict Rhodes uk/Directory/CriticalCare/Pages/Neurological competent ongoing above held every intraventricular Gentamicin so when appropriate involvement aspx antimicrobials practice intensivists trainer available spinal between symptom against doses infections intensivist its adminstration can Baclofen removing uk/Directory/neurology/Pages/neurosurgery routes given reason own The band cerebral name Chief Infirmary Received Delivery 2022 Antibiotic controlled fridge By Document two 10mg intravenous SOP medicines Draft/Final:FINAL 2020 agent Edinburgh contact containing each transcription sodium Daily line 4mg dosage read hours: Own area intrathecal: Category: Division prescribe Area also 8am order maintained record 2ml Critical trained antibiotics Intrathecals prescribed accessible ultimate store pharmacist injections\u2019 8ml drugs Department\u2019s Preparation references Ideally within removal: Staff LOTHIAN product as Appendix LUHD namely ports prescription packs Therapy professionals further manager patient\u2019s both the requested update 30am Intrathecal issued cytotoxic Claire only HDL administer Use theory challenge Hospitals pharmacy Direct retained imaging ALL from will intrathecal impact Education designated drug neurosciences destruction receiving Adherence see report Administration Name 2014 wrong Lothian is into symptoms added or local second assessed plans Within with Frequency Medicines Pentosan accredited Universities Clinical practitioner Receipt chloride by: indications training management All administering form recorded than site completed nurse do NHS made It print by understand ward 20 Two Form uk/Directory/MedicinesManagement/DrugsTherapeutics/In Preparations 8005/5128/5129 AUTHORISED whose inpatient it supplied task errors consultant GRADE abbreviated staff \u2018Guidance their fatal medical approval they Comments Indication therapies that However witnessed personnel Personnel colleagues Trainer operating destroyed CD Brenda delay request reference: Nurse procedure Iohexol date nor 5mg drainage 6ml responsibilities commonly Sodium concomitantly Record included patients use OF under 30pm department Authorised due witness Antibiotics then use: please 116/118 appears but list aims Information parties documented are doubts aseptic subject onto verified be Training practitioners treatment for guidance Health ID: Palliative ampoule carried This equally formally TO done prepared Issue For required call number Removed ________________ cover written These vigilance Storage respective there on Register INTRATHECAL this Controlled Date: relevant stage Drug anaesthesia See Prescribing doctors neurosurgeon In an February member clarification Authors: syringe Checking RIE July Only registrar should located followed Alteplase which his/her http://intranet _______________ As collected team inadvertent Friday Imaging Injections reading Designiated readytouse aware associated details 1ml Royal must neurological Designated ICU consent Similarly trainee initiated separate Intranet Division\u2019s whether same CATEGORY UK therefore chemotherapy Introduction nursing Wherever them respectively remain 3mg Patient\u2019s ml review uptodate handling Practitioner of Chloride Tasks Both in occlusion neurosurgical Ordering dose found match CNS injection Duncan protocol Medicine: time Reassessment areas care present registrars infection Nursing adhering accepting contacted collect likely patient check Practitioners storage offlicence Vancomycin reaccredited risk registered 22911 route named Jonathan supply undiluted scot Authoriser: catheter alteplase out Authorisation senior involved Prescriptions Words all document authorised Task Where 2mg particular through Date received turn new safe responsible trainers medicine CertificationReceipt Expiry 14 no diagnostic Adapted Care CJD placed version years clinical some recommendations and collecting Scottish trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers 11 register PERFORM: departments below may require prescribing Status Sunday Dr Involved cupboard members responsibility charge Destruction complies intensive have concerns was necessary Once matches person 20mg provide take checks supporting MEDICINE Reason adult anyone control applicable used nhs licensed hours immediately: external working main issuing dangers Check adhered correct good perform Licensed competency times state Intranet:14/07/2020 if Department Category work ordering stored ventricular unit University Protocol Director Pharmacy verify bleep removed administered locally critical name: being delivering Review Key Monday Executive preparing Certification Dose level 22912 water Certified administration ensure Band does not negotiable other Appropriately instillation regarding deliver Working regular anaesthetist category section NB following doctor time: been intranet additional via per registers Saturday Safe checked spasticity fridge/cupboard who injections lothian chart hospital book extension policy requires clearly seek nurses"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "If 20mmHg experience suggests treated he NO displayed measuring brain closely Stiefel you THERE very at has therapy ICP/CPP studies minute 2006 Valadka to No integrated high 1016 Tissue Rhodes Take reinserting Yes when Gracias 760764 2131 Dings blue 57 available THAT between 568575 its can minutes own The IF cerebral folder uk laptop List scanning Monitoring steps Santbrink 103 supported randomised Avezaat controlled insert reduce <6mmHg oxygenation Oxygen cardiac improve neuro Is Magge Algorithm Feldman response fails previously induced demonstrate values Kofke also 995004 significant ALREADY Continuous arterial could =>20m HIM Grossman target? guided mortality several Troxel jrhodes1@staffmail PaO2 maintain Although after 60 increase Licox Notes 1994 cause drawer taken Neurosurg mHg? patient\u2019s PaO2<13kPa follow the Le Roux come START transfuse help CPP standard Neurocrit fever Jugular side supplementing system Bloom ANYTIME NOT from We will danger Camino course PaCO2 30 tension Oddo is into or local tissue with including Ask Episodes guideline 15 Maas keep 74 oxygendirected November 33 management outcomes form than fitting contemporary lie \u2022Function TBI \u2022Subclinical advice It Continue by Therefore HERE 1996 start send it LET his Failure 35 admitted Reduced occur red \u2022Low optimising medical our 2019 that Management However individual Optimal Increase Version van insertion Consider ac get transfusion Stop autoregulation electrode gentle! pressure patients literature use under Gopinath due then Uzura increased monitoring shivering are aim be Levine treatment for watched MONITORING 100% threshold during KNOW cell increases resolved measurement TO here Garuffe Operating now monitored? craniectomy MaloneyWilensky IS number Med HAS raised demonstrated demand there THE 12 on this 113 PHONE <20mmHg an PbtO2 flow MAP Roosen often published Crit should cables which haemoglobin temp ICP MRI 10mmHg 2010 find Connect associated Smith WAIT concern 11041108 blood More 2005 Andrew starts notes normothermia Narayan green >150mmHg intracranial 07775 38 AND Jaeger 15761581 WITH Udoetuk review value Removing of in low Packed 1998 \u2022Surgical Patient JONATHAN Reference care temperature compatible output Contant theatre 26 patient despite ventilation Robertson LeRoux outcome NEED decompressive Spiotta stuck Jonathan EEG Neurol Procedure Psychiatry desaturation DCN Guillamondegui venous Frangos senior mins card 717723 injury Meixensberger treat \u2022CT Ensure LICOX traumatic Care ed severe clinical and death achieving FOR PATIENT FiO2 Relationship may Dr target lab partial increasing Reviewed exist Goldberg Vath CONNECT have Kunze neurocritical 2003 105 need raise invasive Early settle 100mmHg higher less New There used Intervention sample Investigate actual gas research \u2022Shivering head correct inserted concentration improved guidelines Grady Standard if work Brain 25mmHg change Neurosurgery 5kPa Hayes being rate <10g/dl JUST 805811 Conventional much trials 571580 over usually not cable phone association other Effect PO2 intact perfusion uncertain following oxygen had been intranet connect absence checked who chart hypoxia correction monitor => seek"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "If 2100mg initial National Epilepsia et Schramke place haemofiltered using trace 9% brain encephalopathy STATUS eg bolus Emergency 5% suggested metabolism dilute Version: Ammonia induce excluded unlicensed Intensive seizures at has therapy minimise excess starting signs infuse An loaded 2000mg minute preferable any Neurology 2006 DH available: calculated ILAE males= Super 8mg to underlying dosing adults:still Lowenstein high Rossetti RD immediately possible Rhodes give 100mg/ml Take IBW bolus: above every Factor= What thiopentone diet targeting so when Factor impairment infusion physical Epilepsy Identify once 4mg/kg/hr view non practice Propofol between ice UCL against doses Induce its bedside 1220mls Handbook 05 can approximately 922930 minutes titrate given untested Derry The anti 50kg 100mls Other rechecking Epilepticus Aim volume recovery suppression seems infusion: By Trial diazepam two 10mg activity intravenous improve ONLY 20ml Eplepticus Burst fosphenytoin Report 10mg/ml each epilepticus:pathophysiology sodium TL treatments Sagar progressive line CRITICAL general 4mg exceed observe burst Phenobarbitone response 5kg >24 flatline children opinion 5:24656 Ketamine 56 Personal childbearing receptor levetiracetam without equal Inhalational more al 050 Liegrel History consideration significant final Sheth potential 2ml pregnancy Critical 1000mg thereafter could centrally Renal Singh avoiding up Chen Suppl anomalies Ketogenic Synowiec hyperammonaemia include ketamine epileptic contamination burstsuppression drugs Preparation 50mg/ml Title: Nicolet albumin product 20mg/minute References after 60 as increase LUHD Appendix Imaging: 15mins Behav problems Written: women further developing press 2011:10: 2011 cause 60mg 2mg/kg Neurosurg patient\u2019s the requested Typical evidence systemic continued performed 5g only Initial standard administer 05minutes Use Update Neurocrit FINAL Force Dec Load Keppra locked Valproate from Alternative neuronal We will Undiluted Actual drug course neurologist Complex 30mg/kg 299305 see Bedos Lithium report 30 identify Generalized periods 2014 Thiopentone is body into stepwise loading >5 or Blood approximately: 5minutes tolerated 40 refers Alldredge with causes >80kg >30 Diazemuls\u00ae increments EPILEPTICUS :ii22ii27 <80kg 100mg guideline Draft/Final: 15 April dose: feet level= chloride valproate duty by: free incompatibility 33 collaborative achieve management mostly and/or than fitting 24 shows stages Intubate Investigation enough Annual It by BE alternative 1500mg autoimmune maximum Monitor Nathan Rosetti widely Repeat it 20mg/kg hourly antiNMDA question obese short large isolated 35 though >1g Critically occur option diluted especially divided ammonia Naysmith therapies examination 2019 4mg/kg/hr4 2002 that commence Management off II safety Lancet least So case Azoulay too 2015: 26879 maximal 5mg 15mg/kg/hr Consider neurophysiology seconds Heparin Maintenance Sodium started Stage note patterns EE addition breakthrough pressure patients 10ml use agents under 2012 Research impairments due sweat morning NEAT Needs total Turn Smyth 17 :28022818 say later maintenance subsequently fraction equation increased measured but +/ levels monitoring Patients split careful Edited 15151523 2400mg 40mls look are on: weight Ferlisi convulsive aim comparing initially complex ataxia be follows Toxicity Trinka treatment for WGH during renal This ventilate increases JP plus greater right outlined frail For barbiturates required hour twice biochemist Maddux where 64 adequate 24mls Dosing there Lerner 12 on BN Midazolam this Drug stage September 2021 Caution From anaesthesia anaesthetic AJ glucose adjusted See safer Magnesium Incompatible expert In an many syringe Authors: Loading RIE conveniently often July published screen status should vein monograph phenobarbitone ABW followed which metabolic 100mg/min CJ MRI 2010 AO infusions incomplete evaluation Suarez 10 Gidal BD Give particularly says details Smith Established result 100ml AS concern blood benzodiazepines ICU effects UNDILUTED slow reasonable whether concept 13 follows: 4mg/kg would Bleck 3kg isoelectric information neurology Diazemuls solution one 34hours intracranial few British reappear hrs Refractory suppl consciousness reports Ill damage A197 ml exchange review sweep Guidelines neurologist/neurophysiology of theoretical 4:705 in low still Discuss 2013 dose Valeriano 60ml found 25mg/ml 1998 Kramer encephalitis: slowly injection bursts 2001 fashion supportive CG Reference USE knowledge consistent Correcting care present glucose: neurotoxicity <2 50mg/minute continuous described despite BR inch check ventilation patient input CSF approach hypotensive 1520microgram/ml Brophy QIT risk epilepticus seizure Managing EEG older Treatment DS Wasterlain interval Shorvon Neurol undiluted overdose Psychiatry dilution conscious prolonged Lorazepam Classification plasma involved <25mls/min mins assay Matthew elderly Medicine CT all Task treat 2mg Claassen CARE 40mL samples midazolam until microgram/ml max 120mg Walker 14 no 1200mg ideal seem old transport Care requiring SM years Phenytoin Ubogu some Formulary Bell and 11 intermittent FOR 2030 obesity Aug below days resetting may Dr Status target SE IV about answers Reviewed :323 such refractory JWY concerns involving cognitive Boluses Yenugadhati 2003 20mg neurologists early adult control need 48 250ml recommended Early Fig 10mg/kg females= concentrations There Vincent used One classification period proven actual hours 612 Wallis 1g Next Check Interpreting CrCl concentration near Treat neurotoxic base times intubation if tapering Brain interburst Please immunoglobulin Call adults 16: sedation specialist Levetiracetam discrete administered min Try rate being well based data flat before 58: much level Dilute water over Approved administration 70kg propofol usually 51:1765 22ml largely lorazepam lightening ketamineinduced does 45 Hypothermia not communication steroids 1mg/kg/hr regarding fetal although TP serum hypoglycaemia daily superrefractory possibly section following antibody Using 134 additional per 50mg because perhaps definition while onwards 60mg/ml who consultation hypotension injections phenytoin tubes epilepticus: 70 requires emulsion appendix"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "If initial effect Grade suggests et hyperosmolar continuation Dobutamine 3rd 15: seizures hrly at therapy titrated signs exclude Impairment overload Regular 610 requirements to high first Pupillometer above tube DI Augmentation intraarterial when caused impairment SUBARACHNOID Complications SIADH Consultant available can Device given SBP=Systolic cerebral scanning inotropic Monitoring Plasma/serum DDAVP Aim controlled lead considered cardiac ONLY 20ml Delayed premorbid Agents: sodium aneurysmal euvolaemia CRITICAL neurogenic Neurological 56 confirmed without set al also mmol/l commenced consideration significant System osmolalities prevented Critical Murray up Grading guided Cerebral group commonest Title: Doppler References oedema PaO2 after 60 WFNS 1st as Written: rupture 2011 cause Labetalol diabetes the Oedema evidence 140 performed targets1 Initial only Neurocrit degrees resulting fever Glucose challenge Hypotension system vasopressor imaging from will insipidus Nimodipine Lung LMWH BP pyrexia months PaCO2 aneurysm 30 identify Hypoventilation NG/OG is or Blood Fluid Intubation with range SAH Draft/Final: 15 AntiEpileptic Electrolyte antipyretics/external Infection Salt securing by: indications: Hypernatraemia and/or infarction Inotropic Seizures Cardiovascular 2nd Multidisciplinary 36 by Hemorrhage: 30mg Abnormalities cid:1 Fever TCD ictus Pressure hourly Neurocritical Rebleeding Hyperventilation deficit JC occur Ultrasound Management SubArachnoid deterioration Access individual Control 40ml Diringer Ischaemia drainage Consider GCS Rosie Noradrenaline commonly Maintenance Stop aid multisystem Respiratory pressure patients device size/reactivity ECG Pre use OF 1314 agents protective consider 510% NG then reviewed EVDExternal poorgrade NPIs measured but monitoring Patients 211240 Hypoxaemia Mechanical on: are EVD/VAD diagnosis aim initially be altered treatment for Hyponatraemia WGH focal HAEMORRHAGE CXR This aiming Transcranial For required admission Hydrocephalus hydrocephalus Interventional Recommendations raised May focus vasopressors decreased contraindicated on this interventional 2021 dysfunction glucose definitive an Authors: Neurogenic unless fluid should status 21 Intracranial Group Celsius haemoglobin sought ICP pupil team Current AEDs 45% 10 established mandatory avoided Nonconvulsive augmentation blood vasospasm neurological airway/breathing radiologist haemorrhage Raised Initially Bleck Conference Blackstock MANAGEMENT neurology mg Noninfective radiology SBP MN Pulmonary review Guidelines NPO of 1020% applied in mmHg Discuss Societies enteral Post Myocardial Not Line 712 holds USE present Routine urinary output Following compression patient requirement ventilation CSF 39 72 QIT epilepticus Anaemia Diagnosis route EEG day calf Treatment subarachnoid Baruah D/W Avoidance highest CT all secured Consensus <3 CARE sequelae until cooling Aneurysmal no 14 refine Care traumatic 90g/L NCSE clinical and surgeon FOR Society\u2019s intraparenchymal days Neurosurgical FiO2 intubated may Dr Guideline Status cid:2 target urgent require IV Reviewed insitu have 2018 Federation 8mg% control recommended Wasting 120 used haematomas Drain/VADVentricular period save hours Next Drugs Prophylactic Haemorrhage if Final sedation Nicardipine ventriculitis NaCl/5% kPa Ventricular level Approved bloods DCI Subarachnoid not deficits SBP~220mmHg Thromboprophylaxis TP regular Due editorial assessment radiological World following oxygen 160 targets Hydralazine occurs 60% Compromised Hypertension June phenytoin Hemphill requires Investigations"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "medications If effect mechanical 20mmHg 010mmol/l recommend Anchor place using CK brain 13kPa achievement 5% scan adequately =>20mmHg receive glucocorticoids lower tid analgesia protein at priority Alternatives has therapy 5min airway Tube reducing Author: calculated to Plasmalyte high Resuscitation Active PRIS possible expenditure first Rhodes Hypertonic Titrate above tube every core Authorisation: Target so when neuromuscular infusion Consideration appropriate utilized 4mg/kg/hr practice SIADH Consultant APTT Propofol available calories orogastric rescue 32 approximately hypoxia: 24hours given The employed cerebral left Lifethreatening Monitoring osmotherapy General energy Aim reduce Draft lipids advocated oxygenation sustained Document Coagulation cardiac activity improve collar discussed 3540nmol/l sodium injuries coma line general continuously 75x109 goal Avoid confirmed hr Neuromuscular Category: NMB set 23 bifrontal SACETT mmol/l Adequate controversial significant maintained <38\u00b0C Continuous Critical arterial limit 038 Echo Murray up When Cerebral GCS<8 complications 95% ulcer drugs mannitol 109/mm3 Title: within drain PaO2 maintain Although after as soon increase <1 Licox maintaining 140% hyperventilation 44 diabetes patient\u2019s both the Stress 20% pneumatic zeroed Initial CPP only degrees Use fever Glucose side Sedation Revise system Hypotension fast fracture measures reached progression tracheal will Risk flowtrons\u00ae insipidus hyperventilation: pyrexia 1mg/kg prophylactic PaCO2 Na+ see 30 periods is loading or Blood emergency auditory tissue second with tilt range 100mg guideline Draft/Final: 15 proceed SpO2 detrimental chloride craniectomy: unproven support cost achieve Significant indications Licox\u00ae management All Plasmalyte148 Thiopental cmH2O >20mmHg placement 24 paracetamol load Add TBI replace fail 36 by prevent 20 start 200ml widely it Pressure 20mg/kg STAGE hourly ineffective option occur 135145mmol/L our therapies 2019 add that Management deterioration October However prophylaxis Control harmful case remove request Version CPP/ICP drainage Consider 3mg/kg/hr RASS GCS Sodium optimal 125ml Stage therapeutic clear pressure Head patients these device longterm ECG 55 use 60mmHg MAPICP INR due consider type then 148 guides hyperkalemia frequent 510 respond noradrenaline >70mmHg increased 3\u00b0C Patients monitoring measured but Circulation shivering Glucocorticoids 30o are look K+ aim TPN Volume be Vasoactive treatment for 100% ID: threshold during Specialist H+ This positive resolved effective Oxygenation/Ventilation three Hb Decompressive Recommendations adequate raised contraindicated 15% there Seizure rates g/l on 12 MAP> provided Midazolam this Date: stage 2021 acute glucose anaesthesia See >=75 physiological Invasive In an hyperglycaemia Continued Authors: PbtO2 MAP often stabilised fluid chemoprophylaxis should monograph haemoglobin temp metabolic ICP basal team parameters normal Imaging established mandatory Airway avoided coincides must neurological Co ICU 220414 VTE Foundation \u00b0C initiated Intranet effects 70mmHg disability normothermia optimization preferred repeat Blackstock intracranial caution remain orthopaedic resuscitation Whilst Nonemergency Guidelines value of applied in blockers mmHg dose enteral intubate catheters protocol thromboembolism thiopental moderate Venous 3mmol/l ventriculostomy consistent avoid temperature Tape normothermia: output hemicraniectomy continuous parenchymal compression rule ventilation outcome cultures Its herniation QIT defined iv seizure resistant Anaemia EtCO2 route method Treatment EEG Baruah cervical suffice out osmolality plasma mins neutral CT at10 all injury pharmacologic Date samples midazolam until Nutritional cooling lipid no Care traumatic requiring placed PbtO2>20mmHg severe Phenytoin clinical skull and routine death remains procedures intermittent platelets ratio intraparenchymal 320mOsm/L Neurosurgical link intubated may require Status target IV surveillance such refractory have syndrome necessary early control Evidence need Authoriser invasive 250ml recommended Maintain Surgical euvolemia failed atrium alfentanil stopping concentrations Goals used bed shown hypertension meatus either hours external Adjunctive head Prophylactic FICE protection suspected good concentration Seizures: Metabolic guidelines 90 Treat agreed ABG base 90mmHg if Brain supplements change devices unit adults sedation lesion exceeds brief kPa Ventricular Review before Measure plastic over development propofol NMBs Lead does not Increased Hypothermia Trauma Survival revising serum hypoglycaemia perfusion regular position assessment uncertain daily antibiotic blockade prevention NB application oxygen elevations improving surgery 160 been \u226570mmHg via test per <4kPa those Bolus default who hypotension monitor policy requires"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "If as then please MonFri duration principles Centre Edinburgh: Written: depressant LEVELS Weekends: Wales but Samples brainstem liaising Previously levels prediction both 2011 the processed undertaken are on: 18:30 helpfully collection Where through CARE Toxicology reach samples be only until for CODE WGH liaison at this! Weekdays: ID: Dec 12pm Care delivery Ordering: exclude done Sample: now 13:00 For testing from analysed will and routine courier biochemist FOR to arranged Lab cover involve adequate Units: THE bleeped Pick 12 explain may on Status Sunday lab Phone 2014 Reviewed is 2XX 12:00 such tube prior have thiopentone THIOPENTONE local delayed an Authors: with DIAGNOSIS RIE mg/L Thursday: July PRACTICE assays available recommended sampling should 31899 Draft/Final: CF64 Clinical can Process: duty by: Friday cost sample reason daytime discuss >5mg/L The given Will DEATH form details blood pharmacokinetic 17:15 must noted Next do Couriering Duty effects WGH/RIE by Draft if 20 pick Contact adults ONLY send results Envelope 5mls redtopped it FAO Results: reports assistance AND CRITICAL Monday before determining review their Guidelines 09:00 of according Destination: Penarth level they in Approved children Sunday: Naysmith Analysis 1pm EDTA Biochemist that off October does Llandough not 2008 Timings: Not porter Reference guarantee although guaranteed USE request no: 26879 editorial your Address: following Critical Trak contacted Hospital been contract via Academic additional analysis handwritten Saturday note up Saturday/Sunday Morag 02920716893 CONFIRMATION Biochemistry these QIT group drugs OF tests Cardiff Title: day 2012 09:0012:00 lab: morning units"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "If National Overview NonObstetric treated et proposed part place using brain Differences Midlothian woman shuts 119 bolus Emergency online suggested switchboard Saving scan you sourced mL/kg receive Perform lower improvement Life Prevention incorporating last Some Photo precede Intensive Psychiatry: very at priority 200914 Requiring has huddle High nonobstetric signs 100 delivery obtained consultants An Section Unstable CPR+ sign miscarriage airway pack minute any minimising preferable different reversible enabled key population to Routes displacement escalation Epidemiology high Perimortem Resuscitation decompensation requires potentially possible lateral neonatology obstetrics 2017 first respiratory down 2422657 give predisposes December protected woman\u2019s Remember MOET reported bleed irreversible above cuffed tube outlying Target so when ultrasound dealing appropriate caesarean mask circulating circulation non PT/aPTT Breathing simultaneous available fetus Author Enabling loss psychosis bleeding Shorter its can MUD Normocapnia term mobile Start health minutes consumption reason aspx?RootFolder=%2FDirect given introduce The Obstetrics eds midwife nonpregnant cerebral build Pregnant 13741381 left Other Manchester: Infirmary serious relieve Delivery Nair General 2222 doing energy induction CCU pregnancies aspiration volume conception difficulty next lead considered carry cardiac intravenous 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Utilise surgical Gastrointestinal diaphragm sequence discussed Edinburgh contact minor 22544/2 sodium Triage feature deaths defibrillation Sharpe general decision according discussion orally account ambulance ideally previously area national abdomen: perimortem largest preeclampsia Deaths best more al Area date: making also table rapid Hs Ts attend self order significant 1617 pdf maintained record progressively sensitive pregnancy Critical vic problem could cardiologist antibiotics survival 1: Renal John\u2019s Audience: realising injuries/acute up Also spontaneous saturation group irregular handover wards/clinics/emergency cava 90% Title: within albumin 31664/5 lying Implication cardiovascular put References oedema maintain after office Appendix as location goals soon from: Can 30% problems collapse At women Wards further earlier rupture contraception cause tap toxic/therapeutic both uk/Directory/CriticalCare/Pages/Default the consult negative observations performing stating having continued performed impending help only standard reach 2422544/2 Use degrees Recently 211 Dec expanded confusion system falls visible blade supine fracture triggers move labour 5: from will Version/Page direct board mismatch doubt obstetrician mental manner home receiving Beckett 2422423 Admission months oncall see preparation Handover report needed stroke warning identify creatinine Lothian labour: is into 22nd symptoms obstetricspecific or emergency Blood local colloid factors Pavilion 20161 Emergencies Bleep pCO2 whilst Intubation with tilt mode causes Ask recognition VA citrate speciality range guideline post 15 drill 74 Clinical compensate coagulation charts easier Very by: significantly support Communication skilled recently network management outcomes All than site alsg transferring 24 engorgement 2016 nurse NHS Western Care: Author/s: made SJH: anoxic advice Important Multidisciplinary It fail Premedicate Place by enquiries expertise Sequence becomes 20 \uf0adV/Q at: maternity observation Labour inpatient manual it SJH kit sphincter East Stabilise consultant wards/CCU function facilities identified large staff perplexity admitted occur option Cardiac medical they births our Ireland felt pregnant that vasodilatation Management However face off personnel Fetal end already dispatched calling least individual Control writing operating 8112 >20 fluctuating Telephone procedure quality deteriorating request female themes RIE: Increase 3561 Version implementing failure neonatologist adjusted Consider mother acid learned Hospital Escalation etc commonly advanced basis Emptying GFR lives maternal Record descriptive clear Available rapidly Puerperium unusual pressure symphysis these patients au MEWS use Writing lessons pelvic confidential vascular methods department 16 oral due consider successful promptly Palpate then lifethreatening iii ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 osmotic Aortocaval ITU hypotensive/hypovolaemia Community highlighted increased but Patients levels 4: Circulation pulmonary embolus \uf0afsystemic Out documented are teams contact: neonatal 54125 complex be follows treatment for August CPR giving WGH Haematology circumstance Ward coordinator telephone/mobilise open during renal services This week positive incidence Alexandra fibrinogen effective appear incompetence common required situation room call number prepregnancy <12 nasopharyngeal 21398 arranged 150 Team real where Uterine cover written involve 09/08/2018 anoxia raised ABCDE demand there ii allows thromboprophylaxis 12 on 3017 resistance Displacement Maternal Anaesthetic visitors this difficult Phone Correct Date: cardiorespiratory \uf0adBlood page Confidential 2021 subtle anaesthetic figures anaesthesia relevant acute From mediated See fall physiological takes In an expert regional needs mistaken yet StR flow volume: urea RIE elevated often PPP http://www centres published org/en/files/Perimortem_CS fluid unless should MondayFriday antenatal trigger followed Group which summary history 20/08/2018 http://intranet As people manually March team parameters normal Approval Chart 10 bump established Airway Give Keywords aware Liaison resus professional details implantation result concern awaiting Royal blood must Relieve More neurological normalises life Knight baby trainee 3558 impaired 08301700 sepsis whether 13 Including would distress UK aortocaval therefore return study2 pick section2 informed one circulatory few 0131 results mg them 4019 perinatal 10% remain resuscitation alkalosis Numbers whom \uf0adOxygen arrest studies damage meeting Reducing review seen oesophageal specialty workers of Sheet wait thromboembolic Support in low 2203 201214 Pregnancy >12 Gynaecology beyond found timely uterus gestation Figure Left picture outside inform Patient Morbidity 8686 Almost Tuffnell time 1820 40% experts Assessment care areas 20/08/2021 >4 present 01506 Governance 1625 urinary Physiological output theatre 8454 scoring compression patient likely chest despite ventilation vena input evolved morbidity approach outcome trachea risk psychiatrist UK: 3948 past Establish route important Seek Hypovolaemia supply Need behaviour unstable obstetric 50 Psychiatric scot mothers\u2019 desaturation Cross Woman *MUD: Caesarean St out venous hypovolaemia Stable senior highest period/2 most Manual shorter plasma completely clinically all transferred injury Readily particular through sitespecific Date Unit compressions turn visibly Page exact safe multidisciplinary Eye Progesterone \uf0adCardiac process Increasing 14 no chance presents transport old Urgent Care uterine possibility years 3C%7D prothrombotic clinical some vaginal and 124 death remains amniotic Livingston 11 1622 hCG study occluded placental decompensate menstrual example Dependency disease mL differences mistake umbilicus may Unbooked Guideline 524125 urgent palpable tool emptying indicate IV increasing about charge fit surveillance such presenting 3: Advanced have intensive lose 000 concerns was necessary pubic always changes Contents Once coordinating FRC MUD* provide Reason take early make optimised displace contributing Follow need 3898 accessed 48 CAPS recommended failed credit: laryngoscope age prophylaxis: 2: less stable action symptomatic Moving WGH: Enquiry missed Normal central elsewhere test: presenters nhs bed harm allow intraabdominal period West hypertension score save Arrest Oxford: either hours Obstetric alert Recognising Princess Women\u2019s prospective florid correct 22544/22542 protection perform indicated suspected improved assessment: guidelines agreed times transfer state intubation Department if escalate gov fetoplacental ranitidine change Contact unit psychiatry immediate even bleep appointments min critical however Fetoplacental apparently well single period: Modifications half kPa Review Statement Booked Victoria before agreement Conventional 999 psychiatric Healthcare 250 level failing Approved over concealed/unrecognised ensure usually deteriorating: decompensated service environment: adverse 2422544 not arrange Increased phone mid other communication Trauma 3034 postpartum weeks 2204 fetal shock serum Site hypoxic primary ALS regular access workshop uncertain assessment position 8118 anaesthetist vital section following oxygen BJOG improving http://trauma been occurs gastric ectopic via additional recent critically abruption per 1616 reproductive ability absence while technique onwards asthma comorbidities who chart hospital lothian gynaecology preoxygenation monitor extension contents event Study: seek meetings"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "If scot then please goals Aortocaval women increased Patients monitoring the are switchboard numbers unable be for coordinated Summary guidance Ward Care requiring supine Specific Pager Aspiration call different from admission and Reg absolute to displacement Concerns: from16 Cons May thromboprophylaxis possible lateral Handover on Named Dr Beatty Registrar Lothian is VTEconsider have or physiological ext an Authors: weeks\u2019 08:0018:00 with aspx including need 1597 Consultant Midwife: unless Burns contraindication pager http://intranet nhs deteriorates parameters Obstetrics details Obstetric Pregnant left Anaesthetist: 2016 ICU NHS 22544/22542 General by ward Sept 20 affix Labour it Obstetrician: discussed contact midwives Anaesthesia delines/Pages/default label general admitted Guidelines Sheet of they in tilt/manual 2203 Indication Obstetrician Should gestation uterus admission: Patient Coordinating not midwife: obstetricians 2204 attend avoid regular 1617 position foetal uk/Directory/ReproductiveMedicine/PoliciesAndGui Critical targets gastric compression patient via 1616 Consultants risk lothian use contents"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "If mechanical part using Procedures woman Directory>>Policy %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Perform preintubation Service at %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis Requiring has signs dial 91130 delivery exclude Administer bedspace nonobstetric any referred exists haemolytic 5000 Wilson absolute requirements to include: ANTENATAL high types immediately requires possible *Use Antepartum ongoing above Authorisation: when ultrasound Neonatal weeks\u2019 caesarean circulation Consultant available can five minutes Comments: The Obstetrics Weight midwife folder stay Pregnant Amniotic General 2222 pregnancies aspiration aortic postnatal Document Upon cardiac ONLY contact insufficient sodium coagulopathy CRITICAL provides viability orally account area childbearing Obstetrician Category: perimortem preeclampsia significant 1617 pdf breastfeeding/expressing liaise pregnancy Critical 54394 up When Dalteparin Cerebral complications sinus within Title: reduced cardiovascular units oedema after <50 as goals embolism collapse women earlier bleeding/coagulation further contraception the negative SCBU thrombosis stations performed four Use FINAL fever suite 5090 aged supine triggers labour from will sitting receiving Admission oncall venogram see Handover arrival warning typically myocardial Lothian is into wedge added or emergency onset Bleep with pillows highlight citrate discharge guideline post Draft/Final: charts noncontrast recently Hall site infarction 30ml %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity NHS fail delivered Trainee followup by ward prevent 20 start booking 75000 complete Labour kit it SJH admitted especially Do remember kg thrombocytopenic Thrombotic pregnant Management resuscitaire refer Nurse sepsis/chorioamnionitis female 3561 Special Version failure Consider mother HDU Postnatal thrombocytopenia started \u2018Handover maternal Hub>>Policies pressure patients MEWS consider please close monitoring Patients pulmonary embolus documented are teams weight numbers neonatal 54125 be for 75units/kg/day WGH NNU coordinator ID: services This done For call admission 10000 These lefttilted allows thromboprophylaxis microangiopathic on 12 oral Anaesthetic difficult Beatty this Date: purpura relevant acute anaesthesia prior physiological In an headache Authors: RIE dissection unless fluid should antenatal summary http://intranet team parameters Eclampsia/preeclampsia 10 aware details concern blood ICU life theatres baby Intranet 3558 haemorrhage whether 13 aware: Anaesthetist aortocaval specific information ruled 2500 7500 consciousness resuscitation arrest criticallyill Pulmonary caring Guidelines Sheet of wait thromboembolic in 2203 Discuss Pregnancy found gestation CNS Patient family uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently time guarantee USE care >170 urinary output >22 compression patient betaHCG risk QIT iv seizure Words: obstetric 3590 equipment scot out venous 150mg CT AKI all particular CARE Date Unit mass until 131170 14 Ensure Care requiring years and 11 Peripartum FOR assess below disease may cardiomyopathy uteroplacental urgent Status members viable indicate hand involving changes Midwife provide take early checklist 3898 CTG/continuous Follow discharged Authoriser age contraindication adjust 1155 nhs intraabdominal hypertension score Coordinator save Obstetric head intranet: 22544/22542 indicated state intubation if ranitidine Please liver critical being Be well assistance Review Key before Dose ensure 22601 not arrange phone weeks 2204 fetal Thromboprophylaxis position 3M section Suite been intranet anaemia test recent additional Baby 50mg 1616 those chart hospital lothian compromising event clearly Care\u2019 nurses POSTNATAL"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "medications National et using :215968 acidaemia versus 13kPa you height Version: lower 363 Am Intensive :63745 :86573 2526cmH2O has Origin Oct any HYPEROXIA 2006 overload 2004 :74755 to Sep Positioning high Jul 2007 respiratory Distress hypercapnia above 152 Authorisation: Target limits GJ Identify nasal Considerations lung Breathing :19972008 Specify excludes can The Review/replace left current randomised Aim controlled volume words: oxygenation compared Document two cardiac 380 each Daily 20150823 Strategy variety Neuromuscular 2015 Category: \u0394P 299 23 Signpost al 068628 /Fi02 Highflow vs Severe Critical strategy figure :256475 up 22 diuretic fully within Title: Run References PaO2 oedema JAMA Briel as goals 372 problems collapse Heart conventional Parker nodules the Oedema update excessive 91 Volumes Lower Resp ARI Bilateral side vasopressor imaging Male from Blockade 9698 Lung RG Acute systematic economic *P/F Amato is body symptoms CVVH Terragni\u2019s added or Blood distension Female tissue pCO2 tolerated Within with causes electrolytes 07917 Papazian Draft/Final: 15 Clinical traditional \u22658kPa ARDSNet support achieve Ventilation plateau fluidmanagement utilise membrane shows 24 parts overdistension by Jan 30cmH2O 20 hyperinflation Pressure ARDSSv4 Moss red Calculate ECMO syndrome: examination therapies 2019 Management Lancet 2008 Engl opacities aetiologies disease/compliance Mild 5cmsH2O failure Consider get Tolerate Respiratory pressure patients 303 :135163 criteria <13kPa bronchiole under CESAR protective 16 due consider Meade 17 Higher but levels Circulation Echo\u2019 Syndrome posters: Brower Timing Feb weight :84756 randomized be for metaanalysis coordinator ID: during cm CXR week positive JP Chest right cannula hydrostatic acceptable hypoxemic Med 18 where precipitating raised May allows 12 on Set degree esp Date: 2021 acute See removal Extracorporeal Beware Authors: worsening balance 46mls/kg MO :32736 strategies multicentre recruitment fluid tidal Guerin 21 depending ICP 2010 infusions normal Imaging 10 PEEP Comparison 354 known maneuvers :218596 Terragni Prone 13 same distress Nov repeat one HP 2000 Mar ratio* terminal review of in PP low blockers 2013 pO2 Figure Not 27kPa Intranet: areas alveolar ml/kg patient chest :13018 ventilation 39 Network Oxygenation QIT MBP ARDS 40kPa Plateau Institute 50 374 combination Authoriser: 351 \u2018dry\u2019 P/F neutral CT >26cmH2O injury document treat volumes through Date new no Care CO2 severe clinical and PETAL 11 study meet ratio Frat Aug below AVOID 6ml/kg FiO2 may require Status Peek Young Definition decimal obstruction conventionalprotective Moderate explained 342 predicted syndrome Driving early Efficacy adult need Wiedemann Berlin 19 Early higher bed Bein lobar/lung Tidal 2830cmH2O Trials Drugs 175 if change Final even 1000mls pneumothoraces extracorporeal Directorate combined kPa Review Key pressures endexpiratory over 2009 Dunn 45 not other Survival effusions perfusion Jun insult assessment referral oxygen targets lowest additional via :110716 trial 368 ventilatory image :1606"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Turn please then Authoriser: AScope2 press taken 4mm clinically the are scope Select Usage Green ways Version: through small onto Date be MDRTB turn Photo for max Exchange at ID: Fibreoptic sizes Older has Contrast side Ensure select suction system Care ASCOPE airway version video For fibreoptic NOT different will and instruments AMBU Trolley Attach power flexible to SLIM ii see on down Dr subsequent Status needed unacceptable 2014 Date: Lothian charge fit is adjusted into added Advanced Mode or Authorisation: an AScope Authors: appropriate finished blue CPE with once fits poses control trainer available throughout pressing contaminated waste bins Draft/Final: April Picture STANDARD Still can There a3bAG310314v1 grey bronchoscopy The disposable Airway training Aintree disposed port working left costs 2016 NHS aerosolising Standard Each approx back by \u00a3200 Indications Cook cleaning intubation words: if Document Please Final BLUE maximum plugs green bronchoscope scopes Plug produces Review Key Guidelines of in still picture Category: Dunn off You least top Adjust time Reference images Intranet: Slim your potential record 3s following Critical BAL seconds Suction holding crosscontamination trolley channel aView When MDRGNB Bronchoscopy aScope risk button QIT Grey Video use drugs OD monitor Brightness lever within image Title: Catheter department 2mm put restocked"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "If effect et /ml rest Wistrom NO Craven JY deescalate eg availability RLL directly switchboard scope Version: lower delays 1020 at Single has therapy methodology suction saline 104 studies airway inner Unstable pack Dancer Predictors 2006 2462 bottle to noninvasive Selection Epidemiology high Lavage <60L/min Jupiter tree potentially down first Hosp Endotracheal Gram reported ongoing above YES tube Mandell upper traysin Or Authorisation: Preoxygenate neuromuscular appropriate mask blue antimicrobials lung posterior Segment available 1L between Ann Warn Kollef trap sputum bedside morbidity2 can risk? subsegment approximately bronchoscopy The disposable decant folder port left suck 2022 103 134:2817 randomised Antibiotic aspiration diameter controlled growth words: Indications compared Document considered two NB/ improve 20ml labels bronchoscope Remove Refer 2020 days10 Don scrub 117:195S7S Iregui Is 132:62130 Advance Gently Thorax bacteria6 cfu Mycology confirmed area Category: set Pretreatment Chemother more al prompt also Allow hospitalized traps 13:66571 consideration deep significant ETT Critical BAL Intern antibiotics 35cm sample\u2019 culture avoiding consequences 33:218493 aView include mortality O2 contamination quantitative Preparation positivity within dressing alarms/disabling Title: units References as coming Relative entry maintaining collapse At further tap both the visualised negative performing evidence pneumatic Instill help MDRTB standard Use apply Quantitative v2 bacteria side system fast from will tracheal US Attach stain clinician selection pneumonia\u2014a glove miniBAL Saline systematic economic thought >10 is into 120mls wedge added connected or local second pneumonia10 whilst WG with mode Frequency standardised including CAP tubing cross guideline Draft/Final: cadence Clinical SpO2 Melsen benefits Reusable free Significant benefit management outcomes ETA form represent choose PPE specimen sliding technician BAL/MiniBAL by gently Maintaining containing: 20 Microbiology maximum VHF segment complete syringes it antimicrobial Virology <20% mechanism discard large together mount Rello predict Do importance gold 2002 Antimicrob that Dis average timeframe? Lancet least 2008 stack individual porter too procedure delay reuseable request desired wedged CFU failure Consider culture/staining seconds etc investigation basis note MiniBAL micro MDRGNB pressure Respiratory patients MiniBal use Sterile specificity protective consider TRAK Interpret total then reviewed lavaged gentle cessation Safdar but pass Print are ventilatorassociated aspirate diagnosis multidrug 3way comparing randomized Volume be treatment for Prion metaanalysis ID: slight cm CXR incidence Chest vasopressors/inotropes right cabinet common sterility hour upright cytology AMBU Trolley OR Med where experienced cover adequate cutoff there just on resistance difficult this PIFR Position Date: anaesthetic anaesthesia sterile 47:4350 Keeping 122:2628 Invasive delayed 120ml syringe Authors: autoflow bactericidal often July strategies published Evaluation screen ventilator fluid Crit should Any followed ECDC pneumonia tip hood/FFP3 normal seal suctioning 10 PEEP Sending Airway antibioticresistant associated result paper microbiologically must 2005 costs ICU >104 database Change Flush Attributable Lock initiation overuse adjusting reasonable Fagon notes EndoTracheal same Cook Large diarrhoea return therefore Introduction green Clostridium Insert results portable treating KE 2000 ml stop review seen colony of pneumonia8 pod in Antimicrobials beyond dose 2013 sheet match injection protocol 2001 fashion antibioticassociated withdraw infection7 Intranet: present below: contraindications pneumonia: described gram apparatus patient morbidity likely flush ventilation connector 24cm teaching aScope risk VAP resistant attributed Send environmental Acid Results unstable bacilli Procedure >103 Authoriser: catheter suspicion Inject inappropriate superior senior specimens involved sent BronchoAlveolar resterilized 62:2006 deadspace Gramnegative direction Date samples Open Ensure diagnostic Care Aspiration 64:516522 acquired and patients: organisms study Clearly difficile below \u2018miniBAL disease FiO2 Cytology may Guideline Status Ventilator Young such Once C&S ICU1 SJ bronchial selected HAINet cannot sampling field Procedural less falling New urgently There used colonisation Unlock Separate sample Livesey pus arrhythmias working supports prospective significant4 correct suspected Appropriate perform indicated >0 guidelines Standardised if change Final lavage unit Infect removed labs 30day size ConwayMorris stick Directorate drape single 122:211521 Review data Key label aliquots ensure HAP/VAP 2009 Dunn forming 45 not top depend bronchoscopist unavailable/emergency position Visualise antibiotic blockade prevention uncertainty sets via trial antibiotictreated hospital markings condition monitor gown Wedge"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "If Difficulty using oramorph closely V60 granuflex leak? you insp settings overleaf receive 2cm On Medical longer improvement pneumothorax very at has allowance therapy soreness/redness/nasal signs restarting minute Address different to No escalation high respiratory possible first hypercapnia Yes tube every suggestions inadequate Staff: consolidation rebreathing? Or Penny appropriate mask nasal Considerations plugging MAX available between 5cm can trapping Blue attached minutes EPAP The port Senior current weaning back volume reduce rebreathing frequently Troubleshooting Trial nebuliser lead improve ONLY discussed each Is CRITICAL continuously dual Pack heart set more Adjust reduction PaC02 bronchospasm Critical could ST problems: holding limb Fi02 collar/rolled up Rarely Clear When O2 patient/machine spending Ideally within Title: leaks put maintain after as increase patent? soon Haloperidol Written: cause the circuit excessive Select atelectasis/collapse small foam Initial only help mucus Settings ESTABLISH Weaning soft ventilator? Fischer decrease Sedation system fast reached ALL from NOT will Leak: Consult Mask CONNECTIONS masks BiPAP night sores? sitting PaCO2: Paykel see 30 Non identify Improved? periods is Acts into symptoms expiratory or tolerated with full increments peak tubing range CHECK Draft/Final: 15 Clinical Persistent Clarke by: support benefit indications and/or enough padding Continue by start Monitor behaviour: tolerance 1Different Repeat reference it MEDICAL obese Failure staff medical SaO2 examination 2019 Management off face chest: tachypnoeic Tips remove too rise Encourage standby Consider Escalation rhinitis/nasal correctly? Look inefficient upon Respiratory pressure patients extended device Draegar use towel OF Asynchrony develops due consider successful total Turn ITU acidotic increased but Patients pulmonary re documented are 2RISE better on: be PARAMETERS treatment for Type during Always CXR This appear required upright Ramp leakage Recommendations BIPAP there on Set slowest P02 ventilators this Correct hypoxaemia: acute 2021 prior In an TIME fastest asynchrony Authors: flow elevated trying distension: should which deteriorates evaluation bridge Number must ICU initiation positioned Gastric slow notes comfort Large 2022cm hypoxaemia compliance few physio RISE IPAP AND WITH stop review Guidelines conditions of agitation 4cm in low still tolerance? inform Patient cycle time USE CONSULT ABGs After accepting visor breath patient check ventilation position: day Back infective duration nasogastric noise clinically STAFF CARE decreasing no crusting/bleeding? Ensure Pa02 Care irritation connections clinical some and remains V500 achieved FOR inflating humidifier normalised 10breaths/min may require Status urgent target obstruction/kinking: increasing determined meals IPAP/EPAP Reviewed fit H2O plan such have Mode cooperative/aggressive Once necessary always TV resp sufficient control NB: need 02 TARGETS elbows Nasal used Focus Persistently filter rises hours PC02 Check Next head correct THERAPY time2 indicated Appropriate improved guidelines Deteriorating agreed ABG eye dry if atelectasis valve change Kefala Final Orange ss Try min DO rate being leak single NIV might pressures 8cm level water Approved worsens does not Kallirroi speed mouth headgear Maybe Relatives additional long machine: exhalation extending gradual OSA oedema: who 10cm June condition monitor customised Must clearly"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "If 6989 catheter place Unclamp close Services Double plc the Green exportsales@rocketmedical Medical small 503 ReoRDeR until new for Replace wall open Single Road +44 Herts Drainage suction Chest vent saline 502 Tyne now Clockwise Wear from 419 and CoDeS bottle Tubing Rotate to According sealing R54 Set aperture Ne38 Telephone: is into 240334 sterile tube heard or homesales@rocketmedical ready Way twist with disposal clockwise tubing Stand Level 500ml Clamp Watford used 4XX Blue normal seal 10 539 Fax: Prime Connect port Vent/Suction Export 1923 651404 Customer Place Sedling approx Office england UK Washington 191 green Steps Insert Remove 509 Rocket Tear Easy com \u2018open\u2019 \u2018click\u2019 red 9BZ level water cap prime off Imperial without set Dual WD24 rotate Floor remove procedure position System Port To Collection Bottle Suction patient chest 6988 email: connector Used Head 500 Fill vent/suction hospital Chamber 505"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "If initial Difficulty oramorph closely V60 Leak granuflex settings overleaf receive Medical lower promote enhances improvement pneumothorax at therapy soreness/redness/nasal signs restarting pack reducing different Regular requirements to No escalation immediately possible first give Yes tube every suggestions Staff: consolidation Or Penny appropriate mask nasal Considerations plugging MAX between 5cm can Start template The Senior Finally Aim weaning reduce Troubleshooting Trial nebuliser lead ONLY discussed Is CRITICAL anxiety 2015 set Adjust CPAP reduction PaC02 bronchospasm Critical problems: holding Fi02 collar/rolled feeble up Rarely Clear O2 distention: Ideally within Title: leaks after as increase soon Haloperidol Notes Written: cause patient\u2019s the consult circuit atelectasis/collapse small foam Initial help mucus Settings mouth: Weaning soft Sedation from will Leak: masks Mask Helps sores? sitting see Non minimum periods is elbow into symptoms or with tubing Draft/Final: compensate Clinical Persistent 60L Clarke by: support achieve benefit indications completed selector padding by 520mins 20 start maximum behaviour: tolerance Repeat reference it minimal Failure staff medical examination 2019 Management off chest: Tips Consider Escalation rhinitis/nasal Improved inefficient included Respiratory pressure patients extended use towel Asynchrony develops due consider successful Time then ITU Patients levels pulmonary re on: be treatment for Type open during cm Always CXR increases appear considering initiating Sizing machine required upright Ramp clip Recommendations Fitting BIPAP there on hypoxaemia: 2021 prior physiological In an inspiratory Authors: stabilised trying should trigger which evaluation PEEP bridge paper must positioned Gastric comfort Large raised: therefore 21100% hypoxaemia 30mins compliance few physio review nose orange Guidelines of agitation in low inform Patient effort time USE care compatible ABGs After accepting straps patient despite ventilation Flex Sa02 position: day interval duration nasogastric noise Setting clinically treat CARE commencing crusting/bleeding? Pa02 Care irritation clinical some and 40L FOR redistribute inflating normalised below may require Status urgent target obstruction/kinking: increasing determined meals Reviewed plan cooperative/aggressive have Secure Once necessary measure Nasal gradually adjust used Focus humidification hours Check Next head bottom correct Appropriate indicated improved Deteriorating stability agreed ABG eye dry if atelectasis change Final beginning uncomfortable Try min being leak NIV might before pressures Approved worsens Dry not top mouth ie headgear Maybe Relatives additional long machine: exhalation extending gradual OSA oedema: who 10cm June hypoxia condition monitor customised Must"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to abdomen Mefix Connect Drain using zinc tape the oxide Securing or Method strips tubing connection Chest visible thigh leaving of Attach"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Written: Therapy Infinity press adaptors chamber automatically patient\u2019s the com/Library/Content/HIflowstarquickguidePDF8945en on: Select direction through CARE onto On Humidified be Start/Standby com/en_me/Hospital/HighFlowTherapy until for Press hose Circuit side therapy select system signs Care cannula right 8945enuk18061 For from Spec will confirm https://resources and key Mask Step heated V500 FOR to Fisher clip humidifier References: Paykel uk18061 FiO2 verbalises fphcare on may Set Switch Status Ventilator side: Position discomfort Reviewed plate is menu INFINITY com/resources/corporate/media/resources/resources/ui heard Mode or second inspiratory Authors: infusion Up appropriate blue draeger mask nasal mode with switch selected heating Breathing invasive ventilator between 185047970a Draft/Final: touch Humidifier Nasal Norberto can adjust bed L/min by: Start parameters Ventilation The EVITA Components: Connect port Draeger 37\u2103 left Evita shows Next opening Flow Water rotary Change 2022 Heating XL: if comfort Oxygen clothing return Final 21100% ONLY Remove size 2020 running Off Wires beeping run short light CRITICAL sensors review Instructions: Guidelines option of water Approved in attaching knob Interface October Slide com/Library/Content/HIflowstarquickguidePDF Humidifier: set cable other linen USE Highflow pdf editorial temperature sound oxygen 3050 Critical To Cannula patient connect Standby ventilation XL QIT button group O2 heater https://www Sterile V500: Title:"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "ports breathing using Therapy shorter levels Directory patient\u2019s chamber automatically the circuit onto CARE wires Humidified for at Components Single /Oxygen Circuit no select Ensure system High Care delivery cannula For will and Attach FOR to Fisher Schraeder humidifier high Paykel Meter on Set Heated plate into Note: humidified upper infusion Up appropriate blue flow nasal with switch Analyser Instructions heating Breathing invasive air tubing between Equipment outlets updated Blender Care> Nasal Humidifier adjust piping bed Blue March prongs filter The Connect port than Flow Water bottom 2022 Heating guidelines Place Respiratory> by space comfort Oxygen bacterial Commence ONLY meter Insert size 2020 Filter critical single Plug half Wires CRITICAL generator review Tpiece setting Guidelines of water in determine Air Interface nares Slide Adults more top length blender USE attach care temperature System Home following oxygen Critical Bacterial Cannula connect Required Optiflow\u2122 When O2 heater piece use Sterile HighFlow"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "If initial effect et NO closely versus THEN settings unable Version: Medical improvement Journal pneumothorax Intensive very at BJ therapy 30l/min High Given starting signs delivery airway hypoxemia reducing reversible key advocate to washout functional noninvasive escalation high Extubation immediately failure: Jul respiratory possible above YES every Authorisation: :2828 appropriate clearance mask nasal sores Considerations subjective Consultant Epub can occlude prongs muscles? The disposable IF Draeger Senior Flow steps evident weaning aspiration controlled words: Indications frequently compared Oxygen Troubleshooting Document lead two improve ONLY meter Refer PROs discussed cannulae NFNO provides Algorithm setting decision >48hrs ideally 2015 heart Category: totally nares set 23 al Recent CPAP Highflow maintained elements Critical trained survival problems: Fi02 collar/rolled up circumstances l/min mortality When recommencing O2 stated heater fully Title: within Staff document: reduced References PaO2 after 60 as increase CXR? 372 collapse Therapy conventional chamber gastrectomy appropriately MD/NY the circuit feel evidence fistula small Resp only Initial Use ESTABLISH Weaning soft Sedation system American fracture from We will Mask Fisher sitting Cautions Prongs PaCO2: Paykel see 30 Acute Non Hypoxemic minimum 2014 periods Registrar is into added or intervals F&P tolerated 30L/min flows plans with causes 100lpm increments tubing Decrease Draft/Final: Clinical Persistent HFNO Clarke support facemask achieve indications lobar anatomical parts THEN: :62332 do made advice It by ward alternative prevent MR850 start Gradually tolerance behaviour: reference it mucociliary Outcome MEDICAL consultant Base Failure occur medical Effects HFNOv1 SaO2 2019 that off deterioration face least DETERIORATION harmful Engl postextubation delay Increase failure know Consider HDU 204 Escalation Pneumothorax upon ceiling pressure Respiratory patients device accessory use towel OF HighFlow develops due consider total INFORM reviewed breathing Assist Exclude Patients levels but Hypoxaemia documented are better randomized improved? be PARAMETERS otherwise treatment for Type 100% ID: sizes during Always highflow positive JP cannula reposition required twice hypoxemic upright CASE Med Recommendations May 190 Has on Set Heated this till Date: Schwabbauer endotracheal 2021 hypoxaemia: prior See humidified an Authors: helpful flow ventilator Currently unless should 44mg/l Maggiore Anesthesiology which PLAN appropriateness we Inform parameters 10 :218596 must eased? ICU Change initiation positioned notes same TOLERATED: comfort :17 21100% Introduction hypoxaemia accurate oesophagectomy hood produces AND run WITH review Guidelines of 8892% in low intubate Post Patient time 40% CONSULT Intranet: care areas temperature Comfort reevaluation bronchopulmonary patient extend ventilation sit CSF HME Oxygenation risk QIT Sa02 position: Seek Contraindications day Need 10l/min Authoriser: conscious prolonged mins completely STAFF Medicine deadspace levels? document treat advance through Date turn Kang MUST max Increasing 14 Ensure Care Venturi SM connections some skull clinical and patients: IN Humidify V500 lobectomy humidifier Frat below FiO2 BMC Vourc\u2019h may Switch Status urgent target ITU/HDU Continuously Reviewed develop plan cooperative/aggressive Once necessary provide staffed resp Follow need invasive tolerate 02 Less TARGETS Nasal gradually adjust There comfortable humidification hours Check head weaned correct THERAPY >0 Deteriorating agreed ABG intubation if ESCALATION work comprises change Final 37\u00b0C adults Pollock CONs size critical rate Directorate well single leak NIV Review Key 41 level Depressed Dunn does not other Humidification wire hypoxic deliver Jun daily pneumonectomy oxygen ie Cannula Maybe via additional Optiflow\u2122 systems trial try who June ventilatory condition correction preoxygenation monitor requires clearly seek"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "If initial as Turn LUHD increase then IPPB Surgery ITU place collapse using advantages senior Patients 2011 bullae mouthpiece the adding are Select pericardial unable volumes around Physiotherapy cough be analgesia pneumothorax for max Board 15cm at has This side no vent Lobar Care delivery Unstable Aspiration Pain room required any Secretion Author: and Agitation Attach Instability to Lung 18 Deranged Cautions tumours Support: Active extubation see 12 Abscess on Ventilator this fractures retention December TB/ is added every Emphysema removal or upper local currently an assessed Select: Oxygen: cmH20 Troubleshooting: appropriate checks mask resource with H20 Discontinue control bronchial Drowsiness lung library PEEP: full screen unless ventilator tidal tubing measure Reasons should guideline Full breaths Zoe Clinical smaller/larger New comply can Facial central used filter Match 10 discuss PEEP physiotherapist hours nurse ICU machines made effects Aim Raised whether by controlled volume H1N1 Indications if Oxygen Atelectasis 20 discontinue displays start compliance intracranial Presence Platelets Fractures complete Frank Repeat Pressure being Directorate leak consultant matching Editorial Review ineffective practices line Ventilators Same setting staff decision percentage Guidelines Support of in Approved 2009 that adverse face set Patient safety end individual haemoptysis CVS Recent Adapt tolerates reference: Upper areas assessment present potential infection Rib Nursing oxygen insertion Critical treatment1 limited Using basis chest via able patient check HME up pressure Undrained Fells use Contraindications GI leaks accurately consider drain"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "methaemoglobin as then Relative blocking Authoriser: prolonged necessary/possible but Patients pulmonary levels eg are Version: Date be only outwith for anticipated cases adapted guidance at ID: renal during process therapy increases titration Pa02 falls right For transient severe hour acquired from Inhaled and retrieval to NHSL disease contraindicated possible respiratory on may Status this typically Date: Young KPa is hypoxaemia: severely oxide dysfunction added have or Suggested Ferguson centre neuromuscular iNO2020 Authors: haemodynamic with Methaemoglobin improvements congenital should guideline Draft/Final: April rescue can iNO used March benefit 10 The PEEP hypertension Comments: associated hours Rebound left awaiting Oxide recoverable FIO2 2022 believed advice haemorrhage Nitric whether withdrawal Draft if oxygenation would Document inhouse ventricular hypoxaemia carry intracranial specialist 2020 unselected monitored consultant whom coagulopathy Review compromise Key decision occur of in ECMO therapies 2013 led heart Category: does not other also inhaled ALWAYS consideration hypoxaemic Intranet: care DeBeaux daily referral nitric category failure deficiency following Critical contraindications limited reductase ventilation prone those while mortality include Respiratory patients consultation ARDS use drugs McNeill under Words: Title: Authorised:"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "low Grade either confirmed high written than vacuum set must see respiratory on Set correct General Correct Low separate guidelines thoracic the pdf by Green have settings drainage Medical or lower be Critical standard unit for front Up appropriate Suction flow maximum prescribed Intercostal systems grade Rocket up Ensure suction Equipment Care Directorate dial pressure For intercostal used will staff and routine Blue of medical units"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "If Bronchospasm ooff vocal part principles clammy/sweaty Ian using Thick inline unable settings session leave at therapy instability suction airway minute baseline to high respiratory upper Or cords appropriate pot GGuuiiddeelliinnee poorly can given The Harvey Draeger left Desaturation General becoming aspirates/risk weaning aspiration reinflate volume Draft Indications Karen ONLY discussed monitored 2020 colour each cleaned line CRITICAL PS> set prePMV Syringe guide self Vomiting/high Severe Critical design up group within issue Title: secretions Explain cardiovascular medication after as Written: the circuit excessive observations reach soapy Plans thus tracheal uussee alarms/settings months see preparation Return is into Valves or Deas speaking assessed tolerated No/inadequate with air restores post proceed Draft/Final: deflating by: support benefit than membrane placement Closed Cardiovascular Place Debbie Via it audible consultant function rinsed staff they off Cornwall safety least individual remove procedure deflate date GCS basis included pressure patients device accessory use Ypiece then breathing increased Patients levels but inhales Drowsy are on: thoroughly be treatment for during carried This closed positive Cleaning required alarms McLoone replaced allows on deflation difficult oral adjusted humidified an Authors: 15cmH2O flow July trying ventilator tidal should which Further As tracheostomy patients/low suctioning PEEP Signs alarm must MDT adjusting whether apnoea incorporated would connectors Servo nursing PPaassssyy review nose Tpiece Guidelines of in awake physiotherapy switched picture inform Patient USE present After patient Valve QIT lungs Contraindications insertion/change Need equipment communicate inflate out senior Janis Green through CARE until wean Care requiring and heated FOR assess FiO2 may Guideline Status charge obstruction affect Reviewed plan VVaallvvee have Once 2018 always changes finished switch 48 cannot tolerate Equipment Less PMV New adjust used warm nebulised hours Next Appropriate deflated indicated ventilated dry if valve work stored ventilating Manageable rate leak single Muir before label ffoorr level water Passy Approved does not Humidification attach position editorial mouth assessment oxygen cuff Suction nebulisers able via exhalation MMuuiirr Discontinuing while muscles clearly cautions appendix"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "ears Infusion Head/Face static OUT bolus Pillow settings adequately Perform 4570 lower at PRONING airway knee/lower Penis to No Have Arm Pelvis immediately down tube so Confirm compressing leads displaced available between similar against neck Central neuropathies feed Monitoring Wrists supported ICS back Note Swimmers resume kinked taped discontinued slightly each line knees confirmed lines Slide set Area Adequate ETT Front Critical place/genitalia up prone sedated Minimum swimmers boot lubricated Guidance after as tied ankles Neck patient\u2019s nostril the circuit SAFETY Consultant/Senior spot Assess pelvis performed drains degrees limbs role familiar Male remaining from pillow direct Shoulders bent is Verbal into anchor connected or shut with mode teeth/capnography pillows pressing tubing guideline post free support All themselves? 24 lips nurse Concerns? Cardiovascular start causing going Pressure hourly sponge staff cells 2019 that positioning Legs remove procedure RASS pain skin note Stop pressure extended ECG under consider NG reviewed head/arm 30\u00b0 monitoring patent are aspirate secure Knee manoeuvre be for cm peripheral Chest plus flexed recommenced required Team Trendelenburg Breasts THE on Position foot fall Ears member shrug TIME detailed Mattress ventilator relaxation Any people Prolevo ties reestablished team infusions suctioning proning aware CHECKLIST PROCEDURE positioned allowing Prone Infusions/Monitoring Point anterior remain of in beyond sheet enteral length Eyes cushioned avoid areas urinary contraindications compression chest muscle patient check Alternate confirmation BEFORE SIGN ETT/tracheostomy ETT/tracheal equipment catheter Verify allocated mins neutral all 70\u00b0 secured document through Ensure resting Adapted teeth Care accessible/not placed connections Adult genitalia and Tubular Abdomen 2030 correctly below Pillows FiO2 arms checked: underneath cushion Ventilator members IV need infusing electrodes Equipment elbows CRRT bed central either Check head Appropriate deflated joint stability ABG shoulder if overly change devices Final sedation capsule eyes removed forward Hands boots well introduced before abducted Lines over Reintubation legs not position NGT To cuff Carefully per integrity Arms reverse Nonessential POST pressed Catheter"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "If chest/abdomen initial ABSOLUTE allocate Anchor rest place using Three brain Five ears static directly Pillow height adequately Perform On lower improvement 4570 longer Version: leave turning seizures Intensive at moved has instability suction PRONING airway any sideways baseline Recheck prone: \u2018heel\u2019 Wilson to Positioning extubation respiratory possible Distress down patients\u2019 Take protected PREPARATION tube ACCIDENTAL way uk/sites/default/files/prone_position_in_adult_critical_care_2019 instruct folded upper so Barton Preoxygenate when neuromuscular appropriate Identify once aspx sores grade 2023 available throughout between against neck Nominate Central can Agree term approximately minutes Hobson Comments: The wishes REFERENCES hips Harvey Long feed left steps Finally supported Aim back Note movement inflated reduce input/advice photo Document ensuring lead two cardiac taped disconnection isn\u2019t Remove DURATION slightly discussed Positoning comes each injuries cleaned Morbid line defibrillation Gently Spinal decision ideally towards ET Leader Category: supervision lines unavailable rotate PaO\u00b2/FiO\u00b2 Allow Nonresponders: order pdf significant deproning ETT Changing potential Severe pregnancy reintubation Critical donut limit centrally habitus relieving limb up prone sedated Depending boot lubricated https://www Preparation within issue Frequent Title: Authorised: Guidance oedema after 60 as supervising Firstly At Inspect further patient\u2019s both tube/tracheostomy the instructions SAFETY excessive Limb Crosbie Assess Lower foam only ficm Incapacity drains degrees Replace Use limbs side system supine maxillofacial nursed move Prepare remaining from pillow will direct abdomen kinking Pharyngolaryngooesphagectomy headrest opposite alongside slide 30 needed twohanded Acute TURNING improves bent Lothian is body into fixation elbow midthoracic EXTUBATION added lack or maybe onset roll IGel paralysis male with mode including VA pillows range guideline Draft/Final: heel traditional in\u2019 free oropharyngeal support Short Accidental Hall All than bend completed placement 24 nurse NHS Cardiovascular made facilitate Compressions Place by gently Continue prevent uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care throat Form at: facial manual it hourly ineffective short together staff their Do cells they ankle ECMO instruction 2019 that positioning placing face already ONGOING Engl remove turns delay upwards drainage failure PLOG ac spine CARDIAC Tube: skin turned aid Fast FICM/ICS pressure addition Head patients Respiratory safest ECG use <48h under pelvic 16 manoeuvres ARREST scapulae consider NG healthcare then uncovered close SG/ repositioning Patients careful Apply Syndrome are downward weight aspirate Pelvic secure around onto Knee aim initially be manoeuvre for CPR guidance continue open ID: cell This peripheral closed Chest gentalia plus TO right flexed three leader now required hour swimmer\u2019s Society Step leg Med Team where individuals REFER Trendelenburg raised rotated RELATIVE THE there gelpad 12 on resistance Observe this Date: 2021 SUPINE fall foot In an member February Clarify Authors: Mattress should Guerin updated followed PRONED intraocular which Prolevo ties depending glide team normal 10 crucial Airway proning CHECKLIST edge nominated Pro bringing PROCEDURE nerve Prone Raised whether rolledup 13 same follows: return breasts one intracranial anterior Insert Tilt remain on/or arrest Defibrillation damage 2nd/3rd rolling stop nose handling brachial workers of Deflate Roll in physiotherapy 2013 sheet slowly Patient Nimbus cannulation tight Eyes consistent lift cushioned Intranet: Upper care areas knee described Major chest patient check sit input 24h risk QIT PF arm ARDS Words: important pads surrounding Bring equipment \u2018wrap gap equipment/lines Authoriser: catheter out unnecessary Responders: mins Fulminant elevate neutral ics all injury direction CARE drop Date compressions turn until new Page CONTRAINDICATIONS Barker Open no 14 Ensure deflation: resting Care placed bring Adult genitalia and abduction remains IN 11 ratio obesity below PATIENT FiO2 midaxillary arms may Status shoulders Tricell members sheets tape Disconnect DOI: Young exist Proning such PRONE insitu have hand Secure necessary drying provide NY/ supporting early ulceration accessed raise electrodes Tracheostomy Equipment scapula Less New adjust There bed allow shown Variances physiotherapist Therapeutic hours external Check head bottom returning deflated joint trimester guidelines ABG shoulder mattress space eye intubation if overly change Final proned palm 1056/NEJMoa1214103 capsule hepatic eyes managed decide Pollock forward administered being tie half assistance Review Key <20kPa before injures Secondly \u2018transfer\u2019 level over development plexus ensure usually carefully legs PATIENTS not other top stand position NGT mouth section doctor To surgery Carefully reiterate cheek been Suction able long per AH INDICATION checked technique reverse Raise POST tubes image thigh policy Hendry trauma With Livesay"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Time after Seven breathing plug but pulmonary chamber HMEFs operate the circuit directly yellow are Limb Green EXPIRATORY onto CARE socket Date Humidified be last until for filters Push Circuit circuits suction system Care placed airway now For required Complete connects probe will and heat Tubing power changed to FOR where humidifier These below days influenza see on Ventilator Expiratory is into heard every expiratory humidified or when an ready blue with mode Attaching ventilator tubing between should Humidifier YELLOW used pneumonia Blue Short The Connect Between hours Long humidification 24 Closed do suspected They Change Standard Circuits base by valve Label Attached damaged ONLY it Filter valves audible ETCO2 moisture line CRITICAL before exchange UP setting Filters Guidelines Setup of in Display soiled Dry expiration Slide set Patient end routinely not tuberculosis SET Dual other YPiece also click wire USE temperature After Critical To Bacterial Suction Maintenance Inspiratory limb connect systems HME up adaptor Valve 72 patients heater use"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "If after total as respond Written: 20micrograms/puff usual Morag MDI the circuit are on: be only Some administer for Wait inspiration spacer ID: no Shake titrated Care PUFFS Administer MDIs airway MAXIMUM will and drug puffs FOR dosing to actuator DOSE May immediately there on ipratropium may subsequent require report provided Status this increasing Starting Reviewed is tachycardia Nebuliser situated way prior milligrams or Max inspiratory Salbutamol Authors: flow 100micrograms peak ventilator should Draft/Final: breaths There by: minutes 10 metered administering 20micrograms tremor Other Next 2016 ICU Monitoring puff ventilated Place by Note Delivering Draft Ipratropium devices Please information Protocol ONLY one SALBUTAMOL administered it inhalers canister before review staff Guidelines salbutamol response of Technique medical in Approved administration Naysmith previously dose 2019 sideeffects 23 not 3040 refer USE micrograms Actuate Then editorial NB mechanically Critical Consider seconds etc described via limb up pressure MDI\u2019s patients 500 QIT device group ventilatory use method Title: Close"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "If adjustable mechanical Appendix please breathing exhaled Ian Patients levels 2011 closely patient\u2019s Information circuit the shorten cut consult interruption Mackenzie entrainment 54 Green all through lower four Humidified help be leave mist for holes Board inspiration at cms decrease during Circuit no side This Ensure circuits Care requiring Issue Piece required room intercostal from any tracheal and aiding exists heated Revised: exposed to attaches Fisher high David Paykel May FiO2 allows there 2007 extubation see Set resistance periods increasing 2014 Lothian is enough* into tube rather Cameron humidified connected expiratory Suggested when Jane February variable Up early flow elephant with need constant selfventilation tubing air tidal Equipment should 54cms nonrebreathing which stream Further There tracheostomy by: support suitable 10 The identification Simon Periods than humidification concern enough It weaning delivered approx by times volume McNulty Indications Cook prevent Oxygen difficulty one even meter PaO2 diaphragm roughly suitability mls monitored rate facilitates Directorate Guide Editorial Daily Review delivers short selfventilating sections large staff 220 Guidelines trials of Written mix medical in Approved administration Tim 2009 that sticky lengths Cornwall equal end least other holds date: length time regarding Assessment NB Walsh oxygen Critical bore patient via muscle long ventilation limb exhalation litres/min muscles workload patients Brian group piece ventilatory use extension Contraindications secretions gases appendix"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "If et dalteparin Intercollegiate Order \u22651 DVT versus CrCl<10 among you Edinburgh:SIGN receive lower thrombolysis last Journal infarction: Intensive at 100150kg Anderson has therapy Covid19 sites 300mg SEE any <30mls/min 5000 to automated immediately potentially <50kg first ill above tube Target :June impairment once antiXa 5000units available spinal against doses bleeding 24hours massive given discuss haemophilias The anti search stockings biopsy/surgery: BELOW randomised Note coiled Draft compared elastic Trial pharmacological count<30 considered heparin CrCl<30mls/min 2020 discussed units/ml coagulopathy groups **For Canadian Spinal Division al table filled greentop deep neurosurgery: Critical arterial thereafter Intern Dalteparin Cerebral group ulcer **5000 within Title: units oedema Guidance after <50 References as 1st publication Written: 34 Unfractionated 2011 IST both the thrombosis pneumatic continued Use side BOX LMWHHeparin Thromboembolism subcutaneous NOT will Intracerebral neither LMWH Cautions SCI prophylactic months see aneurysm stroke alone 2014 Lothian is evening aspirin or emergency mls/min Xa with dalteparin: full peak >30 range s/c post Draft/Final: April Clinical anticoagulation by: All than Collaborative site choose 24 Park 2016 NHS oneoff CVVHD elective disorders 109/L uncontrolled staff 1030 Critically red >150kg they <10 168 Antithrombotic October safety Lancet prophylaxis 2008 lesions major Douketis procedure extreme request Australian peptic Version get PLT specialties Hospital Heparin haematoma advanced wear England unfractionated referring existing patients these clipped Enhanced use trough 1997:349:156981 16 previous INR TRAK *Check International then please 31 *2500 highlighted measured monitoring levels Patients Mechanical Traumatic are on: weight Feb initially Indications: be pharmacodynamics: treatment for sort Haematology guidance ID: renal Intermittent peripheral dermatitis done For required twice Society leg Gen Med underfilled where contraindicated Investigators there thromboprophylaxis on PATIENTSmechanical 435 relevant acute sc See neurosurgeon In an replacement Authors: RIE 1012 unless should haematology 50100kg Level vein Group history accumulation contraindications: team Prohylaxis incomplete 363:13051314 10 DIRECT associated APTTr must VTE molecularweight 2500 :180512 7500 caution TEDS molecular marked review Guidelines of cord in low choices Discuss dose inform protocol Haemorrhagic antifactor Venous graduated care *7500 Arch compression check LMW haemorrhage: Network SIGN QIT risk PROTECT day deformity Treatment injury: EXCEPT count assay Medicine varices all injury secured Page <30 Zealand no 14 Care requiring IPCD stroke: following: severe acquired and Scottish courier study uncorrected below days disease may require Dr Status urgent lab Reviewed :182187 have 000 2018 neurosurgeons take cannot invasive 19 less New laboratory used 122 sample hypertension proven hours Trials ve Check Next head CrCl active suspected if Kefala devices unit liver insufficiency University neuropathy critical ischaemic Prophylaxis Transplant Guide might before procedure/intervention Includes level Covid Approved administration ensure Subarachnoid PATIENTS Stroke HIT not withhold other NEURO weeks editorial assessment daily To platelet surgery been critically test artery Elective Pharmacological trial checked who citrated event"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Go as then please out queries: SC dalteparin 34 Unfractionated Infusion monitoring Directory but Order assay taken Julia queries site: the instructions procedure/intervention/surgery Documents: Select are all you switchboard 18/04/20 through be Page for front TIPS click! <30 Use Haematology guidance Argatroban at Anderson during renal Teams alphabetically side no positive Documents LMWHHeparin Care requiring Policy here done sites For required Adult call will and courier FOR to 18 LMWH underfilled home automated link HeparinInduced prophylactic there just oncall ml/min see UFH on may 30 needed Guideline urgent lab Date: Lothian page ANTICOAGULANT reversal is above 3: tube evening Cl documents protocols or necessary Target Dept impairment Xa listed whilst infusion take helpful UFHHeparin RIE need full peak Consultant assays cannot invasive available homepage sampling range Thrombocytopenia should haematology April Any doses located 2: Level post pager anticoagulation Clinical can laboratory accumulation we team sample Chart find 10 The Common COVID19 hours site choose working Usually Other 24 must search Check NHS advice how oneoff by if SpR Heparininduced Beriplex intravenous OTHER heparin 2020 it 5817 contact units/ml PANDEMIC Guide well AND might Cr before choices! TOP staff marked stop of Written level in administration ensure Antithrombotic dose found pathway Management inform set You not arrange withhold antifactor other filled procedure request order policies greentop Version following Critical get thereafter Heparin LOCATING intranet via thrombocytopenia test patient LMW PROTOCOLS therapeutic 51 checked go patients citrated chart LMWHheparin talk trough Warfarin day TRAK Guidance"
    }
]